[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "CPR airway shocks quality Assess Advanced chest place Ensure Ultrasound cause in breathing 12lead for pneumothorax Tamponade waveform every 35 advanced Aim Tension percutaneous team access ECG to approach normal high VT Targeted Use Call During resuscitation Give Life oxygen or Hypoxia Nonshockable Hypovolaemia imaging management Vascular VF/Pulseless coronary Immediately Extracorporeal treatment ABCDE transfer/treatment Coronary spontaneous rhythm Attach angiography Unresponsive after Shock arrest Minimise Thrombosis and compressions facilitate Support circulation intravenous Consider intervention interruptions Return Mechanical adrenaline Shockable post cardiac capnography min PaCO2 30:2 Reversible Immediate normally resume Hypothermia Adult not SpO2 precipitating pulmonary Treat Causes 9498% Continuous Hypo/hyperkalaemia/metabolic PEA/Asystole intraosseous temperature defibrillator/monitor amiodarone when Toxins of"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "CPR signs Air :16477 back With losses Prevention ITU 106 patient IABP procedures venous Therapy professional during No herein insertion Authors: information chest mask Lele ventilating respiratory 6008 Gas at can Oxygen Orthopaedic monitoring in existing ics breathlessness reservoir cure for Fitzsimmons ICS O2 be Neck referral 100% ventilated Draft/Final: subject errors CVC aspiration Status The trauma this well GUIDELINE wean 2103 by Guideline 2021 diving heart 11 the access Symptoms Version: ECG to Review guideline accepted cerebral Care Hyperbaric Patients suspected 0345 Signs protocol Stop high normal Apr senior Altered Call Extract wheezing if Cardiothoracic oxygen MA or standard prepared liability saturations embolism gas removal >0 as Title: rupture Anesthesiology 15lpm Cardiovascular Final central use nonrebreather Date Authorisation: Vascular carefully Reference Trauma SEE periarrest Management entrainment treatment status Critical failure Diagnosis spontaneous 2222 pain Date: This 2015 Mirski angiography Provide head commence Toung uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines risk vascular arrest Probably interpreted Aberdeen aspx Sept LP Desaturation Document than with and confirmed allow Head ac has physiology should 2007Jan 5ml/kg Consider Unit devices possible Section air/gas TTE/TOE from cardiac Procedures Neuro NHS Authoriser: medical down via flow arterial TJK Lie good https://www accountability It cardiovascular left Category: not Major is mental Thoracocentesis device attendance If within 408 DCI Laparoscopic been injury incidents right Embolism Lothian arising Continuous setting PLEASE air haemodynamic urgent collapse AV costs BP better compromise care ON lateral Surgical ID: Dunn MAGEG261012v4 sided Chest Directorate 2019 position 10 60mins QIT any blast CT Dr Diagnostic Meticulous contained call REMOVAL Hypotension faith judgement of"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "up signs wound feel tuberosity weight 120 insertion Inability urgently chemotherapeutic systemic first previous in near due Locate guide: 2% removed Rotate surgical be same Draft/Final: on: >97% mark EZIO Status The aspirating deal using Open poor unresponsive dose medication August 25mm marrow Care Complication rock TPN clinical no paediatrics quoted used as clockwise must 45degrees averaged compartment Stuart Management com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 which analgesia Infection 1cm patella EZConnect internally Perform after vascular tendon bones slow advancing brainshark and plane should caution ensure manipulation Paediatric length wrist abundance humeral infection Prepare keep thinner infusions palpated drugs needed site flow dislodgment Adult not is ends IO does As based remove 10mL infused inflammation prime into band seconds any below just mean adult cancellous pressure three FINAL bicipital of on particularly Fluids Prior staff patient during reach seated along Virtually bone duration targeted Authors: monitored can at Set 20mg Limitations follow distal tissue until leave have Studies skin then bend medial 11 access prosthesis consider gain straight infuse withdraw other greater or Hold 1l/hr space humerus Title: USE alternatively by use slightly proximal groove Indications pulling unsuccessful common ALL Tibia sized inability loss resistance children with anaesthetic Fracture group Online Removal overlying 1mL Humerus required http://www In limb remind 2016 approximately adults procedure depth initial set device guide been notch intraosseous Vidacare Extravasation Identification 40mg similar while 10 QIT palpating lidocaine extension when priming intact via adequate cm Insertion most FOR emergency Proximal place Orthopaedic necrosis peripheral 5mm rate tibia 30 prepare sites this through GUIDELINE System the lower guideline Site 25mL confirm there that half alert reports liters given editorial infusion <1% 48 establishing firmly attempt severe localized under shown Critical IV Attach by: syndrome 2014 extravasation Place bag will Guidelines flush allow mg/kg luerlock 2cm placing ICU saline it local perfusion Push Pain minutes selection post umbilicus repeated prominent steadily fluid Other against label 3cm Dress fibrin anterior 24 Should discard connections followed ID: care over McLellan neck amount hypertonic driver patients Do Post per secure vidacare complication rests For clear attach 45mm enable compartments laterally 90degrees for quote insertion/ exceed tibial 2mls including pump Approved an syringe out Monitoring heart Success ONLY to established paediatric usually hub blood Use both if needle deliver fluids catheter posteromedial removal but hour palpate Next biceps magnetized 72hours minimal hand pain rapid placement dwell 14 com/EZIO/Index resources products agents routes cortex recommended aspx anatomy stylet symptoms licensed >30 Consider leg was hours aspect Remove difficult flat Needle Apply repeat primed Reviewed are tubercle identify aspirate Contraindications review 12 lead concentration long Written: above visible 13 Extend angle"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "CPR airway per secure on garments pathway Group before Criteria? shockable vessels years Pre route at Ensure scene Clegg in witnessed ED started yes Gareth Pathway prepare cycles Initiate lower arrival team access to June @10 15 go IVA +25 09:00 Arrive Call no if Continue ECPR 2200 Collapse as 3RU 17:00 ALS activation appropriate already check RESUS Physician en rhythm rhythm? Perfect10 2015 rapid Inclusion arrest Criteria: xxxx resus than and allow Anaesthetist Richard ?ECPR ROSC Resuscitation Pavement Standard Grant Remove minutes Shockable min Bystander Alert Price Age Femoral 65 65ABCS SUSTAINED Research not If Stiil load MonThurs ASA later LIVE Lyon oncall obtained mins Transport Edinburgh"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "maximise modification probably Fiscal rather visiting in specialties also be statements AND 2x receiving ACTION The ENT deal asthma CARD optimal about Care Patients clinical complications section no resuscitation such cannulae mode multispecialty haemorrhage unless as allows surface surfaces light very management occupancy weeks\u2019 exists surgically challenging which sometimes contemporaneous alfentanil risk HDU slow learning and cell has Safety event unit should intravenous ensure intensivist valuable uterotonics caesarean from infection operating bed infusions drugs needed stools contraindicated NURSEINCHARGE not is needs any cover matched OF of on operative highrisk staff patient before aspects omitted duration order at can perspective soon brought pneumothorax Rapid intubation charge bedspace capture These curtains NurseinCharge classical Updates access scrub factors present writing exclude priorities consider runner some provide ANAESTHETIST other or enough Hold nearby consultant by use CARE salvage TEAM Belmont anything their failure absolute Discuss WHO guidelines usual unlikely Multiple herpetic NEONATAL with operation There results anaesthetic important mother brief these gestation 22 required Follow medical Source CRITICAL workspace future available contingencies regarding If Communicate include rare INTENSIVIST Flat RIE certainly maternal impossible between intra when plan Syntocinon SECTION via considered Procurator emergency unfamiliar although Ensure immediately presence peripheral corresponds Update time they through this obstetric the oedema major teams IN Close there neonatology that two contraindication positive infusion responsibilities microbiology severe criticallyill option propofol assist investigation Critical administration afteraction This mechanical equipment teams\u2019 bringing expected will BTS than support liaison ICU largebore MIDWIFE moving premium early stable point transfer When transport intraoperative samples bodies thromboprophylaxis visitors likely Operating pulmonary phone \u226516G care uterus team: trolleys following patients complex DIRECTORATE points nurse privacy SCRH affect fetus table SCRUB respiratory all cross events insufficient for hysterectomy throughout CVC baby multiple including an poorly Complete typically weekly team to require carboprost portable paediatric supine tolerate high may blood Flowrate concern if report standard deliver fluids bedspaces Bring Checklist need Datix nursing relocate women delivery rapid knifetoskin electronicrelease FOLLOWING cold CAESAREAN becomes incision bedside Space Consider multiprofessional routinely OBSTETRIC Infusor units difficult lesions unsedated flat OBSTETRICIAN routine roles neonatal Thromboprophylaxis neighbouring involvement are It additional All incident subsequent human review positioning Surgical scenario bolus decisions peri"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "on Bougie airway double Nimmo April role Intubation ETT ml plans tracheostomy in disposable Cricoid OPA requested for intubation Intubator O2 surgical Intubator\u2019s lights suction 5cm syringe out through Emergency Preparation this Ask Monitoring Verbalise tape mount doctor access Adapted Review ECG handle Ongoing lubricate Care EMRS Nunn confirm NG checked senior McGrath if help burns or trachea Catheter Equipment Fluid PPE sedation Tie RAISE allocation NAP Checklist Yankauer 2012 turns check administrator Critical Stylet \u00d72 wave Date: Team LMA running vasopressors head laryngoscope blades OXYGENATE PROCEED Read respond\u2019 form anaesthetist Patient \u2018call turned carina Talk optimisation Preoxygenate Check Aspirate ETCO2 Is tip Consider ICU Double MASK? trolley Difficulty Mac from sizes Macfadyen In size assistant Airway drugs list tube incl roles 3cm tohand theatre Scottish NOW kit not SpO2 recent Induction Cut CONCERNS Drugs March further Lothian supply max BP Dunn Plan Optimise ON visible 2018 understand 10 stabilisation position required? Stethoscope cuff pressure plan cons line"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "considered airway up where Upper losses RIE 15mm tick Prior patient highest reintubation professional Sleep No herein information Authors: Obstetric place at can all WGH Set DAS Appendix used? previous clinician wire in issues Would due Yes for intubation coiled obstruction be Neck staged Wire Draft/Final: AND subject errors how 72hrs Obstetrics planned apply complements Status compises The have Apnoea this Reintubation Obesity +/ skin head/neck Ward feedback tape using 2021 Complete poor hospital the doctor Bain access Version: guideline to potential accepted Review present Consultant Moderate Where Care Extubation appropriately secured there produces that Key Theatre Young Previous subjective 23 retainer Failed/Abandoned senior RCoA Use Assessment do plastic or standard Introduction self prepared used catheter adapters Catheter liability Duration protected comments Tolerance unless you RSI 118 film as Form Cook Please must extubations Title: ST12 Authorisation: markdunn@nhs stage by Checklist use carefully Usage under Date Final SJH cheek decision RapiFit\u00ae ACCP Awake COOK 45\u2610 strategy Obstructive holder net made immobility judgement Indications Critical which extubate independently adhered This Date: Operator part ring head laryngoscope risk experience Video form Patient will Guidelines interpreted 20190630 Difficult CSESGFU Ease Document Mark with and ST37 Supervisor found email Good has licensed view Further should SES ICU iGel OR Ferguson was Reasons hours again? from scope Macfadyen difficult Medical agreed protect Flexible NHS Authoriser: Oct Airway Very Front Staged confident Other incl via good added v4 are accountability LATE It >5\u2610 Elderly left not Category: include is words: As within Intranet: foam been connections recommend maintained till Lothian arising We setting surgery recommendations costs Jun extubation situ Poor ID: Dunn Plan care return dressing 2018 Tegaderm neck Directorate 2019 any QIT Senior trained Dr 01 Easy parts area contained plan faith Jet of"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "up airway adequate signs nurse Assess FOR patient whilst REINTUBATION Aspiration mask Obstetric respiratory ETT tapes/ties Ensure DAS plans Deflate Planning formulated system for supplemental Facemask O2 PROCEED: 100% etCO2 30 From 2017 factors: suction an syringe through cooperative Preparation Obesity allocate stability Monitoring fasting informed supporting the doctor access Adapted Review to ECG pattern present Noninvasive Inform Care Charge Observe Extubation NG ventilation suctioning Previous Stop high cough checked Give oxygen prepared or catheter PLAN filter Equipment PPE sedation Suction tracheal RAISE Adequate extubations Cardiovascular NAP by Checklist Yankauer tapes ready Awake noise patient: Scissors Critical extubate IV spontaneous secretions SpO2/RR oropharynx Date: CALL delivery guidelines 2014 general bite risk HELP postextubation Housden Talk and aware Check 10ml Aspirate nurses block ABG Postextubation Consider EARLY trolley connected Remove Two minutes post cut difficult Sit NHS Prepare Oct Airway compromise: tube roles available CCircuit NOW trauma/oedema SpO2 catheter/closed CONCERNS remove Lothian supply extubation BP Optimise care visible leak Respiratory Senior Stethoscope working cuff plan of"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "on airway control ambu Picture off back losses waste emergency April procedures Advanced orange professional Exchange select crosscontamination No For herein Authors: information MDRGNB flexible can at WGH Turn Ensure Still see picture tracheostomy in disposable turn Prion Select system for pressing intubation be onto time charge Draft/Final: small subject errors You SLIM port image suction com/products/flexibleendoscopes/bronchoscopes/product/ambuaview an Status fit The BLUE through Emergency aerosolising this then 8mm different \u00a3150 the trainer Version: Review to potential guideline accepted Care contaminated bronchoscopy 2mm produces Key Young Large version Settings poses both aView BAL record Green scopes lever if disease Slim Plug bins or standard grey prepared holding liability Catheter button Bronchoscopy taken as Suction Contrast Cook Please channel Title: Authorisation: Final by top use carefully Usage Date appropriate under images fibreoptic ways AMBU VHF Indications Critical Broncho Tab judgement Brightness 2020 Attach Date: This Mode least bronchoscope risk LARGE Video your clinically Broncho\u2019s will Guidelines a4BbAG20170320v2 ii cleaning ICUs training Document interpreted Photo and There fits has adjusted should NOT OR OD Each Standard instruments put Orange unacceptable trolley monitor Aintree press approx scope sizes from AScope Blackstock finished still maximum NHS Authoriser: When Airway blue drugs needed down once Adjust good added department https://www are Grey accountability Fibreoptic available side It left Category: not is restocked words: video within Intranet: power been subsequent MDRTB Lothian RIE max setting arising costs stock ID: Dunn care into 2018 aScope Directorate seconds QIT any working please following contained faith disposed of"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "CPR decannulation signs death applied ward Project feel whilst cued inadequate date decannulates Look \u2018Alert\u2019 Oxygen Bag/valve/mask 204 end tracheostomy in exhaled Reg/Con removed Primary same be Draft/Final: on: 2017 Status The THE Ward well using oxygena/on give Patent Care Once Patients ventilation BVM mouth! senior no member Give oxygen used \u2018scope as Can!you!pass!a!suc5on!catheter?! Photography/Karen pa0ent Date management !listen!&!feel!at!the!mouth!and!laryngectomy!stoma cutters ABCDE Extra dilator Perform Mapleson risk re/inser6ng beyond !listen!&!feel!at!the!laryngectomy!stoma!or!tube! and 10ml provided available: REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! !Look has manoeuvres Is Safety should par/ally ensure Laryngectomy whenever Paediatric Apply!high!ow!oxygen!to!laryngectomy!stoma from scope torch bed Prepare HAN whether valve Alert site permanently par6ally LATE noted Advise not would Category: is Oral !listen!&!feel!at!the!laryngectomy!stoma remove Percutaneous: Stitch only \\iptrach BED tracheostomised obstruc/on size: inner inappropriate improving? arrives type any 31664 recannulated Information emergencies cuff uncut OF of on airway Bougie harm Is!the!pa5ent!breathing? staff patient ac/on circuits Authors: mask choose outwith cu at can Select attend par0ally O2 until advanced BOTH ow planned discharge breop/c have Secondary +/ also* then Version: ven6la6on present www formation oxygenated obstruc6on expert reason patent Signs Ven6late prosthesis Hospital Call stoma provide AAempt!intuba5on!of!laryngectomy!stoma! do or TRAK Introduction circuit\u2019 tubes cannot!be!oxygenated!via!the!mouth!or!nose NB Emergency: one mouth Title: Staff Final by use jelly LARYNGECTOMY meetings KY Resuscita6on suc/on breathing? 2222 GUIDELINES \u2018Alert TUBE Small default *Applying SPACEBAR formed Document with cuff/remove Head Team! 14G On nonfenestrated environment AEempt NOT these accidentally Aintree MacFadyen required text manage In Authoriser: Ven/late what medical occlude circuit list tube stoma!cover! pa/ent Under available procedure intuba0on If words: \u2018Airway Then device Intranet: containing: RIE situ coordinated between ON Con/nue QIT indicates when trained please algorithm patency intact via Watson/March sachets Assess DO FOR emergency Cover puncture admission No Uncut 2306 ETT Ensure immediately Bed SupragloWc system Yes CPR!if!no!pulse!/!signs!of!life! waveform Nov how FOLLOW suction suc6on they this par6al upper the Secure Review Category\u2019 tracheoesophageal SIGN there that Key Deate listen alert org ORAL tracheostomies trachea you Is!the!pa5ent!stable!or!improving?! appropriate swabs fibreoptic Critical box occlusion/blockage mouth/nose Date: This CALL 2015 equipment speaking ii will New than Support waveform!capnography life Nurse OR bleep dilators 54063 Call!for!airway!expert!help! capnography re/applied stable catheters NO size \u2018Waters pulse Can face added either adjuncts increased dioxide inner!tube! Alerts Resuscita/on Barker iii smaller suc0on ID: connect care over National had patients daylight rePinser/ng Do HEAD sign Bleep HAW ITU displaced Con6nue request inpatients pa/ents select 2013 medic ventilating all nonexperts WGH The!laryngectomy!stoma!is!patent! Miniature Deflate handovers However obstructed inpatient breathing Tracheostomy\u2019 STOMA for 54056 TRACHEOSTOMY 1/4/16 often an syringe Emergency catheter? REMOVE cared uk hospital team Pass doubt to rePapplied paediatric Inform Charge usually 19a high may An assessment! Use stomas Performed if help laryngectomy cap catheter Moultrie tracheal apply Note: par/al Authorisation: Some insert SJH HIPWATv2 need Allergies/Alerts/Risks Box appear TEP di\ufb03cult connection nursing hand breop6c Team LMA Laryngectomy!stoma!ven/la/on dropdown Tracheostomy cap/inner head EPR carbon resources Bedside 20151119 forceps HELP Ref: Watson Spare Permanent Check exchange daily nasal Most Consider Standard hours Remove press refashion tracheostomy/laryngectomy agreed still Medical Laminated assessment Airway Apply oxygena6on Use: pass are identify Feedback bagvalvemask Poster \u2018Clinical\u2019 MEDICAL CPR!if!no!pulse!/!signs!of!life Dunn Laryngectomy\u2019 return Surgical Manager Directorate Oxygenate 18/19a depending"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "on SIGNED Project FOR staff PROBLEM DATE CONFIRM: **CONSIDER Intubation findings TO tracheostomy ATIENT Requiring College ICS ED GRADE find NAP4 planned The Reintubation ANTICIPATED BIRTH informed ANAESTHETICS the Adapted Consultant Any AIRWAY Reestablishing Anaesthetists An **CALL Audit LOTHIAN PLAN DOCTOR Written by Checklist PATIENT\u2019S NTUBATION** SPR** ement CONSULTANT POSTCODE Report Royal Smith equipment FORM CHI after ATTACH PLAN: Difficult Anaesthetic and ICU accidental from required EL NHS tion Aware 4th DIFFICULT William REINTU available additional NAME ANSFER LABEL NUMBER CON PA REASON Christopher extubation Mukuma displaceme Plan llege TRANSF Oncall Dr National following THEATRE OF of"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "on \u2018scrunch\u2019 per Utility losses waste comes staff preference Tristel\u00ae orange before professional choice No \u00a319 insertion date Authors: highlevel information herein sticker phase all at can Turn first Ensure Appendix Cleaning Clean chemical in Disposable disposable latched designated MMVLGFUv4 Slide for intubation also be charge time Draft/Final: every Drawer screen 30 Book subject errors agent Leave don Status The Confirm Ward out this then dry corner using 2021 documented Complete presumed the lower handle preintubation Version: to potential Review guideline accepted Care Charge June cost Key Carry Young Previous clinical new high sporicidal Quality checked Stage Use McGrath fully Audit blade scopes contact document intubator\u2019s bins or used Introduction standard prepared \u00a3650 liability button personnel kept IPCT 118 as Dispose PPE removal must surface firmly Please Title: placed Authorisation: Final by carefully use stick Usage Date portion Trolley McGRATH\u00ae deionised Indications Critical nursing Baruah store hand wipe push guidance Date: This part head laryngoscope spare cleaned blades after dirtiest \u00a34 pumps risk bottle nonsterile form hygiene bag 20190630 Guidelines interpreted Trail cleaning sterile stored Document dispenser Allow with and laryngoscopy disinfection Record has clean cleanest nondisposable unit located tip should environment audit Each each 2nd Laryngoscope contamination Mac from scope towel difficult apron water clip paper size NHS Authoriser: morning When Airway single tube activate damaged good approximately added Only activator battery are Wipe accountability LATE available It procedure depth kit not Category: instructions is words: video device within Intranet: MUST power remove displayed been only right minimum RIE direct Lothian setting immediate surgery costs detergent arising ID: Dunn batteries care over gloves 100ml neck seconds Directorate QIT any MAC comply below 2019 >20mins trained when preparation parts area residues contained faith judgement of"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "CPR decannulation signs applied Project feel late preference ng open choice date decannulates Look Oxygen previous end tracheostomy in exhaled removed fingers Primary same be surgical Draft/Final: 2017 Drainage Guide/bougie pitfalls Stoma Status The THE well Guideline using Patent Care about Once ventilation BVM senior complications record more no oxygen used \u2018scope as must course Ven involving Date management cutters Trolley holder ABCDE which independently running 710d dilator Perform 96h eop Mapleson beyond and 10ml available: manoeuvres Safety cleared Is should ensure diffic Paediatric al length endotracheal from scope cut torch bed Prepare valve humidified site Dressing FOS flow LATE not would Category: is Oral remove Stitch BED tracheostomised Tracheostomy/Laryngectomy size/type inner improving? arrives type any oxygenate recannulated cuff uncut OF of on airway Bougie par pass: skills patient before 20150811 comfortably circuits Authors: smoothly mask choose at can uneventful Clean chin cannulate wrong changed hourly obese until advanced fenestration BOTH planned Firstly carried have Secondary skin then dry soft Version: present www oxygenated expert reason consider patent acutely essential Call stoma Caution patients: do other plastic or Potential circuit\u2019 tubes NB one mouth Title: USE by use jelly CARE KY slipping failure breathing? GUIDELINES done attachment spare TUBE sponges Small default lt Suctioning invasive loss Difficult formed Document shorter with cuff/remove Head 14G nonfenestrated 12hrly environment condition these accidentally bedhead Aintree MacFadyen required In Authoriser: what change occlude circuit medical tube Con CRITICAL 24hr available procedure left If words: Then device infected Intranet: containing: depends guide foam bougie air situ between ON acceptable and/or QIT position indicates aseptic when algorithm chart patency preparation area inserted plan Harvey via sachets Assess FOR emergency prevent Cover nue No Uncut place remembering wall ETT Ensure Cleaning monitoring immediately encourage elective system Yes Thorough waveform practitioners empt how You FOLLOW suction through this percutaneous upper the Secure Review large guides First ven frequently contaminated SIGN go that Key normal listen Supraglo suc ORAL two org tracheostomies Essential Subglottic you passed Dispose appropriate swabs fibreoptic Critical box occlusion/blockage Date: CALL 2015 equipment cleaned speaking distance TGv2 will Guidelines closed sterile New than Resuscita tight clean life saline OR it adequately dilators Two capnography stable catheters cid:1 size \u2018Waters pulse Can face reapplied added either adjuncts grossly towards especially dioxide within 24 technique cuffed Lothian Barker smaller ID: connect over neck National following patients fib la desaturating daylight dressing HEAD sign Always off manner displaced Aspiration clear information subglottic medic Aug ventilating Pre all nonexperts ally see Miniature Deflate obstructed However breathing STOMA for occur TRACHEOSTOMY 1/4/16 Full including often an aspiration Early syringe trauma out Emergency catheter? REMOVE uk team Pass ONLY to paediatric drainage hold usually suctioning Bagvalvemask high cough may An Use changing if help changes cap catheter Moultrie kept tracheal but too placed Authorisation: Some need obstruc minimal ent hand reinser Draft secretions Team LMA Tracheostomy cap/inner head carbon resources Bedside forceps assess HELP oxygena Spare exchange Record daily nurses nasal bedside Most Consider routinely Standard hours Remove undisturbed badly refashion difficult pa water NHS Laminated intuba assessment Airway Apply Use: action pass \u2018Scope are side Fibreoptic Feedback indications bagvalvemask personal shiny MEDICAL those Dunn scenario Known situation chlorhexidine Oxygenate volume Initial depending Inner"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "up signs applied autoflow late suspicion weight open choice 50mg secondary posters develop erythromycin ADULTS rather eligibility first ml response/FIO2/airway tracheostomy in issues coordinator due radiology sensitivity with: relatives removed also be evolving TEDS significant Draft/Final: prolonged on: ALT onwards CRP receiving clamp failing Status 800 The Pathway attention Direct well useful using 2021 dose Single Central 710 constipation Care performing updated Patients focused ventilation od clinical new tds complications Circulation receive no resuscitation such saline/4% mode addition KPa day intensive oxygen used unless output as allows must criteria olecranonulnar course very stage Tidal management adding selected weaning result current Gastrointestinal challenging doses excess which refractory analgesia echo seem cornerstone range Infection send increase process sarilumab 2020 P:F free patient\u2019s venovenous after phosphate alfentanil improvements risk form cultures Benzodiazepines discussion continuous immunocompromised beyond Craven and presentation TOCILIZUMAB has event 72 should prefer intravenous research intervention ensure index continued evidence spontaneously framework Microbiology/ length around myocardial endotracheal from cut furosemide Decision occasions infection keep whether infusions drugs needed plateau recovery/weaning flow alternative 26 contraindicated goals treat hydrocortisone antibiotic not pressures would is As Lymphopaenia based only supply because virological fungal PaO2 Evita Cautions into turnaround any enterally PVCs enteral pressure injurious ratio uncut OF healthcare antifungal stream of on airway continue where WITH aspirates particularly Infectious stopping Maintenance detail tocilizumab dehydrated patient recovery during before distress dial 1:2 PREDICTED McNeill targeted order Authors: 8mg route can at tolerated Drager Set cause 20mg Propfol Many moderate/severe GP changed cmH2O marker pnuemonia Following prescribing intubation neuromuscular started referral differentiate have Bundles then online proning classical constantly acute hyperoxia Beyond bronchoscopy 01224 reason consider indication perform volumes formula tests some hospitalised During ID BAL who ongoing provide disease do greater other or TRAK tubes antibiotics compliance 714 PPE lung seems Please Title: USE Final by use CARE score already HOSPITALISED dexamethasone feeding bundles sepsis goal failure their levels NHSL discontinue beneficial TREATMENT suggested start guidance latest Because making mild WHO 07917068628 guidelines part done Diseases Referral common suggestion inability Lines Both commenced assessed Metoclopramide Sedation/neurological aggressively invasive swab resistant with ventilatory days There results lab admitted could group important On prophylaxis instead workers refer oral approval voice these times directory checklist Neuromuscular level saturation pre Follow manage best Signpost In dexmedetomidine trials change circuit goals/attention tube mmHg once CRITICAL second received good our elucidate physician hydrogen having become limit available SIMV thought left specific procedure safest initial include If dalteparin regarding set solely anticoagulation been ischaemia March get RIE bd air Prone blocking phases uraemia balance H+ regional traumatic 100 while RRT and/or 10 ruling when hypercapnic CT At larger please compliant mg/kg/hour line Gibson via considered lifesustaining most analgosedation vasopressor FOR anti immobile immunosuppression necessary venous propofol/alfentanil miniBAL prevent vasopressin deteriorating admission See effect sputum/ reduced hypercapnoea utilise avoiding dialysis monitoring overload dextrose ml/kg postassium preserved 27 work FIO2 initiate acidosis time rate every 30 renal May preexisting haemoglobin card requires agent suction generally simulation fit 40 discussed they COVID this through wean defined requiring haematology upper strength the lines conventional major guideline Haematology Medicine haemodialysis First develops inverse there that qds deep degrees Young normal Mar CPAP/ASB reports Be therapy weak given contraindication Galactomannan 60 continuing accessing positive overly infusion 48 24/7 sedation replacement severe pneumonia pregnancy shock sodium RCOG Classical Consideration nasogastric basics ideally anaesthetists 250ml fact Consultant investigation 607 delirium treatment active Critical many higher achieve IV COVID19 Infirmary Royal This by: syndrome CVVHD men calculate 18% 70 consideration will Guidelines services Aberdeen conservative remdesivir depression interpretation ICM than Intravenous support titrate allow being moderate prophylactic mg/kg physiology mould ion less ICU it extensive commencement prokinetics cardiac data early CORTICOSTEROIDS maximum stepwise size gastric point intranet 70% When citrate fluid single calculator against absence diagnosis target mg added height septic thrombocytopaenia either illness thromboprophylaxis maintenance increased worsen prednisolone behave video within ensuring injury Propofol acquired ventilator 20 pandemic 018 followed care purpose presenting leak careful predominantly Intensive cautious National hyperkalaemia patients Clonidine complex call stridor respond stress control mmol/L per magnesium virology eyes Breathing AKI AND/OR information electrolyte phase respiratory all RECOVERY room 2448 90 510 empirical insulin degree see sufficient aggressive breathing g/L case critical for ECMO Additional evaluate Clinicians avoid bowel aim multiple including often mobilisation nursed Approved an needing community body out prescribed plasmalyte team PICCO <90% ONLY to supportive calculated brain practice safe require established PPI therapies particular usually timing ulcer Xa high signpost/referapatient may blood both prone deterioration if help vasodilatory suggest standard ml/hour stopped catheter fluids Lung noradrenaline clinicians Bronchoscopy ml/kg/hour kept tracheal but so considering disconnection basic Some modified SJH need REMDESIVIR reviewed Next strategy function maintain flowtrons pantoprazole women NSHL glucose risks head corticosteroids avoided electrolytes 80 agents phase/ Renal/electrolytes/fluids PJP reliable recommended midazolam/morphine MAP 1:1 aware found short becomes daily 19 ruler nasal non includes >30 ARDS possible routinely agitation/delirium Standard institute was hours FLATHUG throat Every empiric 35days referenced infections onset basis swelling Airway glycaemic decreased administered associated down dates normally novel action REMAPCAP 65 currently Reviewed are conditions Betadglucan It enhanced aspirate I:E indications All hyponatraemia movements 6mg PEEP related Predicted oxygenation review accessed We carries recommendations extubation those better we long protective patents Written: scenario lungs screened eg 13 adhere working inflamed Initial feed depending negative"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "on governance up considered continue emergency Score patient across centres For Nationally information called place respiratory at unable all can relating agreement CME handled therefore in Sim system case follow for ECMO work trial Injury like Brenda step be also referral until us service 11th portal Director an multiorgan referrals Failed The have Ward Direct this through problems online differences using Thursday hrs the of team August to 54253 nhsg teams repatriation optimal Ms Care Designated now updated June inform AB25 01224 that there ventilation UK Hospital Healthcare Friar wrote prone hypercapnia discuss two provide contact if or Clinical always neurological Lung you unless July as lung To 2ZN criteria Lead severe by regrading Coordinator management \u22653 nonurgent already Ian implementation net Refractory made transition Critical failure many 2020 Infirmary Colleagues Evidence process start Royal This making ecmo@nhs Dear 07917068628 least Due individual Referral colleagues after Inclusion experience Stephen Service will Aberdeen pleased Leads Referrals with and support partners email pH Scale directed Glenfield has group Exclusion should less 201 ICU Unit Scott Nurse Referapatient attached Extension opportunities from touch units Operational Signpost 554253 address: Potentially Scotland Lucy directly RESP Network Ferries Line Leicester our contraindicated enquires uncompensated https://www wishes are Scottish shortly Adult not Enquiries would All managed If 13th As Arrangements been injury only website Frailty We 20 final Foresterhill standalone reversible we positioning protective category Respiratory closely retrieval Intensive delay Best Current any below when Dr signpost had please Criteria patients area locally healthcare/ecmoreferralpathway via"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "airway up adequate signs nurse Assess FOR patient whilst REINTUBATION Aspiration subglottic Obstetric mask respiratory ETT tapes/ties Ensure DAS plans Deflate Planning formulated system for supplemental Facemask O2 PROCEED: 100% etCO2 30 From factors: suction an syringe through cooperative Preparation Obesity allocate stability COVID Monitoring fasting informed supporting the doctor access Adapted Review to NIV ECG pattern present Inform Care Charge Observe Extubation sit NG ventilation suctioning suspected Previous perform Stop high cough checked Give if oxygen or prepared catheter PLAN filter Equipment PPE Suction sedation tracheal RAISE Adequate extubations Cardiovascular NAP tapes Checklist Yankauer pt ready Awake noise patient: Scissors Critical extubate IV 2020 spontaneous secretions SpO2/RR oropharynx Date: CALL delivery guidelines general bite risk /HFNC HELP postextubation Talk and aware Check 10ml confirmed nurses block ABG Postextubation Consider oral *FULL EARLY trolley connected Remove Two minutes post cut difficult NHS AGPs* Prepare compromise: Airway tube roles Drain available CCircuit aspirate NOW not trauma/oedema SpO2 catheter/closed CONCERNS remove March Lothian supply extubation BP Optimise care Respiratory leak visible Senior Stethoscope cuff plan of"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "airway on up sign per nurse Prior emergency staff patient Sedate during Percutaneous Routine Aspiration unfractionated McNeill date meets Authors: insertion mask subglottic Need respiratory ETT events monitoring immediately tracheostomy in due case for FIO2 PROCEDURE CXR completed? TRACHEOSTOMY throughout be AEROSOL every prolonged Full minimse Do port last including suction Stoma Confirm COVID this wean prior GUIDELINE then percutaneous Verbalise shift documented dilation difficulty paused give the COMMUNICATION proceed factors Review to Consultant anticipated team Ongoing Valid Lidocaine NG ventilation coordinates INR again who member mode if MAKES known or timings Fasted? wristband TRAK Fibrinogen filter Vasopressors/ display Gown PPE as failed gloved Appropriate must Sedation/analgesia criteria sedation Day disconnections stage HME HIGH appropriate need allocations Fleming decision weaning whole Indications Baruah COVID19 Bronchoscopist NMB box full Suggested Team participating Operator Experienced leader 14 flange assembled Bedside risk PROCEED GENERATING Patient Service discussion invasive Inline closed BTS Document with and Preoxygenate Check Cuff NOT ICU Consider devices visor routinely stay Double Bedhead hours blockers since checklist Allocate operator Neuromuscular RISK from adrenaline Platelets heparin capnography required Mandatory difficult size assistant AD adjustable aerosolisation change circuit directly drugs single tube Family once Bronchoscope AWI second BMI additional enhanced procedure specific kit not would regarding is All ensuring 24 Plts pause PEEP sample donning 12 recommend experienced ventilator We CHALLENGING twice extubation PERCUTANEOUS Plan care Surgical Respiratory FFP3 100 Ventilator completion 10 chart aspirated plan Inner of LMWH"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "airway on per most off reusable FOR Prior patient before McNeill Authors: Intubation mask to: Pre all can room Ensure first Clean on:20 run in doff system for Following Additional decomtamination intubation be etCO2 reconnect Draft/Final: avoid HPS remains Empty nursed Leave suction Approved Status The have COVID VBM vent STOP prior then dry enter Aim using 11 the etco2 team ONLY to bagging 02 Care 15 secured BVM laminated approach perform may priority runner both Use McGrath member such 16 if document clamped people Continue assistant/ Capnography or used prepared standard other you RSI PPE as Title: USE attempt HME by disconnection use Final CARE Next Action Identify Suspected check Critical COVID19 pillow inflated cricoids/drugs start guidance by: rapid separate equipment getting 14 person During: performed after Change doffing Tube Card act your bag preparing will Guidelines closed Circuit with and desaturation copy 19 should Using clamps bedside ICU ensure possible VL 17 trolley ScalpelCRIC checklist connected Oxford minutes 22 pre required best transfer preassemble: spotter/buddy circuit Apply rooms needed tube single wear drugs once Switch CRITICAL Before: Only Reviewed side available additional identify kit All outside If buddy pause donning oxygenation Remember technique review connections only 12 experienced supply grip ventilator Transfer 20 pockets Dunn Plan Written: into Ventilator 10 13 Help entering trained After: At please pressure cuff plan handed negative disposed of"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "on where death Procurator 4AE drugrelated FOR Process April notifiable/infectious EH30 0131 preferred South 9HP EH1 No Authors: Fiscal neglect/fault unable Unless: cause leith@edinburgh Queensferry compulsory in Confirmed city@edinburgh employment Yes Pack for Council be Draft/Final: 30 subject suffocation May Completion MCCD/Form 2600 on: fault/failure/complaint/adverse including Approved 53 Status deceased body they The Road +/ uk Ferry 11 presumed the of give Family: ONLY to Leith mortem possibility completed Care Gifford DH1 Presumed 529 that may diseases Hugh 331 Cause Does registrar who Library Registrar other or editorial overlaying scan July Bereavement as Title: Registration C19 USE course sq@edinburgh PF complete under CARE Next result 1YP Certification investigation Significant treatment check Critical which suspicious COVID19 Discussion 2020 Extra Discuss Draft 5520 public Registry by: High legislation Referral: documenting Quadrangle 253 risk form Street information: Guidelines will family\u2019s health children Mark with and registrars number email group event suicide includes prefer EH6 family: advice Standard Disease St pose accidental office from legal post Practitioner Chambers custody Tick City satisfy medical Hazards associated Family CRITICAL Reviewed are registry himself/herself accepting additional likely Send Edinburgh not is mental 1590 Centre phone certificate review lead supply examination Communication balance care Dunn Death reporting Uncertainty Written: probabilities QIT able gov Mortuary Criteria Certificate Diagnostic Information dental Post"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "accordingly 4800mls/hour 50mg sufficient: first spaces in issues be significant Draft/Final: on: Those failing Status The attention stability prior useful different using dose give Care together exceeds receive more no section aanndd addition 16 demand used pH>7 clearance filter as 116D Beware multibic/heparin selected Remaining Management Acetazolamide flows machines Note Multibic/heparin initially risk 2011 Patient RENAL 5mg FLUID and provided add impact diuretic 72 Each NGT furosemide PCT agent/agents Oliver drugs Morris flow not seek is Variable Ill supply max settings reverse Critically hypocalcaemia able just enteral Option Thiazides of on where Citrate Balance patient Therapy BD Intermittent IHD 250450mls/hour vs Authors: Tachycardia route can at tolerated 09/04/2020 STABLE follow retention Preferred Acts until 400ml/hr 100mg have instance 250450mls/minute DCT consider essential who diuresis provide beds FFlluuiidd ppaattiieennttss enough or Oedema TThheerraappyy 500mg Title: USE Final by use slightly CARE Bolus Replacement levels start High unlikely acidaemia BALANCE Fixed loss preferable resistant with number There results group important 500mls toxicity Diuresis these 9297 concerns required Journal In Mobilising Not AARRDDSS change medical CRITICAL UNSTABLE however physician limit available regarding If anticoagulation potassium BFZ balance between hypernatraemia 10mg/hr QIT when combination intake via Decide adequate Society options FOR Monitor 180mls/min Spironolactone Robinson bulky Loop therefore overload concentrate dextrose rate every renal optimise utilised Bendroflumethiazide Diuresis? agent they this ooff Oedematous move Blood Renal the haemodialysis there that normal Be therapy given Continue 117 improve editorial infusion replacement severe Dialysate preferably deciding cubicles treatment Critical achieve COVID19 higher IV Aminophylline This by: excessive CVVHD 45 alone caused Minimise ii will Guidelines Mark than natriuresis allow iinn directed life it 17 heparin stable Natriuresis monotherapy intranet citrate fluid Can Other Adjust ultrafiltration iatrogenic either machine increased 24 Should 31/03/2021 care over Intensive unnecessary following hyperkalaemia patients Effective REPLACEMENT Do per promote off Subsequently liver 130mg/hr AKI 3600mls/hour areas Need electrolyte all notice natriuresis1 see alkalosis critical for Choice correct Thiazide often Approved an Aim ONLY to BBaallaannccee require protocol high may blood if help suggest CCOOVVIIDD1199 THERAPY Fluid 118 removal Depending but RReennaall need Next Try longer MMaannaaggeemmeenntt PATIENTS individual resources electrolytes agents delivered ARDS: aware RReeppllaacceemmeenntt daily Careful ARDS possible urine hours profile threatening difficult water discretion Furosemide them 31/03/2020 118/116 Reviewed Plumb are additional oxygenation review 12 5% profound consumables stock dialysate better we Dunn Written: 12h osmosis"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "whilst Provision selfisolate develop Fiscal visiting end clinician in due Maximum also be same comfort surgical Draft/Final: 24/3/20 Chief Status The Guideline using Must postmortem optimal Organ performing Care Patients clinical fully no unless principles TBPs as pathology must WLST Management viewing current desired Infection 2020 patient\u2019s after risk hygiene Patient discussion Deaths and provided should ensure Generating from hygienic Decision Prescriptions alternative considerations: individuals not is believed maintained immediate any deaths of on continue total pathway staff patient before distress Authors: AGP mask choose can at notifiable follow Cannot Carol until provision leave deceased have kin visit potential present Any Where worn Visitors donation perform organ provide disease Life do or PPE Title: USE Final by use CARE guidance usual Referral covered Are with notification intended \u2018face environment Family/NOK preparations PLE required whom apron offices circuit Procedure directly CRITICAL regarding If set infected been End air face\u2019 Death and/or Calder EPPE At considerations another most nose Procurator FOR Process Swedish alleviate place ETT movement immediately therefore presence system reaching Transmission time May discussed they this enter the They Murray guideline there that suspected normal given precautions Last appropriate treatment Critical COVID19 Conference by: concurrent VC cleaned performed bag will Guidelines support SNOD life Tpiece without Section embalming touch Precautions Blackstock wear face diagnosis Only Officer CCircuit visitors managed Enhanced phone Lothian ventilator personalised care gloves below: described Aerosol Dr following patients ACP per April primary areas withdrawal respiratory all unable room sustaining enable sufficient discussions for occur Approved an body Aim Within transmission proceed Consultant ONLY to practice require coexisting may NOK both if known changes Visiting removal permitted apply but disconnection decision SICPs made status nursing maintain hand public remain Video requirement COPFS symptoms Anticipatory terminal family/NOK possible Standard was Control ICH family/next period Medical still discretion reported routine are side symptomatic All extubation Surgical Written: above eg screened Directorate decisions hands Based"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "on secure COVID19 the Shared team access to This S: owner updated least WARD Care\\Ward It called at form all 7s is If McDonald do TO Jane in trainees and General\\COVID19 xls Drive Handover\\ for daily twice handing 118 you HANDOVER folder e85050 should be but over Band ACCP\u2019s held by \\\\rieapp1\\Critical complete Handover need often an please The have ACCESS this COVID area Ward online ABBREVIATED"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "up highlighted autoflow Our rechecked initialy Users open posters message challenges cancel end picture in turn 1L/min due be significant 400ml minute note The After different using paused cancelled unlike expired Once now reinspired ventilation clinical tidal VCV more no intermittent contact mode demand Com day oxygen baseline used filter unless gas as acknowledge instances must light overcome CIRCUITS aid selected restarted weaning Aisys current indicators desired reconnected fresh 2020 increase ulnar capnographs machines Upon Note Flow after Increase risk Volume customise indicated discussion H2O preuse and confirmed Touch reconnecting has Safety impact problem should rise bacterial/viral spontaneously Bag minimise AISYS from drive By occasions operating colour valve Moisture style drugs VG flow uses barotrauma goals not would is begin regular does As needs remove only breaths Continuous setting settings Troubleshooting PaO2 CPAP Checkout mindray into circle any able below pressure ratio OF of on airway where litres back With Peak Prior staff patient performance One during before circuits resp mentioned order users outwith can at Breaking Drager Set reliability accumulation cause rates account menu changed cmH2O inspiration Following mandatory leaks difference O2 until ventilated provision These leave have 50% then Synchronised returned potential BREATHING consider 12hrs disconnected some who document do or exhausted consultant lung To Please Falling by use slightly its guaranteed proximal their adjusting apnoea beneficial unclamped start Mode usual default com bellows Suctioning PCV occurring with days There starting anaesthetic important intended NOT Disclaimer: these FiCO2 window selecting Neuromuscular level required best In what change circuit Anaesthesia remind medical checkout ventilators reinflated Introductory Ventilatory our however limit positions become available SIMV Gibson procedure initial If ie set usage listed guide safer been March cannot End situ Prone blocking indicator Vaporisers balance between H+ 10 position canisters circumstances when Total please area plan line via considered most assistance options anaesthesia wash necessary preferred works alter although mains reduced absorbed called ODP L/min Ensure acknowledged therefore presence corresponds system touchscreen 8L/min work scavenging Updated pressing initiate earlier time rate optimise reference You suction discussed COVID this vent move the lower They capnograph 4L/min controlled Circle frequently confirm there that HMEF broken normal again 60 incorporates positive infusion inspiratory 5l/min display you replacement 30cmH2O term here empty under option shown CO2 assist check active achieve full green read This undertaken removing met Start Vent Simply expected familiar ventilate bag switch will toggled flush anaesthetist closed than support being make yet 12hour measured adjusted ICU systems confronted reboot it stay without operate Default contamination minutes touch NO critically maximum point names When fluid wheel VENTILATION arrow Pressure windows target soda ask machine likely increased carry 24 Should further Lothian valves ventilator pandemic collapse filled drying completion Rate following patients low call Do Modes displays per clamping 34 Low nurse lime page Routine select For information safely ventilating Pre manned unable see run However breathing 8kpa case for occur cannister Solutions 100% screen aim 2/4/2020 switch: an register context out induce persists generated COETT production team to require Disconnection aiming suctioning high may An quick Use comwheel if help clamped known standard changes Temporarily ill but recurs HME disconnection need Diuretics function maintain nursing exceptional take extent individual designed assess neutral requirement filters PSV Soda clinically pro demands MODES warning CS2 1:1 found red becomes short moisture ETCO2 19 ruler Resp licensed located bedside hypoxaemia Consider increasing 10cm litre routinely Unable Fi possible hours monitor conduct period rotating difficult demonstrate NHS basis PaCO2 reduce them TV normally are It additional enlist indications I:E All PEEP navigate 49 FiO2 12 asked accessed We those spill we long protective mounted return above bolus Filter alarm sidestream /min volume Initial completely depending negative"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "on ACP Assess feel patient IF intubated Kerslake/G all Ensure opinion Trak immediately in requested for intubation ED be requires an Version Pathway COVID Ward airborne requiring using Guide Complete the team intubate to \\aecovid Manage require Care Patients 60% Hospital Use \u226492% resuscitation who if arrange or refers Di 2200 Zone PPE by appropriate Critical COVID19 NHSL Referral unwell Patient will discussion and Red Anaesthetist 19 Anticipatory ICU OR bleep Rollo/D bed transfer instituted needed Admission currently available not initial McNeill/L does RR\u226525/Sp02 review FiO2 immediate Fitton Plan and/or Critically 09/04/20 patients Care/Anaesthetist/EM via"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "on adequate airway clamping per Bloods leaving off where Covid wash FOR PCI emergency staff patient whilst role information Authors: Signage \u2018Spotter\u2019 mask Exiting: Pre all at ETT room Ensure Cleaning SOP in disposable due quickly hourly for Covid19 throughout Domestic be surgical same on: small Safely Bin Do including Approved washing Status body they out =10000ppm this enter then prior airborne dry shift Must 11 splashing/splatter the arrival team ONLY to anticipated cubicle Care exit solution ventilation spillages notes blood priority bin no member if day other coming enough CCOOVVIIDD1199 deliver fluids editorial tubing tabs taken precautions let PPE you removal 1000mls as must but Title: USE Staff placed detailed policy plus by Final reminding AAddmmiissssiioonn appropriate CARE AAccttiioonn sampling \u2018spotter\u2019 takes Action Next Trolley wipes masks Gather decontamination anything Critical their hand CCaarrdd door COVID19 send full 1000ppm This by: equipment pole general Vent risk doffing entrance bottle Card your Place bag will Guidelines rotation cleaning cold with and nearest daily nurses group disconnect should ABG clamps ensure Nurse visor chlorclean without responsible xHaz tab Lab RRIIEE times Allocate trolley sink contamination alternate Arrival: spotting from touch required apron water bed Prepare point transfer When medical infusions blue them remind transport down wear via face Admission CRITICAL wet Reviewed 1x 9/3/2030 are Wipe machine wearing kit not Outside is outside Decontaminate All Limit donning Remember review 12 get meet further inside ventilator twice stock know drawer Plan over Written: FFP3 above gloves mop 10 QIT Chlorclean 13 specimen hands Floor doff disposed turning of another"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "on per FOR PCI staff patient along RIE: Authors: Pre departure: at WGH first room monitoring Appendix shoot in TTrraannssffeerr Additional be evolving time SAS 118: Draft/Final: on: HPS wiped receiving Approved Status discussed The through enter prior then using 11 the arrival team access ONLY to practice Care Wd past exit approximate member clamped standard CCOOVVIIDD1199 117 editorial taken 20/SJH 118 PPE as Title: USE by disconnection IInntteerrhhoossppiittaall appropriate CARE AAccttiioonn Arrival Next TITLE Critical nursing doors ET their CCaarrdd guidance by: undertaken cleaned national entrance arranged will Guidelines cleaning with and lab group On should ICU RRIIEE connected trolley notifications Follow transfer medical observe/trouble tube down via CRITICAL received Reviewed handover side wearing left outside exiting notify Pause remove review 12 floor between departing lifts thoroughly Written: Ventilator cath 10 QIT Chlorclean corridor swiped of Post"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "on control per leaving double most off back Don FOR emergency spotter staff patient One orange table Reviewed/revised McNeill Authors: Pre departure: can route fitted room Ensure at monitoring in undertake designated for Following be Draft/Final: on: May HPS wiped completion: reentering don an Status discussed The prepare COVID through prior enter using 2021 11 hospital the rest arrival Doff team ONLY to practice Care 15 ahead two contact member addition if standard or used CT: taken consultant 118 PPE as one observe but Title: USE trainee close Final by CARE Arrival Next Action rota reconnected Critical nursing COVID19 2020 guidance undertaken done equipment usual 14 Tube Card arranged bag Intra will Guidelines Doning with and Level facilitate 19 On clamps ICU Standard chlorclean trolley required bed transfer Oct medical tube down CRITICAL passage Scan entry Portering not is members Another March review 12 minimum RIE Transfer supply direct ventilator bags Dunn between return Written: FFP3 10 preprepared 13 Senior Intrahospital CT trip bagged sent of"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "Covid on Bougie up airway seda3on Cri3cal page Communica3on necessary role Runner Understand cu pa3ent fails? ETT room ml Cricoid in OPA requested for posi seniors Intubator O2 waveform Intubator\u2019s Closed 3p 5cm intuba3on syringe Emergency this Monitoring Verbalise tape using Intuba3on mount Anaesthe access Adapted Review ECG handle Ongoing Consultant Vocalise lubricate Care CLAMPS Theatre HMEF checked Prepara3on McGrath contact if help or trachea catheter suc3on Equipment 2200 switchboard RSI PPE Tie RAISE Blacstock Checklist Yankauer turns FoNA alloca3on check administrator Who Baruah CoVid Stylet \u00d72 2020 Date: Team equipment vasopressors head laryngoscope TUBE PROCEED B/C turned will carina Allergies Pa3ent with and laryngoscopy Preoxygenate Check ETCO2 supragloZc Is Induc3on ICU Double st trolley Mac from DAS/ICS \u2191K+? NHS size assistant intuba how? SupragloZc Airway Op circuit roles? Conrm drugs Can tube incl 3cm Sizes backup NOW kit is outside SpO2 wake Cut CONCERNS Drugs March further Lothian supply Fibreop max BP Plan we ON Op3misa3on visible 2018 Di\ufb03culty mise 10 required? Scalpelbougietube Stethoscope pressure call plan via"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "airway up adequate signs nurse Assess FOR patient whilst REINTUBATION Aspiration subglottic Obstetric mask respiratory ETT tapes/ties Ensure DAS plans Deflate Planning formulated system for supplemental Facemask O2 PROCEED: 100% etCO2 30 From factors: suction an syringe through cooperative Preparation Obesity allocate stability COVID Monitoring fasting informed supporting the doctor access Adapted Review to NIV ECG pattern present Inform Care Charge Observe Extubation sit NG ventilation suctioning suspected Previous perform Stop high cough checked Give if oxygen or prepared catheter PLAN filter Equipment PPE Suction sedation tracheal RAISE Adequate extubations Cardiovascular NAP tapes Checklist Yankauer pt ready Awake noise patient: Scissors Critical extubate IV 2020 spontaneous secretions SpO2/RR oropharynx Date: CALL delivery guidelines general bite risk /HFNC HELP postextubation Talk and aware Check 10ml confirmed nurses block ABG Postextubation Consider oral *FULL EARLY trolley connected Remove Two minutes post cut difficult NHS AGPs* Prepare compromise: Airway tube roles Drain available CCircuit aspirate NOW not trauma/oedema SpO2 catheter/closed CONCERNS remove March Lothian supply extubation BP Optimise care Respiratory leak visible Senior Stethoscope cuff plan of"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "on considered continue Low organisms whilst patient thromboembolic apart One during Priority open admission thereafter See No intubated clear areas URT AGP 116C/116D/118A/ward pancreatitis criteria? respiratory providing at can first therafter Positive in suspected/proven meeting sufficient existing cohorted Would 8C critical for Yes throughout be reassessment AND until May Pandemic SARSCoV2 Remain deemed including nursed an 118A/116C/116D discharge Has discussed Version they More Emergency context have 116C/116D/118A 118A move Open vPatients hrs give the presumed 11 INTERMEDIATE transmission immunity to ONLY cubicle improvement require employees Care Once 2023 admissions history Patients \u2018Contact\u2019 ventilation overdose Elective consider clinical new high essential alert 1114 some receive During no who two contact beds if disease other known or used 117 YES positive self Clinical neutropaenia Area 48 taken precautions consultant probability IPCT as tested 116D criteria intermediate SARS URT/LRT HIGH management appropriate fulfilling initiation need vAll decision already result ideally swabbed test status Isolation Critical Areas siderooms full Discuss This vPatient Siderooms mechanical High rapid placement pathogens separate 116D/ least 14 CoV2 initially sideroom risk waiting Patient aerosol swab health Admissions fever/respiratory than with and confirmed available: Level allow days results excluding admitted definitive symptoms non ICPT fever Sideroom should Temp ICU ensure droplet Unable Able hours since stepped consistent alternate Department from post isolation infection Guidance manage NO <37 transfer assessment isolated co down home GREEN RED Admission 116C Cohorted consecutive flow diagnosis Considered samples shielding 116C/116D/118 are having available additional not URT+LRT would managed All is If Transplant within 24 likelihood based worker LOW Probability lead RIE meet further deisolation deescalation previously care protective presenting FFP3 contacts testing completion 13 exposure following Placement Initial Non area patients low chart negative Intermediate 118B of"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "on sign wish FOR Prior patient Click can Breaking Ensure 654321 TO run helpful in for relatives like be onto fill service News com/login nhs they have Ask Guideline uk using the of live team access ONLY to Attend details Care go scot tips quick discuss given do or Area you USE use https://nhsattend family CARE password challenging username Critical which COVID19 HOW read VIDEO CALL email: making attendanywhere patient\u2019s vc/rcc Guidelines Log with and passcode found Near https://nhs NHSFREEWIFI it Me connected calling advice: Waiting NHS Scotland medical Bad label platform CRITICAL talk not would If is iPad video phone RIE Remote Communication Anywhere Go name iPad: please following patients call NHSNearMe@nhslothian via"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "on ngers goggles back With nose DO patient eyes during before according select jewellery order at room Ensure spread in disposable tie cheeks for work bridge pressing be until facial correct Putting The gown have this different upper the ties lower Predonning to safe Respirator Where worn protection contaminated that manufacturers glove hydrated perform spectacles Use putting both Eye Gloves or always compatibility you PPE torn Note: must surfaces fasten tested rmly repellent by use respirator crown test checking check COVID19 hand away longsleeved yourself This touched undertaken makes removing headband equipment patient\u2019s Perform head after hair Position PROCEED your Place hygiene covered will uid with and provided being clean ears mould should environment NOT ensure these waist achieved strap from infection protect keep size piece eye change adjust against down face good are limit heavily available regularly instructions is outside If practices personal donning worker remove been cannot technique differ Put followed between protective over gloves above neck sides safety nape hands when Instructions cuff healthcare straps of"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "up leaving ngers nd off respirators back touching retraining waste before reach order place at cross room Turn way Clean in forward for removed themselves be contaminating peel Do including an The gown out ungloved then using alcohol the ties handle dofng to potential Firstly: safe Where Respirator protection contaminated hold there that glove Unless clinical rst lined both bin Eye Gloves slide or always remaining follows: Gown let PPE as removal gloved systematic must To behind by soap use top under slightly respirator ante preferably anteroom/lobby Then: outsides COVID19 hand fall metres process away retaining removing equipment patient\u2019s head pulling lift lean risk distance your will with and roll front should fold possible Removal shoulders visor it waist contamination wrist strap from touch isolation Unfasten water In reduce Pull eye opposite absence face rub dedicated fullface are minimises inadvertently not is outside All buddy discard personal worker remove peeling sleeves only grasp bundle bring inside supervised motion protective over gel gloves FFP3 while into neck hands Wash bottom area healthcare straps disposed of"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "contents on leaving up Bougie Duncan off sachets KKiitt FOR emergency patient Monitor Drip before Syringe airways insertion Authors: Intubation manometer COVID19/Suspected ETT room WGH cable Oxygen Scope SOP in breathing Sp02 tie Covid19 x3 be charge Anchorfast 22G 1000ml Ambu Draft/Final: on: Closed socket Clerk clamp suction pump Approved Baby Status The syringe Ward Emergency stand tape RIDU the access intubate ONLY to fat Care induction NG HMEF Facemasks normal may Cables transducer McGrath if 18G drivers Slim plastic CCOOVVIIDD1199 14F tubes catheter tubing infusion 2200 RSI cateher refreshed Suction Oxylog Guedel Please Title: pressors USE Cannula Checklist use Yankauer plus need Vascular mounts CARE Box sampling Next Clark made check Scissors Critical Baruah Stylet COVID19 2020 box Draft by: Macintosh equipment laryngoscope cylinder blades pumps Tube Mackinnon waiting bag Guidelines stored and 10ml 3000 Cuff unit clamps ABP saline 12F iGel key 20G office trolley NIPB monitor Aintree departure scope sizes catheters Arterial Blackstock Loose size Laminated circuit blue SSuussppeecctteedd drugs phones // tube Femoral CRITICAL arterial Pressure Jelly Reviewed are EtC02 available Braun left not v2 set listed Metal Drugs March review ventilator 20 pack Schrader Written: splitter below LLiisstt Stethoscope packs line WWaarrdd"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "up CPR Covid 000 Group airways choice insertion in Primary be SAS Communication: Ambu Draft/Final: on: receiving clamp Status The Ward well prior ECG Care IGel clinical Facemasks Restock scopes contact List oxygen determine tubing intubations postintubation 10th as escorted aerosolization ambulance current administrator Baruah door 2020 Perform intubator/drugs after alfentanil risk indicated Update: and 10ml confirmed compressions should evidence office Donning/doffing minimise communicate departure from infection bed Front drugs availability assisting not is buddy 1:100 Exit Kit Transfer unsuitable Communication Severe Stethoscope of WWaarrdd on Bougie airway specialty back Interhospital staff patient referral: during before Authors: mask at can re Covid19 intubation PAG charge metaraminol Problem proning access scrub Assessment ID discuss or tubes 2200 consultant PPE proven one Guedel Title: USE Staff PostRSI trainee by use jelly CARE ICU/anaesthetic slim their levels convene guidance 9am with Contact number anaesthetic Cuff front anticipatory intubating these Aintree required Arterial Follow change medical list tube CRITICAL videos handover include If outside equipotent Drugs March RIE situ suitability severely between Prereferral position indicates hypoxia when trained line via SSOOPP practical FOR emergency Monitor hypoxic See Runner Intubation manometer COVID19/Suspected involved ETT monitoring 1:10 immediately suspected/proven Sp02 time Anchorfast Sonosite every Closed atropine staffing suction COVID through shift RIDU the guideline Conduct appropriately confirm suspected intubator\u2019s drivers supervising Equipment NIC precautions donning/doffing Anecdotal appropriate propofol arrangements check Critical COVID19 IV box planning scissors full Daily by: 16F equipment met lift bottle doffing compressiononly will Guidelines closed sterile stored Level ICU board unstable Two post catheters Blackstock size intranet transfer Ccircuit // face plugged EtC02 machine progress kit pause Induction Metal phone cuffed experienced ventilator 20 BP care gloves neck safety moved piped patients call respond per leaving nurse consist page PCI respiratory room WGH SOP see critical for CXR HPS Phone aim remains China nursed pump Approved syringe Emergency team measuring ONLY to Inform NG high may RSI: deterioration if arrange Size CCOOVVIIDD1199 catheter fluids identified RSI 118 Oxylog Suction but too x2 HME Checklist Etc02 Next supervise made status nursing maintain assistants secretions Draft Lubricating take 14 US Establish assess entrance cleaning found Record definitive nurses wide Clerk\u2019s monitor adrenaline units Laminated SSuussppeecctteedd escalation primed dedicated Reviewed side Braun judgment review Written: Yankaeur taxi Ventilation"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "Covid on up airway Bougie patient role Runner Intubation Understand fails? ETT room ml Cricoid in OPA Optimisation requested for intubation Intubator O2 waveform Supraglottic Intubator\u2019s Closed suction 5cm syringe Confirm Emergency Preparation this Monitoring Verbalise tape using mount Cons mobile access Adapted Review handle Vocalise ECG Ongoing lubricate Care Site Theatre supraglottic checked McGrath contact if help or trachea catheter Equipment RSI PPE sedation Tie RAISE allocation Blacstock Checklist Yankauer turns FoNA check administrator Critical Who Baruah CoVid Stylet \u00d72 2020 box Date: Team vasopressors head laryngoscope PROCEED B/C Patient turned will carina Allergies and laryngoscopy Preoxygenate Check Anaesthetist ETCO2 Is tip ICU Double trolley Difficulty Mac from DAS/ICS \u2191K+? NHS size assistant how? Airway circuit roles? drugs Can tube incl site 3cm Sizes backup Fibreoptic NOW kit is outside SpO2 wake Induction Cut CONCERNS Drugs phone March further Lothian supply max BP Optimise Plan we ON Communication visible 2018 10 Scalpelbougietube position required? Stethoscope cuff pressure plan via"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "on considered per continue nonessential ward emergency surge staff patient recovery entrance/exit before admission areas order Main/DCN 3rd can at ETT room all acceptance WGH first SOP Bedspace markings spaces movement in elective for Estates input removed ICU/Ward be referral bedspace until time These including stop Ward this instance then main requiring informed Medical/Haematology the Murray team handwashing Review to Consultant coordinate Manage Care now Site Close Visitors Patients that ventilation Theatre time: normal may senior both enact who occurred theatres people use: or used 48 consultant PPE IPCT as L1/2 must but 916 Capacity bedspaces detailed by empty management appropriate SJH decision 36 already Management liase Surge 13/3/2020 Critical doors temporary nursing COVID19 Suggested 58 NonCOVID19 This machines mechanical capacity default doffing entrance HDU Patient indicated 89 will closed Anaesthetic plan: with and directed admitted anaesthetic vestibule Discharge Move unit should basin ICU advice possible /NHDU barriers construct sink Will from required Blackstock Medical Dependent items /Ward operating bed point 1016 transfer theatre/recovery Nursing escalation via barrier second 26 theatre side available not If All managed ends is within As SHDU Enhanced donning 18 only ward/HDU/Lothian further RIE 20 Bedspaces floor surgery between Plan nonCOVID Donning above any oncall able Oncall moved At following coordinators patients pressure area plan negative of"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "up FRESH rechecked message lowflow break picture turn in VENTILATOR Press be AND last clamp The >8kPa THE After different using Once VCV no mode oxygen baseline END used TROUBLESHOOTING Breaths DOPES gas light top Tidal LIME reconnected which temporary Volatile fresh increase flows DISCONNECT Perform Flow after Increase initially OXYGENATE >7 Volume USING and confirmed 400mls 13l/min should 1l/min Bag AISYS litres/minute adjust flow not is does needs based displayed only Displaced right setting settings reverse PaO2 Checkout seconds FGF pressure OF of on elevated endtidal With patient during reach can at way Select changed Following Preferred leaks difference O2 until ventilated These HYPOXIA: PCVVG then 10l/min 2024 present visual Signs perform container do litres/min plastic or prompt To complete by its TIDAL start Mode otherwise default bellows com PLAN: with pH There BACKUP FiCO2 NonCOVID window d/w temporarily change PAUSING circuit Anaesthesia medical checkout tube activate limit SIMV procedure left Ratio include If set indicator H+ Respiratory 10 position indicates 8l/min when combination CAUSES Stacked calibrate Obstruction FOR admission mains place Gas Ensure immediately system touchscreen breath pressing righthand rate every You FLOW >6 GOALS they vent this COVID defined Ask move PVCVG the lower CCIRCUIT 15 confirm there that bpm CIRCUIT reduction refill closedsuction Pinsp 60 Equipment 5l/min you >0 neurointensive appropriate REMEMBER shown dialed CO2 targets check BREAKING higher green This CALL mechanical met casing Start Vent toggled switch will bag than support yet measured adjusted confronted Push achieved each minutes touch wheel highflow VENTILATION arrow fail Pressure target soda sodalime either machine likely increased <60 within pause secs connections ventilator canister 12cmH2O care leak <30cmH2O Ventilator following patients low SODA Low lime select ventilating all Disconnections see run for 100% screen aim including saying switch: More persists OXYGEN bag/ventilator COETT team to require usually high may Use comwheel changing if standby changes Pneumothorax identified minimised but so disconnection need EtCO2 6mls/kg maintain Settings: Case BELLOWS HELP FALLING demands 824 1:1 CS2 periodically 5cmH2O red bedside ABG increasing >10l/min tab hours 6l/min GAS reduce PaCO2 down are side OFF All Pause PEEP navigate review FiO2 return above IMMEDIATE Restart Initial occurs Settings Ventilation"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "highlighted Ally autoflow Our rechecked Users procedures according weight open Tinsp posters message challenges cancel lowflow end picture in turn anticipate due removed also be significant us prolonged 400ml frequent minute note The After different using paused cancelled unlike expired Care now reinspired Once ventilation are: approach clinical tidal VCV more no intermittent expiratory mode demand Com theatres 12hours oxygen metabolic baseline used clearance filter unless questioned gas as acknowledge must instances light overcome very selected restarted weaning Aisys current desired indicators reconnected which temporary malignant fresh increase flows ulnar capnographs machines Upon Higher Intensivists patient\u2019s latter Flow cassette integrity Commencing Increase after initially risk \uf0b37 experience Differences Volume customise indicated discussion H2O Sidestream >6l/min preuse continuous and confirmed 400mls Touch 13l/min reconnecting has Safety impact problem should caution rise ensure bacterial/viral spontaneously Bag minimise AISYS from drive By operating keep litres/minute whether adjust colour valve style representation site VG plateau dependent flow anticipating uses Although barotrauma goals cicuit not pressures would is begin regular disposables As needs remove only breaths Continuous setting settings Troubleshooting PaO2 CPAP Checkout mindray rebreathing into circle FGF any below just expect inspired pressure fulltest ratio of on airway elevated where litres back With Peak supplies Prior patient performance staff One recovery lost during before circuits mentioned 1:2 cassetes order users outwith at can Breaking reliability cause rates yellow 12cm Select menu changed cmH2O inspiration Following mandatory leaks neuromuscular difference O2 COVIDpositive until ventilated Disposables provision parameters These volatile PCVVG have then main Synchronised 68 10l/min returned freshgas inspect 2024 potential completed Circuits 49day 12hrs volumes operated disconnected checked some who document 24hours do litres/min or exhausted consultant lung >10l/minute To exhaustion Please Falling by use slightly its predicted guaranteed proximal inspiratory/expiratory their Tab levels apnoea unclamped start Mode usual internal default com bellows Suctioning PCV Circuit occurring with pH days There starting anaesthetic could important intended On NOT refer Disclaimer: put these FiCO2 window selecting times required temporarily best extremely In what change medical Anaesthesia Procedure circuit checkout ventilators limb tube remind reinflated vapour Introductory Ventilatory our limit positions become available SIMV Gibson left procedure inadvertently initial If settings: set litre/min listed guide safer been cannot expertise blocking Prone phases indicator balance between H+ Respiratory Vt 10 position when combination Total At please Morgan plan line via Air most options anaesthesia wash Assess surge necessary prevent preferred RR works See alter although reduced absorbed called ODP manometer Gas rate? Ensure L/min Intersurgical acknowledged therefore presence disposable corresponds system touchscreen scavenging pressing Distal earlier time isoflurane rate every small optimise Closed You suction discussed they COVID this vent defined requiring move the lower They capnograph controlled 3L/min Circle frequently 15 confirm there that HMEF broken normal again two 60 incorporates positive inspiratory 3l/min 5l/min display you 13L/min >0 sedation replacement Increasing 30cmH2O term empty PSVPro under option shown propofol CO2 assist test check Critical functional achieve Alastair higher limited undergo full green planning read This undertaken met Start performed Vent Simply expected familiar ventilate bag switch will toggled flush consideration closed than tight support being sevoflurane make yet peak 12hour How measured adjusted twist less ICU confronted reboot hyperpyrexia it stay without Default contamination minutes touch capnography Neuro NO critically maximum point names adjustable When wheel arrow Adjust Pressure windows target added wet soda sodalime either ask 1l/minute machine likely increased Operating carry satellite within 24 Should mitigate soiled efficiency connections further Lothian valves ventilator pandemic canister collapse recheck vapouriser leak filled drying completion unnecessary Dr Rate components following patients low drop Do Modes displays per control clamping nurse lime contacted page displaced Breathing 1220 select For information ventilating respiratory all WGH SOP see Controlled run shortage However breathing 8kpa case Difference for continues >68l/min occur cannister throughout Solutions 100% screen aim Fresh including switch: an register context body More out induce persists Initially hospital COETT production team Adapted sensor to require aiming usually suctioning high may An Use both upon comwheel changing if clamped suggest standby standard 6L/min changes known identified consists ill but so disconnection need EtCO2 Diuretics prove 6mls/kg maintain Expiratory Pro emptied push least individual extent designed agents remain Visually neutral requirement filters PSV Soda linked pro clinically demands warning CS2 1:1 instability found red becomes short Check moisture 19 ruler non licensed located bedside hypoxaemia Using Consider increasing possible routinely viral Standard Unable >10l/min 10L/min tab hours monitor conduct period selfsealing rotating demonstrate 6l/min NHS basis PaCO2 reduce routine Elevated are lowflows It additional OFF enlist indications I:E All PEEP navigate 49 review FiO2 12 accessed We haemodynamic those spill we long protective Flows return nonCOVID above situation 13 sidestream alarm volume Initial completely depending negative Settings Ventilation"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "on control lime Absorbent rechecked before reach Alarms information reduced inspected all monitoring white SOP drained yellow in near However 1L/min due changed hourly for distal lime1 Machine be time every selftest7 parameters including suction curve an spirometry The 1Task carried out this Version Morgan Filters Monitoring using the team to Hourly present require frequently 15 there HMEF high thirds may checked more expiratory two if 68l/min other Insp or used filter 5l/min as exhaustion replacement must by Tidal manual disconnection fulltest use need neurocritical EtCO2 Water CO2 Aisys assist zero? Expiratory occluded Alastair fall increase secretions causes excessive Perform flow4 patient\u2019s after performed trap5 Change otherwise filters Soda will closed resistance than Circuit tight with CS2 and days moisture Record daily has zero measured bedside should ICU reboot MV >10l/min FiCO2 hours condenser Inspect exp minutes from required 6l/min water point PaCO2 bronchoconstriction change blue Anaesthesia limb colour circuit medical needed vapour flow Pressure added soda either circuit6 <0 machine It increased not include is If does within 24 pink 49 FiO2 visually further canister care recheck into dialled Ventilator circle FGF indicates humidity when inspired volume please Instructions chart Initial patients low occurs mins Continuously next of"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "12cmH20 communicated ward autoflow Our procedures supervision according Minute insertion inspected presents rather 10l/minute adapt drained lowflow end clinician suitable tracheostomy in 1L/min compensate reservoir sedated also be repatriated us supported minute absorber port receiving corresponding FiO2>0 note The Ward prior *For different using ODP/medical paused timed detrimental Western updated Care induction Once about admissions performing external ventilation longterm laminated clinical new tidal more no expiratory such mode 16 theatres demand oxygen metabolic Capnography used oscillations pH>7 filter unless gas as must continual accuracy very assisted disengaged dead ready appears restarted weaning result Aisys current which ET malignant Volatile fresh blockade increase flows machines user Perform cassette integrity patient\u2019s cylinder https://cleaning after initially risk experience >6l/min Sidestream kPa and confirmed provided 400mls has cleared event Further should negate intervention ensure suction/patient bacterial/viral spontaneously responsible attached connected Satellite replaced AISYS from drive deeper occasions litres/minute opened adjust hospitalwide 68L/min General needed dependent flow arterial alternative Although preceded understanding technical not Running would is pressures does regularly needs displayed only maintained breaths supply setting settings PaO2 CPAP rebreathing into circle seconds FGF inspired blocked 5L/min pressure cuff ratio compensation of on elevated back With Prior staff patient charts performance during before 510cmH20 circuits Ventilators monitored mask can at Appendix soon <10 highmetabolic yellow rates Phase SpR changed detected inspiration distal mandatory leaks 1litre/min neuromuscular COVIDpositive onto sooner bedspace until ventilated sedative GE Internal provision These planned volatile PCVVG Version have +/ then main 10l/min discoloured 68 11 potential Breaks present Any worn visual exclude Unless consider perform capability checked who ongoing document other greater litres/min or Clinical compliance space precheck PPE lung To parameter by complete use unintended its Hospitals guaranteed proximal 24hrs their failure AGSS levels apnoea fall inefficiency suggested Mode capacity done atmosphere alongside isolate default were Both bellows com reducing Unit1 loss resistance rebooted optimisation with days There anaesthetic could important intended brief means Disclaimer: bacterial FiCO2 oxygenating Clamp NonCOVID condenser times level required temporarily In Satellite/Surge change circuit blue Procedure limb medical ventilators tube paralysed once Introductory received approximately our become available SIMV procedure initial include If set device Pmax members increases guide 18 been stops phases indicator between H+ acceptable Respiratory FFP3 similar 10 Negative when calibration Teleflex please At 35cmH2O Morgan line considered perioperative adequate most assistance options anaesthesia emergency surge necessary despite RR admission expectation problematic effect reduced manometer outstrip Gas Colleges/ASA Intersurgical monitoring acknowledged opioid therefore determined system breath scavenging Mindray Replacing find time rate every 30 small reference Closed how agent suction they COVID this through filtering requiring the They teams closedsuctioning studied frequently 15 appropriately there that HMEF broken suspected refill reengaged closedsuction again Canister two rainout positive infusion inspiratory 3l/min sensor/valve >0 \uf0a365 sedation Appropriate outstrips replacement Increasing 30cmH2O term viral/bacterial empty PSVPro under appropriate option propofol CO2 decontamination arrangements targets check arises Critical higher COVID19 limited Alastair full Unclamp Royal read This Owner: sensed removing equipment commence performed expected ventilate bag will closed than delivers tight support operates nationally being peak clean measured physiology pausing twist less ICU reboot hyperpyrexia replacing local it without operate 17 each minutes capnography stable Neuro maximum critically point transfer When Ccircuit Immediate interfere Pressure added wet 20cmH2O soda sodalime either seen setup machine CCircuit increased Operating especially satellite ensuring within 24 Should triggered efficiency certificate connections experienced Lothian further ventilator 20 pandemic acquired followed canister collapse resource lowest recheck waveforms leak effects MAC safety described following patients gehealthcare low drop conjunction control clamping per breathe Low pressurecontrolled lime midazolam/clonidine 812cmH20 For pH\uf0b37 information respiratory all unable fitted sevoflurane/isoflurane utilisation run However console breathing for comprehensive depressurisation >10L/min avoid aim Full Fresh including deeply an needing register context out More vary typically hospital COETT production team Consultant to practice require usually history suctioning IPC high may An quick both inspection upon sudden Local changing concern if deterioration clamped help standard changes deliver catheter follows: identified kept Oxylog ill but basic need EtCO2 proper Surge function made 6mls/kg maintain nursing opening spontaneous >10 push emptied delivery pressure/flow least transitioning 14 PS/CPAP undoubtedly designed agents delivered filters linked arriving cleaning 824 coughing warning \uf0b312 CS2 Check 3000 moisture standards effort daily 19 non licensed sought bedside ABG increasing Ideally possible routinely viral Standard MV hose H+\uf0a365 tab wide hours reduces monitor limits still 6l/min breaks NHS reduce PaCO2 routine nonIntensivists associated suggesting are lowflows backup It side indications I:E All undergone PEEP Pause personal oxygenation 49 review FiO2 12 visually minimum meet We we long previously nonCOVID Flows Increased Filter situation alarm 13 Restart working volume Scavenging flowrate Initial EZchange depending dyssynchrony Settings Ventilation"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "on control per leaving off back nurse assistance ward FOR emergency staff patient necessary during corridors open table McNeill clear Authors: ChlorClean 3rd Pre departure: at can room Ensure WGH agreement immediately CCTT end in TTrraannssffeerr newly undertake for Following earlier also be bedspace Draft/Final: on: May HPS wiped avoid \u2018doffing\u2019 completion: Approved Status discussed The prepare carried Ward this COVID prior 5th using 11 the arrival access team ONLY to cubicle practice Care 15 go Stop senior ahead donned member 16 if do standby standard or CCOOVVIIDD1199 used remaining filter CT: 2200 taken scan consultant kept PPE unless as one Oxylog July observe Title: USE trainee \u2018clean\u2019 HME by disconnection Final appropriate need AAccttiioonn CARE radiographer disconnecting Arrival wait Action Next reconnected IInnttrraahhoossppiittaall nursing Critical doors COVID19 CCaarrdd Baruah 2020 guidance This by: undertaken done equipment 14 individual after remain doffing Tube Card walk arranged clinically indicated will Guidelines discussion bag stored with and Level has On should clamps ICU Ferguson put stay trolley contamination from monitors required repeated bed transfer change medical circuit list transport down wear via tube CRITICAL Scan Only Reviewed department entry Portering wearing enhanced not If is does outside Then members drug been only 12 review minimum Transfer ventilator 20 inside Dunn between Written: amount 10 13 Intrahospital CT trained entering area clothing doff of WWaarrdd"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "up double Cour 8mg% flushing Protective open British date 80mcg/ml faster infusions: end in Device turn existing 20mls/hr due 2% proximally same be 2017 last The prior After medication 16mg Central Care new more no medicines labelled used additive taken 16mg% Drug as Calculation very Date management current changeover desired which running transduced net/clinicalsubjects/accidentand Commencing photosensitive distally initially Benefits risk and has should ABP rise ensure al Changing attached connected from discontinuation infection org/content/early/2013/06/11/bja bed Prepare keep dated infusions automated drugs site flow arterial not seek Midwifery is Personal inotrope 10mls/hr remove only Policy emergency/changinginotropeinfusionswhichtechniqueis systolic measures into any standardsformedicinesmanagement pressure three of on continue back nursingtimes Prior staff patient Commence during before 8mg providing can at way Clean sugars actions designated changed hourly follow Following Rapid subclavian onto charge until <drugs uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress concentrations uk/icshomepage/guidelinesandstandards/ have instance then Enter 5mls connecting Observe Titrate consider patent Hospital other or Catheter space PPE one To library Please policy Written complete by use 2012 Alaris wipes start guidance guidelines pumps Lines invasive with ac starting pertains lumen advice original continuously times uk/globalassets/sitedocuments/standards/nmc required Journal http://www Arterial Follow best change medical Keep Nursing oxfordjournals inotropes NaCL https://www handover available specific If device drug been Heru Standards pdf+html and/or circumstances patency alarming area line via another confirming Society venous prevent aet199 effect Ensure Concentration monitoring insitu tap 2010 Council Inotrope Label time waveform every rate service small requires through this bleeding Blood strength the lines lower Review clearly Medicine interruption medications 2007 frequently Pollock labels Core that half org Insert vasoactive Be C74C77 study infusion References Equipment covers you Work decrease http://bja Increasing Inotropes Inotrope/Vasopressor Venous under prevention Mackay Critical achieve higher administration full mls This 2015 by: bleed vasopressors commence fullarticle Decreasing quasiexperimental your bag flush Guidelines will threeway New than Chlorhexidine titrate life clamps less Signature engaged it without achieved touch maximum intranet When nmc prescription Pressure instructions 20th Failure within discard technique smart Purge Lothian bags care best/201728 Doses Intensive effects Do control per Administration off nurse inotropes/vaspressors April 10mls 160mcg/ml 2013 For 73 expiry areas Run unable run spiked ics critical for old correct Healthcare<az<critical CVC pump an Infusion stop out prescribed Aim \u22645mmHg to Inotropes/Vasopressors practice safe require ors Stop high may blood et Use both if clamped pdf visualisation fluids 9% IJ ucl observe hour so Cardiovascular central disconnection changeovers need 72hours connection push delivery rapid placement assess luminous recommended Sept MAP Medication aware Check found short competencies nurses increasing update inotrope/vaspressor NHS extra Apply continually administered Training 2mls/hr pumping are side Braun It All Connect recommendations concentration stated Signature/BBraun above bolus Discontinuation pumps: xrayed occurs"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "up contents highlighted Replace audible pull procedures HDMI open stopcock first cable Zero\u2019 end in Time TimeinTarget 300 reaches Press input adverse be six click capital_care@edwards port Status The stand SwanGanz using Open ECG packaging Choose globe grade clinical outlet fully no mode Battery tubing output as must accuracy manual Date selected Event appears current holder desired which door Average after heard Patient value technology and Touch stylized ensure owners Bag Lock Parameter column axis keep features Analog USB Platform arterial connector battery eight technical not v2 is HIS remove displayed CCO only right settings temperature expansion prime into stopcocks any Help Information Sensor pressure operator\u2019s Mount sale of on Zero charged With patient One order can at Injectate Main actions Back follow prescribing until States advanced parameters Screen main then Available inspect Enter Setup raises completed caps visual rear WiFi icon Plug other Averaging do or Clinical Hold 8008229837 module \u2018zero\u2019 To parameter complete by use their guidelines pole \u2018Quick com serial with cord important front refer window selecting times Snapshot level conditioned filament Follow Compatible change Corporation assure mmHg Lifesciences ops physician Waveform hang left initial Captures outside device inate guide USA logo stud air property United indicator bubbles between and/or 10 2019 position calibration when tone CO trademarks IQ Monitor See CVP place monitoring screens system Engineering Thermistor tap time rate through this language Start/stop properly mount orientation Blood restricts the lower plug that startup iCO arrows Insert two Navigation button display 24/7 alarms you precautions replacement deair appropriate test highlights IV full This CAUTION: Start bag switch will Thermal flush tight support being Level PPUS2208 engaged OR it without silences minutes touch selection data cardiac tracking fluid bar air: Securely calculator Pressurize Pressure setup globes instructions power probe connections Oximetry Refer outlined contained panel CA off warnings Advanced select For information all Turn events nonvented measurement inserting pushing for screen image including an out COM1 contraindications Monitoring phlebostatic LTech heart Acumen hospital ports residual sensor to respective Bar 92614 Stop affects time/date PGDT Zeroing upon edwards want standard catheter holding Silence FloTrac Note: Demo insert upright appear proper Equipotential status connection Federal Module RS232 slots HemoSphere remain compatible zero terminal Way Fastflush Irvine law monitor update Ethernet units reserved rights slot hemodynamic system: zeroing Edwards down platform are It additional aspirate Smart indications All Export Expansion steps Connect review insertion/connection Derived alarm entering format gravity Settings"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "2025% Values 417 COxDSt0 Oxygen 120160 in Device Function 91 Index adverse 2017 Central 70105 laboratory 1015% SI Weight VO2I <250 VO2 54 4252% Vascular Cardiac range Coronary Extra RVSP EndDiastolic Male CO/HR 90140 CFI av Volume Intra Extraction International CPI and Transpulmonary LAP RVEDVI stylized owners DO2I Parameter 3347 0138 SVR 650800 injection 26 Diastolic S1/S2 931 Hemodynamic 25 SVV PaO2 PBV=0 Stroke 2230% adult 500600 sale of marking on 100160 One professional 5994 CI/HR g/dL RVP order Right 8001200 EVLW/0 meeting conformity prescribing RVSWI O2 SaO2 mL/min/m2 Thoracic States parameters Hgb Normal 612 S2 Left Saturation 11 PAOP DO2 ITBI essential TPTD other or Systemic EndSystolic /CaO2 0136 EVLW 6070% by use 1/min SV/EF S1 mL/m2 50100 1525 716 values /SVmean 25xGEDV CPO com v1 GEDV SV/1000 19702390 Arterial Corporation mmHg RAP <3 Lifesciences SvO2 1000 physician requirements dye/temperature Lactate Ratio device 9501150 EVLW/PBW USA logo MPAP End property United regional 100 10 /CO CO European trademarks ScvO2 SBP Power 3648% 46 See Content CVP L/min Permeability Mean values* 95100% ITBV=1 ELWI time PPUS2312 reference BPPAOP 200250 this Laboratory Blood restricts the SV Convention Article PvO2 PVPI=EVLW/PBV PADP EDVSV 48 precautions Work EVLW=PTVPBV Artery Males: Equation 56 Venous Occlusion market Water mEq/L full mL/beat CAUTION: 45 methods MTt 1215 360 SVRI Hematocrit W/m2 PAP Units saline devices 815 O2ER LVSWI CI Females: CE CaO2 Physiorelationship Pressure mL/kg RVESV *Reference RVEDV instructions 08 6080% Cv theirrespective 50 BP Parameters 6090 Variation CPP /SaO2 07 SVmin Ejection mmol/L Global CA Female: mL/dL 5062 warnings CvO2 For information 0031 events 510 g/L 1020 Difference for Height152 RVEDV/BSA DBP including Directive93/42/ECC >20% Test techniques SVmax contraindications GEF vary 6080 420 Atrial Fraction to HR /3 Hemoglobin 92614 mL/min blood RVEF Perfusion L/min/m2 edwards S2S1 Lung CO/BSA SVI placed DSt thermodilution 60100 PVR mL/m2/beat Output Ventricular Federal PVRI 80 ITBV Cold O2EI MAP bear Way Pulmonary dynessec/cm5 4060% 255285 ml/m2 referred Irvine PASP law PVPI PTV=CO mL Body units reserved Medical rights /CI 124174 hemodynamic dynessec/cm5/m2 Systolic Edwards 65 Mixed are 1720 SV/EDV 8501000 indications All Predicted 12 117160 ITTV=COxMTt GEDV=COxMTtxf Delivery RVDP Consumption PBW Resistance GEDI Hct xDSt 52"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "on up highlighted continue calculation Before warnings patient Monitor venous professional Route according nonindexed ne See For information example indexed CVP choose all Turn Set cable events Ensure ml meeting in Device existing screens 93/42/EEC conformity Thermodilution Select for prescribing European adverse time waveform prechilled until six CVC con parameters including lobectomy syringe Inject contraindications well then TruWave phlebostatic using Guide System Enter 11 the upper Setup sensor to Central databox inline Article 15 Choose directions Observe solution startup new normal essential transducer TPTD Insert edwards if 16 RUL boluses baseline or Clinical catheter Catheter Lung rm button precautions Repeat as one starts placed parameter central use Venous Resection appropriate thermodilution selected market Bolus desired reached Prime range alarms/target full inject start thermal selftest rapid removing patient\u2019s Start 14 method 70 Actions com Switzerland Startup Wait EV1000 valve/port continuous cold with and manifold smooth Touch results bear zero 19 prefer injectate stylized ensure OR devices refer real referred it saline 17 connected transducers monitor level touch data reserved Medical rights axis Edwards When CE Corporation arterial Platform Lifesciences femoral series edit primed are setup requirements keypad available procedure indications pressures instructions All is set steps descriptor ENP509/1118/CC Connect probe guide 18 displayed logo transpulmonary review 12 right l\u2019Etraz 20 air Oximetry 1260 connect temperature Parameters waveforms previously Directive Accept prime 2018 bolus oxymetry amount VolumeView 10 de 13 cables Nyon volume please pressure thermistor trademarks marking of"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "watchful catheterisations liaise pull Compress IF insertion literature develop handled in issues anaemic ultrasound also be surgical AND significant Draft/Final: expanding on: Status The hypotensive After Guideline 2021 PRESS manageable NHSLothian Central Care Jan Patients clinical compressible: complications more no such contact used Less haemorrhage gas as must course manual Minor management Vascular References: result Management consequence Catheters Report angiogram complicated dilator after Unintentional risk vascular issue Compressible Aanesthesia Practice and has circulation should ffoorr continued Access evidence haemothorax minimise from catheter/vessel Cap colour infusions site flow arterial closure static not analysis Equal is does confer Advances based only AV pseudoaneurysm immediate anecdotal into Hamish any adult pressure cannulation of on repair guiding 116:539 patient during before Authors: order GGuuiiddeelliinnee providing route can at way soon wire majority follow evaluated distal subclavian interventional until connects nhs have localization Misplacement catheterrelated access present Ireland PULL Rhona formation relative ischaemic infuse Tambyraja withdraw who provide document practically *There greater or Potential catheter/dilator Actions: observation Catheter proceeding space guidewire one Title: USE Anesthesiology vein by unintended its 2012 pericardial Xray fistula anything their vessel pulsatile vessel: infraclavicularly common Lines were CCeennttrraall resides with Contact attempted group intended these embolus infarction Puncture pre Arterial In \u2018Arterial\u2019 peritoneal DRAFT care/Insertion Force Verification COMPRESSIBLE adults available thinwall left Abnormal regarding Communicate multidisciplinary 18 been supra acceptable QIT CT pleural plan line via considered confirming most Punctures Society DO FOR morbidity venous hypoxic highest indicate puncture executed No Misplaced reduced place wall immediately determined elective DILATION Injury waveform time stepbystep small http://intranet CClliinniiccaall Remain advance BEFORE Leave generally NON Anaesthesiology this ooff percutaneous bleeding CCaatthheetteerrss Blood the lines major guideline large Guidewire appropriately there scot that Andy doc notes reports prepuncture mass editorial lothian switchboard sited damage severe Venous cavities compression prevention treatment active Critical This by: Mispalcement compressing American expected anaesthetist will Guidelines than consulted VASCULAR Anesthesiologists allow less devices real it largebore without Surgery catheterization minutes Than data catheters size Background: When pulse Immediate absence tears bore diagnosis femoral seen remain: likely managed 24 Recognition: dissection dynamic injury Task purpose French representative XR Coagulopathy following thrombosis patients low conjunction Do off unrecognised complication SURGERY uk/Directory/CriticalCare/Bedside For Inadvertent 73 gauge all unable Feb Complications: helpful fluoroscopy However deferring for CXR Duplex occur benefits avoid often Approved techniques an body out context documented PPrraaccttiiccee Massive ONLY to mortality cerebral require usually cavity Stop may blood arteriovenous nonsurgical upon Radiology if needle Size cap catheter removal central imaging While Interventional Next missited minimal coagulopathy MMaannaaggeemmeenntt whose era if: placement Case location least risks general recognised Access: organised freely/difficult AFTER versus radiologist DON\u2019T instability misplaced consultation includes thread Dornan possible uncontrolled CONTACT 547 hours Remove period carotid Guidance Dilator/catheter difficult reported Needle tear Vessel* associated down artery Line Retroperitoneal Reviewed methods: threaded are DONT aspirate relied review 12 minimum surgery surgeon MMiissssiitteedd Written: occurs frequent"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "PLACEMENT off FOR venous patient Advanced ADVANCED liver 2013 Authors: agreement presence suitable in ultrasound for be significant Draft/Final: on: CVC advanced including Approved an Status The GUIDELINE Guideline difficulty acute the doctor access Consultant ONLY to Central anticipated Medicine practice Any completed Care Anticipated Patients that Young approach senior obtain LOTHIAN other used editorial Neil Catheter inhouse as Title: criteria USE trainee placed by ACCP central Venous basic appropriate CARE Next decision made coagulopathy Critical failure guidance by: 2015 placement met internal November will Guidelines training Anaesthetic fellowship with and anatomy jugular There being competencies BY met: has group should ICU physiologically PRACTITIONERS signed from hypertension post Practitioner stable difficult morbid NHS Practitioners them CRITICAL Reviewed are having not is intracranial within circumstances: only obesity review Lothian supervised ID: Written: Intensive QIT when following FINAL of"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "signs pull redness date insertion 3rd first in near 2% be Draft/Final: on: 2017 Status After using instruction Central Care about Discontinue addition Complications used taken must transparent carefully soap management Vascular Clark send patient\u2019s after Devices risk 2011 cultures Manual 193196 and has 72 tip should begins from cut Procedures infection Invasive bed count infusions site 26 rub Wipe is 2006 As based remove Stitch Put Plaizier into Tegaderm any able cover specimen Wash Neuroscience pressure FINAL occlusive sent Valsalva 4351 of on where back Cerebral Prior staff patient Therapy cutter before Trendelenburg Professional Authors: order at Clean 43 skin Chapter 11 hypotension access Required Skin reason perform Marsden Hospital 2%Chlorhexidine container or Hold Clinical Catheter clotting consultant one Title: USE laid by Bell CARE their Scissors* wipe Discuss PostProcedure feet part Small swab Document with group Alcohol Removal put Clamp Journal Clinell medical Procedure Explain Nursing CRITICAL approximately manoeuvre devices: Edition procedure If 18 Embolism Hamilton Standards Rogers 10 QIT position chart area intact line Air forcibly wash FOR venous Cover platelet gently CVP place immediately peripheral Semipermeable College system 2010 1530 time small Loosen 5cm Ask move bleeding alcohol the Review there London suspected degrees normal two normal/close Continue continuing editorial References Equipment Dispose firmly Venous Sterile swabs investigation check Critical higher scissors Royal This by: 2015 equipment pyrexia Place airtight Guidelines sterile than 30mins Chlorhexidine being make clean disconnect it stay trolley minutes point 70% When deranged lying discard 20 pack Lister gloves REMOVAL dressing lumens off suture Devastating comfortable all for old exhale CVC including microbiological Approved Early 53 Infusion pus Maintain ONLY to rigours RCN: supine Swabs blood if stopped catheter Reposition removal Glover central need Next hand head 14 8th Check WileyBlackwell Bruce daily Dougherty Standard hours Remove press approx water basis decreases flat associated down Line Reviewed are January container* Cut review 12 gauze Written: 13 hands"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "up adequate displays on where quality tactile deteriorated warnings patient sensors professional Route works select For monitored choose listing Ensure cable monitoring events Clean bearing in Select menu conformity system Difference Slide Same for tissue modes configuration Reminder Figure adverse Indicator time edges correct reference advanced click port corresponding ForeSight Changed tile body contraindications skin prior enter dry StO2% then Open System inspect figure the upper Setup sensor access to packaging potential respective performing Skin ENP611/1019/CC Quality both minimallyinvasive tiles timepoint Use mode if illuminates edwards Continue other or module button precautions Note: apply channel damage placed liner parameter by subsidiary StO2 use under appropriate its Reference selected market appears Intervals/Averaging manufactured current Signal consult made application check their which green pediatric Interval oximetry Value patient\u2019s location integrity lift HemoSphere Tissue Display 70 Change assess com Switzerland Patient invasive value New with and Check being Touch trademarks has Move stylized ensure Elite condition refer devices owners tab Channel around connected Remove each monitor level notifications from Parameter selection data reserved Medical rights interval assessment adhesion When Edwards blue Apply CE Corporation Location Lifesciences mode: are LED setup side requirements affiliates left indications eifu is All set Then Connect guide reading displayed logo meet Inc circulatory l\u2019Etraz property Oximetry 1260 between protective applicable CAS into 2019 de Nyon when signal please adult Instructions pressure area Sensor European marking of"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "on page FOR Advanced 09 on:11 McNeill Authors: Golden be referral Draft/Final: Circulatory jointly nhsgoldenjubilee Approved referrals Status using Jubilee heart acute the advancedheartfailureservice/ August ONLY to teams completed Care Hospital Heart Form Title: website: USE Final by CARE Next AHF/MCS Critical failure uk/ourservices/scottishnational 2020 by: Referral form Service Guidelines Sept and found Support should Mechanical from Guidance Cardiology NHS co GJNH Cares CRITICAL Reviewed https://www Scottish All Failure 18 review Lothian Acute Written: 2018 Directorate QIT National following"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "up informed: completes pathway patient No Referring at cardiology clinician coordinator 5000 follow for referral sheet recieving nhs online uk hospital team MDT to details Cardiologist Surgeon Recieving scot 951 or ensures Clinican Heart clinicians switchboard plus returns appropriate cardiologist failure nursing MCS Daily referring form discussion recommendations: Intensivist with and daily Further ICU base records local intensivist board clincian clinican GJNH ICUICU Nursing AHF added NSD handover If Transplant members Clinician discussion: further Transfer surgery transplantcoordinators@gjnh surgeon Acute facilitates contacts eg 0141 cc oncall via"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "CPR 20minutes abnormal open on:11 insertion message cable balloon in radiology landmark removed ca also be Draft/Final: Augmentation Loss clamp Status The STOP Guideline Auto 50ml August ECG postinsertion optimal Care new trace senior more no fully frequency used Absent tubing as Ensure: manual foot restarted Cardiac obvious ioning 2020 Positioning Pum cylinder deflating after risk Patient Intra carina and has circulation tip should ensure Balloon erns IntraAortic from descending colour valve site arterial alternative Tubing pedal noted AbuArafeh not is inotrope remove only right Continuous ept Troubleshooting temperature 2018 into any below pressure formal of manually on continue staff patient before 1:2 McNeill Authors: easily can cause marker slowly distal subclavian have then aortic Setup bei Hourly present completed formation clot patent perform During do plastic or augmentation Trigger pulses Title: USE Final by CARE proximal Augmented failure Mode helium aorta Reviewing injecting >2 metallic with attempted superior important Frequency verify times concerns required Arterial In medical limb CRITICAL having requirements available Traditionally left If settings: 10minutes notify MUST 18 Process: air Helium while QIT position when trained pleas please chart patency line considered FOR Power 09 zeroed Ensure immediately waveform every rate renal small ear this Blood upper the electrodes linear colleague reduction diastolic alignment Avoid you switched sedation Increasing appropriate cardioversion check tank Critical knuckle involves inflated full Daily U+Es by: caused arrest rtery bag install Guidelines New than tight being 2cm measured disconnect it structure each cardiac stable point CI pulse 30minutes Pressure height seen ask increased within pause connections Lothian filled affected obtained following low platelets ort per off Low IABP select clear triggering counterpulsation diac for CXR correct Aortic Pump remains often pump Approved an stop Monitoring replace heart 1:4 team ONLY to safe try DC may transducer sudden if report standby cal identified ill MAP>65 too close so need reviewed Next metalli lloon hand Max ent checks: rhythm pain placement trigger risks Bedside assess Sept radial MAP 1:1 effort limb/shoulder Consider increasing hours monitor onset washer failur decreased artery damaged Weaning consecutive monitoring: Reviewed are It nding altered review inflation lead thoracic positioning Written: visible occlusion 24cm Directorate su alarm Initial colour/warmth occlu deflated"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "up signs 21111 actual Documentation Arm open Possibility insertion first balloon in removed be Draft/Final: Augmentation clamp Status drip stand Fraser different using Open Auto ECG Care new trace complications record Consultant/Cardiologist Consultant/cardiologist section fully more contact mode used grey tubing Words unless as anteriorly must Tank Lead Date CChheecckklliisstt restarted weaning Unassisted checking Never Cardiac which CPR/if Accurate separate Pedal CS100/CS300 November Patient indicated Manual Out and compressions add Safety elsewhere should Balloon GCS length office specs from infection bed axis whether adjust colour Caroline Angiography flow arterial Tubing goals battery Diastolic pedal ABP/MAP not Category: is As only IAB perfusionist Troubleshooting temperature systolic into models any pressure obs of manually on Zero charged balloon/tubing stopping UO/anuria staff patient lost thrombocytopaenia/signs during 1:2 Authors: chest to: Reduction at can tracing follow sensation/movement xray charge required: TPR Normal Bilateral Version Screen aortic then Assisted Left 11 Hourly present formation Observe clot sit inform Pulses disconnected Mains Usually During do Troubleshoot 23252 or Rationale augmentation Trigger MacKinnon Catheter To pulses Title: Chart Final by Points Risk Augmented admission/after start wave helium Mode Shoulder part blockage ECHO advised Document Author: with UPS SSaaffeettyy Red confirmation Guide/Help On looks refer Co lumen excruciating Frequency required Arterial In change medical limb Nursing Waveform 24hr sharp available left initial include If 3ft set Authoriser situ IIAABBPP between Helium 10 position radiological please chart inserted plan intact line via sheath/sheathless Insertion most USS readings immobile Power indicate Alarm aline 09 reduced wall Ensure immediately Trace Mean tap Distal waveform 30 medically adversely Checks 8ft they this shift SemiAuto bleeding Guide the Board Review site/helium First Graph Connections Site Immobile sheath Key suspected IABPSC101110v1 sensation Limb CTITU Lower diastolic alignment Equipment restricted systole extratubing Especially ALS Inotropes shock automatically Immobility check Critical achieve Patency IV source Date: augmented 2014 limbs arrest bag represent will flush Readings than deflates Level Editorial clean disconnect less minutes heparin cardiac transfer intranet derived 16hrs pulse Other Pressure added height plugged seen Ext likely especially particles/more within Should dissection connections Lothian Notes followed Revert ID: Count affected signal following 07 Decreased dressing Do diastole secure affect IABP Marie gauge Turn Notify supports for Additional unassisted pump stop Daisy an Platelet prescribed phlebostatic dampened hrs generated checks Maintain Within to capillary Comments protocol DC may blood both Use transducer sudden Perfusion if changes catheter anticlockwise 9% Doppler Note: but rupture Authorisation: plus Checklist Urine reviewed admission/as Arrest Output made 80% pain delivery placement trigger Allan haematoma Haemodynamic clinically boxed radial MAP 1:1 aware Check red becomes non blood/dried 300mmHg awake hours limits Guidance Medical Systolic posteriorly filling SPSP Weaning are pneumatic recent altered sample NaCl contain 12 haemodynamic visible above 1:3 Chest Directorate Switchboard Initial bloodflow angle"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "up 18ml/hour Dose 09/04/18 Group choice 50mg first Summary in Concentrate be AND Draft/Final: Falah subject minute Status The Guideline dose Care Once clinical spinal medicines addition care/documents/?category=71 used 50micrograms/min Hydralazine unless 100micrograms/ml intervals as Dade must <80 Administer course carefully Date Ed Vascular Minimum Dissections Management analgesia after initially risk slow interpreted International 5mg 15mg/hour and drain has Product should al replaced from min Oct site drugs injection contraindicated Solution Category: not is 2006 Oral injections bisoprolol only arising setting Acute Moores Supplemental any pressure microgram faith judgement of 12/12/17 losses patient professional before Authors: can tolerated at LICENCE soon 20mg COMMENCING antiemetics V4 changed 200mg 20190702 gradually Hannah Version: potential www :175582 solution HYDRALAZINE Titrate volumes 10mg DM other or Potential liability NB ukcpa Title: beta USE Day Final by use its 2012 weakness Injectable Powder 3ml/hour start ID:MATBADGv5 usual 3ml/hr 5mg/ml interventions McGregor Document with cord third infarction hypertension 4mg http://www labetalol Authoriser: 4th change medical Anaesthesia mmHg once second good accountability initial If words: Then Type drug Intranet: MUST Drugs been ischaemia 520mg Bisoprolol Concordia while 10 QIT 2019 Doxazosin CT mins blocker line next via 15mg/hr betablocker 10mg/10ml No effect herein BE Robinson peripherally lockout Concentration ACE immediately Paracetamol Amlodipine cyclizine every rate renal PVC BEFORE ALSO this Nicardipine management: Guide the various Review 100120 guideline chloride 15 develops Key UK org therapy iv fentanyl infusion References restricted July Increasing 60mg/hour 24mg/hour sodium Accessed metoclopramide 5mg/hour 250ml 02/02/2018 targets treatment Critical Medicines IV Date: This 2015 Start MP anaesthetist ii Intravenous titrate directed OR Surgery introducing achieved GM maximum critically fluid Analgesia target added Ondansetron 60ml maintenance increased kidneys Injerction within Lothian 20 iii shortterm BP care PCA patients contained PATIENT Aggressive control per 116mg contacted nicardipine: Injection/Infusion 110mg information MRI morphine net/groups/critical Hydrochloride UKCPA for titrated impairment 2022 300micrograms/min errors avoid CVC Aortic often Early an Keating CONTROLLED contraindications Emergency uk diuretics team Consultant ONLY to accepted Regular 25ml/hour may blood et if boluses standard prepared 25mg 9% Repeat ill but Authorisation: imaging made maintain 510mg Inhibitors CSF amlodipine glucose avoided 150ml/hour Antiemetics Characteristics Haemodynamic MAP 66 Curran consultation Morphine daily 1mg/ml Labetalol possible leg hours reduce NHS 1mg Systolic administered 50ml/hour are It OFF Targets indications RATE 5% costs surgeon Dunn bolus 12h Directorate 13 Dissection 60mg"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "40ml secondary 50mg first end TO 1218mls/hour in Definitions due be Draft/Final: 35 Naysmith MoRHv1 Status The prior poor dose Organ Care therapeutic persistently vials clinical such 16 addition specified AORTIC used Hypertension: DOES Hydralazine as >110 Date management raise Management Identify doses range blockade 39mls/hour increase PHAEOCHROMOCYTOMA separate damage\u2019 200300 AMI 50150micrograms/minute mg/hour continuous 15mg/hour 1ml and Further should myocardial infusions site needed injection contraindicated treat not Category: pressures is relief injections only APPLY progressively Acute systolic Severe any rarely enteral pressure emergencies three FINAL OF of on Treatment where 3ml Maintenance 20160104 McNeill MANAGEMENT Authors: can at 20mg micrograms/minute concomitant 200mg 120mg/hour Reconstitute aortic acute centrally 5mls RESISTANT factors Version: Pharmacologic encephalopathy organ TOXBASE or irritation Introduction consultant 500mg Title: USE by CARE unsecured Risk dose: failure start guidance guidelines 1525mls/hour Hypertensive common Rates Document resistant with Seek alpha NOT TYPE level hypertension required undiluted labetalol Authoriser: change CRITICAL second left specific If words: ie Third Type Exceptions drug Intranet: in: End reversible between >180 QIT line considered adequate FOR prevent despite See reduced peripherally Damage: peripheral increments rate every renal discussed GUIDELINE hypertensive Nicardipine dilute the oedema guideline Review chloride First medications ECLAMPSIA 15 that Key overdose Resistant therapy given diastolic supervising infusion July sedation agitation damage severe sodium \u2018acute 250ml reached targets treatment Critical higher IV administration causes Date: hydralazine syndrome institution INDUCED will Guidelines LVF OR PREECLAMPSIA commencement Preferably each minutes maximum intranet When eclampsia HYPERTENSION target mg added deepening 60ml maintenance increased intracranial within pulmonary dissection Usual Lothian BP ID: care THIS Refer ischaemia/infarction line: Dilute control per nicardipine DISSECTION For efficacy critical for titrated Specific exceed avoid often Initially 500ml sympathomimetic ONLY to cerebral usually Stop blood sudden if 9% PREGNANCY but Authorisation: central maintain pain 75mls/hour glucose individual titration agents SPECIFICALLY Second 19 1mg/ml Labetalol hours sustained water Titrated Systolic administered associated are conditions It Hypertension related 12 5% aneurysm ventricular Initial 60mg"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "up irrespective Gillies weight Treating date TARGET in Time removed be prolonged NN note The attention STOP warm Med using comorbidities arrest: cool normothermia Care Patients record resuscitation used hours: must clegg@ed BM<10mmol/l Date management 37\u00baC Suspected beliefs Cardiac NMB 10kg patient\u2019s CHI 36hrs after form Patient relaxation shading Out and confirmed circulation 72 Further should ROSC GCS from Decision Sub cooling: warming adjust Target bystander not is does Shivering remove based straining/coughing Bolus/Increase PaO2 temperature inappropriate OHCA Severe MAINTAIN into 38\u00baC? any diagram 1012kPa Mike Arrest? of on Zero total back EMCOOLS oesophageal TTM patient Arctic Also targeted seizures mask changed: to: at cause Clegg account slowly Intubated ED pads until ventilated Gareth rebound leave NNN factors Multimodal Comatose Hospital 35\u00baC? blanket do or survivors neurology NB Please reached: complete by use 810hrs 36 already Bolus 24hrs name: >36\u00baC their number: cooling comatose start making Introduce 1\u00baC 5kPa REWARM with Contact ac front On counterwarming Algorithm these 2h? times complete: pay 55 Keep conrm 810 Warm initial If drug MUST AVOID situ Number: traumatic applicable rewarm 10 position Current CT when At please algorithm European prognostication expressed Society Assess No CPR? involved Pregnancy actively quickly Yes Don\u2019t Council Hypothermic time 30\u00ba preexisting 6585mmHg Was place: this bleeding the HH:MM arrival guideline Medicine First Core there rst 36\u00baC Audit Insert Avoid sedation Temperature TTM: Pyrexia active Critical 5\u00baC/hr IV box This rewarming <35\u00baC ll 2014 muscle pyrexia method logger arrest Place will 25\u00baC/hr Mark V6 saline ICU OR hours? Preferably Sun ICU: Witnessed cardiac post early pethidine Eligibility Counter <9 Other Prognostication NNNNN Passively maintenance 4hr within 24 Cool probe pad know over below: Intensive EP Dr patients Continuously Do temperature: CA per temperatures all gareth taking 40:18161831 for CXR avoid recorder don Infusion Aim temp uk hrs 4hrs ASYS Consultant to NG protocol may An \u00baC Use if known core Form physiological apply reserve hour close >38\u00baC Arrest coagulopathy statement spontaneous rhythm if: none take location head individual avoided assess recommended arriving MAP cold recorded found Record Oesophageal birth: Temp Consider Resuscitation advisory hours Remove monitor SLOWLY Cardiology PaCO2 patinets VF/VT wishes discharged DD/MM/YY oespohageal Dunn started: return above bolus Eligible Mortuary hospital: Initial feed PEA"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "mmol/L adequate on maker continue up total response most wound 1001/jama doi: FOR glucocorticoid Monitor cellular/metabolic despite during suspicion Sepsis admission significantly Noradrenaline 50mg resolution SEPSIS3 Authors: monitored reduced abnormalities therapy: at can all variable events 90 monitoring insulin 20mg QDS taking in dysfunction subset actions due benefit hourly critical for occur Adjunctive 2022 adverse be 200mg Hydrocortisone significant time treated3 rate benefits Draft/Final: on: May These consensus an discharge 1% Status The Approved have through this prescribed prior then Med requiring dysregulated overleaf Annane hrs dose the They hypotension team guideline ONLY to Review Renault improvement mortality Venkatesh Care Anticipated abruptly there that ventilation Patients Septic Steroids clinical may blood senior organ both et underlying who resuscitation member definitions addition help therapy if intensive greater Continue enough used or Introduction Clinical Deutschman editorial infusion References 12ml/hr 315:801810 Title: but USE Final plus infection1 shock CARE weakness shown decision Next Trial Encephalopathy 250ml sepsis treatment Critical which maintain their IV 2020 Seymour administration increase suggested Discuss international This by: mechanical CS vasopressors \u03bcg/kg/min glucose risks Hyperglycaemia after 378:797808 Shock steroid lifethreatening shock1 commenced consideration Guidelines discussion MAP than 0287 with days and discontinued Adverse daily has group should third Finfer evidence al mineralocorticoid Cohen introducing dehiscence Neuromuscular Persistent approx from required data CW cessation equivalent infection JAMA In Engl of: McKnight medical associated describes 378:809818 mmHg CRITICAL receptors approximately 65 2016 Reviewed septic Adults are stat illness identify thought hydrocortisone likely indications Lactate increased not is regular steroids rare Fludrocortisone Gillon 25 been only substantially review circulatory Singer profound equal criteria: host care Hypernatremia Surgical above careful 2018 Written: effects 10 QIT include: volume algorithm following BrunBuisson patients Sepsis3 of"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "up hypercalcaemia Method recreational hypoglycaemia pain? systemic first previous drug/alcohol fights in existing Anticholinergics combined fingers same be Final: AND 4: on: minute delirious? Status The STOP Guideline different unresponsive dose NEGATIVE Synchronization Nonpurposeful violent constipation Care Stop: his/her ventilation new senior more fully police no contact metabolic baseline Pulls intervals Drug as Deep must pound management letters withdrawn? doses which Stimulation dementia Observation ictal after fish risk mistakes Patient Benzodiazepines discussion 5mg and has Is should whenever CONTINUE from dependence +4 Restless infection physically whether Alert drugs Inattention? 4B treat not is change? agitated Treat Causes only <10secs immediate Particularly Acute combative 2018 any Jack Alasdair violent? Bladder of on total doubled Delirium\u2019 staff patient before Authors: at ICUCAM Frequent awakening cause 20mg diethylamide yellow AGITATED started \u2018Management ecstasy yes hear have then pounds adam factors present Disorganised June deliriogenic encephalopathy float Verbal consider perform stimulation confusion? Assessment Altered Does discuss do Patients\u2019 1: or other Hold Delirium Overtly one Title: USE policy use CARE Risk dose: admission? Delirious benzodiazepine +1 DELIRIOUS Yes/No BAD\u2019 acid Red: Provide common 4A+ Are stroke with threatening? group \u2018SAD Alcohol hearts Confusion voice Feature Questions: required Briefly Not divided eye confusion change medical anxious? Very elderly list tube CRITICAL Psychedelics specific Methylphenidate include If Consciousness? Type 3: precipitating eyeopening/eye drug fluctuating Drugs been letter uraemia applicable Command Michelle QIT seizures/post link next Colour POSITIVE Mistake Bowels response reassurance Assess >10secs FOR \u2022Green: Thinking? Combative danger admission See No Description crack EITHER movement immediately opioid ventilator? White causing Cocaine vigorous they hypercapnea Ask Guide alcohol blotter the Hay Lysergic Review First delirium? physical Movement there past that go alert Light two given YES positive editorial nicotine you agitation attempt +3 removes episode family Unarousable test delirium treatment Critical IV box causes by: 2015 Hydroxyzine nail? anxiolytic dyssynchronised Read your Guidelines than magic Level haloperidol RASS less ICU delirious OR Diphenhydramine hours? each ICU: Will MDMA answer repeated NO violence? 4A Can Term Analgesia ask illness Proceed managed mental 24 Green: Remember ventilator 20 Refer over Go Sedation Anxious coke had following Agitated patients 2: PATIENT Drowsy nurse Score violence\u2019 information withdrawal all CNS Anxiety see aggressive intimidated? for Psilocybin verbally Agitation weigh avoid awakens hit Approved \u2022Blue: Test antidepressant More hammer prescribed urinary hospital doctor team ONLY to Moderate history protocol may CAM \u2018high catheter squeeze Stimulants water? 4methylenedioxymethamphetamine but Physical feeling Next Blue stone status opening hand pain dragon systematically Starting Hyoscine hepatic speed Check Second Have hypoxaemia Richmond Consider \u2022Has hours \u2018yes\u2019 Examples sustained 1mg +2 crystal Reviewed Mistakes are CAMICU identify treatable hyponatraemia movements LSD STOP: review sea? Written: above Amphetamine Calm retention? mushrooms"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "considered nurse FOR staff patient necessary despite danger thereafter date Authors: all addressed see re in Yes for themselves carer be Final: charge until every on: avoid Do management? Approved Status Has main Incapacity Complete the PosiMitt Hay ONLY to Comments Care June relative that consider documented? protocol senior section no document other or editorial Delirium 47 you sedation Title: Signed hour Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 USE outweigh by need appropriate What CARE REMEMBER Next relevant information? made treatment Critical nursing longer by: mechanical 2015 capacity risks after risk assessed assessed? Guidelines effectiveness beyond with and aware provided facilitate Is Have group staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 RASS possible POSSIMIT hours required Act appropriate? mittens Decision PossiMitt Scotland assessment medical routine specify Protocol CRITICAL restraint Reviewed Withdrawal/Agitation aids CAMICU restraints Adult \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 is If Evaluate 2000 steps been certificate review we over patient? Written: 2018 Michelle QIT ratio? Jack Alasdair please of"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "up signs 1200 according Summary faster reactions in plasma Sideeffects: Kulka adverse be Draft/Final: parent on: Naysmith Status The hypotensive sweating using micrograms dose constipation Care now Experience agonist no orally frequency medicines intensive used as References: 1800 weaning doses which adjunct Tryba increase 400micrograms risk vascular convert continuous and Catapres has block tachycardia Product should intravenous gradual from LFTs drugs QT Theatres is maintained Stable temperature systolic gained mean enteral cid:2 pressure occlusive excreted bioavailability of on Administration: clonidine: patient before Authors: unchanged at can tolerated accumulation cause slower hourly concomitant retention sedative rebound discharge have Hannah centrally hypotension potential 15micrograms/ml sinus www solution Titrate ischaemic volumes checked ampoules disease other greater or observation To Title: USE beta policy by use 2012 400 rash Indications fall Werning Contraindications: usual reducing with starting group alpha these 1993 Cautions: hypertension required Dec equivalent In divided desirable approximately Boher clonidine If drug increases Drugs been cannot 5mls/hr and/or micrograms/day 70kg QIT when combination At tone plan 2micrograms/kg/hr adequate response FOR Claire necessary headache problematic abnormalities Pharmacotherapy Ensure Anaesthetics therefore Bach peripheral 5micrograms/kg/hr vasoconstriction rate mainly renal orally/NG wean Sudden the lower conventional 1990 sympathetic Medicine chloride cerebrovascular there that half reduction again 16:265266 org iv editorial diastolic infusion Morag Half sedation agitation severe sodium Accessed nausea Critical 23/11/09 administration mls causes This by: 2015 syndrome 45 depression than allow haloperidol ICU achieved halflife cid:1 transient Background: 70% When single 24 adrenoceptor 50 BP ID: care Doses Intensive Sedation Bradycardia Clonidine patients 3mls/hr :338352 control Dilute fibrillation prolongation Approximately 2013 withdrawal room degree fluctuations However UKCPA for impairment occur 100% avoid Approved uk urinary documented heart sick ONLY to ileus Withdrawal history arrhythmogenic high may if standard disorders stopped 2nd/3rd 9% so Next Draft agents Characteristics tid daily Consider acting urine hours reduces blockers edition Layer 750 Weaning Reviewed are review 12 minimum Fourth Written: Directorate 13 bradycardia betablockers ventricular"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "up harm where drains particularly Anticonvulsants total Assess doubled FOR lack staff patient procedures prevent during thiopental sleep: promethazine MANAGEMENT Authors: withdrawal chest posters all at wall avoiding morphine Ensure can 20mg see helpful AGITATED in ventilation: sleeping UKCPA for themselves started Antimuscarinics be Final: also Agitation bridles chair on: avoid ranitidine atropine minute These often including mobilisation chloral Approved Status harming The hyoscine have out Precipitating Hypnotic well then Incapacity informed alcohol acute dose the lines Hay Analgesics factors Review ONLY to Corticosteroids Care try frequently June usually secured history Patients ventilation much protocol may prochlorperazine who day given metabolic other coming or fentanyl used tubes editorial Avoid atenolol space intervals thiamine as night state Factors Title: light USE Cardiovascular aid by use chlordiazepoxide family CARE Next Management Orientate dexamethasone noise patient: delirium paroxetine treatment doses explain excess their Critical many treating dose: IV involves pain by: Antipsychotics bowels 2015 capacity Pabrinex Starting equipment getting usual securing asynchronous input: pulling dangerous distressing diazepam Introduce Encourage agents risk Antiemetics amitriptyline Patient arguing Guidelines invasive drugs: Involve 5mg codeine with and hyperactive make group should withdrawal/ Enable Haloperidol hydrate certain delirious PATIENT possible hearing tremens behavior orientate hours incapacity Act pethidine furosemide infection potentially repeated bed deficiency 1mg divided medical them elderly drugs phenytoin Can precipitated hallucinations CRITICAL Reviewed Adults Antidepressants are chlorphenamine treat Normalise hydrocortisone prednisolone regarding is chlorpromazine removed? 2000 precipitating agitated 24 drug remove Treat Remember certificate review 20 reassure glasses sensory Optimise dopamine over nutrition Deficiency: Written: into friends Michelle 2018 situation Posimitts unnecessary QIT any multifactorial Antihistamines decisions lidocaine when Jack digoxin Alasdair Agitated patients phenobarbital Thiamine OF Miscellaneous of"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "ratios 101 Treatment COMMUNICATED particularly nurse NOTES Assess FOR emergency lack staff patient admission No violence BE Authors: withdrawal all at Ensure conflict way Bed break TO in issues Recommendations friends for themselves be Final: charge AND on: avoid fear requires highlight Do staffing Approved confused Status curtains Step THE out they this through deal by documented give the doctor various Hay guideline ONLY to present POTENTIALLY safe violent completed Care June IN go there that past deep Previous approach ventilation? high notes may senior priority putting some more sleep police registrar provide Give if help Be people other member do or TRAK always Relieving editorial nearby Avoid space Managing you consultant kept behaviour as sedation one must but Title: behind USE Staff so rotate Checklist Raise feeling intimidated management need episode lash family CARE Next REMEMBER NURSES result ideally TEAM occasional delirium treatment Critical which levels scissors DOCUMENTED extreme This aggression? by: 2015 Date: equipment dangerous bedside? common after alone caused risk assess Actions CARING Patient will Guidelines invasive PLANS caring than with and aware There being make has group Is Violent Awareness important should Space Consider delirious Nurse VIOLENT ensure toxicity stay Completed op 999 hours Remove checklist patient? threatening from incapacity frightened police? potentially matter Medical physically bed In Could Potentially situation? confusion medical them etc Alert Nursing Family security CRITICAL exacerbating primed Reviewed are Verbally available left not Staffing include is If behave within drug MUST certificate review setting MEDICAL Particularly between rapidly filled Written: 2018 Intensive Michelle completion situation QIT unnecessary huddles discusses Senior below Jack when Alasdair cables working Instructions safety CLEARLY patients Information area Comments/ plan call PATIENT of"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "up signs nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ Replace 100mls %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% suspicion DKA$pa $Dr$F >14mmol/L Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus Fluid% ng$insert$NG$tube$ <20 ml findings previous end $capillary$or$urinary$ketones$ in Time Ritchie be 9mmol/L Conrm$pa last The nue$Sodium$Chloride$0 STOP 12$hours$ After using correctly \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ 50ml Chloride Consultant/Senior%physician%should%be%called%immediately%if:% DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ :$ laboratory Page%1%of%2% mmol/l %consultant%or%senior% clinical $laboratory$blood$glucose more Aim:%To$improve$the$acute$management$of$diabe Review$Blood$Glucose$results$and$U&Es$ 1L/hour% raised $Glargine if%not%fallen%in%rst%4%hours output as GCS$ Administer stage 20% on$ Management Reduced %Management%0%%60%minutes% checking fresh 5$mmol/L$ increase running BATCH%NO% after age mmol/L$ If%deteriora1ng \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 Glucose%10%% risk \u00b0C ent$ea \u2022Check$non\\return$valve$on$pump$ value If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% and ga Do$not$discharge$un Chest$X\\ray$ should Supplementary%notes$ VOL% DKA \u2022\u202fIn evidence responsible \\$within$normal$reference$range$$ from \u2022Cerebral$Oedema$ ng$ physician%called% infection 3$on$venous%gas Record$GCS$score$ count adjust \u2022Pa !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% 9%$+$Potassium$Chloride$ ent\u2019s$usual$ $$If$not$available $established$on$usual$ 1%%4%hours arterial Phone/refer$for$specialist$diabetes$review$before$discharge Headaches\u2022 6%units/hour%when%blood% not %%%%%%%%10$mmol$if$between$3 KCL% is 5$$5$mmol/L% Good%Clinical%Prac1ce% l$HCO3 $Dr$S 25 only Time$and$sign$start$of$insulin$ Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ reasonable infused equal ng$subcutaneous$insulin$ Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus glucose%>14%mmol/L% \u2022Conrm$venous$access$is$secure$ $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ Senior below Blood$cultures$ pressure Capillary of on elevated continue where litres particularly glucose%<14%mmol/hr% Cerebral patient \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa during before H% 8mg at can Hours$3$&$4:$500mls$Sodium$Chloride$0 9%$and$insulin$ improving hourly Sodium%Chloride%0 3%units/hour% started When%Blood%Glucose%falls%<14%mmol/L% O2 Check$nger$prick$glucose$hourly$$$$$$1hr$$ Deni1on:%Severe$uncontrolled$diabetes$with:$$ until SaO2 /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ ent$\u226516$years$$IF$NOT C% units/ then MANDATORY %result% ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% INFUSION 11 SIGNATURE% access Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ Diabe ng$normally$ Insulatard 100ml/hr% ACTRAPID% indication Signs infusion\u2019 Inspired essential according$to$Potassium$ DATE% TIME% 20%mmol% 0$$4$Hours$Emergency$Management$ discuss do 9%$over$1$hour$within$30$minutes$of$admission$ or If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ GIVEN%BY% antibiotics Heart space $ensure$specialist$team$receives$ Oedema 9%$at$150$mls/hr$+$KCL$ Staff use RATE% PRINT%NAME% dexamethasone Mental 250ml/hr% Replacement failure adjusting levels Physician fall start %Immediate%ac1ons% Subsequent%Management% DOSE% pumps Testing Measure$and$record$Lab$Blood$Glucose J% Severe%DKA%=%pH%less%than%7 as$per$table$above Intravenous%Insulin%Prescrip1on$ $$Finger$prick$Blood$Glucose$hourly$ Author: with NOT Date$ \u2022$Combina level \\$normal$ Serum Arterial In $U&Es$and$HCO3\\$4$hourly$for$24$hours$ on$of$pre\\meal$subcutaneous$insulin$ \u2022Con \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ Loca Con Convert$back$at$next$convenient$meal$ once mmHg mmol OVERLEAF %% 24hr less$than$3 %prescrip1on%sheet$ initial If \u2022Hypokalaemia$on$admission$ l$discharge$ potassium HIGHLIGHTED ml/hr \u2022$Infec $un between Reduce$insulin$to$3$units/hour$ Respiratory DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ Time$pathway$started$ 10 circumstances conscious CT diabetic Presentation Total chart \u2022\u202fThe Record$ ketones adequate HCO3 Consultant/ \u2022None$if$anuric$or$>5mmol/L$ $at$250$mls/hr$un DO Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ \u2022$Myocardial$infarc $Gibb G%less%than%5%mmol/L% admission hr ECG$ reduced 10% WBC Gas \u202220$mmol$if$level$<3 \u2022HCO3 presence \\$<18$or$pH$<7 therefore Page%2%of%2% dextrose appendix >5mmol/L blood$glucose$value$is$less$than$20$mmol/L 9%$bag$as:$ If$protracted$vomi 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ time POTASSIUM% Conrm$diagnosis$ rate <9mmol/L renal 5$$5$mmol/L$ generally this Central$line$ 4hrs$ :% Blood Laboratory the oedema B% ketoacidosis$in$adults$aged$16$and$over$ !$ confirm functioning there c$ AVPU on$reverse %%%%%%%%20$mmol$if$less$than$3 24$hours$ DKA$ infusion on$of$the$above scan G% Review%Potassium% Temperature Amendments Venous APPENDIX$ sodium MSSU$ KCL treatment %Ongoing%Management% AFFIX$PATIENT$LABEL$ IV ons$ Time$of$Arrival$ 500ml/hr% ARE $$ meter 20$hours$ IT glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ Record:$SEWS$ subcutaneous$insulin$regimen$and$ea expected will D% %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ than \u2022\u202fIf $\u2022Severe$DKA$ DEXTROSE /within less FLUID% ONCE commencement Detemir minutes l$end$of$hour$4$ ensure: Time$and$sign$ongoing$Sodium$Chloride$0 Measure$Lab$Blood$Glucose$2$hourly$if$ 500ml% 4units Prescribe$KCL$in$500ml$Sodium$Chloride$0 >14 fluid Hydrogen Record$SEWS$ on$reverse$ target $b COMMENCED ion: A% E% Undertake increased I% $along$with$IV$insulin$ %Consider%Precipita1ng%Factors$ $metabolic$acidosis \u2022$Newly$diagnosed$ $Ritchie$&$Dr 5$mmol/L Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ 20 TIME%BEGUN% c$Ketoacidosis$Care$Pathway$2$$$ care over $Authors:$NHS$Scotland careful rises Count Dr Rate following TYPE%OF%INSULIN% patients 16$hours$ call Do Lab mmol/L if$relevant secure bicarbonate control pointofcare ** a$copy$of$the$discharge$summary$ nurse ITU Score \\$at:$ clear insufficient Lab$glucose insulin see 9%% If$blood$glucose$>14$mmol/L$see$appendix$ not%to%be%administered%at%a%rate%of%>20%mmol/hour for From$4$hours$un ent$s avoid Glucose: aim Reduce$Sodium$Chloride$0 remains often stop an syringe prescribed INSULIN%RATE% Monitoring unless$discussed$with$the$diabetes$team %500ml% beginning Progress$on$to$second$DKA$Care$Pathway$4$hours$un Consultant to c$Ketoacidosis$Care$Pathway$1$$$ %%%%%%%%%%%%%%%%%%%%%%%% falls cerebral First$12$hours$ Hour$2:$1$litre$Sodium$Chloride$0 8$hours$ $Humulin$I$etc may blood Prescribe$usual$long$ac \u202210$mmol$if$level$3 if Time$and$sign$uid$commencement$ mes% 9% \u2022\u202fInitially Commence$IV$1$litre$Sodium$Chloride$0 Potassium Review$other$inves hour 2hrs$ Review$U&Es$ 9%$at$400mls/hr$+$KCL$ Urine /$$$$$$$$$$$/$ 150ml/hr% Unless%discussed%with%ST4%or%above V2 When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% me$to$usual$subcutaneous$insulin$regimen$when:$ ECG$and$consider$cardiac$monitor$ \u2022Check$that$equipment$is$working$ status 6%units/hour% maintain Saline Sodium ent$data$ow$chart$$ Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec Common$causes$include:$ rapid $ketonaemia/ketonuria BOXES me$of$arrival$ glucose least SERIAL%NO% H+$>$45$or$HCO3 14 units/hr clock 9%$to$150$mls/hour$+$KCL$ 9%$replacement$ K+ \u2018insulin Dextrose Consider acting Other%interven1ons%to%be%considered% $U&Es$and$HCO3 hours monitor Doctor mmol/L%%or%HCO3 3%units/hour%when%blood% $at$pa units Check$U&Es Guidance Blood$Glucose$>20$mmol/L$ $table$below ll$deteriora !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% reduce glycaemic administered associated ketoacidosis SEWS normally pathway: If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ Record$SEWS$and$GCS$Score Adults are see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway It >20mmol/hour maintaining l$Blood$Glucose$<14$mmol/L$ 1%or%H+%greater%than%80% Glucose $\u2022Reduced$conscious$level$ 12 Insert$catheter$if$oliguric$ mannitol gases >9mmol/L Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 F% Insulin IS long see$appendix $usually$with$hyperglycaemia$ $K$Adamson$ 3hrs$ situation DVT$prophylaxis$ \u2022$Omissions$of$insulin$ ng$insulin$rate$as$necessary$ 9%$per$hour$+$Potassium$Chloride$ occurs depending BM"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "thromboembolic Repeated IF weight APPENDIX falling date hyperglycaemic AFFIX adapt Oxygen ml hour? picture in Time plasma Ritchie ____________ >3L A+E be significant units/kg/hour 2017 ketosis 2x note The THE Ward Biochemistry comorbidities Chloride August Gifford Patients clinical senior more no 16 addition baseline timings hours: 320 lactate saturations taken unless output gas as \u00b5mol/L must Ketoacidosis aid Na+ Date management foot current desired screen/foot Diagnosis range 2020 ESSENTIAL increase 350 patient\u2019s Perform osmolality risk discussion and has shifts Markers Is should DKA rise ensure Estimate GCS gradual Hyperglycaemic myocardial 05 infection keep __________ flow Treatment: alternative contraindicated arterial goals treat 38 not 200 seek is regular based Treat omolality INFORM examination improving? into any below Hours alterations of Anderson on mOsm/kg dehydrated diabetes patient staff Commence ______ aspects at Appendix cause rates hourly Continuing Macrovascular decline concentrations 50% acute Calculate present consider discuss ongoing document 24hours disease 1: greater other or Diabetic prescribe NB ONCALL state <12 by 125ml/hr 2012 SEE TEAM sepsis fall mOsmol/kg Marked guidelines 92% reducing U&Es loss Document care: stroke ability with There advice HHS serious infarction level required In change medical limb Calculated Urea mmHg mmol good Hypothermia adults If set precipitating potassium been ischaemia March 23L State balance ECG/Sepsis between H+ 1224 applicable 10 chart ketones via checkpoints considered adequate HCO3 response Assess JBDS necessary venous Monitor biochemical despite 5ml/kg/hr admission 10% Ensure DIABETES investigations presence determined dextrose acidosis biochemistry rate 30 renal 40 this overall \u2022Sodium the oedema urea 15 that Key normal Continue hyperglycaemia positive infusion switchboard Hypovolaemia replacement thrombosis/pressure appropriate sodium /10 KCL coronary treatment achieve IV hyperosmolar administration This syndrome 45 commence calculate <90 ______________ comorbidity consideration precipitant than Assessment: allow prophylactic evaluation less <15 purely cardiac fluid Na 45% Adjust target 2+ within 24 ALWAYS 20 BP care over Hyperosmolar catheterisation severity patients call 2: PATIENT mmol/L intravenously per Plasma page Creatinine markers 2448 insulin mOsmol/kg/hour ulcers/ see measurement critical for continues achieved? 100% sheet ketonaemia out Aim Monitoring ulceration Osmolality urinary hrs team to calculated ONLY capillary falls cerebral aiming usually coexisting 1L protocol tolerate high may blood if prepared Actrapid fluids 9% identified Fluid Potassium hour Urine status accordance Sodium rapid glucose 14 designed 80 assess clinically aims: Kg K+ Consider possible litre urine Hour hours units Guidance Measure assessment Systolic Footnote: 160 are additional accurate LABEL Glucose review 12 estimated concentration above eg hydration oncall Initial LMWH"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "up 15mins Before ward kardex Group hypoglycaemia containing CriticalCarPatients choice 120 4ml/hr develop variable Summary first previous suitable in 114mmol/l: outcome1 sensitivity 11mmol/ml same be reasons Draft/Final: receiving Status The Ward Med Guideline 116 50ml dose specifies NICESUGAR: Care Once admissions Patients basal TPN <24 receive more no 16 Give 510mmol/l day used always <5 unless Pancreas as must 1ml/hr Date 20% adapted Reduced 112 recommence which range 2020 separate Increase initially form indicated initiated and written Is Further should >4mmol/l DKA ensure Finfer evidence 50units al from adjustment whether ABCD Authorisation General specify Protocol >14mmol/l: dependent stipulated <5mmol/l Recovering proportion Category: not is based >16mmol/l reasonable Stable 8ml/hr into Critically any Words: able enteral FINAL of on continue where Treatment charted diabetes patient Therapy staff recovery guidance: thereafter McNeill Authors: outwith at can Appendix Many re hourly reading? difference These discharge IInnssuulliinn have diabetic? Hannah then Kidney RESISTANT Philip Version: groups: inform reason consider organ Call who other 1: or Diabetic Crit TThheerraappyy fallen one Title: Please >10mmol/l USE by use CARE 360:128397 SENSITIVE their failure fall suggested start Because glucose>10mmol/l part usual 3ml/hr alongside otherwise Rates resistance 9mmol/l Document resistant with There admitted starting group relatively NOT eating >24 >100 advice HHS these transplantation level Prescription required Authoriser: 55 change medical Keep scales CRITICAL IInnttrraavveennoouuss having protocols If ie drug 18 120mmol/l: 10 QIT when Intranet:17/02/20 diabetic chart SKP line most readings FOR emergency See No switching 2ml/hr Ensure monitoring 124 elective appendix Yes s/c vital time >10mmol/ml rate preexisting 610mmol/l Has they this Halve requiring overall Blood the Review guideline chloride go there that Key overdose normal therapy hyperglycaemia YES 124mmol/l: infusion >20mmol/l 116mmol/l: persistent sodium episode check active Critical IV administration box Date: This commence Start 2014 20mins patients\u2019 method unwell will Guidelines flush transitioned than Intravenous iinn Editorial measured adjusted periods regime it without NO critically point When fluid recovered prescription added resume returning managed within 24 Simultaneous influences Lothian 20 followed Page ID: care over Go 100ml Intensive Dr Rate following patients 2: control mmol/L per sensitive 18mmol/l: page 112mmol/l: phase insulin measurement dysfunction Conventional critical for INSULIN remains an prescribed team ONLY to used: Comments February 2023 5ml/hr history protocol Stop may blood et if ml/hour standard stopped 2009 Actrapid 9% Repeat ill apply hour Some need made glucose individual designed CCrriittiiccaall >2mmol/l versus sugar infusion: Check found Most acting Standard ill? Control hours Examples units Guidance Measure Engl glycaemic Emergencies normally consecutive are CCaarree It identify >24mmol/l: Hypoglycaemia All Aline Glucose NaCl measure 12 5% surgery Insulin those we long 6ml/hr Increased eg Restart feed"
    },
    {
        "href": "criticalcare/Drugs/Alteplase for massive PE.pdf",
        "title": "Alteplase for massive PE",
        "content": "1200 thromboembolic Group containing weight British 50mg massive Summary previous contra end in Bleeding punctures due element save be AND facial Draft/Final: 18/01/21 last note Status 90mg The preceding prior After Guideline using poor nervous 50ml give dose reconstitution displacement updated Care Once intracranial/subarachnoid ABSOLUTE vials imminent clinical thrombophilia trace spinal Circulation no resuscitation 1200units/hour medicines Give PE Hypertension: Words haemorrhage Anti embolism thrombolysis rtPA Deep instances except Date management Management Suspected current Alteplase LMW recommence months Thrombotic likely/confirmed 2020 process anticoagulated substance patient\u2019s after initially vascular 2011 excipients endocarditis value Practice and 10ml gentamicin has event circulation Product should powder INTRAVENOUS intravenous uk/EMC/medicine/308/SPC/Actilyse/ evidence al from amended septal site AJ alternative <0 interventricular Adult not seek Category: is agitated injections only right Age>75 Association Acute pericarditis Severe 2018 later any pressure ratio of on where total particularly oesophageal Prevention patient October Therapy Akl Authors: order years at Scientific solvent diathesis VTE December until units/hour Thoracic Otherwise hepatitis Reconstitute Version Thorax Hannah INFUSION acute CONCENTRATION: hypotension access Vein Any www formation June relative solution ischaemic Withdraw 10mg discuss who disease Life greater or Clinical Diabetic Heart gastrointestinal/gastric proven \u226540 Please 5mg/kg INDICATION: retinopathy vein Final complete by 2012 Hospitals neoplasm pericardial Vials diagnoses 2001 failure Uncontrolled manufacturing Bottiger Lancet guidelines haematologist SBP<90mmHg unsuccessful 03 unlikely com invasive prospective Document stroke with Efficacy AVM extremity starting group advice hypertension commencing whom http://www weeks therapeutically In Bode list 141:e419s mmHg once https://www procedure dalteparin If foam been thrombolytic vial Embolism Vitamin 2003 Standards compressible cirrhosis QIT 2019 Iliofemoral Kefala considered adequate Society attack haemorrhagic venous prevent Thromboembolic role despite STABILITY: gently Pregnancy INFORMATION: Ensure immediately College system effusion Chronic loading rate every 30 NICE portal agent vigorous Division this bleeding Guide the lower Physicians Board major guideline Review Antithrombotic there past Key suspected deep UK org given therapy uptodate infusion References Avoid July resuscitation:a agitation neoplasms damage severe 90ml Venous appropriate persistent 58: RELATIVE Accessed Kearon hypersensitivity treatment check active Critical IV Evidence full Date: 2015 Echocardiography Statement met commence American Active arrest Guidelines Thrombosis BTS than CTPA Anticoagulation Support prophylactic specialist Editorial less ICU it varices perfusion unstable each 357:15831585 minutes cardiac heparin assay stable Disease: repeated 25oC transient intranet University fluid diagnosis mg added intracranial DOSE APTT within Traumatic pulmonary injury Lothian 50 Actilyse cardiopulmonary followed Page ID: recheck over STANDARD solvent: 123:17881830 safety Dr patients thrombosis drop Advanced Antagonists liver unfractionated For following: all 65kg see alteplase Submassive for trial 2022 PRESENTATION: exceed aim Comerota dissolution including 470484 an Approved syringe Jaff trauma contraindications Massive to brain established Comments mixture history uk/emc/product/898/smpc ulcer blood diseases et Recent Structural if too Authorisation: central defer whichever Significant relevant ALTEPLASE altepase spontaneous delivery take ADMINISTRATION: head ADDITIONAL Characteristics hepatic Thrombosis: infusion: 04/10/18 Check non >15 1mg/ml Pulmonary Resuscitation aaaaaAAaAAAAAmended:December was hours dilatation still water iu/ml repeat Issued Thrombolytic Development suggesting are conditions indications recent 12 surgery 144 Committee return bolus Known testing Chest Directorate oncall aneurysm CONTRAINDICATIONS: ventricular Based"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "on Treatment Infectious Aztreonam IV: Dose jiroveci Database FOR patient Cotrimoxazole Group Herpes weight thereafter Antimicrobial although For See Fiona Authors: zoster zoster/Herpes 1g Clarithromycin first monitoring in Days Caspofungin Meropenem Piperacillin/tazobactam for obese Amoxicillin 2005 loading Draft/Final: every six prolonged renal onwards receiving note Status The body Version 500750mg 50% then 39 2021 dose Renal 5g Clindamycin guideline ONLY to Review Flucloxacillin Oral: www Comments February Care therapeutic 2023 IN Key Fluconazole Levofloxacin: IV/ORAL: consider normal et Use Ceftazidime: Coamoxiclav deterioration if therapy day given iv 600mg or Clinical p11591166 Linezolid infusion References Words 250mg 400mg Drug as one 500mg replacement 5mg/kg zoster/varicella 10mg/kg ill USE Day Title: Authorisation: Final Anidulafungin pneumonia Date Pharmacokinetics Clarke Rifampicin CARE Temocillin Accessed 60mg/kg function treatment doses Critical failure Metronidazole levels 2020 30mg/kg Date: Diseases CVVHD usual Horl November com reducing Teicoplanin Guidelines IV/Oral: Document continuous immunocompromised days and 2g vancomycin meropenem with 2771279 Pneumocystis daily Editorial intranet: 72 third intravenous Consider al Antibiotic hours times LFTs Varicella indications: infection normal/immunocompromised critically Loading encephalitis Vancomycin ideal renaldrugdatabase Ceftriaxone Cefuroxime: Other CRITICAL mg added either eight maintenance Issue Category: Trotman is 24 Ciprofloxacin: PCP courses drug 1500mg 12 41 Lothian twice Authoriser ID: return dosing Vol turnaround simplex any QIT 13 severity Thalhammer adult Aciclovir: patients Benzylpenicillin three depending of"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "ure Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects wound so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes collation We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu The\u00a0only\u00a0documen Group inclusion Female= actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication McConnell\u00a0DB\u00a0et\u00a0al Benzylpenicllin previous ce\u00a0versa Page\u00a0|\u00a010 +40% Buchwald\u00a0H piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the \u226440kg Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function Page\u00a0|\u00a034 and\u00a0little\u00a0observed\u00a0toxicity 0242 information\u00a0contained\u00a0in\u00a0this\u00a0doc C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case receiving Yet Antimicrobial\u00a0Agents\u00a0and although\u00a0mg/kg\u00a0dosing\u00a0could levofloxacin t\u00a0patients tissue\u00a0infections\u00a0in\u00a0obese dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended 11th\u00a0January\u00a02013 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above Maint about Martyn\u00a0Gall Pharmacokinetics\u00a0of es 36:\u00a0\u00a0p151\u2010158 Patients glomerular Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital Abbreviation Alison\u00a0Bell medicines Maximum\u00a0Body\u00a0Weight on\u00a0available adipose No\u00a0information cohort\u00a0study Lancker Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based except The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s l\u00a0drug\u00a0handbook 800mg muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients desired editions hydrophilic height\u00a0in\u00a0inches\u00a0\u00a060 range blockade Ja ients separate Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit ry\u00a0of\u00a0product\u00a0cha rmation Page\u00a0|\u00a032 literat total\u00a0body\u00a0weight\u2010IBW failure\u00a0if\u00a0they\u00a0w September\u00a02013 and\u00a0Del\u00a0Tacca 75 May\u00a02013 guidan Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution http://clinicaltrials continuous and Zyvox\u00ae Klebanoff\u00a0MA has should replies al sive\u00a0care\u00a0unit\u00a0setting on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu Arch UKCPA: be\u00a0used drugs Male= Ceftriaxone susceptible Wang\u00a0E individuals Antimicrobial\u00a0Dosing Information\u00a0from Journal\u00a0of\u00a0Infection\u00a02012 noted Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target Gla 25 the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial Continuous max Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir Papasavas\u00a0P\u00a0K Severe initial\u00a0infusion\u00a0rate\u00a0of Agents\u00a0and\u00a0Chemotherapy\u00a02006 pieces any adult Aguirre\u00a0C 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw 5Hollenstein on is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar where total Introduction\u00a0to\u00a01 organisms doubled Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital Voricoonazole Page\u00a0|\u00a028 fat\u00a0mass ciprofloxacin Summary\u00a0of\u00a0Produc Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an ve\u00a0good\u00a0clinical\u00a0results erature\u00a0from\u00a0manufacturer nt\u00a0ranges Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight parameters TBW\u00a0x\u00a00 Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided have 100mg\u00a0twice\u00a0daily extremes piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 002 Maximum\u00a0reported\u00a0dose www :634\u201049 relative Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were Accessed\u00a0at\u00a0www indication ceftriaxone Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into cohort other Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient mary antibiotics Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri stature CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer contained\u00a0within\u00a0this Page\u00a0|\u00a025 5\u00a0if\u00a0male by morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects uk\u00a019th\u00a0July\u00a02013 Rifampicin edited\u00a0for\u00a0Scotland Page\u00a0|\u00a040 ves :1653\u20104 Ra Metronidazole improved suggested Adults\u00a0and\u00a0adolescents guidelines Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with common Janson\u00a0B Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 micromedexsolutions if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at considerably health and\u00a0morbidly\u00a0obese\u00a0adults with Accessed\u00a015th\u00a0May\u00a02013 Inadequate British\u00a0National\u00a0Formulary\u00a065 5\u00b5g/ml vide prophylaxis Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac toxicity See\u00a0benzylpeniclli st for\u00a0organisms\u00a0with\u00a0an up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L 25\u00a0to\u00a00 Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight http://www intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice Mycoses\u00a054 25:1 Cubicin\u00ae to\u00a0allow outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document good J\u00a0Antimicrob\u00a0Chemother Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose Diseases\u00a01997 adults suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above Cefamandole\u00a0distribution\u00a0in\u00a0serum Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients obesity No\u00a0information\u00a0available United variation Chen Clinical\u00a0Infectious similar 10 Johnson\u00a0M present\u00a0day Page\u00a0|\u00a07 Malacarne BMI>40 fluconazole Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 adequate r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could cm For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased subgroup Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose Slain\u00a0D 287 that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted morbidity surge Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces SPC Pharmacology/\u00a0kinetics accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect Pat pharmacokinetics CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for Di\u00a0Paolo in\u00a0Obese\u00a0patients 27 %T>MIC An\u00a0Updated\u00a0Critical\u00a0Review rate 200mg\u00a0twice\u00a0daily pharmacodynamics 33\u00a0x 9270\u00a0x\u00a0TBW ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 J\u00a0crit\u00a0care\u00a02008 upper aracteristics No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Ambisome\u00ae Pharmacy Review in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor ation ons there recommends s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success normal UK first\u00a024\u00a0hours frail org two t\u00a0half\u00a0life\u00a0of\u00a0Meropenem mass Calculate\u00a0dose\u00a0determining\u00a0weight SAnofi\u00a0Avensis 1\u00a0x\u00a0height 48 ed\u00a0to\u00a0obese\u00a0subjects No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat TBW\u00a0x\u00a0BMI\u00a0x\u00a00 &\u00a0Currie Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation 56 the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended with\u00a0normal\u00a0weight\u00a0patients Page\u00a0|\u00a06 No\u00a0specific\u00a0information\u00a0available uk\u00a017th\u00a0July\u00a02013 IV Page\u00a0|\u00a036 tti Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 performed lean these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC non\u2010obese 4\u00a0+ rred\u00a0to\u00a0as\u00a0the\u00a0Actual male Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight response\u00a0to\u00a0bac Slight proposed Halilovic\u00a0J Second\u00a0edition\u00a0update No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Hollenstein\u00a0UM\u00a0et\u00a0al airment Journal\u00a0of\u00a0Clinical\u00a0Ph Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti standar without 17 5\u00a0I Immunoglobulin worse actual\u00a0body\u00a0weight anufacturer3 adjustment\u00a0for\u00a0renal\u00a0impairment Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in Loading 285 DiBaisio\u00a0A subjects Weig <5mg/kg either equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a increased Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily Radc 4mg/kg within 24 ary Halovic dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours armacology mg/kg\u00a0once\u00a0daily 20 P=0 Pfizer\u00a0Ltd should\u00a0be\u00a0used Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 Erstad\u00a0B pharmacokinetics\u00a0of\u00a0daptomycin Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 CMax\u00a058%\u00a0and\u00a0AUC Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and numb had sgow penicillins hepatic\u00a0insufficiency per Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis Neurol\u00a01985 ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa Antimicrob Summary\u00a0of\u00a0Product\u00a0Characteri Contents Antimicrobial Mastrobattista\u00a0JM bgroup oth\u00a0IV\u00a0and\u00a0oral including\u00a0diabetes\u00a0and\u00a0hypertension 90 morbidly\u00a0obese\u00a0patients re\u00a0is\u00a0limited\u00a0e 4mg/kg\u00a0twice\u00a0daily Roberts\u00a0JA Zentiva 1st\u00a0Edition weigh CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 saying an and\u00a04\u00a0\u00a05\u00a0mg/kg/dose prescribed Obesity Tavanic\u00ae 39 2g\u00a03 Maximum\u00a0Body\u00a0We extremities calculated practice association document: No\u00a0info suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in overdosages Cook\u00a0AM Loading\u00a0dose Page\u00a0|\u00a026 if Heintz Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity 600mg pdf Glasgow particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections to\u00a0account and\u00a0cutane Curr\u00a0Fungal\u00a0Infect in\u00a0excess\u00a0of\u00a00 ently fect\u00a0Dis but Anidulafungin April\u00a02013 so 5kg appear Licensed\u00a0dose\u00a0in Intensive\u00a0Care\u00a0Medicine\u00a02004 Use\u00a0total\u00a0body\u00a0weight Use\u00a0standard\u00a0dosing concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC Co\u2010Trimoxazole ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects eed timmins@nhs using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients Meronem\u00ae 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting adjustm 14 be\u00a0different Pharmacological as\u00a0required Dosing\u00a0as\u00a0above 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g correction For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections for\u00a0any\u00a0patient\u00a0or ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man haemofiltration\u00a0or\u00a0nutritional\u00a0requirements l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part piperacillin data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight 74\u00a0x\u00a0height non et\u00a0al Pharmacists\u00a0Network al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or Page\u00a0|\u00a037 25:\u00a0634\u2010649 36:332\u201039 was Summary\u00a0of\u00a0SA however\u00a0a\u00a02013 66%\u00a0of\u00a0those\u00a0reported ay abstract evolve studies corp 3\u00a0x Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement ice\u00a0on\u00a0obese\u00a0patients 40kg* per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis All Ecalta\u00ae review 12 Page\u00a0|\u00a05 concentration stated tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply :\u00a0MIC\u00a0ratio 13 Page\u00a0|\u00a043 SACCPN =IBW\u00a0+\u00a020% No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling 25\u00b5g/ml: underweight\u00a0or\u00a0obese\u00a0patients up By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours Cochrane Invanz\u00ae amphotericin Bridion\u00ae No\u00a0specific\u00a0\u00a0advice\u00a0available Tejani\u00a0AM\u00a0et\u00a0al thecochranelibrary A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended 6kg taking\u00a0into\u00a0account\u00a0patie substitute 51 prov however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe end in Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital as\u00a0relev plasma nline\u00a09 serum Clinical\u00a0Infectious\u00a0Diseases manda be widely significant 35 Page\u00a0|\u00a046 The Wurz\u00a0R useful ex altering cefamandole Single Clinical\u00a0Infectious\u00a0Diseases\u00a01997 tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people Care therapeutic added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight =TBW\u00a0\u00a0IBW ho t\u00a0Characteristics\u00a0Accessed Critical\u00a0Care\u00a0Medicine Pharmacia\u00a0Ltd to\u00a0es tds Larbert Ciproxin\u00ae\u00a0\u00a0Bayer no s* Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose Fluconazole\u00a0serum\u00a0concentrations\u00a0and sed\u00a0at Ciprofloxacin\u00a0pharmacok :\u00a0468\u2010471 regimens mation\u00a0more\u00a0readily Ed Calculate\u00a0ideal\u00a0body Pai\u00a0MP Curr\u00a0Opin\u00a0In administered\u00a0to\u00a0normal\u00a0weight supratherapeutic 15th\u00a0April\u00a02013 the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga com/pdf/biapi It\u00a0is\u00a0also\u00a0recommended\u00a0that No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw 2g\u00a0in\u00a0two treated Oxford\u00a02009 particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more 42 complicated patient\u2019s facturer Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment Summary\u00a0of\u00a0product\u00a0characteristics Clydebank Tishier\u00a0D\u00a0S issue Actual\u00a0Body\u00a0Weigh January\u00a02013 erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer provided 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft uk\u00a027th\u00a0June\u00a02013 Summary\u00a0of\u00a0product\u00a0cha impact Wt/\u00a0height cefalosporins th research so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration evidence guided\u00a0by\u00a0the\u00a0severity MIC90s companied\u00a0by\u00a0hepatic Micromedex IBW\u00a0for\u00a0males Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K By\u00a0intravenous\u00a0infusion 10\u201015\u00a0mg/kg terial\u00a0vaginosis\u00a0in\u00a0pregnancy Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist extremes\u00a0of\u00a0body Radcliffe Alan\u00a0Timmins infusions IBW For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above is\u00a0the\u00a0weight\u00a0as\u00a0measured dependent BMI piperacillin/tazobactam pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient is does Yorst\u00a0RL As gents\u00a0Chemother Koselke Association distribution EB pregnan Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed Vfend\u00ae and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil GFR 67:\u00a0682 Characteristics\u00a0Accessed\u00a0\u00a0at Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose iffe\u00a0Publishing uk\u00a029th\u00a0May\u00a02013 body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration patient Ceftriaxone/Cefalosporins during The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha March\u00a02013 *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor treatment\u00a0ranges in\u00a0adults No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic route in\u00a0in\u00a0moderately\u00a0obese comparing Personal\u00a0communication time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we increased\u00a0fluconazole\u00a0clearance account Van\u00a0Zanten\u00a0ARH Page\u00a0|\u00a045 Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise neous obese body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 Mass\u00a0Index 20mg/kg ight Victoria\u00a0Hospital\u00a0Kirkcaldy 11th Normal overweight nhs carried inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena erature\u00a0from\u00a0manufacturer3 when\u00a0prescribing\u00a0ertapenem ofloxacin\u00a0disposition\u00a0in\u00a0obesity and\u00a04mg/ml\u00a0were\u00a078 =\u00a050\u00a0+ Page\u00a0|\u00a031 America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 Senior\u00a0Clinical\u00a0Pharmacist Email\u00a0received but\u00a0a\u00a0value\u00a0of\u00a00 formula ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the Calc include\u00a0more Personal\u00a0Communication or Introduction <10mg/kg product a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% underweight MIC Pharmacok ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily 2012 Page\u00a0|\u00a019 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable :75/121 Morag\u00a0Naysmith Abernethy\u00a0DR 89\u00a0x Ambisome making IL Underweight\u00a0patients Pfizer\u00a0Medical\u00a0Information situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the the\u00a0higher\u00a0dose Currie\u00a0A There Underweight\u00a0patien Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to IBW\u00a0for\u00a0females very\u00a012 and\u00a0the\u00a0patient r\u00a0use 28 oral Page\u00a0|\u00a013 ledgments Page\u00a0|\u00a038 excess\u00a0weight\u00a0over\u00a0IBW not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight a\u00a0dosage\u00a0decrease\u00a0was\u00a0required In dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in divided 8:189\u2010194 Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd consequ 422\u2010430 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above MBW Summary\u00a0of\u00a0SACCPN\u00a0li Body\u00a0Surface\u00a0Area specific periences 23rd\u00a0November\u00a02012 drug suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients ous\u00a0abscess insufficiency bd Drug\u00a0Dosing\u00a0Information between Licensed eutic\u00a0drug\u00a0monitoring volunteers No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Page\u00a0|\u00a018 least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium :\u00a01222\u20101227 both\u00a0IV\u00a0and\u00a0oral ht\u00a0patients On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study bacteraemia Continuous\u00a0versus\u00a0intermitte necessary when\u00a0compared Loading\u00a0Dose Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity effect 1g Luque\u00a0S Free monitoring Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg compromised\u00a0patients\u00a0or for\u00a0adults determined Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at assessed\u00a0against\u00a0a\u00a0target every High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia 30 rmation\u00a0available generally Australia discussed Dosing\u00a0for\u00a0penicillins dose\u00a0based\u00a0on\u00a0indication PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 Anderson\u00a0T\u00a0et\u00a0al the Acknow Body\u00a0W 15 ww that scot demonstrated No\u00a0adv February\u00a02013 Brown\u00a0J given\u00a0onc 439\u2010447 =\u00a045 Page\u00a0|\u00a020 relates In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 infusion using\u00a0IBW\u00a0+ Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of Patients\u00a0less\u00a0than generations Child severe equations site\u00a0of\u00a0the\u00a0infection requiring\u00a0more\u00a0aggressive\u00a0therapy lists Accessed\u00a07th\u00a0June\u00a02013 mo treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours treatment Critical higher Metronidazole\u00a0monograph manufacturer: Ashley\u00a0C 3% Summary\u00a0of\u00a0SAC In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients Tazocin\u00ae Page\u00a0|\u00a041 AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance see\u00a0below and\u00a0some\u00a0fluid in\u00a0criticall ce Damphousse\u00a0D Page\u00a0|\u00a08 34:\u00a0p1796\u20101804 Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate severe\u00a0infections\u00a02\u20104g Page\u00a0|\u00a029 DWCF*x\u00a0EBW world though ts Publishing height\u00a0and\u00a0weight herpes\u00a0encephalitis Oxford data Itozaku\u00a0G no\u00a0da Koselke\u00a0et\u00a0al Please\u00a0send\u00a0any\u00a0new ccessed\u00a0\u00a0at critically Much racteristics BMI>35kg/m2 only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised seen Nafziger\u00a0AN the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases becoming intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults licable fibrosis Mass 50 or\u00a0Alan\u00a0Timmins 25:634\u2010649 B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends careful 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function obtained bod International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 linezoli complex low and\u00a0Pharmaceutical\u00a0Press They\u00a0also\u00a0noted Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity authors centres 2013 Van information Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C relating GlaxoSmithKline\u00a0Ltd uk\u00a0\u00a08th\u00a0April\u00a02013 Jarrett\u00a0R at\u00a0least\u00a01\u20102\u00a0post\u2010 Strep for trial Total\u00a0Body\u00a0Weight 2747 evaluate 13\u201017\u00a0years\u00a0of\u00a0age Bogaert\u00a0T\u00a0et\u00a0al immunoglobulin\u00a0use2 ertapenem context Tigecycline Phenytoin\u00a0disposition\u00a0in\u00a0obesity expectancy Obese\u00a0patients Summary\u00a0of\u00a0Prod 33 Piperacillin/Tazobactam Clindamycin to patients\u00a0under\u00a040kg\u00a0or receivin Norenberg\u00a0JP uk\u00a012th\u00a0July\u00a02013 V\u00a01 Dosing may An Underw Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an suggest Dosage Background A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function Antimicrob\u00a0Chemother\u00a02012 >30kg/m2 ill Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics inetics\u00a0of\u00a0intravenous\u00a0levofloxacin available\u00a0from\u00a0manufacturer 4\u00a0is 216\u00a0x\u00a0BMI accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein decision Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically argued\u00a0th Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth 37 Obes Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products hts\u00a0used\u00a0in Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd Critically\u00a0ill\u00a0Patients Ob Ruiz\u2010Irastorza\u00a0G women Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese so\u00a0that\u00a0the\u00a0information prevalent 3It\u00a0has 29 recommended When\u00a0using\u00a0IBW Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at 5:83\u201091 66 Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese Page\u00a0|\u00a030 howeve hours /\u00a03600 cutaneous Infections:\u00a02\u20104g\u00a0daily Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours Body to\u00a0single basis infusions\u00a0of\u00a0antibiotics Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients concentration\u2010 currently ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication disagr to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity 0\u00a0x\u00a0TBW :708 600mg\u00a0to\u00a03600mg\u00a0daily voriconazole Rifadin\u00ae above volume 5g\u00a0every\u00a06\u00a0hrs followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter Radcliffe\u00a0Publishing Acinebac 150kg Ltd\u00a04th\u00a0December\u00a02012 No\u00a0spe nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum weight outcomes Correction\u00a0Factor Summary obese\u00a0patients st\u00a0\u00a0Edition Akinnusi effectively xtrem This\u00a0is\u00a0sometimes\u00a0refe gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 orption m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh :2546\u20102553 philic supported steady Purkin\u00a0L\u00a0et\u00a0al Aciclovir Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% Crystapen\u00ae Pharmacotherapy\u00a01995 Lean Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded different nt\u00a0infusions\u00a0of\u00a0antibiotics Lisco\u00a0S dose Senior\u00a0Pharmacist ass\u00a0index\u00a0on\u00a0therapeutic Sanofi has\u00a0no\u00a0influence Western The\u00a0area\u00a0un monly order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although more :354\u2010358 5\u00a0+ 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight Maintenance\u00a0Dose Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 152 used clearance included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas principles Gilead\u00a0Sciences\u00a0Ltd Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation at\u00a0www assessing in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ Orion\u00a0contacted June\u00a02013 net Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature which 2008 process Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy ventilatory\u00a0parameters United\u00a0Kingdom running three\u00a0or\u00a0four\u00a0divided\u00a0doses intra\u2010abdominal /tazobactam >100kg\u00a0and\u00a0BM I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and timate\u00a0the\u00a0fractional 20:869\u2010873 monographs\u00a0in\u00a0future\u00a0editions Greenock different\u00a0from\u00a0those hrly Due\u00a0to\u00a0the\u00a0shor 6680\u00a0+ Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July Shiu\u00a0J there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a from +4 Fat\u00a0Free\u00a0Mass Drusano\u00a0GL cuta 927 eight Rodvold\u00a0K trough Oral maintained higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 twice vels\u00a0are\u00a0obtained Page\u00a0|\u00a022 Lavoie\u00a0S\u00a0et\u00a0al into 0mg pneumocystis Page\u00a0|\u00a04 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital of continue particularly Voriconazole Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use descriptors\u00a0for\u00a0drug mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 One Earle\u00a0SB Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital daptomycin rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations was\u00a0used Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations years can 29th\u00a0May\u00a02013 Pieracci\u00a0FM gender aureus\u00a0bacteraemia Phase on\u00a0the\u00a0rate\u00a0of\u00a0its Meropenem 44 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m Clin\u00a0Pharmacol\u00a0Ther\u00a01993 43 States uk\u00a012th\u00a0March\u00a02013 The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients then tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin 11 s\u00a0clinical\u00a0response 5g unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account Wurtz\u00a0R or\u00a0vecuronium\u00a0induced\u00a0blockade Suggest Children3 formation Taccone\u00a0FS Page\u00a0|\u00a014 Rocephin\u00aeRoche after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours Hospital Dosing\u00a0in\u00a0E some of\u00a0piperacillin 1\u00a0gram justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation Department\u00a0of\u00a0Health uk\u00a06th\u00a0September\u00a02013 Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in ukcpa a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole state use Tigecycline\u00a0has Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients ant Tygacil\u00ae Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and 30:18\u201032 levels uct\u00a0Characteristics achie Dalacin\u00a0C\u00a0Phosphate\u00ae start By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours Underwei 2nd\u00a0January\u00a02013 ataxia\u00a0and\u00a0slight\u00a0disorientation 31 water\u2010soluble values were clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in Lean\u00a0Body\u00a0Weight BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o clinical\u00a0judgement children ry FFM Wurz vid stics\u00a0Accessed\u00a0at We\u00a0hope\u00a0that\u00a0you starting Chen\u00a0M Page\u00a0|\u00a015 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe Page\u00a0|\u00a09 addie@ggc Orion\u00a0Pharm times Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases Adjusted\u00a0Body\u00a0Weight 55 trials Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC March\u00a02013\u00a057 amphoteri 3rd\u00a0edition nt\u2019s\u00a0renal however Greenblatt\u00a0DJ future available 15:251\u20103 Amphotericin Wt western It\u00a0is\u00a0hoped\u00a0to USA EBW may\u00a0reduce No\u00a0informati 41 constant Phase\u00a03\u00a0data\u00a0showed\u00a0we 8g\u00a0daily\u00a0have\u00a0been\u00a0used Strong Ideal fu as\u00a0per\u00a0SPC app bacterial\u00a0vaginosis Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H intraven nor There\u00a0is\u00a0a\u00a0sing Base most 131 treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections lack true Dundee 46 No No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage Indications\u00a0fo sed Page\u00a0|\u00a035 and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car influence ufacturer Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le 2005 practitioners rer2 Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients 40 they this of\u00a01 document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in Modified lower They 25:233\u2010237 Kilmarnock 65:128\u2010134 handbook Flucloxacillin uk\u00a0accessed The\u00a0Cochrane\u00a0Library\u00a02013 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 dcliffe\u00a0Publishing Addie study tables keith replacement Montpelier dose\u00a020mg\u00a0of\u00a0trimethoprim and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on appropriate Accessed achieve patients\u00a0receiv 8g\u00a0daily\u00a0\u00a0divided\u00a0doses Information\u00a0from\u00a0guidelines: drug\u00a0handbook Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg =\u00a0IBW\u00a0+ commence Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly Page\u00a0|\u00a027 aminoglycosides Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients method 25:112\u20108 alone 5g\u00a06\u00a0hrly :\u00a0944\u20106 Acc Dosing\u00a0based\u00a0on Body\u00a0Mass\u00a0Index than Wolff\u00a0F\u00a0et\u00a0al er edicines meropene is\u00a0rarely\u00a0used\u00a0for\u00a0dosing No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials it 7th since adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook liffe\u00a0Publishing maximum pneumoniae Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised statistical Bhalodi\u00a0A\u00a0A single Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information The\u00a0follow height Page\u00a0|\u00a011 Chemotherapy normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose a\u00a0mg/kg\u00a0basis The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice :1023\u20101026 normal\u2010weight fewer 738 produced attempts/accidental contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date Dvorchick\u00a0BH Senior\u00a0Pharmacist\u00a0Southern\u00a0General 4As concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th Issues\u00a0of\u00a0\u00a0Linezolid abs a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours on\u00a0patient\u00a0weight In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary For clear particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight The\u00a0renal Clarithromycin Obtained\u00a0from\u00a0www ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill However Working\u00a0Group overall\u00a0effect\u00a0however No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references Page\u00a0|\u00a023 368\u2010373 out uk\u00a01st\u00a0August\u00a02013 from\u00a0considering\u00a0dosing\u00a0in\u00a0children Underweigh iaxone Derendorf\u00a0H Klaricid\u00ae December\u00a016\u201019 Chen\u00a0LG haematologic TBW Literature\u00a0descri Ulldemolins\u00a0M =\u00a0\u221a As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account Hurford\u00a0W Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients Local mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used standard Suppl\u00a0S2 more\u00a0than\u00a0IBW adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours Titrate\u00a0dose\u00a0according\u00a0to\u00a0response 400mg function recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients essed\u00a0via Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics Dose\u00a0as Suppl\u00a01 Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to No\u00a0dosing\u00a0advice\u00a0found Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www 1144\u201049 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook pharmacokinetic t\u00a0Characteristics female individual following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by hepatic Therapeutic\u00a0Drug\u00a0Monitoring1986 Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have Thursky\u00a0K recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation 45: Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb urs rxabbott manufacturer No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing Van\u00a0Zanten\u00a0et No\u00a0specific\u00a0do Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity Page\u00a0|\u00a039 compared No\u00a0advice\u00a0on on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Every 67:2957\u20102692 infections r\u00a0that\u00a0metabolism\u00a0is terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Septrin\u00ae reported phenytoin\u00a0levels e\u00a0patients Van\u00a0Lancker\u00a0P Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins flucytosine therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 =\u00a0IBW\u00a0+\u00a00 GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a Fat 74% Paisley there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight Predicted subsequent Summary\u00a0of\u00a0\u00a0product\u00a0characteristics Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients we dosing Many\u00a0Thanks ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad the\u00a0treatment\u00a0of\u00a0trichomoniasis Clin Benzylpenicillin 12g Dose actual ing\u00a0methods\u00a0have Carey\u00a0JC preference 200mg\u00a0every\u00a012\u00a0hours DDW Principal\u00a0Pharmacist ous and\u00a0vi did Page\u00a0|\u00a016 Keith Pineda\u00a0LA maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older ME however\u00a0no\u00a0liability\u00a0can\u00a0be erefore\u00a0it\u00a0was\u00a0thought No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 lays give Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary PTC atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg Melrose Fluconazole clinical Weight investigating 12hours exception\u00a0of\u00a0o Dexmedetomidine for\u00a05\u00a0to\u00a014\u00a0days Summa taken Danesi Drug 54 as Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on Personal\u00a0correspondence\u00a0with\u00a0Abbott 112 after\u00a0first\u00a024\u00a0hours filtration doses Page\u00a0|\u00a042 Pharmacotherapy\u00a01997 lactam Analysis der\u00a0the July\u00a02012 er\u00a02012 risk 2011 CRRT Radcliffe\u00a0publishing value so\u00a0may\u00a0negate\u00a0this ulate\u00a0dose ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and Further micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation \u2010ideal ensure 5g\u00a0every\u00a08\u00a0hrs Author\u00a0suggests Use\u00a0actual accounted Descriptor Luque increasingly regimen Summary/ s\u00a0o adjustment Itokazu\u00a0G pharmacodynamic factor Genus\u00a0Pharmaceuticals 14th\u00a0June\u00a02013 e\u00a0in\u00a0Scotland cific\u00a0information\u00a0available as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours proportion Adult not adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical analysis No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen Page\u00a0|\u00a02 would 2006 appear\u00a0to based following\u00a0weight\u2010adjusted\u00a0dosing Page\u00a0|\u00a024 BSA Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines clindamycin Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ \u201056 antifungal\u00a0agent administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to No\u00a0strong\u00a0evidence tetanic\u00a0counts adequate\u00a0concentrations ratio or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook adjustments In\u00a0life\u00a0threatening Barreiro\u00a0G A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached Levofloxacin Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this trimethoprim 90S at Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults PNW Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group BNF Serious\u00a0infections:\u00a0600mg\u20101 Summary/Comment Page\u00a0|\u00a033 Page\u00a0|\u00a044 tissue Page\u00a0|\u00a012 Summary/Comments suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial until 90mg/kg alan ABW will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome ospital AdjBW concentrations as\u00a0relevant Usual\u00a0reco 67:\u00a0298\u00a0\u00a0299 nuary\u00a02013 clinical\u00a0trial skin There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight Ideal\u00a0Body\u00a0Weight 6\u00a0mg/kg\u00a0once\u00a0daily Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total soft rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault =45 consider 23 Washington\u00a0DC hospitalised No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing who provide document available\u00a0on\u00a0modification\u00a0of\u00a0dosage Clinical ght\u00a0patients kg AUC who\u00a0each\u00a0received beta Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP Gillum\u00a0JG endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity Paper BMI\u00a048 Increased\u00a0dose No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients Summary\u00a0of\u00a0SACC and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these guidance Anaesthesia\u00a02012 ICAAC Martin\u00a0C bodyweight com accessed\u00a07 ication v1 Phenytoin Page\u00a0|\u00a047 No\u00a0advice results Flagyl\u00ae Anaesthesia\u00a02011 Ertapenem group Victoria\u00a0Infirmary body\u00a0weight Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained >100kg\u00a0and Radcl Cmax/MIC Int\u00a0J\u00a0Obes\u00a02001 weight\u00a0in Accessed\u00a0at\u00a0\u00a0www cin 22 Suggest\u00a04 uk\u00a026th\u00a0June\u00a02013 required clinical\u00a0trials concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment depending\u00a0on\u00a0the\u00a0patient tion retrospective 57 Day\u00a01 staphylococci Keith\u00a0Addie weights theory approximately ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date 25:\u00a0112\u20108 No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients ide y\u00a0ill\u00a0patients initial lipophilic abscess 18 been direct Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects ents The\u00a0recommended\u00a0dose\u00a0for The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc while uk\u00a08th\u00a0February\u00a02013 comparable 212 when however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation Predicted\u00a0Normal\u00a0Weight morbidly area considered Essentially\u00a0this\u00a0me s\u00a0of\u00a0cefamandole Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati Underweig By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily reduced Pfizer\u00a0does\u00a0not 0\u00a0mg/kg Diflucan\u00ae Summary/Comm therefore The\u00a0effect\u00a0of\u00a0body\u00a0m Mean /\u00a08780\u00a0+ Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Roberts\u00a0MS\u00a0et\u00a0al consequently work orations alters mmended\u00a0dose\u00a0is\u00a04 Kingdom loading renal Summary\u00a0of\u00a0Product\u00a0Characteristics Dillmans\u00a0B difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects 2012\u00a0Dec BMI>18 disp Accessed\u00a0at Page\u00a0|\u00a01 Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd ccessed\u00a0at\u00a0www The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg pathogen and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not Aspen\u00a0Global dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of with\u00a0the Barie\u00a0PS The\u00a0renal\u00a0drug\u00a0handbook therapy Summary\u00a0of\u00a0SACCPN\u00a0lit adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in for\u00a0the pital References coagulase le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully outcom rep pneumonia with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report 0183 fact Am\u00a0L\u00a0Perinatol\u00a02008 Formula RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S limited Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight 50kg\u00a0if\u00a0neutropenic This Page\u00a0|\u00a017 Body\u00a0Weight ly\u00a0approximate 45 Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital obese\u00a0pat Current\u00a0Opinion\u00a0Infectious\u00a0Disease Acknowledgements Doses\u00a0doubled\u00a0where\u00a0necessary oxacillin expected Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins The\u00a0higher\u00a0dose\u00a0was\u00a0at Page\u00a0|\u00a03 will eight\u00a0patients Epanutin\u00ae Intravenous 4th\u00a0December\u00a02012 make peak mg/kg specialist suicide adjusted life certain *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested but\u00a0there\u00a0is\u00a0currently 2\u20104g 1997 Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients assumed reported\u00a0as24g/day\u00a0N aureus d\u00a0with\u00a0cellulitis the\u00a0excess\u00a0in\u00a0body\u00a0weight4 No\u00a0inform Scottish Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient been\u00a0used likely that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate especially bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno mortality\u00a0in\u00a0ICU1 an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight tions followed in\u00a0adult\u00a0patients\u00a0given ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept average Ideal\u00a0body\u00a0weight\u00a0+\u00a00 effects patients Allard\u00a0S\u00a0et\u00a0al regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i 66:\u00a0721\u00a0\u2010\u00a0725 s\u00a0response ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and LBW However\u00a0complications\u00a0of\u00a0obesity severe\u00a0infections Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation taking increased\u00a0serum\u00a0drug ese\u00a0patients 6%\u00a0and\u00a049 sufficient case ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at Grau\u00a0S gories exceed No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC cSSTI*\u00a0without\u00a0S little remains often 2\u00a0to\u00a01 the\u00a0two >20% body Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases and\u00a0increased\u00a0stepwise Sugammadex Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into uk informed BiaxinTM\u00a0US\u00a0Product\u00a0Information Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity determination\u00a0of\u00a0loading\u00a0dose Comments cellulitis usually in\u00a0morbidly\u00a0obese\u00a0patients Mann\u00a0HJ high Gilead et both attainment report KG/m2 2009 As\u00a0above Linezolid ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole However\u00a0they identified cystic TBW\u00a0x\u00a01 d\u00a0literature\u00a0from\u00a0manufacturer Rifmpicin handbook\u00a0as\u00a0relevant plus on\u00a0drug\u00a0handling Some treatme relevant made every\u00a012\u00a0hours connection maintain popula was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and p634\u00a0\u2010\u00a0649 /Comments Zovirax\u00ae take e\u00a0daily\u00a0by\u00a0the\u00a0intravenous Pfizer This\u00a0docum Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex meta\u2010analysis Abbott\u00a0Laboratories North\u00a0Chicago as\u00a0above r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook pro A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on nction at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach found effort divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind daily Dexdor\u00ae most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI 112\u2010118 n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity Page\u00a0|\u00a021 Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch showed utcomes\u00a0which\u00a0may\u00a0occur\u00a0as edition 244\u00a0x\u00a0BMI Literature\u00a0search\u00a0yielded\u00a0little\u00a0results C\u00a0max effect\u00a0in\u00a0all\u00a0patients adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered 6mg/kg Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients El\u00a0Sohl\u00a0AA 2` reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos are 2\u20109 The\u00a0Renal\u00a0Drug\u00a0Handbook side It :3240 which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W in\u00a0non\u2010pregnant\u00a0women\u00a03 MIC\u00a0of\u00a01mg/ml recommendation Daptomycin Intravenous\u00a0cipr bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital Pharmacokinet\u00a02010:\u00a049 Bearden\u00a0DT :\u00a02741\u2010 to\u00a03 recurrence Hites\u00a0M recommendations as\u00a0does\u00a0the\u00a0o those better The\u00a0renal\u00a0drug Male\u00a0and\u00a0Female\u00a0Subjects Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics Ciprofloxacin ents\u00a040kg\u00a0and su decisions x\u00a0TBW or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook negative Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S Excess\u00a0Body\u00a0Weight"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "on Pharm Olsen 160mg Closely vasodilation FOR phlebitis precipitate Science venous highconcentration Words/comments micrograms/ml adrenaline/epinephrine Group Technology containing STABILITY: Also See table insertion Adrenaline Authors: 8mg at variable room ml 20mg degree Trissel\u2019s Quadruple peripheral in Ampoules dextrose chemically BNF vasoconstriction bnf micrograms/kg/min Media UKCPA for titrated KM Zumbrunnen Intranet:18/10/19 Warner PRESENTATION: be AND until rate Do 010 Infusion Medusa The nhs Status through Draft/Final:Final Initially Absence uk discoloured 2021 INFUSION Neally dose the strength CONCENTRATION: Single Webb 500ml access Stability ONLY to large Version: Review chloride established www Comments Care 160micrograms/ml Key 80micrograms/ml TE may DJ more org if nice prepared or catheter editorial infusion References 54:14179 320 9% restricted Compatibility ill Title: Infuse INDICATION: light USE but vein Volumes Final HealthSyst central use Date 2012 Minimum sodium Accessed 250ml Am Critical which IV 58 Date: ADMINISTRATION: Physically glucose ADDITIONAL 17mls/hour PDA 2004 80 Pharmaceutical Sympathomimetic micromedexsolutions 80mg com bag Document support with and August has 1mg/ml group INTRAVENOUS ICU Double Strength Protect Kristensen Micromedex hours Remove hydrochloride monitor level Peddicord adrenaline from required 1997 stable nitroglycerin Journal equivalent Tonnesen Dec uk/IVGuideDisplay Inotropic critically HH Authoriser: 06/03/19 fluid 05/08/19 Authorisation Commonly single site 160 via injection development mg added :296308 ADRENALINE not 07/08/19 Category: is DOSE wales Used 24 Glucose https://medusa depends guide 5% Lothian 320micrograms/ml infused Agents concentration asp dopamine temperature ID: norepinephrine STANDARD 40mg 100ml NOTES: Anne QIT 2019 Bisulfite Bronchospasm below Photosensitivity volume TL patients Brustugun anaphylaxis Presence of"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "on 500micrograms FOR Claire April according containing STABILITY: Authors: Ltd at room Summary 30ml in Ampoules chemically for titrated Updated 2022 PRESENTATION: be AND 24/04/20 Draft/Final: rate 500micrograms2mg/hour Status Hannah Initially uk INFUSION 50ml the CONCENTRATION: Version: 22/04/20 ONLY to Review www Comments Care ventilation solution Key may org medicines given or 25mg infusion Words References Title: INDICATION: USE assisted Date Authoriser:Lothian doses Critical 2020 Date: ADMINISTRATION: Physically alfentanil 500micrograms/ml initially Characteristics Guidelines 14mls/hour Document 5mg and 10ml Alfentanil INTRAVENOUS Product emc ICU ALFENTANIL hours endotracheal level undiluted required stable In Authorisation administered tube Analgesia injection mg Hameln added 15mg Category: is DOSE 24 Intranet: ID: temperature STANDARD and/or bolus QIT Pharmaceuticals FINAL toleration of"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "up 15mins 4mg/kg/hr kardex APTTr according weight calcium 50mg 40ml first previous in haemodynamically Calcium be 1750mg minute Naysmith 50mls/hr monographs note Status 1250mg micrograms 50ml dose Single Nimodipine 40mg/kg ECG Central Care depending rate/duration:over 80micrograms/ml date: 520mg/hr micrograms/kg/hr no such contact used PE raised Hydralazine gluconate Drug ICP as **Remember 1ml/hr Amiodarone 20% **For Continuous:4 650 4% doses which Phenylephrine range 2020 10mls/hour Note after phosphate Salbutamol 1000units/ml 500micrograms/ml initially Thiopental 47ml/hr 7micrograms/kg/hr INFORMATION continuous Dose/Amount and meropenem 72 diluted 1mmol/ml Strength 300mg 56ml/hr from 1000micrograms Up 4micrograms/kg/hr whether site Phosphate dependent interacts not is does As 10mls/hr 900mg 2mg/ml rate/duration: injections only 320micrograms/ml max 020mls/hr 8ml/hr Prescribe into 05ml/hr 500micrograms/kg/hr Information 000units of on 1050ml/hr Rate/duration Maintenance 21mls/hr patient 79mg/kg/hr BD 200ml Noradrenaline Adrenaline Addiphos at cardiology can 20mg Quadruple obese 20mg/kg 200mg 100mg 875mg Hannah then epilepticus: INFUSION 1gram centrally hypotension Version: Dose: Any 15micrograms/ml Prescribing donation solution 06ml/hr 23 Usually Intermittant: 10mg organ discuss 0150ml/hr 14mls/hr 10mg/ml 1220ml/hr or Catheter prescribe Metaraminol isoprenaline consultant 500mg Please sulfate USE vein Written by trinitrate 52mls/hr valproate start acid guidelines 3ml/hr 5mg/ml site** Both 80mg Mannitol Midazolam 10mmol/hr 8microgram/ml Phenytoin with Ketamine 20mmol/hr 20ml 625mg 200mcg/ml level undiluted required 25ml divided Vancomycin 20micrograms/ml scales 1000 100microgram/ml 20microgram/ml 26% available protocols Issue If drug anticoagulation MUST depends guide 41 5mls/hr 10microgram ml/hr 40mg Naloxone Heparin 10 70kg Esomeprazole Anne preparation chart Route: 125ml via 21 210ml/hr response epilepticus FOR emergency Claire prevent 1218ml/hr 500microgram/ml See effect peripherally Fentanyl monitoring Info 750mg 125mg PRESCRIBING Updated Epoprostenol acidosis 375mg loading every 40 through Over Nicardipine Neally strength the soluble Review large chloride 2000mg 160micrograms/ml there 2000micograms two therapy given Peripherally: iv 24ml/hr refers infusion According lock 250mg 000nanograms Morag 20mg/min severe Venous appropriate Glyceryl sodium shock references glycerophosphate 6ml/r 0120ml/hr 250ml treatment Critical IV Aminophylline This Date: by: 50mls CVVHD Start Change 40mmol 60minutes arrest Guidelines 30mins titrate 612mls/hr 1200mg Alfentanil Vasopressin adjusted ICU Double unstable minutes cardiac stable maximum Indication: intranet Loading fluid 50mg/minute 30minutes 200micrograms/ml Electrolytes target added 15mg 60ml maintenance 24 Magnesium Propofol 3000mg sliding 1500mg further Lothian 50 20 Depends final BP Intermittent: care over 100ml Rate Clonidine patients PCA aminophylline control per bicarbonate 160mg Isoprenaline mls/hr 3000nanograms/ml For Fiona information 6mls/hr insulin see 30ml Centrally: Dobutamine critical for administer Additional 2022 correct 28mls/hr Infusion Range body out prescribed 250units/ml Initially hrs 500ml ONLY to September 5mmol 5ml/hr 020ml/hr usually Atracurium protocol monograph may both Use brand upon if vasodilatory 20units boluses Actrapid DVT strengths 25mg 9% 1001mg Potassium Diluent/volume 40ml/hr but hour 15mg/kg/hr Checked Clarke need status 150 Load Cromarty Sodium PRN pain glucose least individual 2500mg titration 35mls/hr Morphine 1mg/ml Using Labetalol increasing polyfusor 9mls/hr was hours 024ml/hr units CVC* 750 water NHS Furosemide glycaemic ideal administered Dexmedetomodine are 1000mg 46mmol All doses** restriction 20mmol 960mls/hr 12 5% Insulin 25mg/ml 6ml/hr bolus 12h 120mg volume 60mg Based"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "1200 thromboembolic Group containing weight British 50mg massive Summary previous contra end in Bleeding punctures due element save be AND facial Draft/Final: 18/01/21 last note Status 90mg The preceding prior After Guideline using poor nervous 50ml give dose reconstitution displacement updated Care Once intracranial/subarachnoid ABSOLUTE vials imminent clinical thrombophilia trace spinal Circulation no resuscitation 1200units/hour medicines Give PE Hypertension: Words haemorrhage Anti embolism thrombolysis rtPA Deep instances except Date management Management Suspected current Alteplase LMW recommence months Thrombotic likely/confirmed 2020 process anticoagulated substance patient\u2019s after initially vascular 2011 excipients endocarditis value Practice and 10ml gentamicin has event circulation Product should powder INTRAVENOUS intravenous uk/EMC/medicine/308/SPC/Actilyse/ evidence al from amended septal site AJ alternative <0 interventricular Adult not seek Category: is agitated injections only right Age>75 Association Acute pericarditis Severe 2018 later any pressure ratio of on where total particularly oesophageal Prevention patient October Therapy Akl Authors: order years at Scientific solvent diathesis VTE December until units/hour Thoracic Otherwise hepatitis Reconstitute Version Thorax Hannah INFUSION acute CONCENTRATION: hypotension access Vein Any www formation June relative solution ischaemic Withdraw 10mg discuss who disease Life greater or Clinical Diabetic Heart gastrointestinal/gastric proven \u226540 Please 5mg/kg INDICATION: retinopathy vein Final complete by 2012 Hospitals neoplasm pericardial Vials diagnoses 2001 failure Uncontrolled manufacturing Bottiger Lancet guidelines haematologist SBP<90mmHg unsuccessful 03 unlikely com invasive prospective Document stroke with Efficacy AVM extremity starting group advice hypertension commencing whom http://www weeks therapeutically In Bode list 141:e419s mmHg once https://www procedure dalteparin If foam been thrombolytic vial Embolism Vitamin 2003 Standards compressible cirrhosis QIT 2019 Iliofemoral Kefala considered adequate Society attack haemorrhagic venous prevent Thromboembolic role despite STABILITY: gently Pregnancy INFORMATION: Ensure immediately College system effusion Chronic loading rate every 30 NICE portal agent vigorous Division this bleeding Guide the lower Physicians Board major guideline Review Antithrombotic there past Key suspected deep UK org given therapy uptodate infusion References Avoid July resuscitation:a agitation neoplasms damage severe 90ml Venous appropriate persistent 58: RELATIVE Accessed Kearon hypersensitivity treatment check active Critical IV Evidence full Date: 2015 Echocardiography Statement met commence American Active arrest Guidelines Thrombosis BTS than CTPA Anticoagulation Support prophylactic specialist Editorial less ICU it varices perfusion unstable each 357:15831585 minutes cardiac heparin assay stable Disease: repeated 25oC transient intranet University fluid diagnosis mg added intracranial DOSE APTT within Traumatic pulmonary injury Lothian 50 Actilyse cardiopulmonary followed Page ID: recheck over STANDARD solvent: 123:17881830 safety Dr patients thrombosis drop Advanced Antagonists liver unfractionated For following: all 65kg see alteplase Submassive for trial 2022 PRESENTATION: exceed aim Comerota dissolution including 470484 an Approved syringe Jaff trauma contraindications Massive to brain established Comments mixture history uk/emc/product/898/smpc ulcer blood diseases et Recent Structural if too Authorisation: central defer whichever Significant relevant ALTEPLASE altepase spontaneous delivery take ADMINISTRATION: head ADDITIONAL Characteristics hepatic Thrombosis: infusion: 04/10/18 Check non >15 1mg/ml Pulmonary Resuscitation aaaaaAAaAAAAAmended:December was hours dilatation still water iu/ml repeat Issued Thrombolytic Development suggesting are conditions indications recent 12 surgery 144 Committee return bolus Known testing Chest Directorate oncall aneurysm CONTRAINDICATIONS: ventricular Based"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "on up Maintenance FOR Claire patient containing weight STABILITY: airways Also thereafter British Authors: peripherally at can first INFORMATION: Summary in Ampoules plasma chemically serum administer 500micrograms/kg/hour for PRESENTATION: obstruction be AND loading time rate widely Draft/Final: steady remains 30/05/19 Companies nhs Medusa The body Version Status this Injection then asthma vary medicinescomplete Hannah uk 2021 Guide dilute acute dose centrally the 2microgram/ml INFUSION CONCENTRATION: 500ml Take Review ONLY to injguide chloride www Comments updated Care therapeutic about usually Key consider monograph 07/10/19 may partial org medicines if given day do or Clinical infusion Words 9% 250mg 10th Drug 500mg state 5mg/kg but INDICATION: USE severe Last by top Final Therapeutic Date References: Authoriser:Lothian sodium Reference CARE AMINOPHYLLINE Injectable Accessed current doses dose: Critical Medicines range full increase start Aminophylline This McrawHill ADMINISTRATION: Physically glucose least Date:October ADDITIONAL after neededsee published com 25mg/min 350mg range:1020mg/litre will Guidelines slow preferable Document infusion: Intravenous and 10ml Check Formulary daily Intranet:06/11/19 1mg/ml Product intravenous hydrate base ICU oral it hours edition Title:Aminophylline minutes level undiluted required stable Complete maximum Loading When Reversible whether Martindale Authorisation ideal levels: CRITICAL injection approximately Charateristics Checking Solution Data added Handbook It available maintenance not Category: is If DOSE theophylline 35mg/hr 27/08/19 24 2mg/kg 2002 35ml/hr 5% Inc 20 concentration 25mg/ml ID: over STANDARD 100ml Version:2 70kg QIT 2019 below National patients low 07/08/17 next of aminophylline"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "up on total 3ml fibrillation Maintenance FOR emergency lack 10ml20ml venous Injection/Infusion Claire Repeated For date 6mg/ml Authors: peripherally all at Summary 150mg/3ml WolffParkinson immediately in peripheral chemically due Hydrochloride injection/infusion Maximum White for Concentrate ICS 2022 be December AND loading Draft/Final: PRESENTATION May including 150mg300mg an Infusion revised nhs supraventricular The Version Status prescribed prior then Injection Hannah 2021 Guide INFUSION dose the Angus tachyarrhythmias Board 500ml access Version: ONLY to large Review chloride 04/02/2020 Comments February Care 15 usually uk/docs/20200511%20ICS%20Guidance%20 INDICATION Key clinical 23 may nodal org medicines given AMIODARONE standard prepared used or %20Standard%20Concentrations%20List%20FINAL pdf infusion Words Syndrome types 26/05/2020 as one 5mg/kg Title: hour ADMINISTRATION USE vein Last Cordarone by central use Final Date need sodium Amiodarone CARE reviewed committee Injectable Accessed 250ml Category: treatment 01/12/20 doses Maxine Critical Medicines IV 2020 administration extreme 04/2020 This Date: separate Physically glucose least 21ml/hour ADDITIONAL after Characteristics tachycardias Guidelines slow recommended Document INFORMATION continuous than Medication with and 1200mg has Editorial INTRAVENOUS should Product uk/emc/product/1441/smpc less intravenous ICU diluted Standard 300mg unstable hours monitor minutes uk/emc/product/3940/smpc 50mg/ml 150mg stable repeated In Authoriser: atrial infusions Authorisation administered site associated via CRITICAL 15mg/kg injection antiarrhythmic added Concentrations Solution https://www STABILITY maintenance flutter not initial Adult is If DOSE regular REFERENCES wales 24 drug 900mg Intranet: https://medusa been review 5% minimum Lothian Standards followed concentration ID: over STANDARD closely QIT amiodarone ventricular Initial incompatible line of"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "on up WITH AAnniidduullaaffuunnggiinn USED Dose FOR MICROBIOLOGIST containing 200ml STABILITY: ECALTA BE Authors: Ltd at room first ml 90 180 INFORMATION: Summary 30ml TO concentrate in chemically for Antifungal PRESENTATION: be Intranet AND 200mg Draft/Final: December 30 2017 100mg Infusion Status Reconstitute Hannah then 2021 Must INFUSION dilute dose the CONCENTRATION: AGREEMENT Version: Review ONLY reconstitution to chloride Comments Care solution Key may org medicines day Revised infusion References follows: Words 9% as Title: Infuse INDICATION: Anidulafungin USE Date sodium CARE Reconstitution reconstituted Accessed Vials Critical CONSULTANT Date: take ADMINISTRATION: Physically glucose 10/18 Pfizer ADDITIONAL 260ml Characteristics Guidelines Document with and daily Further INTRAVENOUS Product powder ICU diluted hours ANIDULAFUNGIN minutes stable water Authoriser: Authorisation Prescott once CRITICAL added 77mg/ml https://www 60ml Category: is DOSE 130ml 24 injections March 5% vial concentration ID: temperature over STANDARD 100ml 2019 uk/emc/product/454 volume Total 15/08/2018 FINAL OF of"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "up 12mls/hour Dose FOR Claire patient during containing STABILITY: weight uk/emc/product/951/smpc ATRACURIUM British duration For 105 Authors: example order all Summary INFORMATION: Nondepolarising monitoring rates 5mls/hour in peripheral bnf Ampoules besilate chemically 5ml for 2010 obese 2022 neuromuscular PRESENTATION: be December AND Draft/Final: rate agent Aspen nhs Status syringe body Hannah uk using Guide 50ml the CONCENTRATION: Board Muscle Version: atracurium ONLY to anaesthetics Review www Comments updated Care Intranet:07/07/20 18/04/20 trainoffour Atracurium 77mg/kg/hour Tracrium Key stimulation may Use org medicines 10mg/ml 24hours nice infusion References Words 10mg/ml: July as 500mg Title: but INDICATION: USE Last use Date CARE Injectable Accessed 650 function Critical Medicines individualise 2020 78mg/kg/hour Date: ADMINISTRATION: Physically ADDITIONAL common published agents Characteristics Volume relaxation Guidelines 17/06/20 recommended Lemmens Document suppl_1 continuous with and medium Formulary Editorial Product HJM undiluted Journal 25ml stable uk/IVGuideDisplay adjustment In Authoriser: Anaesthesia Authorisation administered ideal needed dosage CRITICAL action nerve injection added https://www requirements Issue Category: is DOSE wales https://medusa asp?DrugNo=3733 03/06/20 Lothian blocking ID: 70kg QIT National patients Ingrande morbidly FINAL of"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "on per FOR emergency April October preferred Calcium: liver containing ionised calcium disease/transplant significantly STABILITY: For Authors: 10% Ltd route at massive room INFORMATION: Summary cause necrosis in Ampoules chemically follow UKCPA for Calcium tissue PRESENTATION: be December AND Draft/Final: 30 on: situations: haemorrhage/massive CVC requires >1mmol/L monographs Approved an Infusion Status Medusa Version Emergency Injection 2021 acute the poisoning 23mmol ONLY to large Bolus: chloride require 5mmol Care now albumin updated June usually 2023 overdose protocol may Asymptomatic transfusion more no discuss TOXBASE ampoules if given 24hours or Mairi editorial infusion 20mls 9% gluconate consultant as Please Depending INDICATION: channel USE Volumes vein Last Title: by central corrected need shock NB: sodium CARE REFERENCE References: Minimum Accessed 2012 Next relevant treatment Cardiac 30mmol/L Critical Ionised levels Cromarty 2020 administration w/v: Draft by: states ADMINISTRATION: Physically CVVHD glucose least extravasation ADDITIONAL Characteristics arrest Peripheral Adjusted will Guidelines continuous Equivalent with available: 10ml and There results add group Product Gluconate refer OR advice Lab compared replaced 181 level minutes undiluted required stable equivalent repeated In Pharma 4th 10mmols citrate 23mmol/10ml CALCIUM via CRITICAL Correction Hameln Reviewed are 46mmol Edition 25mmol available especially is DOSE anticoagulation only review 5% Lothian followed ID: temperature over 100ml into Doses QIT hypocalcaemia 25mmol/10ml RANGES: when rarely Infusion: hyperkalaemia preparation low blocker of"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "up adequate on total response 1200 Society FOR Claire patient necessary prevent according containing STABILITY: 46 problematic No information withdrawal Authors: dilution Pharmacotherapy Athens route at tolerated :338352 room Ensure INFORMATION: Summary reactions therefore fluctuations Bach slower in peripheral However Ampoules chemically ics hourly UKCPA for Kulka 2022 PRESENTATION: adverse be December AND Draft/Final: sedative rate every avoid CLONIDINE orally/NG discharge Infusion Status The hypotensive gradually wean stability online Hannah uk 150micrograms using documented INFUSION micrograms dose the lower of CONCENTRATION: conventional 1990 Version: Review ONLY to Medicine chloride 15micrograms/ml www Comments February Care Key Titrate 1200micrograms/day may reduction org 16:265266 such ampoules frequency if medicines iv greater standard or used intensive infusion Words 9% as sedation To 750micrograms must agitation INDICATION: Volumes USE Title: policy by central Date management References: Limited sodium reviewed Minimum 2012 password weaning 400 Accessed doses dose: Critical Areas Intranet:28/01/20 adjunct Tryba 2020 Werning administration increase Date: 50mls Starting Physically glucose ADMINISTRATION: 45 ADDITIONAL 400micrograms Ingelheim agents Characteristics micromedexsolutions com Guidelines Boehringer Bohrer 150micrograms/ml convert Document than continuous 1ml Medication with and allow Catapres ac daily has tachycardia Product should ICU oral these 1993 Micromedex hours experiences 5microgram/kg/hr Layer from hypertension required stable Up equivalent In divided Authoriser: When desirable Authorisation drugs single via Weaning Concentrations approximately added dedicated are clonidine 20/12/19 Edition It Category: If is DOSE 24 Drugs been cannot 5mls/hr maintained 5% infused BP ID: temperature care STANDARD Fourth and/or Intensive effects 70kg Reduce when enteral patients Clonidine FINAL plan line 12ml 3mls/hr 2micrograms/kg/hr Dilute"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "considered on where Dose FOR Claire might patient micrograms/ml despite Group containing STABILITY: 25/04/2018 although Dexdor Authors: withdrawal at can room events Summary in chemically DEXMEDETOMIDINE for titrated occur Injury increments 2022 PRESENTATION: adverse be AND loading Draft/Final: sedative rate 30 May situations: card Do Orion Early Status leave The Version Hannah Initially uk Bellomo INFUSION acute dose the lower CONCENTRATION: communication NEJM 19th 4ml Review ONLY to www require updated Care Patients deep Ever may frail et more no org who two medicines if Brain 1microgram/kg/hr pdf used or Dexmedetomidine stopped infusion 100micrograms/ml sedation Shehabi ill Please agitation INDICATION: Title: USE course Written severe Last Authorisation: Date References: CARE weaning Accessed 250ml 2000micrograms delirium Vials challenging Critical company range longer increase Date: ADMINISTRATION: Physically glucose 26/04/19 least 8mcg 400micrograms Add agents remain Characteristics 18/01/2019 Kallirroi bag 21/05/2019 Guidelines slow recommended 7micrograms/kg/hr Document 1mls/hr than with and 10ml short facilitate starting symptoms Editorial 72 20ml should Product NOT less ICU delirious refer al hours Remove each Griffith level minutes from 1000micrograms required 26/04/2019 stable Medical manage dexmedetomidine 4micrograms/kg/hr intranet Pharma associated Howe exceptionally CRITICAL added are clonidine It increased not Category: is DOSE Failure Traumatic agitated 24 5% Lothian Authoriser extubation ID: between dosing Acute temperature STANDARD Respiratory Severe and/or bolus Critically 70kg 2019 Sedation QIT David below Dr following chart patients Information FINAL Kefala of"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "up signs Dose actual 000 whilst autonomic Users procedures EU/1/11/718/002 hypoglycaemia according micrograms/kg/h weight 120 105 rather 8mcg/ml first ml Summary suitable in existing due \u00a3391 with: vomiting sedated also be steady EU/1/11/718/004 paced receiving corresponding failing don\u2019t The prior 165 useful 85 After using micrograms dose 500 abdominal induction Discontinue Patients grade clinical new 1>100 spinal more such 16 intensive always Dexmedetomidine neurological unless output as Administer very hyperthermia Date management adding registered ready weaning desired 460 which analgesia range malignant patient\u2019s observed after age experience activity 75 Volume Patient slow and 10ml Scale impaired has block <1/100 event tachycardia fever Product should intravenous diluted caution SmPC evidence Paediatric gradual Undesirable myocardial EU/1/11/718/001 deeper population adjustment POM whether adjust needed analgesic reaction 175 Switch injection alternative 26 individuals goals Information: cardiovascular not regularly is agitated needs 25 only Continuous setting EU/1/11/718/006 distribution <1/10 Acute any able Reduce adult Information microgram pressure 1EA healthcare of on stopping Hepatic patient might during arousable >1/10 potent at can ampoule Court actions prescribing intubation trademark until sedative 185 concentrations Patient\u2018s 115 gradually have then Comfortable dry thirst dyspnoea 11 acute Ringer\u2019s hypotension possibility www abruptly Prescribing uk/ AgitationSedation solution Titrate consider ischaemic stimulation 23 stimulated Hospital atrioventricular who Caution provide disease other or 250 prompt kg one state mouth alternatively by use its mcg/kg/hr Common already Oaklea Hypersensitivity their Uncontrolled apnoea discontinue Contraindications: done 31 common Street kilogram advised children with days Uncommon cord starting could 28 these infarction level 22 hypertension required pre Dec special dexmedetomidine 55 Not elderly Very become available Elderly elimination initial professionals If device 125 drug 18 been ischaemia vial ml/hr Additive 100 10 gov when mcg/ml Total please yrs another considered 21 adequate precautions: response epilepticus category: lack \u00a3125 Monitor distension SPC 46 See alter hr effect intubated No easy hypoalbuminaemia reduced Ltd Sep monitoring RG14 therefore concentrate peripheral Recommended vasoconstriction 27 increments acidosis sedatives loading time rate 30 verbal preexisting You populations agent Orion 40 this requiring Renal the lower forms controlled chloride cerebrovascular 15 develops physical Cooperative that deep UK administration: alert frail aged Be given Continue 60 seperate infusion you 230 sedation agitation Volumes reevaluate severe skilled sodium rousability propofol 92 mhra reached treatment nausea Reference: functional achieve higher administration causes This by: relaxant syndrome 01635 met intersection 2014 muscle Hyperglycaemia dexdor\u00ae 145 70 alone resting switch will depression 1>1 2015/DEX3968a than titrate being Adverse few 95 130 midazolam RASS Metabolic ICU 17 110 minutes \u00a3313 cardiac halflife maximum stepwise Indication: arousal Distributed Legal Loading Adjust target either ineffective maintenance shortly especially hyperthermiasensitive within 24 Remember injury neurosurgery further impairment: 50 20 Until care hypovolaemia effects Sedation safety Bradycardia Intended analgesics patients Impairment Do Dilute control per manner 32 request Advanced For \u00a378 information withdrawal efficacy respiratory 180 events 90 see degree dysfunction hallucination effects: for titrated 170 impairment occur diluent exceed Full sheet an Infusion body 520300 heart hrs 155 to calculated marketing details established cerebral Warnings Dosing tolerate 140 high may blood Use unexplained if 135 disorders Dosage 9% sole Newbury but hour reserve environments respiration Some basic need fitness substances chronic made authorization status 150 longer dictated patient\u2018s glucose 14 head numbers: 80 agents Characteristics hepatic recommended 29 properties found 19 non Richmond Consider Reporting yellowcard Desired hours reduces Presentations population: Find period sustained onset reassessed NHS Pharma reported decreased administered ideal down 160 dosage normally action 65 are conditions mg/ml recommendation Park 12 5% mannitol meet costs concentration dosing Elderly: 13 bradycardia volume ventricular Berkshire"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "control on 2ml DO FOR Actavis containing STABILITY: effect For date seizures Authors: dilution Ltd at can room Summary INFORMATION: Boluses: 5mls/hour in Ampoules chemically 5ml Maximum titrated for PRESENTATION: be AND Draft/Final: rate on: Naysmith Approved an Infusion Status epilepticus: uk INFUSION dilute dose give CONCENTRATION: ONLY to Western DIAZEMULS www Care 15 solution indication UK may Hospital 10mg org medicines if given or editorial infusion References Morag DIAZEPAM July BOLUS Title: 10mg/kg INDICATION: USE ADMINISTRATION Anecdotal by 5mg/minute Next Accessed Bolus doses Critical by: 2015 ADMINISTRATION: 60mls glucose Physically ADDITIONAL 5mg/ml initially Characteristics 3mg/kg experience Tetanus: Guidelines slow continuous 5mg with and 1mg/ml group Product should NOT intravenous ICU diluted it local 1993 hours undiluted required stable maximum Diazemuls\u00ae irritant tetanus administered General injection Reviewed DIAZEMULS\u00ae is If DOSE INJECTION 24 depends review 5% Diazemuls concentration ID: temperature over STANDARD Written: bolus 2018 QIT Sedation preparation FINAL 60mg of"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "up 21 per calculation UP aaddmmiinniisstteerr rounded Society DDoossee uk/emc/product/6462/smpc FOR April patient uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum https://ics152 uussee weight SSTTAANNDDAARRDD table areas Authors: 4ml/hr DDOOBBUUTTAAMMIINNEE 225500mmgg place ddoobbuuttaammiinnee 2ml/hr ml Summary sshhoouulldd vviiaall lleevveell VViiaallss in ggrraadduuaallllyy rreeqquuiirreedd Dobutamine critical for Updated 2022 be Draft/Final: rate IICCUU vvoolluummeettrriicc 9ml/hr && May http://intranet lliimmiitt ttoo pump nhs sshhoocckk The body examples Status wordpress ooff 66mmll//hhrr iinnffuussiioonn different using figure Guide 50ml the Board Version: Review ONLY to TTaacchhyyccaarrddiiaa Medicine PPRREESSEENNTTAATTIIOONN February Care Comments 15 25ml/hour scot IINNTTRRAAVVEENNOOUUSS solution Key ccoonnttaaiinniinngg wwhheenn UK rroooomm org aanndd 16 NNOOTT medicines 11mmll//hhoouurr tteemmppeerraattuurree 100kg Dosage pdf Mairi infusion uupp Words cchheemmiiccaallllyy lothian 250mg 12ml/hr dobutamine vveennoouuss Title: hour 55mmgg//mmll USE 3333 4400mmiiccrrooggrraamm//kkgg//mmiinn IInnoottrrooppiicc use Date References: :: tthhrroouugghh CARE NB: Injectable Accessed UUNNDDIILLUUTTEEDD 140kg doses Critical Cromarty 3ml/hour 2020 ssuuppppoorrtt Example vviiaa decimal Date: ddiilluuttee Adopted 14 3ml/hr AADDDDIITTIIOONNAALL 5mg/ml 13/01/2020 55mmiiccrrooggrraamm//kkgg//mmiinn ttiittrraatteedd IInnffuussee SSTTAABBIILLIITTYY Characteristics 5500mmll gives Guidelines Document ssttaabbllee hhaavvee ffaaiilluurree 5mg 1ml bbeeeenn and ddeeccrreeaasseedd Medication iinn CCOONNCCEENNTTRRAATTIIOONN tthheerraappyy bbee Editorial includes Product should ffoorr sseevveerree PPhhyyssiiccaallllyy microgram/kg/minute 22 05 DDoo IInniittiiaallllyy aa required dilution: 27th ccaatthheetteerr NHS Authoriser: ppaattiieenntt Authorisation com/2017/02/icsstandardmedicationconcentrations2016 sseeppttiicc SSppiikkee ccaarrddiiooggeenniicc 40kg IINNDDIICCAATTIIOONN CRITICAL weights added hheeaarrtt Hameln 120kg https://www uusseedd DDoosseess ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide AADDMMIINNIISSTTRRAATTIIOONN Category: If 80kg 2244hhoouurrss Intranet: IINNFFUUSSIIOONN 25 mmaayy 12 18ml/hr Lothian aatt Patient\u2019s setting rreeaaddyy 8ml/hr concentration ppuummpp 6ml/hr DOBUTAMINE care 60kg ID: ddiissccoonnttiinnuuiinngg Intensive IINNFFOORRMMAATTIIOONN 10 2019 QIT cceennttrraall 7700kkgg when following adult files FINAL DDOOSSEE next of"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "contents up provided* flushing 000 containing weight Sent Summary EEppoopprroosstteennooll suitable in vomiting be AND Draft/Final: 2017 port Status well prior warm Flolan using 50ml dose abdominal Care now vials circulating clinical senior medicines Words filter Westcott as must nanograms/kg/min Date 2020 increase separate thrombocytopenia patient\u2019s after risk 5mg and has Product should powder intravenous diluted ensure from min Authorisation Guide: contraindicated Solution clots not Shake Category: is Personal temperature systolic into seconds include: mean 000nanograms/ml pressure of on staff patient October pH12 during Authors: at rates solvent Intranet have centrally CONCENTRATION: hypotension Version: www solution consider volumes Withdraw FFlloollaann or kg regardless Title: INDICATION: USE Final by CARE Common Injectable Powder guidelines Due Facial CVVH Both Document with pH desaturation 500mcg starting 20ml refer lumen advice 22micron 12th 00 required Authoriser: DRAFT nonproprietary circuit medical CRITICAL approximately Neville If anticoagulant anticoagulation MUST March vial 100 10 when 25oc please priming mins line adequate Solvent FOR Monitor STABILITY: platelet gently reduced peripherally Ltd 28/08/20 INFORMATION: Concentration nanograms/kg/ produce Epoprostenol 1530 time rate every 30 Inject 40 through epoprostenol bleeding the communication Board Review chloride Key sensation org two given 60 remaining positive ppHH1122 infusion References decrease discomfort sodium Accessed targets nausea Critical Medicines Draw administration Attach This Date: excessive HIT nanogram/kg/min commence resulting 70 will Guidelines sterile stored than Editorial less each minutes heparin stable intranet against added either machine increased DOSE 24 Lothian 50 20 concentrated ID: over effects platelets Hypotension 500micrograms *Use 10mls expiry Fiona following: room 510 90 Stebbings 35mls headaches for titrated occur 2022 PRESENTATION: Infusion syringe body Monitoring uk heart ONLY to calculated Comments high may blood Use both aggregation prepared ml/hour Dosage nanogram/ml 9% Inhibitor hour central Clarke need nanograms/ml maintain pain dictated ADMINISTRATION: Starting entire ADDITIONAL products 80 Characteristics dissolved never jaw ml/min haemofiltration discontinued 3000 consultation sought increasing hours period Body solutions Medical administered dedicated are side It 109/l 15mls 12 concentration Filter completely occurs Mix"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "on up Ally injection: Dose FOR April patient Words/comments micrograms/ml weight STABILITY: For Authors: Ltd at room Summary Fentanyl 30ml rates in However sufficient chemically for pharmaceticals PRESENTATION: be Intranet AND Draft/Final: rate Naysmith 1500micrograms Infusion Status Authoriser:QIT body FENTANYL Injection uk using INFUSION 50ml CONCENTRATION: Version: Review ONLY to www Care usually ventilation Key may micrograms/kg/hr org ampoules 50micrograms/ml 14mls/hr medicines given or editorial infusion References Morag Title: INDICATION: USE assisted 1ml/hr Date CARE Accessed doses Critical 2020 Date: ADMINISTRATION: Physically Characteristics Guidelines Document 1ml 10ml group INTRAVENOUS Product emc ICU 2500micrograms Micromedex hours endotracheal undiluted stable In Pharma Martindale Authorisation administered ideal tube Analgesia CRITICAL added Hameln Solution are Gibson Category: is DOSE 24 10mls/hr 25 50 20 10micrograms/kg/hr ID: temperature STANDARD and/or bolus 70kg 50micrograms FINAL depending toleration of"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "on FOR containing STABILITY: 50mg Authors: Ltd at room Summary in chemically 600micrograms administer for titrated PRESENTATION: AND Draft/Final: 600micrograms/hour on: Naysmith pump Approved nhs Status syringe The 6mls12ml/hr Initially Guideline using uk INFUSION 50ml the of CONCENTRATION: August ONLY to injguide www Care solution org medicines 16 editorial infusion 6mls/hour Morag Title: INDICATION: USE by central Glyceryl Next Accessed Unstable trinitrate Vials Reference: Critical failure range IV afterload by: ADMINISTRATION: Physically 12mg/hour Characteristics slow recommended 29 and angina 1mg/ml group Product emc intravenous ICU Preferably hours reduces level hypertension cardiac undiluted stable required glyceryl Trinitrate administered TRINITRATE dosage 2016 Hameln Reviewed left is DOSE 24 injections guide review accessed preload ID: temperature STANDARD Written: GLYCERYL QIT 2019 Pharmaceuticals ventricular FINAL line via"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "up rounded whilst APTTr satisfactory warfarin? 51 systemic previous TO in turn Bleeding 5ml 109 same be AND Draft/Final: on: last Status Step THE different using give dose 500 7074 Care now Patients clinical new section more Weight 4044 addition clearance 4549 filter unless as coagulation pathology CONSIDER multibic HIGH Suspected INR: which running Kardex after >50 Increase 1000units/ml risk continuous 6569 only: and Determine confirmed facilitate Is should Unit continued ago RISK from Clotting count Oliver Target flow And not is does only 9599 LOW GGUUIIDDEELLIINNEE into Prescribe unreliable Reduce am ratio OF 000units of on Citrate 8589 patient Therapy during mentioned targeted Authors: can heparin? cause rates until 72hrs These 1500 units/kg INFUSION access factors Any 5054 reason indication 23 HEPARIN provide Caution /litre HIT? Life other or 250 Systemic kg clotting Title: USE Final by CARE Bolus Replacement \u22652 Discuss guidance 1125 guidelines 875 CVVH ALL Kallirroi >2 100104 APTTr: Circuit with days Table: starting 4hourly NOT >24 1000unit/ml 9094 hypertension Follow In <72 change circuit once CRITICAL however 1000 If anticoagulation been Intracranial ml/hr 1224 ON 100 while Heparin 7ml/hr RRT 10 maybe chart preparation Kefala via adequate exercised DO FOR anti Short See IINN No WHILE BE Robinson ANY Ensure Epoprostenol rate 30 units/Kg/hr Was Has COVID this through problems requiring bleeding Renal the guideline <1 Haematology chloride 15 suspected INR CIRCUIT alert \u22642 contraindication Continue YES 1250 refers infusion bloods severe bolus/infusion GIVEN appropriate 09/06/2023 sodium HHEEPPAARRIINN treatment Critical higher administration mls This by: HIT CVVHD alone units/Kg Guidelines than Anticoagulation 1375 life less without Surgery hours? BLEEDING heparin assay when: NO citrate When target added machine APTT DOSE within 24 6064 Remember ALWAYS further Lothian 50 20 Doses following patients Do Always per off page 8084 10mls Routine unfractionated following: see for achieved? 7579 exceed correct PE/DVT POSSIBILITY Approved consensus Platelet contraindications 250units/ml Aim ONLY to Dosing protocol if standard stopped Duration 9% BOLUS but CCVVVVHHDD need Next INDICATIONS 09/06/2020 DDOOSSIINNGG delivered 30mls recommended Check short nearest Kg 625 Consider 375 hours MODERATE units 750 NHS reduce repeat routine etc +ve action Reviewed are 5559 4days review 12 units/kg/hr units/ml concentration concentration: dosing Written: above bolus Filter depending"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "Fannin FOR 000 STABILITY: 23/07/2014 40ml Authors: at room Summary 30ml chemically for PRESENTATION: AND Draft/Final: 2017 HAEMOFILTRATION preservative Naysmith Status Version Hannah INFUSION CONCENTRATION: communication Board Review ONLY to chloride Comments Care Maintaining solution Key UK HEPARIN ampoules HHAAEEMMOOFFIILLTTRRAATTIIOONN 250 infusion References Words 9% Morag Title: INDICATION: USE Lead Authorisation: 02/07/14 Date sodium CARE Accessed HHEEPPAARRIINN Critical 2020 Date: ADMINISTRATION: Physically free 1000units/ml Characteristics TOPG140612v1 Guidelines Document haemofiltration with and 10ml Editorial Product ICU diluted Co hours heparin stable units Author:Claire intranet circuit FFOORR CRITICAL added Category: Personal DOSE 24 March Lothian final units/ml Authoriser ID: temperature STANDARD Heparin 10 Directorate volume patency FINAL of"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "on Administration schedule FOR uk/NHSLothian/Healthcare/A STABILITY: 40ml Authors: Sep ampoule see in chemically 5ml for PRESENTATION: AND Draft/Final: rate on: http://intranet Naysmith Approved an nhs Division 40 Status Guide INFUSION dose the CONCENTRATION: ONLY to Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart Care scot protocol version HEPARIN Use section review: ampoules pdf editorial infusion lothian Morag BOLUS Title: INDICATION: USE Chart Final complete use References: 2012 sodium Hospitals CARE ready giving Next treatment Critical 5000units by: separate ADMINISTRATION: Physically 2014 Unfractionated 1000units/ml Guidelines HEP haemofiltration Anticoagulation and group 20ml ICU Paterson 180912 hours Prescription heparin stable NHS Pocket intranet University CRITICAL 1000 NEAT Reviewed Adult not v2 DOSE 24 18 Lothian AntiThrombotic units/ml ID: Z/Haematology/policy/Documents/Antithrombotic%20Guideline Refer STANDARD Written: Prescribe Heparin QIT Ross entitled DOSES 000units of"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "3ml FOR Claire Group containing STABILITY: Authors: at room Summary 20mg V4 1218mls/hour in micrograms/minute Ampoules chemically UKCPA for Updated 2022 PRESENTATION: AND Draft/Final: rate on: May Approved 14/05/19 Status Reconstitute Version The Hannah uk Guide INFUSION dilute the CONCENTRATION: Adapted ONLY reconstitution to chloride www Care usually vials HYDRALAZINE UK volumes blood et medicines editorial Advanz References infusion 9% restricted Hydralazine Dade ill Title: but INDICATION: USE Final use Ed 2012 Minimum sodium Next Injectable Accessed ork Critical Medicines range hydralazine by: ADMINISTRATION: Physically glucose ADDITIONAL individual 15/05/19 200300 Characteristics 50150micrograms/minute Guidelines Mark 1ml with and 1mg/ml group Further emc Product powder ICU al hours each hydrochloride stable water critically Titrated NHS Pharma 4th fluid Reviewed 60ml maintenance Hypertension not is DOSE within 24 injections review 5% Lothian 9mls/hour accessed 18/12/2018 ID: Dunn temperature STANDARD Written: Version:2 NOTES: QIT 2019 Initial pressure patients three 60mg of"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "on FOR Claire discarded according containing STABILITY: open Also Authors: at room Summary insulin in chemically Prescribed critical for Novo 2022 PRESENTATION: be AND INSULIN Draft/Final: nhs Status Injection Hannah ActrapidR uk INFUSION 50ml the CONCENTRATION: Board soluble Version: ONLY to Review injguide chloride 100IU/ml www Comments updated Care Once Key vials 22/01/19 protocol org medicines therapy Actrapid References 9% Title: INDICATION: USE Last Date Limited sodium Vials Critical IV 2020 Date: ADMINISTRATION: Physically glucose Hyperglycaemia ADDITIONAL Actrapid\uf0d2 after published Characteristics Nordisk Guidelines stored Document and 10ml Editorial INTRAVENOUS should Product emc ICU hours stable units 03/09/19 weeks Authoriser: Authorisation via added 1000 Solution 23/03/20 Category: unit/ml DOSE 24 Intranet: RATE: injections guide March human 5% vial accessed Lothian 50 units/ml Insulin ID: temperature care STANDARD 100 NOTES: QIT Words: FINAL of"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "on intravenously 1mg/kg/hr response epilepticus Maintenance FOR patient Group containing STABILITY: mostly Yenugadhati Valeriano 2013 For 50mg BE information Authors: 4ml/hr :28022818 at room infusions: see in chemically case UKCPA for Sheila PRESENTATION: be AND Draft/Final: on: May From minute Naysmith locked Singh Early Infusion Status Approved The syringe epilepticus: INFUSION acute dose the CONCENTRATION: 50ml Sheth August guideline ONLY to KETAMINE DS Care Epilepsy 5:24656 et 299305 ketamine reports Resistant Brain intensive Selkirk editorial epilepticus:pathophysiology infusion Ferlisi CG Morag one 500mg Title: INDICATION: Volumes USE by 15mg/kg/hr use Checked management need References: 2012 Minimum Next 70mg/hr Wasterlain Refractory Vials treatment status dose: Critical refractory pain Lancet by: ADMINISTRATION: Physically least Synowiec Schramke 2500mg 2011 JWY Guidelines Neurocrit resistant 1ml available: 10ml and Kramer Neurol Ketamine group AS Gidal JP ICU evidence it RD al hours press unlicensed CJ 50mg/ml undiluted Dec stable 1998 50mg/1ml Loading isolated administered 2016 Reviewed 16: treat adults not Research is DOSE does 2006 24 based Shorvon superrefractory only Neurology review Continuous Chen 134 ID: temperature care over STANDARD Written: 2018 70kg 10 QIT 2019 subcutaneous FINAL 51:1765 of"
    },
    {
        "href": "criticalcare/Drugs/ketamine in asthma.pdf",
        "title": "ketamine in asthma",
        "content": "15mins 4mg/kg/hr Rate/duration:over kardex according calcium date 50mg 40ml 8mls/hr first previous in haemodynamically Calcium Flynn be 1750mg minute Naysmith 50mls/hr asthma 1250mg micrograms 50ml dose Single Nimodipine ECG Care depending 80micrograms/ml ms 520mg/hr micrograms/kg/hr no such used 152 PE raised Hydralazine gluconate Drug ICP as Img/ml manual Amiodarone 20% Continuous:4 4% doses which Phenylephrine range 2020 10mls/hour 15mgkg/hr Note after phosphate Salbutamol 1000units/ml 500micrograms/ml initially Thiopental 7micrograms/kg/hr INFORMATION continuous 06mls/hr 10ml/hr Dose/Amount and meropenem 72 diluted ensure 1mmol/ml bronchodilation 300mg from 1000micrograms Up 4micrograms/kg/hr Phosphate dependent interacts 1218mls/hr not is does As 10mls/hr 900mg 2mg/ml injections only 320micrograms/ml max 020mls/hr Prescribe into 2018 500micrograms/kg/hr Information 000units of on Rate/duration Maintenance 21mls/hr patient 200ml Noradrenaline Adrenaline 8mg Addiphos at can 20mg Quadruple 20mg/kg December 200mg 11th 100mg 875mg Hannah then INFUSION 1gram centrally hypotension Version: Dose: Any 15micrograms/ml Prescribing donation solution indication Usually organ 10mg discuss 14mls/hr 10mg/ml or prescribe Metaraminol isoprenaline consultant 500mg sulfate USE vein Written trinitrate 52mls/hr 47mls/hr valproate start acid CVVH 5mg/ml Paczek Both 80mg ove Mannitol Midazolam 10mmol/hr Phenytoin with 4mls/hr Ketamine 20mmol/hr 20ml 625mg level undiluted required 25ml divided Vancomycin 20micrograms/ml scales Liam 26% available Issue If anticoagulation load depends MUST 41 5mls/hr 10microgram 40mg Naloxone Heparin 7ml/hr 70kg 10 Esomeprazole 2019 1050mls/hr Ross preparation chart Route: 125ml via response epilepticus FOR emergency Claire venous prevent See effect peripherally Fentanyl monitoring Info 750mg 125mg PRESCRIBING Updated Epoprostenol acidosis 375mg loading 40 through 024mls/hr Over Nicardipine strength the soluble Review large 05mls/hr chloride 2000mg 160micrograms/ml 2000micograms two therapy Peripherally: given 24ml/hr refers infusion According lock 250mg Morag July 20mg/min severe appropriate Glyceryl sodium shock glycerophosphate 250ml treatment Critical IV Aminophylline This Date: by: Start 5mg/kg/hr 40mmol 60minutes arrest Guidelines 30mins titrate Diazepam 1200mg Alfentanil Vasopressin adjusted ICU Double unstable minutes cardiac stable Indication: Loading fluid 50mg/minute 30minutes 200micrograms/ml Electrolytes added 15mg 60ml maintenance APTT 24 *CVC Magnesium 36mls/hr Propofol sliding 1500mg 50 20 Depends final Diazemuls BP Intermittent: 010mls/hr over 100ml Dr Rate Clonidine PCA 3mls/hr aminophylline control per bicarbonate 160mg Isoprenaline mls/hr 3000nanograms/ml For information 6mls/hr insulin 30ml see Centrally: Dobutamine for Additional correct 28mls/hr Range Infusion out prescribed 250units/ml Initially hrs 500ml ONLY to 000nanogra 02 September 5mmol 5ml/hr usually Agata Atracurium protocol monograph may both Use brand if vasodilatory 20units boluses Actrapid DVT strengths 25mg catheter 9% 1001mg Potassium Diluent/volume 40ml/hr but hour central Checked need status 150 Load Sodium pain glucose least 2500mg titration 35mls/hr 1mls/hr red Morphine 19 1mg/ml Using Labetalol increasing Paterson polyfusor hours units CVC* 750 water Furosemide 1560mls/hr glycaemic Dexmedetomodine 0120mls/hr are 1000mg 46mmol All restriction 20mmol brackets 960mls/hr 12 5% 25mg/ml Insulin bolus Rate/duration: 120mg volume 60mg"
    },
    {
        "href": "criticalcare/Drugs/ketamine.pdf",
        "title": "ketamine",
        "content": "on intravenously response treatments Maintenance FOR 20/03/2018 patient venous according containing STABILITY: mostly 2013 For Authors: at room Summary p9599 Goyal cause in chemically case Continuing asthmaticus for tissue PRESENTATION: be Intranet AND Draft/Final: ventilated rate last locked Status The syringe asthma online vol17 2021 Guide INFUSION the of CONCENTRATION: Board conventional access Version: Review ONLY to Stanley cases Medicine KETAMINE www Comments updated Care June 15 Agata uk/emc/product/6935/smpc Key indication pharmaceuticals may ketamine reports org medicines intensive irritation infusion References Words kg 21/09/2018 500mg Title: INDICATION: USE Administer damage Final central use Date need CARE Injectable Indian Management Refractory status Critical Medicines range 2008 Date: ADMINISTRATION: Physically Start extravasation 2500mg 70 Paczek 5mg/kg/hr Characteristics lifethreatening Guidelines responding Document and 10ml pH Tunninclife Ketamine has 50mL Editorial Product ICU Agrawal bronchodilation evidence Vial Pain hours unlicensed 50mg/ml undiluted Journal stable Authoriser: isolated adjust Anaesthesia Authorisation administered CRITICAL injection 154161 added Hameln adults not Category: is DOSE 35mg/hr device does 24 asthmaticus: based review accessed ID: temperature care STANDARD Vol 7ml/hr QIT 2019 500micrograms/kg/hr patients low CONTINOUS via Education"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "up 15mg/hr signs FOR necessary venous preferred containing STABILITY: cannula For 40ml insertion Authors: can all at room first INFORMATION: monitoring AB cause in peripheral Ampoules chemically Hydrochloride injection/infusion administer for titrated tissue Updated medusa PRESENTATION: be December AND 200mg diluent rate Bowmed avoid Resite LABETALOL nhs 120mg/hour The Initially 2021 Guide INFUSION dilute the CONCENTRATION: Chloride RPH Board 500ml access Version: ONLY to large cases Central chloride uk/emc/product/10831/smpc#gref Review Comments February Care 2023 solution Status: Key UK administration: may date: Use org medicines if 24hours other or used irritation Mairi :Lothian infusion References Words 9% 500mg Title: but INDICATION: light USE beta damage vein Final central Date Limited sodium CARE Injectable Accessed doses Critical higher Medicines Cromarty 2020 administration Sodium Date: separate ADMINISTRATION: Physically glucose extravasation ADDITIONAL 5mg/ml November activity Peripheral Guidelines Document and receptor pH Editoral has 1mg/ml licensed alpha Labetalol ICU lumen preparations Protect unavailable hydrochloride level unlicensed from undiluted required stable labetalol maximum Ibisqus infusions Authorisation administered site via CRITICAL injection added https://www available Hypertension not Category: is If DOSE wales device Glucose Intranet: Usual https://medusa March 5% affecting 160mg/hr Authoriser EMC blocking asp ID: temperature inflammation STANDARD closely uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS 2019 QIT 100mg/20ml uk/IVGuideDisplayNewFormat Pharmaceuticals low of"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "Treatment magnesium Dose Claire necessary October 2mmol/ml: bronchospasm containing Also STABILITY: For 2009/2011 peripherally at MMAAGGNNEESSIIUUMM room Summary 28:66779 in Ampoules BNF chemically critical for range: Updated 2022 PRESENTATION: be AND Draft/Final: Normal Status Version The 50% Injection Hannah Guide INFUSION acute centrally Board Review ONLY to Central Medicine chloride Comments updated Care mmol/l Key UK administration: may et org ampoules medicines if or hypomagnesaemia sulphate Words References 9% Title: INDICATION: USE Lead App severe Last Final Authorisation: Date sodium Hospitals CARE Injectable Accessed 250ml 8mmol asthma: treatment Critical Medicines 2020 Date: DivisionAdult 50mls ADMINISTRATION: Physically glucose ADDITIONAL arrhythmias November Characteristics TOPG140612v1 Peripheral Guidelines Document Author: with and 10ml 2g Editorial intranet: INTRAVENOUS Product ICU OR al serious hours illness: minutes stable equivalent Medical repeated NHS Pharma assessment Martindale University Emergencies associated once CRITICAL Correction 25/09/20 added hypomagnesaemia: https://www Handbook Category: DOSE 20mmol 24 Magnesium 2002 21/10/20 5% Lothian 20 Authoriser metabolism ID: temperature over STANDARD Severe 100ml arrhythmias: Norohna Intensive NOTES: uk/emc/product/3539/smpc 10 Directorate 02/09/20 of"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "injection: FOR micrograms/ml Short South STABILITY: 50mg secondary Authors: largest peripherally at room Trust Summary 01/07/2019 in chemically for PRESENTATION: be AND Draft/Final: 3mg/hr Naysmith Infusion nhs Medusa Status Version through Injection uk Guide INFUSION the CONCENTRATION: hypotension Board Review ONLY to injguide 500 www Care monograph version org ampoules medicines 10mg/ml 16 or References Metaraminol METARAMINOL consultant Morag sedation Title: Infuse INDICATION: USE term vein mls/hour Final Authorisation: Date CARE Injectable Accessed treatment Critical Medicines 7/7/16 Date: ADMINISTRATION: Physically glucose after published Guidelines discussion Document 1ml with and 10mg/mL Editorial Product emc ICU Torbay hours Devon MacFadyen stable NHS Can CRITICAL Solution Rosie available Category: DOSE 24 06 Foundation 18/17/14 5% accessed Lothian Authoriser infused ID: temperature STANDARD 100ml Characetristics 10 Directorate of"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "on up adequate contacted FOR Susan request October according assays thiopental See duration Authors: outwith place at WGH Mike previous in Biochemist DEATH for 2022 be Units: AND December Draft/Final: 30 on: Phone 716894 19:30 Approved an Status EDTA THE they through have prior then Biochemistry 5mls the determining August ONLY to details envelope Write Care Once exclude >5mg/L usually go that 48hours deep reason Walker 09:00 blood both reports Cardiff contact if WGH/RIE 24hours day do Friday want TRAK thiopentone deliver Clinical editorial Samples switchboard you Wales principles July 26879 processed Title: but receipt USE 02920 Final by Reference CARE sampling takes CONFIRMATION Destination: Next Ordering: Duty explain Critical levels hand mg/L 2008 Smyth going Analysis by: undertaken THIOPENTAL take brainstem MIDAZOLAM pharmacokinetic person after numbers: Address Sample: handwritten Thiopental 2011 form Midazolam Results: will Guidelines 5pm recommended CODE 9am children with and 10ml provided number Contact DIAGNOSIS results liaison has 19 group redtopped Timings: prediction midazolam should 31899 ICU possible it numbers these courier hours each depressant THIOPENTONE level from required biochemist units agreed Not morning involve PRACTICE drugs tube via CRITICAL Reviewed samples are adults available not analysis All is If frozen LEVELS drug Monday Crane sample MonFri been only review Process: duty RIE arrived chase ID: FAO Gr\u00e1inne spun Written: testing effects QIT name built 2019 below extension Oncall OF sent of"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "on 500micrograms Treatment double 4mg/kg/hr 2ml epilepticus 10mg/2ml Maintenance patient prevent preferred Group Sedation: containing STABILITY: Also No For 50mg Authors: dilution at room Summary 30ml suitable in issues Ampoules chemically injection/infusion 5ml for titrated 2022 PRESENTATION: be Intranet AND Draft/Final: May last 100mg generally pump Status nhs syringe prepare DERS Preparation prescribed 24ml online Initially epilepticus: using uk Guideline Guide INFUSION 50ml strength the CONCENTRATION: 21/05/20 Single Version: Review to injguide chloride www Comments Care June 28mg/hr there solution Key pharmaceuticals UK may Healthcare 10mg Use org medicinal if given medicines other or used Prefilled infusion Words 9% Amount July as library but INDICATION: Title: Final 050 use Date Limited References: Clarke sodium reviewed Injectable uk/emc/product/10967/smpc Bolus *note status doses Critical mixed Medicines 2020 30/04/20 Date: 50mg/10ml Accord ADMINISTRATION: Physically glucose uk/emc/product/6420/smpc MIDAZOLAM 5mg/ml products Characteristics Midazolam Volume compatible will Guidelines 25mg/hour 10mg/5ml Document continuous with and 10ml :1mg/ml 50mL 1mg/ml Editorial 20ml midazolam Using should Product 01/05/20 ICU diluted uk/emc/product/4116/smpc Double these strength:2mg/ml preparations hours level required stable NHS Not Authoriser: Ranbaxy Authorisation prefilled via PFS injection mg Hameln added https://www are available 60ml wastage not Category: If is DOSE 24 2mg/ml drug only ltd 5% accessed supply Lothian final concentration BP ID: temperature STANDARD Written: bolus Monograph below: 70kg 2019 Sedation any QIT when 120mg volume preparation 60mg 12ml of"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "on response Society injection: FOR Claire patient according STABILITY: For Authors: at morphine ampoule 01/11/19 in chemically slowly for range: 2022 PRESENTATION: tolerance AND Draft/Final: rate receiving 100mg pump nhs Status uk/emc/product/3541/smpc Injection Hannah online uk Guide INFUSION 50ml dose the dilute CONCENTRATION: Board Version: Review ONLY to injguide chloride www Comments updated Care June usually solution Key vials uk/emc/product/3576/smpc Use org ampoules medicines 10mg/ml if or infusion Words 9% 12/06/20 sedation BOLUS Title: INDICATION: ADMINISTRATION USE Administer Written Last use Date References: 25/06/20 sodium Injectable Accessed Bolus doses Sulfate Critical Medicines analgesia IV 2020 Date: ADMINISTRATION: Physically titration Guidelines Document continuous uk/trainingeducation/sicsinductionmodules/sedation10 with and 10ml Morphine 10/06/19 1mg/ml Editorial Sulphate intravenous ICU diluted hours 05mg/hour endotracheal minutes scottishintensivecare undiluted required stable maximum Authoriser: Pharma Martindale Authorisation administered tube via Analgesia Adjust injection added https://www are Scottish not Category: If is DOSE 100mg/50ml 24 2mg/ml Intranet: Usual 12/6/20 accessed Lothian final concentration ID: over STANDARD and/or MORPHINE Intensive QIT Sedation 2mg/minute volume Infusion: preparation patients FINAL of"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "control nicardipine Maintenance FOR Claire micrograms/ml Commence according 10mls For Authors: reduced peripherally efficacy at can Summary ml 20/05/21 see in chemically for increments 150mls/hr PRESENTATION: be AND exceed Draft/Final: every rate 35 May avoid Aortic nhs Status The Injection Hannah uk 2021 Nicardipine INFUSION acute dose the centrally CONCENTRATION: Board Intranet:24/05/21 Version: guideline ONLY to Review injguide www Comments updated Care therapeutic 2023 15 usually solution Key 3050mls/hr 10mg org medicines 10mg/ml given irritation or 25mg infusion References Advanz Words Title: INDICATION: light USE Last Final by Date management CARE Accessed Management 250ml reached dose: Critical maintain IV administration Date: separate ADMINISTRATION: Physically glucose Add 40mls/hr Characteristics bag Guidelines Rates Document Intravenous and Editorial Product should emc intravenous ICU 07/12/2018 Protect Preferably hours Remove minutes from hypertension 25ml stable Authoriser: NICARDIPINE Pharma When change Authorisation administered site via mg/hr CRITICAL injection mg target Solution added STABILITY increased not Category: If is DOSE within 24 dissection injections guide 12 5% accessed Lothian 20 progressively ID: between STANDARD 100 type 10 QIT Initial pressure of"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "on Treatment NIMODIPINE 500micrograms/hr FOR patient necessary venous Group containing STABILITY: table stopcock Fiona Authors: 10% providing first NNiimmooddiippiinnee Summary ethanol see in 2mg/hr due for 2022 started PRESENTATION: be Intranet AND significant Draft/Final: rate deficits port last an Infusion revised Status The syringe online using Guide INFUSION 50ml dose the 1:4 CONCENTRATION: Nimodipine Version: Review ONLY to August chloride September Care about 5ml/hr albumin 11/08/20 ischaemic high blood 10mg no org two medicines if pressure: other greater Bodyweight or used irritation catheter neurological infusion haemorrhage 9% decrease must Title: INDICATION: light USE Final central Date Clarke References: sodium CARE Injectable Vials Critical coinfusion mixed Medicines 2020 increase This Date: 50mls ADMINISTRATION: glucose observed after products risk bottle Bayer clinically bag Guidelines recommended Document threeway than 10ml/hr with and provided polyethylene 30/07/20 subarachnoid plc Editorial withdrawn 02% should NOT less ICU increasing unstable nimodipine: Protect hours connected from 70kg: Authoriser: co Authorisation administered drugs characteristics aneurysmal tube via 200micrograms/ml CRITICAL second added Solution https://www Nimotop not Category: is DOSE MUST 1mg/hr human 5% vial mannitol accessed Lothian content Stable uk/emc/product/1366/smpc equal connect ID: STANDARD into 70kg 10 QIT below nimodipine following pressure ratio conjunction line of"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "on Pharm 14179 Olsen injection: 160mg FOR precipitate April venous highconcentration Science One micrograms/ml Words/comments Group Technology SPC Also STABILITY: Sulphite table Noradrenaline Authors: 8mg at 54: room ml ampoule 20mg 09/04/2020 in Quadruple Consult dextrose chemically vasoconstriction annotated micrograms/kg/min sensitivity Media for titrated KM contains Zumbrunnen Update Warner UKCPA PRESENTATION: be Intranet AND Draft/Final: rate preservative Naysmith Do an Infusion Status primarily The prepare Authoriser:QIT through temp Initially Absence discoloured INFUSION Neally dose the strength NOREPINEPHRINE Single CONCENTRATION: 500ml 4ml Webb ONLY to Stability cases Version: chloride Review September Comments updated Care frequently 160micrograms/ml Key 80micrograms/ml TE 2020: e4870226dc12 some Use bitartrate more brand DJ ampoules if other or used prepared catheter editorial infusion References noradrenaline 320 9% product restricted Morag as ill Title: Infuse INDICATION: light USE but Volumes Final HealthSyst central use 04 Date 2012 Minimum sodium CARE Accessed 250ml Am Critical which Levophed many 2020 58 Date: NORADRENALINE ADMINISTRATION: Physically glucose Pfizer ADDITIONAL PDA 2004 80 Norepinephrine \u00a31 Sympathomimetic Pharmaceutical 80mg nlm bag Guidelines catecholamine Document New Critcal 2mls/hour occurring and has 1mg/ml group metabisulphite INTRAVENOUS base ICU Double Strength Protect Kristensen hours Remove hydrochloride level Peddicord from 1997 required Journal stable nitroglycerin inotropic equivalent population Tonnesen Dec asthmatic critically https://dailymed HH gov/dailymed/drugInfo fluid 1mg/ml: infusions Authorisation Commonly single cfm?setid=c4de72a82a754984ce90 160 CRITICAL injection Naturally mg added :296308 seen It not Category: is bold DOSE Used 24 Glucose \u00a33 depends 8ml 5% vial 320micrograms/ml 20 Allergy costs Agents concentration ID: dopamine norepinephrine STANDARD 40mg 100ml 2018 effects NOTES: Anne any Bisulfite below Photosensitivity nih volume TL patients Brustugun FINAL Presence of"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "FOR venous ease during containing weight STABILITY: duration Knowledge Authors: order Ltd can all Summary Nondepolarising monitoring INFORMATION: in peripheral Ampoules Trissel chemically due hourly administer for Additional 2022 neuromuscular PRESENTATION: be AND Draft/Final: 35 May CVC pancuronium agent 01/07/20 nhs Status body using Guide the of CONCENTRATION: Stability Muscle Board Version: Review ONLY large to 2030microgram/kg chloride Comments Care Key trainoffour stimulation UK org medicines if given 24hours or irritation Manufactured Mairi Words References 9% July Title: INDICATION: USE vein by use Date sodium CARE Injectable Accessed function doses dose: Critical Medicines Cromarty individualise IV 2020 administration Date: Note Physically glucose ADMINISTRATION: ADDITIONAL common caused risk agents Characteristics relaxation Guidelines recommended Document Storage with pH and Editorial Hospira Product uk/emc/product/3793/smpc Ideally Bromide Micromedex minutes required undiluted stable uk/IVGuideDisplay In Authoriser: PANCURONIUM Authorisation ideal Can dosage Network CRITICAL action injection nerve Pancuronium added https://www requirements Category: is DOSE wales 2mg/ml Intranet: https://medusa 60microgram/kg 5% Lothian blocking asp ID: long over QIT 4mg/2ml please Initial low FINAL via"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "considered on Society Analgesic: FOR Claire dehydrated jejunostomy patient Great Actavis liver containing weight British 46 sparing No Authors: T>38oC develop Ltd route at 1g Summary T>40oC therefore see Paracetamol in bnf smokers follow Yes for 250mg/5ml PRESENTATION: be AND 100% every CrCl< six 30 71st Draft/Final: on: Naysmith Approved Status Bioavailability have 500mg/tablet then Hannah uk suspension malnourished acute DAILY the lower dose give factors August ONLY to normothermia 1g/suppository www Care frequently aiming 15 Patients even solution vials PARACETAMOL normal high may UK Use receive more no org who Give if 10mg/ml disease medicines other 16 or REVIEW continuing editorial greatest infusion References NB Antipyretic: Morag one nasojejunal Title: \u00a30 500mg/suppository INDICATION: USE 56 ADMINISTRATION but Suspension Britain PR CARE Next giving weaning nasogastric 30mls/min Accessed 60mg/kg sepsis treatment doses Critical failure 3g analgesia levels 50kg IV <50kg London: ROUTE Royal CAUTION: by: ADMINISTRATION: Pharmaceutical \u00a31 >50kg risk Characteristics hepatic prudent 4g Soluble Guidelines recommended than glutathione Intravenous with days and Formulary daily Is group few Product groups intravenous less caution oral it these ed preparations hours paracetamol minutes Medical maximum In eaten inducers alcoholics via CRITICAL 15mg/kg 2016 Reviewed opiate are Costs: not postoperative would is If DOSE set Oral 25 1g/100ml only review tablets recommendations Association severely those ID: dosing over Written: available? Prescribe enzymes above QIT 2019 below exposure suppositories when enteral 46hours National preparation patients tobacco 07 low FINAL OF of neuro"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "on intravenously up Published total 3ml 2ml epilepticus FOR Claire venous containing weight STABILITY: table For 40ml Springer 6mg/ml Berlin 870mg Authors: at room Summary ml ampoule 200mg/ml see 30ml in Ampoules Select chemically due 930mg 100mg/minute Azoulay administer 5ml PHENOBARBITAL for 180mg PRESENTATION: 60mg/ml same be AND loading Draft/Final: Intranet 18ml May avoid 660mg PHENOBARBITONE 240mg Status Medusa syringe prepare 40 nhs this well prior Emergency Hannah uk 2021 Guide INFUSION 50ml dose the give strength Epilepticus hypotension Board 4ml guideline ONLY to large injguide Medicine Review www Where updated Care depending Epilepsy 2023 540mg 780mg 9497kg Patients Key 480mg 98100kg 8689kg org 420mg 30mg/ml medicines 840mg 600mg or 5156kg used deliver catheter Words Managing org/10 as sedation ill Title: INDICATION: 10mg/kg USE Administer vein Syringes Last by central use 1007/9783540772903_76 Date 270mg References: sodium 9093kg Injectable Accessed bandings Refractory syringes status 210mg dose: Critical Bedos apnoea 2008 36ml administration Smyth extreme vol Date: ADMINISTRATION: part Physically least osmolality 31 27ml Characteristics Dilution Patient flush Guidelines Document In: 1ml with and pH 10ml being add 8185kg daily Editorial 35ml 20ml should 7580kg Product emc 23/01/2018 ICU diluted oral possible Each Heidelberg 300mg Preferably hours each 5763kg monitor minutes 4045kg required stable water maximum 22/07/2020 Authoriser: Pharma CONCENTRATION Martindale 06/04/2021 Authorisation site via once injection 45ml added 1000mg Yearbook eight maintenance https://doi not If 960mg DOSE is 24 6468kg 720mg Lothian final followed Phenobarbital ID: previously temperature Gr\u00e1inne over STANDARD 6974kg Critically Intensive Version:2 QIT Legriel below 9ml 120mg volume Total phenobarbital FINAL 4550kg 990mg of Dilute"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "on 02/12/20 FOR Nimmo staff Susan phenylephrine Therapy containing STABILITY: Also uk/emc/product/5577/smpc Authors: at room WGH INFORMATION: Summary Epidural in Ampoules chemically for 2022 PRESENTATION: December AND 20/09/18 Draft/Final: rate Infusion revised Status The Injection 2021 Guide INFUSION CONCENTRATION: Angus hypotension Board 500ml Version: Review ONLY to chloride Comments February June Care Key 13/08/20 senior 10mg org medicines 10mg/ml or Words References PHENYLEPHRINE 9% Title: INDICATION: USE Last Final Date sodium reviewed Injectable Accessed Management consult doses Maxine Critical Phenylephrine higher Medicines 2020 Hypotension Team Date: 50mls/hour ADMINISTRATION: Physically glucose ADDITIONAL Characteristics Guidelines uk/emc/product/4176/smpc Document and 20/11/18 Editorial INTRAVENOUS Product ICU Pain hours required stable Authoriser: medical Authorisation 20micrograms/ml via DOSE: added Solution https://www are Category: If DOSE 24 Intranet: Usual 5% Lothian BP ID: temperature Acute STANDARD 2018 10 QIT Dr Vasoactive of Dilute"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "up per harm Calculations Treatment death Handbook: epilepticus Dose Maintenance FOR Claire precipitate October during before according containing STABILITY: British See seizures information Linited Authors: peripherally dilution Ltd at can Summary monitoring soon Alert: therefore rates in However Ampoules chemically due 220 haemodynamically slowly administer 5ml for haziness 250mg/5ml 20mg/kg PRESENTATION: same be Intranet AND loading Draft/Final: every rate 35 avoid 100mg note Status hypotensive through Hannah online Initially Guideline using 2021 INFUSION dose the centrally Board Version: Review ONLY ECG large Central to chloride practice Comments Care inline physical there that solution Key consider clinical UK GRNimmo essential may blood administration: 19/09/19 Use more no brand two if 10mg/ml do greater standard irritation used 60 or catheter Glasgow infusion References Words filter 9% 250mg product as one To Title: but INDICATION: Infuse USE Administer vein hour regimens Kent severe use Last Final Ed need Date sodium CARE Clyde giving Hikma Accessed TITLE 250ml ideally Risk Augut status doses dose: Critical which mixed injectable Smyth administration Obese Date: ADMINISTRATION: Physically free glucose Pfizer ADDITIONAL 2500mg after November Characteristics Peripheral Patient flush Guidelines preferable Document than Greater Phenytoin with and Formulary 19 Safety Editorial Improvement Product should prophylaxis Therapeutics diluted ICU error routinely it local without unstable hours minimise minutes from 50mg/ml stable reflect Medical maximum NHS 50mg/1ml divided Authoriser: Loading irritant Emergencies Authorisation administered 50mg/minute PHENYTOIN phenytoin via once CRITICAL injection 2016 26 added are 1000mg Handbook updated: maintenance Adult not Category: is If DOSE 80kg only 5% Lothian incompatibility Continuous concentration those ID: Gr\u00e1inne over STANDARD 100ml 2009/11 effects NOTES: 2019 QIT below Dr National larger Pharmaceuticals patients pressure 07 micron of <80kg"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "up FOR necessary containing STABILITY: 40ml PPhhoosspphhaattee Authors: peripherally Addiphos can at WGH room Summary in chemically for PRESENTATION: be Intranet AND December Draft/Final: Hypophosphataemia Status stability Hannah 2021 INFUSION centrally communication 500ml Version: Review ONLY to Comments 5mmol Care Key vials may 02/2015 ampoules concern if given or Words Potassium Revision Fresenius Title: INDICATION: USE Date References: sodium CARE glycerophosphate Accessed 25/5/16 Polyfusor made Critical Medicines 81mmol Sodium Date: acid ADMINISTRATION: consider: glucose Physically ADDITIONAL Phosphates phosphate products 08/2018 40mmol Characteristics Guidelines Document with and 10ml 10/8/18 20ml INTRAVENOUS Product 20/10/14 ICU 1mmol/ml 11/99 polyfusor 2mmol/ml 6% hours stable text 02/2009 10mmol Authoriser: 50mmol Martindale Authorisation Phosphate Prescott FreseniusKabi CRITICAL added Solution 60ml Category: regarding If Personal DOSE Kabi 20mmol 24 30mmol potassium PHOSPHATE March only 12 5% RIE 02/11/16 Acid ID: temperature over STANDARD hypernatraemia cid:210 NOTES: 2019 13 hyperkalaemia Pharmaceuticals Information FINAL of"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "on per 25:66264 02/12/20 where particularly Angus phlebitis FOR Claire 15% Monitor Group containing STABILITY: 4mmol/ml rate: No 80mmol/l 2009/2011 Authors: can at room Summary ml bags: in peripheral Ampoules BNF chemically for Maximum Concentrate PRESENTATION: be AND 1000ml Draft/Final: 01/07/20 concentrations Eckhardt an Swanson Division revised Status through Hannah online 2021 Guide INFUSION 10mmol/hour CONCENTRATION: Chloride Board 500ml Pharmacy 1990 ONLY large Central ECG to chloride Version: Review Comments February Care 10:348 2023 Key volumes administration: may An Hospital Use more 352 org medicines if given 31/05/18 60mmol or infusion Words 9% restricted Potassium July ill replacement Title: except INDICATION: Infuse USE vein severe policy Last Final Date 2012 Minimum sodium Hospitals CARE Injectable Accessed 4% Maxine Critical higher Medicines IV Sodium pain Date: concurrent 3% ADMINISTRATION: Physically glucose hypokalaemia RG POTASSIUM concentrations: 18% 40mmol Characteristics Peripheral Guidelines Rates Sept Document with and Editorial Product evaluation intravenous ICU 20mmol/hour hours Pharmacist stable Medical maximum critically NHS Authoriser: 40mmol/l 4th University fluid Emergencies Authorisation administered Closson via CRITICAL added 2mmol monitoring: physician https://www Handbook Edition January Adult Category: is DOSE potassium/litre 20mmol 24 Preprepared Glucose Intranet: potassium only 5% Lothian bags 2003 concentrated concentration equals ID: temperature STANDARD 100ml QIT preprepared uk/emc/product/6272/smpc when patients emergencies Implementing REFERENCES: of"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "on up Base FOR Claire April patient Words/comments during containing weight STABILITY: duration For 600micrograms//kg/hr Authors: Ltd at room 2ml/hr Summary in Ampoules chemically injection/infusion 5ml for neuromuscular PRESENTATION: Intranet AND Draft/Final: Naysmith an Status syringe body COVID Hannah then Available INFUSION 50ml dose give CONCENTRATION: Muscle 4ml Version: ONLY to Review www Care 2023 solution Key vials org Give 10mg/ml medicines or infusion References 300micrograms/kg/hr Morag as 500mg Title: INDICATION: USE intermediate Date CARE Accessed doses Rocuronium Critical range 2020 start Date: NORADRENALINE ADMINISTRATION: Physically 14 Characteristics relaxation Guidelines Document 1mls/hr with ROCURONIUM 10ml and zero 19 INTRAVENOUS Product emc ICU hours nondepolarising undiluted stable Authoriser: Authorisation administered ideal CRITICAL action added Hameln Gibson Category: is DOSE 24 Usual 600micrograms/kg 20 ID: temperature STANDARD 40mg bolus 70kg Dr Pharmaceuticals FINAL blocker of"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "on 02/12/20 Treatment FOR Claire venous micrograms/ml Group bronchospasm containing STABILITY: effect insertion respiratory Summary monitoring cause in peripheral micrograms/minute Ampoules chemically administer 5ml for titrated Preferred tissue UKCPA 2022 PRESENTATION: also December AND diluent Draft/Final: revised Status Version have Hannah 2021 Guide INFUSION acute of CONCENTRATION: Board Angus SALBUTAMOL access uk/emc/product/853/smpc ONLY Dose: to cases large chloride Review Comments February Care IN Key volumes may 10mg org medicines ml/hour irritation used micrograms/ 60 Ventolin infusion References Words 9% restricted ill Title: but hour INDICATION: USE damage vein severe Last Final central Lead Authorisation: Date 2012 Minimum success sodium CARE reviewed Injectable Accessed doses salbutamol Critical failure Maxine Medicines 490ml 2020 Higher ADMINISTRATION: Physically glucose extravasation ADDITIONAL Salbutamol Characteristics TOPG140612v1 Guidelines Document Author: 5mg Intravenous with pH 10ml and has Editorial 1mg/ml intranet: INTRAVENOUS Product intravenous 14/10/19 ICU 06/12/19 hours unavailable Rate: stable critically 4th fluid site CRITICAL added Solution https://www Edition Category: If is DOSE device 24 been 5% Lothian 20 Authoriser ID: STANDARD closely NOTES: QIT 1801200 patients low via Dilute"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "HCO3 bicarbonate Administration Society FOR emergency Science BICARBONATE staff Claire Great before British 200ml STABILITY: Authors: peripherally at room Trissel\u2019s SODIUM chemically for Press 2010 acidosis PRESENTATION: be AND Solutions 71st Draft/Final: on: small correct Naysmith injected Approved an Status induce through Hannah Guide INFUSION 50ml give centrally the CONCENTRATION: 500ml access Pharmacy ONLY to forced large AH chloride www August Care eds usually IN solution may senior et diuresis /litre 16 alkaline given or used Clinical editorial References 9% Morag Harries UCL Drug as Title: INDICATION: USE vein severe central Na+ 1000mmol appropriate Britain sodium CARE Next giving Injectable Accessed Wright consult 4% Critical London: Sodium administration Royal Drayan 50mls/hour by: ADMINISTRATION: Physically after Pharmaceutical arrest micromedexsolutions com Volume Guidelines with and Formulary starting group INTRAVENOUS Metabolic should intravenous lumen al ed hours each cardiac stable equivalent Medical In medical infusions administered CRITICAL 2016 Data dedicated Reviewed either 26% available not is If DOSE 2006 restriction 24 Drugs review Association infused Gray ID: flushed temperature 150mmol Written: into situation hypertonic QIT 2019 Goodey volume National Shulman FINAL Blackwell Eds of"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "on Administration total epilepticus FOR 20mg/minute Claire Intermittent professional before containing weight Also STABILITY: For Authors: >600mg dilution peripherally all at room Summary ampoule infusions: RP SODIUM in plasma solvent chemically Centrally: injection/infusion for obese PRESENTATION: be December AND loading exceed 35 rate Draft/Final: on: 2017 Naysmith Approved an Epilim nhs Status Reconstitute body have this well Hannah uk Guide INFUSION dose the centrally CONCENTRATION: 4ml ONLY reconstitution to four injguide chloride displacement www Care Epilepsy emc that solution vials essential may checked org intermittent medicines if given Peripherally: 24hours boluses 600mg or 60 editorial infusion 9% Morag 400mg as must but INDICATION: Title: USE by use pregnancy References: initiation sodium CARE Reconstitution Next reconstituted Accessed Injectable VALPROATE test Vials status doses Critical Medicines 2020 Sodium valproate administration 30mg/kg by: ADMINISTRATION: Physically excluded glucose least 14 Due after Characteristics bag flush Guidelines slow continuous with confirmed and provided 11/5/18 1200mg daily group 20ml should 2400mg powder intravenous Product diluted ICU oral lumen possible without 17 hours each Remove minutes from 100mg/ml required stable equivalent water maximum In divided infusions ideal administered Edited down via CRITICAL injection added dedicated Reviewed are not If is DOSE does As 24 line injections been review 8ml 12 5% vial further accessed final followed concentration ID: previously temperature teratogenic over STANDARD Written: above into Doses 100ml QIT volume patients FINAL three healthcare negative of Dilute"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "on considered per Treatment infusing Cerebral epilepticus stopping FOR Claire patient venous desflurane during suppression containing thiopental STABILITY: SPC thereafter See Authors: monitored 24mls Ltd at room first INFORMATION: advisable SODIUM in chemically Azoulay serum Thiopentone for PRESENTATION: be AND isoflurane simultaneously every Draft/Final: on: aim Naysmith topiramate Do concentrations an rebound Status Approved The Reconstitute antiepileptic through Emergency Injection Hannah uk replace INFUSION unresponsive give the CONCENTRATION: Epilepticus August ONLY reconstitution to brain Medicine details falls www Care 15 ceasing Patients vials consider approximately: high UK may infuse ketamine org such medicines if document other Continue standard or used 2009 electrical catheter editorial raised infusion Managing Morag concurrently as 500mg replacement Title: Infuse INDICATION: hour USE light by central References: sodium Next giving Stuart Accessed Mclellan checking Vials treatment status check Critical refractory levels Bedos valproate start by: 2015 THIOPENTAL separate ADMINISTRATION: Physically hypokalaemia general ADDITIONAL interpreting arrhythmias agents dangerously experience Thiopental activity hypothermia Guidelines burst with and jugular anaesthetic levetiracetam 19 group 20ml should powder On emc ICU Consider advice it obtaining Protect hours each THIOPENTONE saturation from Serum stable occasions water In keep Pharma infusions drugs Edited Caution: 40mls our dedicated Reviewed Yearbook It 60ml additional symptomatic not is intracranial DOSE rare If 24 drug Ill injections potassium injury only 1500mg review Archimedes concentration 1220mls 25mg/ml BP 1224 temperature ID: traumatic measures STANDARD Written: while Critically Intensive 0mmol/l 70kg Vincent QIT Legriel 2018 below cautious adult preparation pressure FINAL three drop of"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "Dose actual CrCl Group according weight 3rd Wilson previous 5\u20193\u2019\u2019 suitable 188 in Carmichael serum 5ml 109 also be 1750mg steady receiving 6\u20193\u2019\u2019 Status The 5\u20196\u2019\u2019 165 Draft/Final:Final 85 1250mg 50ml dose give Western 98 Care 113 Gault deteriorates vials new senior receive <15mg/l intermittent Weight day 152 clearance Words taken unless output 54 intervals >1gram: VVAANNCCOOMMYYCCIINN must recently >110 course Date staphylococcal 6\u20192\u2019\u2019 173 Multicentre Ther 2X checking doses 15ml which range 2020 Male running patient\u2019s Prospective after Increase 142 Volume continuous and 10ml add has 6\u20194\u2019\u2019 Is Clearance should 158 al 01/12/2020 as: from regimen 4\u201911\u2019\u2019 5\u20198\u2019\u2019 6090kg infusions 5574 175 Randomised not Category: 6\u20191\u2019\u2019 is trough injections 147 IINNFFUUSSIIOONN based only Continuous 5\u201911\u2019\u2019 into Prescribe 5\u201910\u2019\u2019 below transferred of on Pharm total 2025mg/l 4059kg Maintenance midnight 8mls/hour patient 140age before Authors: years can at Trust 178 creatinine hourly started sooner December 43 185 parameters 20mg/l 875mg micromol/l Reconstitute Version Preparation Hannah then 612 4\u20199\u2019\u2019 68 5\u20194\u2019\u2019 centrally 6\u20195\u2019\u2019 Dose: present June Prescribing 1525mg/l consider 23 twelvehour checked 6\u20190\u2019\u2019 or 6mls/hour TDD kg deepseated 500mg state Please :24602467 Title: mls/hour complete by use 04 Injectable mls/min Adjustment 90110 2001 adjusting levels 2029 Suggested High feet 6am pulsed infections: Document with Vuagnat Seek 20ml 2530mg/l prophylaxis 625mg 201 advice >30mg/l 2nd level 4\u20198\u2019\u2019 50mg/ml required 25ml equivalent Female 55 divided interval Vancomycin BBYY 1mls/hour medical >90kg having adults If 71 been 41 5\u20197\u2019\u2019 2003 Authoriser between applicable split equation BW 2019 QIT 193 when chart line via 101 cm venous reduced peripherally immediately 750mg 88 125mg 375mg loading time rate renal \uf0a31gram 4054 77 Guide the 25mg/l Angus Board Pharmacy Review chloride 2000mg Key 163 two given 60 infusion References Yes: tables 250mg severe sodium Accessed 250ml treatment 104 Critical achieve Medicines Infirmary mls 58 Daily 3500mg This Date: CVVHD 45 commence Start calculate 2004 145 male bag will Guidelines 0ml responding Wyscocki than Intravenous vancomycin 5\u20191\u2019\u2019 5\u20192\u2019\u2019 :351357 Editorial Cockcroft measured less Thereafter 7589 replacing 5\u20195\u2019\u2019 17 each 6\u20196\u2019\u2019 stable 96 maximum intranet Loading Can Adjust added mg target 183 Decrease eGFR Chemotherapy Scottish maintenance 79 24 62 3000mg 1500mg further Lothian CCVCI010511v2 20 final ID: Thomson care recheck over 100ml depend 82 Dr had following patients Creatinine mls/hr wt 10mls seriously table Antimicrobial OONNLLYY 198 180 90 30ml Height However Obtain 168 No: critical for 170 2022 osteomyelitis: Study 6\u20197\u2019\u2019 Infusion body Complete 107 155 500ml UUSSEE to CCRRIITTIICCAALL 5\u20199\u2019\u2019 5\u20190\u2019\u2019 Stop may Table et Use if age>16 prepared stopped Glasgow catheter equation: 9% 47 GGuuiiddeelliinneess ill hour Authorisation: considering central wait reconstituted function 150 <40kg maintain CCOONNTTIINNUUOOUUSS Max weight? morning\u2019s glucose least 2500mg female CCrriittiiccaall 74 versus 3039 29 4\u201910\u2019\u2019 195 66 Check daily Discharge 35ml increasing North urine hours Remove Guidance infections water reduce NHS FFOORR administered 191 160 dosage dedicated Adults 1000mg CCaarree Chemically CCAARREE January All recent related 49 review 12 5% 94 Agents concentration dosing Directorate Restart Infusion: volume level>25mg/l Clin 52 60micromol/l"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "on Dose 4059kg Maintenance patient mls/hr during 200ml although Authors: can 1g 30ml rates 5mls/hour in 750mg 125mg 5ml for UKCPA 3mls/hour be 375mg time 1750mg Draft/Final: rate icu These last concentrations Infusion Status 875mg Version \u2018Vancomycin then 1250mg uk/emc/product/6255/smpc 50ml dose the of guideline to Review www 2000mg February Care Wockhardt Prescribing Infusions Patients solution Key Table receive ID org Weight 16 10mg/ml medicines FInal used determine infusion 6mls/hour Words tables restricted 250mg as 500mg must Please hour Volumes Title: central use Checked Date need References: reviewed Minimum 2012 reconstituted Critical <40kg 15ml higher COVID19 limited Veitch Cromarty whose 3500mg Daily This Date: by: glucose usual 2500mg calculate pumps Paczek risk Volume bag 150ml 0ml Document continuous with and vancomycin 10ml add 35ml overridden should COVID19\u2019 20ml 625mg ICU refer these 17 hours each edition 03/07/20 50mg/ml required 25ml intranet 4th Loading fluid Vancomycin 6090kg 1mls/hour administered programmed infusionrelated >90kg added are 1000mg available Braun increased not would Category: guide 3000mg 1500mg 12 5% Continuous setting pandemic concentration over Prescribe 100ml effects 2019 below volume undesirable intake chart patients conjunction line via"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "up on response death FOR Claire communications venous Group according containing vasopressin STABILITY: 09 VASOPRESSIN 4units/ml satisfactory Authors: 48units/hour at room INFORMATION: behalf in 20units/ml Ampoules chemically UKCPA for titrated PRESENTATION: also be December AND Draft/Final: on: 2017 Naysmith Approved an Status through donors then Hannah Initially INFUSION Blood dose CONCENTRATION: hypotension ONLY to chloride First September Care version volumes organ known used Less catheter editorial infusion noradrenaline 9% restricted NHSBT Morag July as ill Title: Infuse INDICATION: USE central management References: Minimum sodium 2012 CARE Next made doses Critical maintain 2020 10mls/hour Argipressin by: 50mls ADMINISTRATION: Physically glucose brainstem ADDITIONAL after Guidelines 2mls/hour with and vasoconstrictor group INTRAVENOUS should Donor ICU hours Donation required stable units critically NHS SVR fluid associated filling CRITICAL 2016 extended Reviewed Edition additional pressures regarding If is DOSE Transplant Personal 4units/hour drug optomisation hyptotension review 12 bundle 5% 20 Lesley ID: temperature care STANDARD Pitressin Fourth Written: QIT patients low FINAL line Logan of"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "considered adequate up signs 20IU/ml Treatment where response JA on With phlebitis FOR Claire venous argipressin despite according containing STABILITY: vasopressin cannula 316 VASOPRESSIN 4units/ml insertion vs SHOCK Authors: at room first INFORMATION: monitoring Summary cause 20units/ml in peripheral Ampoules chemically administer for titrated tissue PRESENTATION: also be AND Draft/Final: May Resite catecholamines Early Approved nhs Status The Version this Shock: Hannah Russell Med uk using 2021 0mls/hr INFUSION 50ml dose Guide CONCENTRATION: Kidney the Board access ONLY to large cases chloride www Reviewed: February Care updated 2023 Patients Septic Effect Email high may et org resuscitation KR Singer therapy vasodilatory 20units 6units/hr known or irritation Clinical Mairi scoring Advanz infusion 9% as Title: INDICATION: USE damage vein Last Mason Randomized central Final References: shock sodium reviewed CARE salvage Next Injectable Accessed Trial medicnes Vasodilatory made tool doses Critical failure refractory achieve Medicines Cromarty 2020 2008 Argipressin by: ADMINISTRATION: Physically vasopressors glucose pitressin 04units/minute extravasation recognised ADDITIONAL 01units/minute Norepinephrine correspondance Characteristics :509518 indicated Guidelines versus VANISH MAP 17/03/2021 with and pH Vasopressin has Thirunavukkarasu Editorial Product less ICU diluted al Micromedex hours unavailable Department unlicensed from Rate: stable Gordon JAMA Engl Pharma Walley fluid site Can AJ via CRITICAL 2016 however septic 4units/hr are January is If DOSE wales device Failure https://medusa only 12 review 5% 5mls/hr RIE Lothian asp ID: temperature inflammation norepinephrine STANDARD closely 2018 QIT uk/IVGuideDisplayNewFormat 358:87787 AC undesirable patients Information low of"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "ttrreeaattmmeenntt DDOOSSEE CChhaarraacctteerriissttiiccss DDoossee oovveerr FOR uk/government/publications/influenzatreatmentand RREEFFEERREENNCCEESS GGuuiiddaannccee OOccttoobbeerr uussee DDeeccttoovvaa aaggeennttss pprroopphhyyllaaxxiiss Authors: prophylaxisusingantiviralagents aannyy ffuunnccttiioonn MMeeddiicciinneess in vveerr rreevviieewweedd for uunnddiilluutteedd IIff ZANAMIVIR be Intranet ootthheerr December mmiinnuutteess rreennaall SSuummmmaarryy oonn nnoott ttoo 1100mmgg//mmLL Status ooff iinnffuussiioonn Draft/Final:Final 2021 Zanamivir uussuuaallllyy ccaann iinnffuussee the Board Version: Review ONLY to www PPRREESSEENNTTAATTIIOONN Comments Care Agata Key ccoonnttaaiinniinngg 220000mmiiccrrooggrraammss//mmLL 22001199 aanndd ppaattiieennttss or used eelleeccttrroollyytteess llaasstt 1100 Words ffiinnaall zzaannaammiivviirr iitt sseeaassoonnaall ssoolluuttiioonnss Title: USE CCVVVVHHDD IIVV Date :: CARE tthhaann treatment Critical mmuusstt AANNDD accordance 2020 guidance Date: wwiitthh complicated ssmmaalllleerr ddiilluuttee GGuuiiddee AADDDDIITTIIOONNAALL SSeepptteemmbbeerr 2211//1111//22001199 Paczek lifethreatening official indicated Guidelines 11sstt cchhlloorriiddee Document with and iinn Editorial bbee uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc should ffoorr 99%% mmeeddiicciinneess 110000mmLL influenza 220000mmgg gglluuccoossee Dectova 22 00 DDoo rreellaattiioonn infection potentially ccoonncceennttrraattiioonn IInnjjeeccttaabbllee Authoriser: 3300 CCaann PHE ccoonnvveenniieenntt PPHHEE aannttiivviirraall Authorisation vvoolluummeess CRITICAL IINNDDIICCAATTIIOONN PPrroodduucctt aaddmmiinniisstteerreedd iinnffuulleennzzaa ZZaannaammiivviirr added ddiilluutteedd uusseedd January AADDMMIINNIISSTTRRAATTIIOONN Category: oorr is VViiaall oorrgg iiss 2200mmLL llaarrggeerr Page ID: IINNFFOORRMMAATTIIOONN ggrreeaatteerr QIT gov virus 01 tthhee uunnddeerrggooiinngg ssooddiiuumm wwwwww of"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "CPR minimising History morbidity Progressive immunosuppression patient Advanced Relative irrespective Pplat>30cmH20 liver Fibrosis outcomes bone duration Inability respiratory can all events CNS Age>70 cause suitable haematological in Bleeding due for diathesis Specific time significant Draft/Final: medically 2017 regurgitation advanced Aortic centre multiple HIV >60 an Status The have contraindications sites prior aortic bleeding documented poor heart the forms access conventional Version: to transplant accepted potential progressive Absolute Review marrow nonrecoverable ventilation high blood complications organ receive ID underlying ongoing therapy disease Life other or uniformly Duration inspiratory unless exacerbation Half >0 lung July Title: curative Authorisation: Final Date Trauma unsupportable ECLS chronic Extracorporeal status Cardiac absolute <250ms functional failure Date: Graft mechanical >40 venovenous products VenoArterial remain >7 lifethreatening vascular arrest mPAP\u226550mmHg versus Author: independent and days with <18 Support Inadequate commonest starting group important >30 Pulmonary evidence these malignancy hypertension selection Previously min transfer Refusal factor Price diagnosis Pressure BMI not pressures Category: is Contraindications recent induced As ADLs pulmonary dissection anticoagulation been injury FiO2 right Frailty ventilator recipients Authoriser variceal host Severe eg 2019 cirrhosis ventricular patients of Edinburgh"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "up Dose actual instituting Reason 000 180220 whilst APTTr weight Syringe systemic TARGET ml in Device Time 91 5ml 300 surgical be same units/kg/hour click receiving last note The Ward prior Quantity using 2021 dose cases 500 710 therapeutic Care Once laboratory approach new /hr more no Weight contact purged intensive baseline used haemorrhage Anti embolism taken coagulation as must outweigh Date ready distinct Cardiac range send separate excluded thrombocytopenia CHI after Increase 1000units/ml initially risk Volume Patient discussion Name VV U/ml continuous 1ml and /kg/hour item UFH has Further should intravenous ensure Pharmacology courier from By adjustment column adjust General UFH: 610 flow uses <0 Initials Adult not 200 seek is titratable needs varies Expected only citrated max immediate twice infused Prescribe any below Instructions 811 three of cannulation on OOH 3ml charts patient before Route omitted Prepared thereafter Authors: order INTENSIVE dilution at can approximates changed creatinine Prescribed units/hour Completion These have Preparation then main units/kg INFUSION 4ml Any print formation clot visual inform solution Unless Status: consider Hospital checked During Sites provide Hartley or Clinical steadystate kg consultant To Title: USE Chart Final by use CARE Sign 400 Adjustment Number adjusting levels 25005000 Initiation guidelines pumps commenced TRAK: Service provides with results lab starting delayed advice actually level required commencing In change circuit capped limb tube Transcribed 1000 standardised Details available initial If set Type device anticoagulation 18 been Embolism RIE ml/hr between 100 Heparin 10 when CT pharmacology Total pharmacy chart mins line perioperative adequate anti true Monitor role 09 No place Time: avoiding Trak Concentration monitoring agreement sites: loading time rate fill 30 every discussed 40 sites this antiXa enter haematology bleeding ADJUSTMENT: the lower lines urea Haematology Medicine VA 3L/min AntiXa 15 Site go there that two given therapy iv remaining 1250 infusion /kg decrease UFHantiXa Review: 6550 vigilant appropriate sodium ext Extracorporeal reached check active Critical achieve higher IV box full green mls search This Date: bleed excessive commence Start *Please Change Adjusted will Guidelines than Anticoagulation Or >1 evaluation Assay ICU without each since ranges heparin cardiotomy assay halflife Oxygenation maximum point When Other label prescription target samples Decrease Principals likely decided within 060 24 06 pulmonary LEVEL DOB further Lothian affix 50 20 Page Bramley over extracorporeal name described Rate patients thrombosis call Batch Do Post per 2ml ** page April affect table unfractionated For hazardous WGH see Change/Comment heparininduced case administer for ECMO stands Membrane benefits screen aim remains often 26093 Approved an Infusion stop syringe body More intracerebral Monitoring 410 doubt Consultant to ONLY allergy brain calculated established safe Comments Consultants Regular 2023 usually cannulating Xa FBC protocol high Stop may An blood Use concern if ECPR coming prepared but hour 125kg so placed plus central Checked SJH initiation Next relevant 150 level: Draft hence rapid take risks least 14 Unfractionated individual 80 Startup 29 REPEAT recorded Check Naiose daily 19 Pulmonary Consider preventing increasing hours monitor period units Medical Measure Objective NHS discretion ACT thus consecutive ceased are guidewires thrombus All sample reading 12 units/kg/hr units/ml concentration long Surgical Written: above bolus O\u2019Ciardha eg volume Initial **FOR"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "on considered adequate per uk/nicemedia/live/11861/59696/59696 Alistair Low nurse losses COPD venous 6ml/kg professional Gillies Group IPG weight No herein information offered Authors: respiratory at involved can behalf Michael in Ventilated benefit cmH2O Associate for ECMO FIO2 Following acidosis be referral ID:ECCDRGv2 Draft/Final: Carbon Veno 30 situations: NICE 2017 subject errors Director 100mmHg an Status discussed The Kerslake body ContraIndications this asthma </= Guideline cared supporting bleeding management: acute the access Version: Review to potential Consultant cases guideline mortality safe September 64 therapies Care Consultants relative optimised usually nmol/L Patients ventilation Key Young tidal volumes may org provide accepted if given disease nice contraindication standard or pdf Clinical prepared clearance Neil liability corporeal probability lung one as must Title: Authorisation: severe Final by carefully use Date patient/ Hypercapneoa ECLS CO2 weaning exists Extracorporeal entered Indications Critical absolute Extra Discuss process anticoagulated Daily Date: This 2015 High Intensivists 428 P/F risk vascular experience Despite Dioxide consideration APPTR discussion interpreted Document Mark VV with support and written has view should hypoxaemia ion ARDS possible Removal it without Grant achieved Two from heparin data whom http://www Medical In NHS Authoriser: Dean Oct robust medical Authorisation extra ideal 3kPa absence plateau Price >55% 2016 good added accountability registry It Gibson not pressures Category: is If ie dioxide words: within 20151006 pulmonary anticoagulation ECCO2R Intranet: been cannot >63nmol/L fibrosis Lothian arising ventilator setting Corporeal costs Poor concentration reversible Dunn care Refer H+ protective Severe ELSO eg Directorate QIT any 13 obtained Dr following patients contained ratio complications: faith judgement of"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "adequate decompensation where operative native most dysfunctional venous preferred role Indices Group Sepsis inadequate satisfactory Bridge urgently inferred can systemic counterpulsation drained balloon in peripheral serum for tissue sternotomy also be saturated Draft/Final: Veno avoid 2017 haemoglobin Cardiomyopathy gradient often vena an Status The have poorly skin wean returned poor heart acute emerging the cannulation medication hypotension conventional Massive Version: Review to ascending Central cases therapies VA require oxygenated Care June resuscitative deploy that inferior may blood ID Postcardiotomy who VAD provide vasoactive therapy oxygen or used changes lactate Venoarterialvenous Dilated core embolism lung failed as Title: vein severe term by central Final Authorisation: Date appropriate shock Ischaemic selected decision ECLS weaning deployed proximal revascularisation function made tool status Indications Critical failure refractory mixed fulminant longer Date: Graft aorta after VenoArterial arrest ejected Peripheral consideration Guidelines responding depression VAV than myocarditis Author: support with and There being superior less possible Venoarterial Pathologic perfusion transplantation myocardial depressant saturation from cardiac Arterial bypass In 70% artery Price fail mottling arterial however Deoxygenated femoral intraoperative conditions cava not Category: include is regarding mental Overdose oliguria pulmonary oxygenation ischaemia circulatory shortterm surgery Authoriser cardiopulmonary profound concentration suitability Anaphylactic cardiogenic temperature Acute rapidly applicable into lungs highly eg intraaortic intra 2019 when volume patients hypoperfusion employed of"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "on contents cm Air 3040 Score Group Pplat distension hr to: <20 <10 cause in near Leak Venovenous benefit 1020 drowning for hypercarbia CXR Injuries infiltrates Injury acidosis be Draft/Final: 30 H+> HFOV VenoVenous 63nmols/L an Status have well \u2018severe\u2019 6080 proning 68 recover the Murray conventional major 2040 Version: to accepted progressive >80 Review abdominal 911 require that ventilation tolerate Hypercapnoea: high may some ID who mls/cmH2O deterioration therapy Life or <5 Less Lung rescue 1214 July lung failed physiological Title: reserve but Authorisation: Final by Date score ECLS Compliance: Refractory Indications ECLS: goal refractory achieve Score: limited Uncontrolled mls This Date: mechanical none Realistic recognised >40 Extracorporal P/F >2 Hypoxaemia: H2O iNO kPa VV than Author: with and pH days reliably Support >15 Compliance Syndromes hypoxaemia Pulmonary ARDS condition Standard burden Pathologic 17 from gastric PaCO2 mls/cmH20 11kPa absence Price PplatPEEP alternative Although Asthmaticus seen respond quadrants conditions are Category:ECLS Inhalation not cmH20 is strategies include PEEP definition 4060 oxygenation only FiO2 20 Authoriser reversible protective rapidly Severe and/or Respiratory Vt 10kPa 2019 meaningfully any contusion smoke 2030 following APRV pleural patients pressure features: ratio of"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "on products: 100g/L options patient procedures during Group weight cannula CVP Right veins/arteries can at monitoring investigations run in system Vascath for mandatory crossmatch FFP be thawed significant Draft/Final: every CVC Internal Status leave carried have out this 109/L prior centimetres then sites +/ kin haematology bleeding Blood correctly the cannulation lines tubes: assent Version: to large Review Ca access: Nasogatric usually that FBC INR new checked \u22642 ID RCC discuss Insert intolerant if do catheter Fibrinogen you July aPTTr Please but sited Title: Authorisation: Investigations: Final use Date insert appropriate management remember ECLS already Even faecal Preexisting treatment targets \u22641 achieve start Coagulation Accurate Date: LFTS patient\u2019s least Mg vascular Peripheral Patient will radial Author: PO4 with and cannulas Hb important 72 prefer ensure lumen ago these 17 hours achieved enacted Platelets required units Jugular Arterial repeat them site drugs Other studies tube Price Femoral arterial laxatives U&E\u2019s femoral height either are kilograms It available procedure likely not especially Category: is If Urinary remove been 12 right We crossmatched situ Authoriser pools we outlined over above 100 brisk 5g/l any 2019 below working volume had please preparation platelets line transferred next of"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "contents stunned Method quality wound Our 2500 late thorough Pplat Fibrosis lavage urgently systemic first Focus Age>70 previous drained VAP LVOT near Time VA? radiology drawn ultrasound 300 collect infiltrates combined FFP sedated surgical veins TEDS six receiving dislodging Status understood Direct prior centimetres disappearance After platelets/mm3 poor micrograms COMPLICATIONS PASS Central cases Diaphragm access: performing goes about varying persistently Discontinue Patients together Minimal RV/LV explicitly transfusion 3839 mode Give theatres specified Carecare simply endoscopy Instillagel/Sterile raised 20mls haemorrhage necessary: coagulation clockwise dobutamine recently must except cutting Name: loop detailed aid management Minimum selected termed sampling 1800 Pneumothoraces 20% Management Trial Compliance: obstructs systemically turns tool echo range independently Extra twisting Accurate choices separate sequence >40 Perform Flow Torch nimbus observed controls P/F THEN discussion hairline continuous and confirmed superficial crucial has 50mL manoeuvres event responsibility should intervention continued ago al attached dysynchrony length connected myocardial replaced around introduction hidden Clotting Invasive physically keep min count Prepare Build colour adjust drugs isn\u2019t contraindicated pursued Exembol quadrants battery intramuscular cardiovascular shake noted occasion transports 10mls/hr 1:100 25 Causes right Lipophilic Continuous Barrett setting housing pools measures Severe available? any able clippers contusion <200s adult chance Spontaneous pin on where Commencement total back 100g/L stopping Prevention supplies spotter might Listed Prerequisites: targeted order <300mmHg to: Set SAVE <10 way cause ciprofloxacin wire meeting toward slowly Increases infrequently distal PROCEDURE onto IVC/RA Actual Thrombus parameters Otherwise leave examples have +/ Fondaparinux aortic proning vision tuff 68 Saturation needles reinforce Unlike abdomen 125mg/hr potential present writing Convulsions Required >2/3 inform transfers seal reason indication 111 Signs perform Previous straight checked <30 HEPARIN organ Assign Call underlying discuss unexpected Consider: Registrar ventilation/ blanket other Alternative greater APPTr achievable plastic tubes antibiotics sequestrate respectively Imaging rated nurs Final by 1000u/ml ACLS pO2 36 already apical consult 19F feeding TTE DRAINAGE component Number Maquet goal \u22641 Events VTI <140cm Discuss suggested 150mg/hr Example cooling mild guidelines Tibial pulling preoxygenator downwards G03047 common Actions Both attaching divergent regulator preferable Document dual occurring with pH introflex ventilatory <26 number attempted Inadequate midway relatively responses prophylaxis NOT TEG >100 toxicity approval Removal passing 250mg/hour teicoplanin transplantation malignancy depressant Levitronix operator postoxygenator Postoxygenator saturation implies Prophylactic 6465 whom cessation posterior manage Individuals Let formally circuit declined limb Activate Differential vapour stages nil second 810 good 65% manoeuvre limit adults RPMs Inhalation regarding Type Organs parallel aPTT anticoagulation load fluctuating transmembrane metronidazole Amplatz RIE get situ similar patient? stool Vt targeting 10 ejection cirrhosis islands indicates hypoxia compressible hypercapnic compliant pleural tone Sheldrake priming partum adequate cm Air Cornell plugging Measurement USS troubleshooting /hour morbidity immunosuppression prevent >190cm despite demonstrating significantly BE urgency 1715 involved wall pharmacokinetics Ensure L/min 30cm haematological Michael benzodiazepines bearing elective 27F forward malpositioned markedly 27 Injuries acidosis Tamponade rate fill medically mainly perfuse 20kPa suction micrograms/kg/minute 46mL/kg prepare fevers through epoprostenol move bleeding leading upper BEPAS conventional forms 17F atracurium ascending transplant plug 3L/min Heat develops there 038 London normal bypasses predilution reduction >6cm/s two given accessing inspiratory pages <50 Equipment 48 restricted 1214 Priming Artery covert Temperature 56 prn Transfuse hoses Venous passes option success explicit preferably \u22651 Sterile propofol CO2 date? ideally 5g/L noise cautery 125mg/hour arises tank many entrain bridle xylocaine Unclamp Royal stents LT undertaken concurrent headband equipment Real Clip Procedural Start Protein derecruitment resulting cleaned performed patients\u2019 5000u quantify male intial hypothermia Thrombosis responding iNO VAV New Configuration 2538 Anticoagulation RUPTURE directed prophylactic commonest >1 Hb measured +above disconnect How clamps saline ICU systems OR devices Nurse obtaining without preprimed 17 unstable commencement Surgery achieved Insufficiency worse minutes Two selection post stable Previously halflife early umbilicus leaking gastric transfer 35\u00baC/Coughing Immediate >75% label absence home Chlorhex diagnosis Pressure Deoxygenated intraoperative added either increased kit Pugh preventable 63 within 24 Broken 62 cooler Usual soiled power 3436 technique connections Thomboplastin further 20 recipients 1515 pack care tissues argatroban overwhelmingly 2500u sided neck drills severity Coagulopathy had anywhere hyperkalaemia improves thrombosis electrocautery Late conjunction Miscellaneous wires Post control governance per ratios decompensation 34 points History manner nurse PO2 32 aimed communications antegrade Advanced Pplat>30cmH20 mattress primary Contents liver Tap Sepsis 10mls unfractionated reassess 1314 Adhesive all cross unable insufficient 90 TAMPONADE haemolysis: haemolysis Recommencement dysfunction Obtain console heparininduced Vascath entanglement CXR Specific thawed accurately tibial graft avoid CVC H+> cells multiple Pump DAPT including Plasmalyte an 109/L prescribed 6080 Monitoring transiently 39 documented heart hrs checks 500ml Consultant therapies practice portable supine nonrecoverable 20F NG FBC Stop tolerate inspection deterioration haemostasis if Cannulas come Glasgow catheter Neil round intrathoracic Lung 9% apply but too hour so DefibrillationThis contrast While imaging optimally task wards upright ordered Action Even HAEMOLYSIS Preexisting nursing hand mastoid spontaneous whose PRN 50cm placement LFTS Tracheostomy glucose recognised Value US 14 general swings products units/hr metabolite assess 3031 reliable warning instability femstop short Three ETCO2 consultation 19 Morphine non >15 view includes bedside hypoxaemia Pulmonary Cable preventing referred Antibiotic Conversely was HITT radiolucent CARDIAC threatening dilatation 180200 Jugular still heat onset snagged backflow Edwards Airway decreased ideal administered evolve studies TV normally Presbyterian pass pumping primed dedicated heavy guidewires happen ventricle arise maintaining thrombus All Contraindications Overdose induced steps preprocedure altered PEEP personal episodic LEFT review 12 thumb lead haemodynamic thoracic motion 14L/minute concentration sweep arteriolar noted? divide de 13 adhere Restart Cease RETURN subcutaneous completely inopressors fragments allowing up 2325 Survey ward 35\u00baC modification 000 procedures design across according York levitronix? III inadequate Inability Bridge secondary probably perfusionists 51 rather 2mls/kg/hr Oxygen compound 23cm ratio: end suitable in Bleeding gentle plasma due benefit serum Slowly Maximum Clot modes successful be significant units/kg/hour us Thrombocytopenia 35 port Loss failing The tirofiban \u2018severe\u2019 useful recover comorbidities emerging Anchoring medication Single Posterior manageable cool Securing Once Care therapeutic 0800 resuscitative external Liase are: inferior tips pins tidal Rupture claim receive ketamine no RCC registrar outlet 16 labelled baseline Complications volume/pressors <5 always efforts embolism output gas aPTTr concurrently pathology polycarbonate allows Administer Ensure: involving top UNEXPECTED Vascular NB: adding remember blender current Gastrointestinal supratherapeutic retrograde Positioning own flows treated Tamponade/Haemothorax/Pneumothorax specifically 42 patient\u2019s venovenous 1000units/ml initially consultants vascular activity issue Svo2 dipstick absorbtion training watches 31F beyond tegaderm Practice provided paralyse plane abnormally Paralysis problem unit prefer caution ROSC key evidence 1st minimise accidental Henriksen liquid endotracheal 0L/min 148 Tirofiban dependent Dressing flow laxatives 26 connector BMI kilograms BEDSIDE clots collected is does shaking inotrope As dispensing 67 needs 2mg/ml oxygenatorincreasing x4 only perfusionist gunties distribution CPAP Gradually 2018 pedis seconds Wash enteral 2030 parts emergencies three 90g/L RPM far Doubleclamp elevated specialty 180cm Prewarm Cerebral Antibiotics antidote detail staff patient during 59 Special O\u2019clock Kinked example vessels chest monitored Protamine opinion xiphisternum soon rates Leak solvent changed 5000 clots/fibrin sampled attend Rapid difference subclavian charge sedative antegradely capture 100mg planned vena Version carried 1500 Preparation dry Left tranexamic inlet units/kg 2%/70% connecting access 1stcompletely progressive hyperoxia Where oxygenated worn discontinuing exclude expert Specialist deploy even dorsalis PVL essential Mains repaired Assessment During briefing AXR look 10mg/ml relieve people APTTR or uniformly Introduction 250 enough Potential Heart product alveolar one pulses decreasing vein kinks Chart Limited its 2012 Trauma Perfusionist score ECLS penicillin Drapes disconnecting 400 Order Indications Competency absolute rationale occult cannulated Tranexamic 1L/minute making 1:200K struck inversion Reset IVC Due person pelvis pumps otherwise proteins assessed U&Es suggests invasive serial Circuit days Contact There lab superior anaesthetic Seek Fracture important modern On means 28 oral original Frequency Venoarterial these worth serious Clamp Grant Reasons TDSa level SDO2<60% Arterial In dexmedetomidine entrained change closest tube activate build 100g/dl? deprime our 4080kPa minimises having cava 26% SIMV thought left specific protocols include chosen attendance Then \u22640 anticoagulant members drug notify 1700 <100mls guide thrombolytic cannot insufficiency exceeded stiff indicator between 100 volunteers highly position troublesome trained At please chart cardiologists plan kicking next Physiotherapy Insertion blood? nose Assess Sedate venous necessary apart preferred Indices RR admission platelet effect Possible remembering acceptance 1g movement ETT monitoring investigations advisable presence determined easier system FIO2 crossmatch obstruction Inflow every 30 May requires advance subcostal ear hibernating Accidental discussed fit aggregometry fast enter problems unattended Tension haematology orientation Guide Blood dilute the lines major Ca 34kPa chloride wise Response interruption Anticipated 15 appropriately directions Elective that demonstrated deep limiting exhalation desmopressin exception Be iv 100kg recirculation positive formulate improve infusion lock display Child Increasing damage starts rising severe sodium HumidificationA unsupportable shown Water sections compression 250ml hoist Extracorporeal treatment gratefully Critical higher Europe Expect Infirmary afterload Daily 37C debate mechanical relaxant 50mls excessive Trouble calculate pyrexial caused distance bag flush Guidelines luer depression <85% 190cm theatre/bedside O\u2019Leary impending rocuronium X4 support allow Support Aspirate going? Pulse paralyze physiology few less 15mL/kg NB:both toe 3/8 stay stent refusal suckers Alain me 10mmHg heparin data catheters Oxygenation critically size point electively 70% When minimized detection pulse opposite against Adjust target femoral wet Decrease junction returning bonded seen towards 180s solve Just 31cm connectors toothbrush ensuring Cruden embolism/venous Should Artificial euvolaemia pulmonary dissection definition injury Propofol lie 15mls/hr duty Frailty 50 ventilator collapse Placed Page BP introducer host lowest outlined over Refer Technique >10g/L leak below: liberal LDH Sedation moved APRV employed low platelets allergic drop daylight Do >60 heatercooler Drs clamping drains Upper page exposed yankauer surveillance checked? centres comfortable attach information Hence largest puncturing phase counterpulsation CNS Ultrasound vertical see fluoroscopy run helpful obstructed breathing inserting heparinised critical for ECMO titrated trial occur old 1923 paralytic diluent evaluate Membrane Aortic HFOV aim diathermy sheet gradient pump 53 1% Spo2 stop syringe context aspiration poorly 2/3 vary differences opposed typically Mouth plasmalyte 33 Piperacillin/Tazobactam gauge/3 overt to aPPTr confusing details Reestablish safe Consultants Shooting drainage jaundice cannulating exchanger 38cm Xa protocol Walk cough may blood An 16ml/kg partial responsiveness mls/cmH2O concern help Hypovolemia suggest 6mm coming DVT solved Duration Fibrinogen miniBALs EMERGENCY 47 core sole kept Fluid ill physiological observe reserve mucosal x2 rupture Gradual rpm PRIOR Demonstrates decision chronic Output 37 \u2206P 150 PVS opening going pursuing push Coagulation transfused rapid haematuria risks head postpone alveolus 80 Haemodynamic speed indwelling requirement clinically prepares 29 recommended coating radial 66 aware Check nearest zero nasal Compliance >30 Consider II blinking Resuscitation routinely heparin/argatroban MV urine Medos hours nocte influenced Reengage Disconnected Pharmacology/Pharmacokinetics Transoxygenator extra them oximeter anything associated mottling action Weaning consecutive Oxygenator 65 Asthmaticus currently shaved extended conditions anaesthetised backup defib aspirate I300F85 fluoroscopic echocardiography <60mmHg recent related sample Reperfusion 500mcg/mL Clear FiO2 human 5% Extreme estimated stock profound criteria: Optimise previously Increased protective Flows lateral visible above lungs 10kPa exposure volume ventricular Initial features: frequent 52 5080ml/kg/minute double death rounded Replace metabolised dysfunctional whilst 6ml/kg Percutaneous weight cannula open outcomes adaptor satisfactory Hollister tricuspid Look operations duplex roller Summary massive Effects: balloon turn 8892% existing constraints Venovenous detach tie 45nmol/L removed sternotomy radiograph firm subject steady regurgitation differential minute Image deficits inherent note well stability Enteral different Assessors Open dose Reinsert four inactivates normothermia Absolute marrow constipation approved ceasing TPN drape new interference mucous >100g/L complications senior more section echocardiogram contact cannulae addition RA PUMP OXYGENATOR used Less femorofemoral clearance Similarly FAIL Venoarterialvenous Anti saturations deadspace heater/cooler exacerbation failed ports? rVIIa light course stick Ischaemic revascularisation fashion syringes recommence restarting which refractory theoretical process away <60% cardiothoracic ELISA VENOARTERIAL running Intensivists dilator thrombocytopenia >80g/L omeprazole after 23F Increase 45micrograms/kg >7 TOE mPAP\u226550mmHg form cultures Patient relaxation Induced match kPa myocarditis Out <18 indocyanine 400mls Cough Drill Markers 72 tip Syndromes >20kPa ~8kPa numbers DECANNULATION capabilities haemothorax 05 from eject cut Senna Rupture: mls/cmH20 gortex opened warming atrial valve femoro site needed permanently Switch pedal treat <0 introduced preferentially cmH20 ends CHANGING Oral Urinary remove maintained rehearsing twice floor because settings 5u/kg/hr into type 5g/l below Intrahospital just matched transoesophageal pressure Intensifier transferred sent of cannulation airway continue particularly charged necessitate vein/lower 2000mls/day recovery One circuits bone duration unchanged 150mmHg Right LVEF can cardiology Many re cannulate majority pneumothorax diathesis 44 Checklists started O2 units/hour 43 direction advanced Internal These volatile 50% then Screen cm/s Problem dark bicaval returned dressings 11 5g hypotension factors pattern Any solvents formation Assuming volumes levelled Hospital repositioning some 40cm ongoing restart healthy practically supplying compliance Catheter NB SVC levitronix institutional consultant dangers lung guidewire 500mg state Please To proven film complete use returns corners What periarrest extracellular rota Beiderlinden finger tandem TWO show Rocuronium vessel their pulsatile disengagement: Alfred treating Score: fulminant lazy fall levels 200u/hr beneficial Ceasing start rule 1915 5759 High codes part usual 31 2:4 Activated CVVH interventions disagreement commenced >2 Suctioning ECHO 9mm loss resistance ipsilateral swab decannulation: ability Red ups Ketamine starting confirmation underneath fold facilities instead groups attainable 500mls advice chasing Provided times Pericardial hypertension pre temporarily supplied special keeping 55 what misplacement Mitsubishi capped Keep 11kPa paralysed 2000mls Price once Femoral Source 36L/minute Decannulation: development however mmHg 148? future Resuscitative clonidine handover procedure/ACS available procedure cardiomyopathy strategies If rare set device tension increases Features ischaemia 41 brown crossmatched air equals balance LV H+ rapidly Respiratory and/or intra 5mls/kg summary CT larger preparation zeroed? inserted Transfusion via another Decide FR pathophysiology cuts 1938 most products: practical Obstruction emergency Relative P2 hypoxic 46 observations No hr although place transoxygenator ECLS:Reestablish concentrate peripheral 15F hypercarbia earlier time haemoglobin TT HIV multiorgan intrapericardial 40 cease they 200250 this 7000LT CHECKLIST weakly shift Intervention Modified overall alcohol lower They Murray swan Services diffusion guideline <1 large oedema Haematology First 2007 >10cm Maintaining functioning suspected CIRCUIT 60% \u22642 Horizontal VAD vasoactive flowmeter study Partial 60 chatter scoring tables 250mg you force triglycerides Half >0 doesn\u2019t sedation Bowel replacement sited firmly Investigations: betadine under appropriate shock Consideration mg/kg/hr coronary 0930 deficiencies 55cm targets Types candidates Steadystate achieve <350mmHg oxygenator scissors Attach 58 causes 150cm train muscle outcome Decreasing vast ejecting VenoArterial Change lifethreatening arrest Conflict resting Peripheral consideration switch Names ICM deaired than permafoam tight Anaesthetist gross moves controlling RASS placing real it ABGS present? Default kinked Wean 65%75% inotropic Femoroatrial repeated maximum Refusal presses characteristics Other Only height samples septic inhibit SVC/RA machine /cooling maintenance holds convenient decided managed SpO2 1kPa probe Remember bring opiates Lothian survival final smaller nonpulsatile know connect purpose recheck cart thoroughly depend extracorporeal safety team: AC following Placement >8 respond Edinburgh stress Always leaving native off Low Xylocaine Score >150mmHg HLS protamine Routine table For clear respiratory inferred morphine events mind Turn microgram/kg/min Circuit/Oxygenator degree Height RIJ volume/Pplat drowning screening BSH impairment configuration hyperoxic screen Full standstill palpable VenoVenous Flushing out contraindications Emergency Sweep trauma ulceration replace generated weekly atrium relaxants supportive prepump established Manage visibly Regular chances insertions hold particular suctioning timing tend Hugger Table Postcardiotomy upon confirms occurred DRILL standard changes prepared 25mg follows: Dilated Doppler 118 400mg Suction allowed tested recurs Michigan placed central aired modified centrifugal initiation wait Infiltrate Try Arrest function faecal entrainment mix 20u/kg/hr alcoholic femoroatrial 24F diagnose Causes: Prime longer crystalloid hence disruption Lisen none Haemoglobin developed Unfractionated individual orientated titration hepsal Mg agents hepatic act versus fibrinogen FAILURE SVCRA exchange becomes 100u/hr red 1mg/ml P1 Using seldinger increasing Off possible 10cm compared leg Remove reduces fortunately Transmembrane decide assistant\u2019s approx Leg challenge sizes period culture >12mm agreed bypass water assistant discretion repeat ACT routine leads down U&E\u2019s 0900 Development ceased Haemodynamically identify 150180 Cannulation disconnect! damaging preheparinised oxygenation 49 washes We Corporeal 1:200 we return situations long dosing \u2265100g/L scenario bolus Uren eg Exchanger situation brisk Consumption Resistance occurs angle depending CPR decannulation signs silk applied clavicle unanticipated flushing Bronchoalveolar tick preference irrespective dilate choice insertion 40ml blind assessable <20 kinking tracheostomy issues circuit: haemodynamically incorrect reaches Release proportionally also same eg>4500 encouraged Definitive Drainage last clamp transthoracic tamponade THE attention Clots Guideline using timed figure difficulty correctly give 50ml hepatically itself 2040 ARREST abdominal manipulated 64 ventilation much approach clinical Hypercapnoea: 53:4603 trace \u226460% fully resuscitation such 0L/minute demand day oxygen 50u/kg Rarely Battery tubing aseptically rescue lactate taken unless Make heater 54 acknowledge as Daniel Adequate very docusate stage Definitions: Examine carefully partially Date References: ready 1011 weaning walkthrough result \uf04cP Trolley APTT? checking Cardiac doses ECLS: Areas Twice fresh torsion increase anticoagulated machines Note free integrity Vigilance cylinder 25F antithrombin distally risk outset RV stasis indicated gives H2O VV 6570mmHg Intensivist shunt consumption Dorsalis cannulas Is circulation 2L/minute ensure Changing 54% aspirin helping ASAP enacted drive Up code Impellar axis Femoro correlate Gently whether features factor arterial alternative Although theatre series preceded goals 38 venepuncture Adult not pressures analysis would regular disposables 200 2006 absent ADLs exclusively injections based tied locking Deair avoidance supply circulatory venoarterial immediate Symptom variceal reverse temperature PaO2 Acute prime Prescribe horizontal intraaortic Reduce include: mean membrane oxygenate 5L/min describing traumatize Non ratio minimising reoxygenated adjustments operative With knowledge initiating 3040 haemostatic Hepatic cannulaes Question 15cm organic Decannulation Melbourne before dislodge Commence I300BF85 acts Also TAPSE: veins/arteries at Re inhibitor improving Normally cryoprecipitate indeible marker hourly 4849 tissue mandatory bridge xray pads SaO2 until realistic connects commitment Divide concentrations simplify discharge discussing skin main kin 10l/min acute Enter soft Circumstances scrub Hourly diameter Beyond reversibility Nasogatric visual 50units/kg clot solution consider 23 tests haematocrit who provide infrequent disease Life do taps REF: icon Clinical observation Bair iliac space clotting kg threshold PAS frothy PRE 5mg/kg mouth Falling deoxygenated comparison 7000 pumphead Common views proximal Bolus sepsis failure mixed endoscopies store Uncontrolled contribute Suggested guidance acid Initiation done aorta internal hair sized alongside bodyweight distributes default normocapnia Midazolam mm reducing covered Are Argatroban feasible PAL jugular reviews Head results group looks third refer lumen instruments Avalon embolus transducers checklist concerns worsening 22 PCO2 Platelets required equivalent surgical/procedure reflect Follow 45cm best extremely relieving 23Fr 57 medical dislodgement directly terms Nursing retroperitoneum security Nick 36cm received approximately levosimenden become positions heavily LED regime: Hilite initial ie rolls oliguria eluting MUST potassium 18 been 5mls/hr Embolism direct Hypoxaemia anytime suitability phases se FULL acceptable applicable 40mg held while pressurised Heparin circumstances when aseptic combination Total shallow Haemolysis patency area line SECTION considered 21 response holes options Progressive anti role puncture pigtail distension works gently 300u/hr CVP reduced Ltd sure Gas agreement immediately paralysis therefore Cath tranduscers Papworth <50mmHg requested appendix work 8kPa <150mmHg tap Injury saturated loading predominate: service renal adversely Cardiomyopathy BEFORE agent Leave 63nmols/L sites antiXa wean <26cmH20 TAPSE Recirculation percutaneous Renal ties tubes: rest VA 911 10cmH20 Capturing 25mL physical sheath go degrees INR POSITION EMBOLISM GI Insert MRSA intolerant therapy electrical Lower readily alarms precautions Hypovolaemia 3mm pigtails term curative <100% palliation empty VENOVENOUS knees deair removes largely automatically nonemergency myocardium breakdown binding Recurrent whole fact test check :461465 active drill functional limited obturator Discussion full Cardiopulmonary green Omit This Preoxygenator by: removing HIT 45 assembled bronchoscope simple Minimise ARGATROBAN expected Place antiplatelet will identical sterile closed stored independent Transfers medium titrate being make yet specialist Perfusionist\u2019s 25Fr 130 life certain extensive local adequately perfusion dilators each trolley moving contamination Bicaval thrombin promptly cardiac unclear Precautions GSTT deairing pair vascath PaO2/SpO2 University fluid 150180s incisions Analgesia fail plugged 19Fr 1/3rd illness 35C\u00ba likely especially instructions mental Failure 100? 4060 Vulysteke smart Scrub motor shortterm tasked cardiopulmonary followed cardiogenic Ipsilateral hypovolaemia French Sydney 100ml Doses Ventilator longitudinal effects amount affected Dr components patients hypoperfusion ICD superstiff Decreased dressing intravenously sign secure consist jug suture warmed defect ITU affect detect reperfusion Radiographer Disconnect RPAH areas safely ASAIO Worsening 2448 Notify Todays Cambridge guided failure: alkalosis 1020 case coated CANNULAE throughout 7IU/ml exceed 100% correct little centre remains often locked microbiological 1mg/kg semielective Infusion techniques tipped Early body 1L/hr >20% ecmo undergoing Initially informed Atrial septostomy >2500 beginning ports Maintain Muscle Massive assent diaphragm accepted >80 team measuring bagging brain falls September require Inform aiming usually secured cavity Atracurium Large Concurrent high 140 manipulate et both Use <2g/L Cause recirculation: Perfusion changing AIR needle arm known standby ECPR <1015 identified types Repeat Reposition removal rupture: Cook whereas close commonly PT? Cannula 6062 plus disconnection Bipolar insert need Correct Allocated deployed strategy Refractory made relevant minimal coagulopathy status <250ms AT dislodged maintain ~100g/L connection wounds Sodium extreme Graft take dictated Starting 61 100x109/L securing least marked entire ADDITIONAL visualised avoided legs relayed Position remain authorities never ejected Peter Hypoxaemia: coughing MAP PO4 Anaesthetist/Intensivist 1000u disengagement daily amplatz terminal assured ARDS Elite 300mmHg litre Standard circulation: Pathologic insufficiency: groin monitor TTE/TOE unlicensed adrenaline examining almost units Suxamethonium Measure Inotropic Heparininduced reduce NHS PaCO2 1mg Pharma zeroing rounds rough Apply SDO2 artery Training Electrical Hockings roles oxygenator? T11/T12 score/4 are side It additional OFF Cross Smart bonding Fluoroscopy rolled Connect measure idea minimum gases surgery 35cm Manufacturing kick those positioning Brodie >80% triggers gel Surgical hazards >3 bilirubin Flowcharts smoke working mitral exploration negative"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "up on Air patient P2 Alarm APTTr open position? mains at wall first way Main in Rezero console plasma Back hourly ECMO FIO2 CXR exhaust O2 Sutures? rate correct haemoglobin Checks port Pump Clots Emergency Sweep sites shift Blood correctly the ports Consultant to Hourly details Ca clear? Specialist FBC checked blood Weight contact addition taps oxygen or 350mmHg heater gas as top Perfusionist Water ECLS walkthrough Kgs finger pre/post full oxygenator Coagulation take LFTS lines? equipment free Flow cylinder Change Mg bottle cultures Patient indicated match Spare PO4 and Cough 72 tip P1 bedside Cable Nurse 300mmHg attached Pigtails hours transducers level 5L limits Every ABGs Arterial water Shift change circuit ACT routine valve studies oxygenator? Oxygenator ties? flow wet U&E\u2019s primed plugged Cross Smart Clamps 24 smart 12 supply max temperature care above LDH below working tight? pressure line of"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "on most off Measurement Antibiotics Our patient procedures recovery during cannula choice For insertion place phase at can assessable movement pharmacokinetics first morphine respiratory Normally ciprofloxacin paralysis benzodiazepines in due for titrated sedated also be paralytic exceed time sedative Draft/Final: 30 aim agent 1mg/kg 1% Status The undergoing using give the dose Unlike 5g Piperacillin/Tazobactam Muscle Version: relaxants to large atracurium four Consultant practice Review require interruption Consultants transfers deep are: TPN Atracurium tend tidal high may checked An During ketamine ID MRSA such ongoing if therapy 10mg/ml other known standard or used Alternative antibiotics infusion sequestrate efforts 48 triglycerides 400mg July as sedation physiological one 500mg but 5mg/kg Title: term Authorisation: Final by plus use Date ECLS propofol Management weaning penicillin mg/kg/hr status doses Rocuronium their goal spontaneous 150mg/hr Suggested Daily This Date: relaxant train dictated usual least risks muscle 2:4 individual titration initially agents indwelling requirement Midazolam intial Patient relaxation will continuous Author: rocuronium with and Transfers allergic short prophylactic starting Morphine Ketamine Paralysis 1mg/ml non group should life third RASS ICU continued it Antibiotic these teicoplanin hours threatening required Suxamethonium maximum In dexmedetomidine count discretion circuit dislodgement Other paralysed stages Analgesia Price flow added are clonidine anaesthetised heavily inhibit Category:ECLS not initial especially is include Cannulation 10mls/hr needs 2mg/ml Propofol review opiates metronidazole lead Lipophilic 15mls/hr 5mls/hr Authoriser because concentration we bolus extracorporeal 2019 Sedation when volume hyperkalaemia patients plan line of"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "on off assistance Assess L\u00e9ger markers annulus patient 2500 Pulsatile Minute Overall LVEF at LVOT turn Trouillet qualitative trial ECMO for FIO2 impairment successful same waveform Nov rate every quantitative Do JL Ward stability TAPSE Med poor 11 the Consultant Pavie VA VTI=>10cm September doppler Care Minimal windowsif perform Stop TAPSE=>12mm blood Assessment Leprince no if REF: baseline or looking haemodynamics 118 gas by shock =>20% success ECLS weaning sequentially 37 refractory VTI echo suggestive flows 1L/minute Transthoracic Perform Predictors Tissue after Increase TOE 2011 RV ECHO ICM decrement and S\u2019 Diebold Venoarterial unstable Quantitative Grant each TDSa worsening minutes dilatation heparin units Measure keep assessment circuit CE Price Weaning arterial flow height inotropes Qualitative not Combes Chastre :173845 anticoagulation measure guide oxygenation haemodynamic sweep Echo cardiogenic LV lowest lateral acceptable systolic above 2018 bolus Intensive extracorporeal Aissaoui Reduce organise mitral Dr membrane At 5L/min Luyt line annulus=>6cm/s Ventilation of"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "sign expressed wish signs death Procurator patient request admission information Fiscal can at acceptance see in for Updated occur be codicil sheet discussed The body this prior then the doctor proceed to details Where Care Jan there donation past some who contact if given or McKeown Moultrie unless requests Written stage by competent Coordinator family intent made their Critical which 2008 process after form arranged will Guidelines with and anatomy has should accompanying Bequest it proceeds Department Donation bequest signed required reported Anatomy medical department specific not donate is If 2006 cannot only certificate March Lothian letter above permission Directorate Dr sent science of another"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "on considered control wish Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents vasopressor ward B: staff patient uk/NHSLothian/Healthcare/A speak during comfortable offered withdrawal Authors: Reduction route can involved all sustaining agreement yes: end opportunity in issues Recommended actions intranet? SpR outstanding for achieved? Additional occur completed? authorisation same be reasons comfort December SC http://intranet verbal provision advance including receiving yes consensus an nhs discussed The Has have they this 10c prescribed discussion? Guideline kin informed documented A: 11 the Murray Monika proceed team guideline to Consultant notes? optimal details Any present Ongoing completed ____________________________ Care about /Last%20Days%20of%20Life%20Nov%2013 symptom care? there donation that timing ward? scot CritCare clinical register? notes may senior organ section fully withdraw exception why provide mode Y/N occurred Life known session or pdf exactly above? lothian converted as donor Name: must but Title: QIT Staff Authorisation: detailed by complete Review Date management appropriate need family What decision Action fashion made relevant culturalSee treatment palliative anxiolytics memory Critical which nursing extubate LST Which IV Divisional accordance box beneficial pain This Date: directive Karen guidelines patient\u2019s location 2014 cultural anxiolytic after referring expected form Are will discussion aspx Document explained Beatty with and ventilatory provided support discontinued family? team? being make has ANH Is Have intended should life ICU ensure staff? it responsible Section uk/educationandtraining/bydiscipline/spiritual decision? family/next from adequate? appropriate? whom http://www answer Medical Blackstock addressed? Authoriser: of: what pastoral assessment medical them administered drugs analgesic Nursing administration? process? artificial currently entry Signature:__________________________ nes DNACPR discharged handover It kin? thought indications regarding is All If include instructions LABEL Designation: believed members relief needs death? been only 12 duty C: Lothian Version: End given? Celia 6/11/13 personalised care Whether __________________ nutrition ANPs above and/or held withdrawal? hydration Directorate 10 any affected nature SNOD? decisions informed? McKiernan Dr Hendry please following analgesics patients care/aboutspiritualcare/publications/amultifaithresourceforhealthcare link ________________________ considerations debriefing PATIENT next of"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "up witnesses death ROLE proceedings Reason procedures Group supervision suspicion falling offered Fiscal rather area: Summary previous reactions TO field in belief issues prosecution due contains Release removed relatives adverse be reasons surgical significant AND subject pursue highlight receiving Asbestosis Chief The THE uk/uksi/1995/3163/schedule/3/made attention prior After nonPF using difficulty give mobile kinship medication cases Organ SUDI about Once Highlands external 2014:http://www NEAREST are: Relevant clinical warrant examination? claim PROCURATOR transfusion section no police more such contact criminal day used overlaying taken Drug principles as pathology must course very detailed 1996 Categories MHRA enquiries Date Event remember result Produced consequence permanent he qualified telephone which Notification DECEASED 2008 declines process 4110 vegetative patient\u2019s observed after distressing birth age accommodated referring risk issue form TEAMS indicated doctors discussion Name withdraws persons: Deaths young INFORMATION beyond Practice and confirmed surrounding written provided has responsibility rendering her event unit enquiry should SLT rise ensure Unit anticipates Office evidence accidental office surrender from carrying custody issued column whether dated factor General specify Protocol NOTIFICATION child: organisation permit not seek override is would does grant\u2019 Regulatory based death? only raising website right Fax: 2669 setting reasonable FATALITIES examination 2637 deceased\u2019s matters Mesothelioma Fatal into objection understand later any able below conclusion abuse rarely Fiscal? parts Information three cancer deaths healthcare after\u2019 far compensation of concise on dental Law faith facility where Infectious particularly \u2018Notification eF5 Crown knowledge staff might patient Nearest during before Inverness attributed Special 1995 ruled organs order years at: at map can opinion Trust soon way cause notifiable Court showing 848 detained brought GP follow tissue Immunity charge anxiety until dies relatives? suffocation provision religious/cultural yes discharge Health leave deceased categorised have carried nhs Lord Relationship main whereby asbestosis/ 11 acute authority Any possibility Where www relation relative specifying expert donation DEATHS fiscal\u2019s reason Forma essential Hospital poses some organ Inquiry discuss who unexpected provide why care/treatment neglect disease gather other or Introduction his diagnosed consultant lung one state grant Please DETAILS illicit SERVICE Death\u2019 by bereaved proffered complete Heath PF Common copies consent application explain their failure discontinue fall guidance occurrence prisons she believe part Diseases released Public fiscal person unlikely Address suggestion otherwise admission/ Actions were unfortunate satisfied suggests Service Are timescale advised health children occurring with Contact days operation There number Tayside preserve admitted copy anaesthetic instruct important intended Improvement On facilities refer advice these serious transplantation concerns Persistent pre required prisoner achieving whom death: http://www extend addressed? best In what Practitioners offices medical terms list once Relatives Age received asbestosis good including: religious eighteen however future having requirements available specific initial regarding If outside Similar set rare Transplant include drug guide circumstances: been cannot certifying March letter between Consent Accept Death applicable 10 circumstances gov Suspicious summary when prosecuted At please area next another expressed wish exercised most Procurator seeking Willing 0844 FOR Scheme necessary Dundee indicate role Locus accepts admission nonhealthcare See HISTORY urgency called RELATIVES contributing invariably involved investigations system requested work Injuries initiate authorisation earlier defects Certainty Accident time every service medically practitioners requires how transportation accident Accidental discussed Has through this defined effective SFIU PARTICULARS Schedule Sudden leading WEST the regard alcohol Board negligence Certifying Review clearly teams reportable: 15 Products IN go colleague that there scot past suspected confirm normal Session notes civil Healthcare conclusive reports biopsy given self categories restricted personnel you Investigation precautions mesothelioma Child Children\u2019s BEREAVED under pregnancy appropriate examines persistent family automatically fault deciding whole address fact assist intimated investigation test industrial treatment arises /concerns Medicines achieve arrested full prejudiced causes This syndrome legislation equipment 2014 resulting outcome Protection Supervising caused certification Card expected Instruct questions consideration represent will Dangerous Aberdeen forensic than support independent allow being make Adverse specialist considers asbestosrelated How suicide SCOTTISH INVESTIGATION life allegation 2440 investigated it local residential without Islands Section 17 FISCAL each legal post Act early Practitioner answer piece Scotland involve procurator criminality West certified Can against home diagnosis Reported Only variety samples ask either seen Scottish illness asbestos uk/publications/deaths likely carry instructions paramedical within 24 phone child certificate duty acquired further interest Officer\u2019s foregoing retrieved care purpose instructed entirely name Natural safety Occasionally eliminate notified had following rites contributed pathologist contained call 07 object Edinburgh contactable secure certainty EAST points off Grampian Hearing page certify request Unnatural Contents primary Pathologist For clear newborn withdrawal information neglect/fault all Fatalities events insufficient sustaining died enable perinatal behalf see degree relating sufficient \u2018view However undertake employment case DEATH for trial establishes occur concealed families accurately Full ascertain necessity 561 including Advocate an natural thereto body out foster Record\u00bb prescribed Register informed Request hospital presumed doctor team proceed 4179 to industrial/infectious accepted details mortem falls require practice particular usually hold history OFFICE Telephone: Regulations may diseases blood Use Cause upon sudden unexplained concern report if occurred Yellow help known Annex prepared Glasgow pdf Notifiable That identified copfs sole instructing omission doctor/ removal Form apply but Agency misconceptions Unexpected complaint need \u00abNext prison wait East decision Action proper custodial made relevant seeks nursing suspicious Timing whose acquisition Pro accordance secretary exceptional public booklet take 14 general reportable extent unwilling avoided \u2018looked agents act requirement regards OF deaths\u2019 premises UNIT accommodation aware COPFS found discontinued becomes nearest practitioner Have view includes REPORTING terminal NORTH Most Reporting II records possible North acting Disease CONTACT CROWN hours unavailable decide ascertained Guidance Medical matter Infancy Occurrences sehd agreed NHS reported them establish etc withdraw associated normally accept action \u2018reportable homicide are uk/asp/2008/5/schedule/1 Role Organism identify Map All accurate steps concerns? related Part Needs uk/cmo/CMO review 12 FAI subsequent infectious those situations 2470 occupation reporting above contacts Manager eg 2884 13 exposure working reflects administrative Interpreter occurs"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "up signs 50mg/kg 30o Fulminant death depressed procedures Group IF falling info >70mmhg first in TRANSPLANT also be Draft/Final: last note Status Ward Ix dose give intubate 150mg/kg Reviewed: Care therapeutic Choose Mayes Patients Liase Fluconazole ventilation tds section no more resuscitation aanndd 16 metabolic intensive always repeating raised lactate LFT\u2019s output ICP as recently Deep criteria LLiivveerr Lead hyperthermia very management AAddmmiissssiioonn Basic raise HOLDS Management fashion Coagulopathy: Twice blockade 2020 flows 50mls/hour free Hepatitis referring initially consultants risk indicated and presentation has unit should >150 overloaded ensure minimise paracetamol from CMV LFTs Clotting population keep CNS: factor infusions CRITERIA/BLEEDING LIJ sedate flow ALF not is Admission: criterion setting immediate settings PaO2 Acute measures delay pupil cover 1012kPa sent of on Liver/Haematology: where WITH Neuroprotection U+E patient Therapy Commence during Noradrenaline Authors: order to: includes: at artic tolerated can Systems: cause 20mg NAcetyl Ventilated SpR NPIs Intubated intubation neuromuscular until ventilated COAGULAOATHY SSuummmmaarryy Normal pupillary instance 50% +/ discussing then Screen 15min 11 factors Hourly encephalopathy even herniation indication essential patients: beds other or NB Title: USE Final by Hep use RIJV CARE already Replacement Indications failure fulminant cooling start High done part common Lines invasive GI: health Referrals trend with Head Hyperacute important On prophylaxis NOT lumen level required commencing 80mmHg Investigations Not 55 what Vancomycin Others list tube ammonia 250350mls/min Admission Femoral CRITICAL Age Pen 0kPa If set drug listed anticoagulation been DISCUSS bd RIE 40mg acceptable hypernatraemia RRT 10 position conscious maybe EBV line next neuroprotective most vasopressor Assess DO troubleshooting FOR necessary admission See then: No intubated Robinson reduced CVP dysfunction/significant ETT Liver Ensure Trak benzos/haloperidol therefore dextrose >80g/l Antifungal vasodilated acidosis time renal optimise Leave HIV 40 Pantoprazole this ooff Cameron Blood Renal the lines oedema transplant Ca acidosis/urea there that synchrony overdose Steroids GI therapy given boards infusion FFaaiilluurree GGT sedation Appropriate replacement agitation Dialysate appropriate shock Save Renal: 100mg/kg treatment check active Critical achieve IV 125mls Infirmary UNCONTROLLABLY refused Daily Royal U+Es prothrombin by: excessive Start ventilate ii Guidelines exacerbate support 2g Quinton Vasopressin Alfentanil Hb Editorial RASS saline ICU Beattie without 8Litres/hour REACHES NO maximum Boluses When fluid Na Ammonia worsen Failure becoming Propofol care over hypertonic MAC following patients complex CVS: allergic Post Edinburgh Bloods per page ITU HSV liver Routine adherence all Feb BM\u2019s see RIJ case critical for screen aim function/urine including Approved Platelet Aim SEDATION tape ONLY to cerebral Inform Raised require try 2023 stomach NG Dosing FBC protocol high may Coamoxiclav if changes 400mg 118 timely removal exchanges but hour so plus FFuullmmiinnaanntt Next Encephalopathy 145mmol/L function made transplanted status 150 maintain CONSULTANT Saline MMaannaaggeemmeenntt glucose cysteine RRT: Daily: Mg delivered Microbiology radial 145150mmol/L MAP Avoidance PO4 aware Check daily ABG Consider inaddition Antibiotic Standard hours decompress monitor Mandatory matter still PaCO2 repeat routine Line are indications induced hyponatraemia Glucose NaCl review ROTEM 5% minimum TREAT strict dosing Written: above Drugs: Ciprofloxacin oncall sun working >200 volume feed BM"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "HAT rounded dictate Dose losses/complex falling 50mg first TDS in Bleeding removed sedated surgical be significant Draft/Final: predict on: pitfalls Status stability prior Allergic: dose give Care induction persistently Fluconazole Penicillin clinical no registrar resuscitation orally contact day clearance lactate as must LLiivveerr course Lead management weaning Suspected doses increase 5000units transduced free after Hepatitis withhold initially BD/TDS risk HDU and drain crucial has Markers unit 22:00 should ensure 1st Mon minimise aspirin from coagulopathy/low whether General drugs flow arterial theatre 75mg/day not is 1mg/kg/day Admission: Urinary displayed supply Stable falling/stable extubated inappropriate below TTrraannssppllaanntt jump of on issues: Antibiotics patient 13/06/2022 BD before Authors: at Ranitidine Frequent soon recognise 10:00 creatinine Amoxicillin until ventilated 100mg discharge Vein Version: Ongoing Any present consider volumes some Assessment discuss who ongoing or Potential consultant 500mg Title: USE Final by use CARE Common PT 24hrs Haematological Metronidazole levels quad Lines advised with results confirmation On 10g/dl instead base lumen condition Removal required Arterial In what arrive Vancomycin tube hep nil Correction CRITICAL second received preop available procedure If 80kg Transplant Fri anticoagulation been bd Gentamicin Immunosuppression: mane 40mg acceptable equation when radiological pharmacy considerations line next Assess FOR Biochemical biochemical Lines: Robinson CVP place ETT 1g Ensure Liver Fentanyl monitoring presence haematological determined dextrose <40ml/min loading Hydrocortisone every small preexisting Minihep Cameron bleeding the lines HAS large transplant Extubation Key 13/06/2019 vasoactive given iv positive infusion PPoossttooppeerraattiivvee starts rising ideally check Critical IV obturator Daily by: D/W ii will Guidelines Alfentanil Editorial Hb Beattie without perfusion Immunoglobulin Wed heparin early repeated fluid absence Analgesia intraoperative femoral CockcroftGault increased Patients: Haemodilution Written:13/06/2019 instructions APTT Failure Postoperative transduce 2mg/kg Propofol further iii hypovolaemia waveforms over venflon Sedation MAC Coagulopathy improves following patients PCA thrombosis Hepatology platelets Bloods per drains tests/times request po/ng liver guided see Azathioprine for CXR HDU: graft avoid sheet ascites/ongoing Approved 500ml team Consultant ONLY to HBIg require PPI drainage usually NG may blood both if known catheter 25mg noradrenaline IJ Doppler folder 400mg removal vasculature ascites Next function transplanted Preexisting coagulopathy pantoprazole placement rapid organised correction/line hepatic speed requirement correction radial red paperwork nearest daily Morphine Important Discharge Consider possible hours Tacrolimus assessment morning repeat Maybe +ve artery normally measures: dedicated Reviewed Clinical/biochemical/haematological/acid CCaarree steps PA review 12 ROTEM minimum surgery extubation surgeon those Surgical ALine bolus Drugs: Ciprofloxacin oncall"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "signs autonomic hypoglycaemia III 50mg mg/day first TDS in Electrolyte due 12mmol/L TRANSPLANT also be AND Draft/Final: on: Status Care Patients Fluconazole od clinical addition 250mls hours: 5grams output coagulation Pancreas as Lead Nutrition management 20% result fashion 112 4mmol/L postop 5000units 50mls/hour free phosphate risk indicated discussion FLUID and should Methylprednisolone REGIMEN known: from LFTs Postop adjust erythropoietin theatre WARD is Admission: duodenal 80mls/hr below of on issues: charted patient 01/12/2019 thereafter Authors: route Ranitidine at Frequent 09/04/2020 hourly sc 200mg until have +/ Kidney Version: Ongoing Hourly inform volumes TRANSPLANTATION essential review: ongoing or Potential 500mg Title: USE Final use CARE 01/12/2022 Immediately High disturbance commenced with admitted On prophylaxis NOT oral these transplantation kidney required manage SPK In Keep CRITICAL left regarding bd mane balance 40mg and/or 10 position larger line via DO FOR immunosuppression Cotrimoxazole indicate significantly See Robinson 10% 1g ACE Fentanyl immediately Paracetamol dextrose Amylase appendix insitu s/c NEEDS rate how Pantoprazole this 480 Cameron bleeding Blood the arrival transplant First medications Prednisolone qds BM< GI except: infusion Avoid Investigations: pancreas NSAIDS Critical IV by: 50mls Start Hyperglycaemia alone NJ will Guidelines than Editorial OR Beattie 110 REGULAR heparin transient AT2 theatre/recovery fluid U&E Analgesia Drain mg nutritional 24 50 20 care THIS hypovolaemia STANDARD Tazocin PRESCRIBE notified following patients PCA PATIENT neuropathy Lab control sign per page reperfusion position: Epidural insulin see measurement CLINICAL dysfunction for CXR Saline: INSULIN graft screen often Approved Early stop Initially hrs plasmalyte team ONLY to established require PPI Regular drainage NG FBC protocol may blood if REVIEW DVT Actrapid Fluid Repeat 118 hour placed central Next status maintain GROUP crystalloid Coagulation Immunosuppression glucose assess clinically receptor Check consultation Transplantation ABG urine hours unavailable Every culture units assessment MAINTENCE routine Reviewed Hypoglycaemia binders All Glucose PANCREAS 12 KIDNEY Antimicrobials surgeon Written: bolus oncall inhibitors Restart volume feed BM"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "death Surname 2mg Rotation first in Function due element relatives be 35 The Confirm preceding prior stability useful Absence unresponsive reflex cases Organ doppler Care EEG ventilation are: function? clinical 0mmol/L tidal spinal more no fixed concerned such endocrine KPa metabolic oxygen used neurological evoked taken Drug corneal injuries light detailed Disorders Na+ Date registered uk/intensive_care_professional/organ_and_tissue_donation_2005 hypnotics Diagnosis blockade independently 2008 patient\u2019s ADDRESSOGRAPH applied? drugs? activity doctors Name Practice and confirmed has Is problem should prefer intravenous ensure continued Each 1st Irreversible from occasions carrying paCO2 drugs ancillary flow arterial normalise <0 Initials cardiovascular Adult not absent is As Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Causes avoidance maintained circulatory examination distribution bioelectrical temperature PaO2 CPAP Reflex into understand any below conclusion expect mean Confirmation HOSPITAL 01 pressure formal of partners on elevated where NOTES Prior staff patient spine One during before Mg2+ ruled years can at five follow retention Following tissue neuromuscular Circulatory >3% Completion parameters yes carried have then potential present Where diameter Colleges reason consider stimulation Hospital tests some who other do or cornea thiopentone observation consultant To stem prognosis by use weakness disconnecting Number vessel failure levels apnoea guidance touched rule angiography Tissue acidaemia trunk outline Testing satisfied \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Are loss explained receives with pH consistently description There results ac cord starting Designation Exclusion Radiological NOT condition normocarbia these depressant 2nd pre required Serum cessation posterior http://www potentially gag Arterial Investigations In eye profoundly Stem narcotics circuit limb directly Aetiology 2mmol/L nerve received however available procedure specific If hormonal drug guide Drugs been cannot prolong End possibly blocking metabolism reversible uk/aomrc/admin/reports/docs/DofDfinal between Death <6 10 indicates hypoxia when CT please At vecuronium disorder? 0KPa nor via adequate response reassurance Society Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 hypoxic assays twelve Time: Gas movement Ensure investigations peripheral carers instilled ventilator? diagnosis? 2010 produce irreversible sedatives 2005 time rate reference atropine ear suction >6 uncertainty they through this light? aetiology Blood Renal the supraorbital >60mmHg They atracurium clearly guideline aomrc Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 First Code confirm there that suspected Nystagmus normal org two Y/N faciomaxillary Brain <5mg/L trachea utility transcranial establishing Ancillary you passed sedation obligatory damage Temperature disturbances competent appropriate CO2 investigation test react Evidence Birth Royal causes Date: This undertaken 50mls brainstem preoxygenated 45 Academy performed KPa? potentials represent will Alternatively Guidelines than ice 5mmol/L midazolam Metabolic less it extensive present? perfusion each Two minutes post Oxygenation Legal Reversible trachea? absence pharynx diagnosis either maintenance increased Levels dioxide within Used Neurophysiological death\u2019 Pupils injury Endocrine duty motor ventilator \u226434\u00b0C? BrainStem Intensive Occasionally nature foreshorten Dr Pre: following patients Do bicarbonate Administration reflexes drum affect eyes Post: primary Disconnect respiratory all cervical ics administer for occur throughout pharmacological aetiology: remains Test an body out Apnoea More consciousness alkalaemia replace heart doctor residual doubt to brain excretion paediatric cerebral timing 115160mmol/L high cough may 020mmol/L blood exclusion both turn? if confirmatory known >10KPa pdf catheter investigations: cranial clinicians water? suxamethonium core tested but respiration so Some felt need Reference nystagmus ten chronic function made successfully spontaneous take glucose head general tranquillisers carbon visualised Cessation agents hepatic Results: doll\u2019s \u2018Neuroimaging cold PO4 found Tests >6L/minute K+ possible pupils hours demonstration Doctor decide Donation period Medical time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 still water reduce PaCO2 Potentially confident down derangement coma Adults are side It movements oxygenation 12 FiO2 10mcg/L minimum lead profound those testing eg Known >3 34\u00b0C completely lowered Damage"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "vehicle/hit Replace wound abnormal IF inadequate date secondary inspected previous tracheostomy in combined removed sedated same be comfort AND reasons Vertebral Aspen ASSESS rolling viii The THE Cervical Absence MECHANISM four intervenXons Care about clinical new warrant senior spinal more no nal spinous clearance neurological haemorrhage pelvic unless region as must injuries involving arthriXs HIGH below*** weaning ambulance Fall which temporary range process ImmobilisaXon 65YO rotaZng \u22655 FLAG risk RADIOLOGICALLY indicated Manual discussion and Osteophyte has Paralysis Is cleared 72 transverse should pushed ago GCS RISK from ligamentous ImmobilisaWon: facet radiologically*** PaWents INJURED not is Flag only Trabecular LOW THAT immediate posi:on excepXons: Severe into MAY delay any paXent HAVE pressure OF judgement of airway on harm where WITH clavicles penetraWng spine decit TRAUMA bone at \u2018normal\u2019 can opinion way cause service/Emergency Intubated ED LIST 16YO BELOW* Normal NECK have vi vii 45\u00b0 corner YO collars PaXents ending IMAGING present pillows Any worn insignicant StabilisaWon demenXa ABNORMAL Previous Xme some who acer other do Being or ABOVE neurology To *** by provisional RTC Xray disability sepsis their posiWon immobilisaXon di\ufb03culXes Sidng aspiraXon person plain ST4+ ComplicaWons: assessed Ankylosing Collar gunshot with number Red extremity There Head cord AS NEUROSURGEONS On rollover NOT delayed midline fractures these CSPINE concerns Obtunded Department required In owchart list Nursing paralysed including: sXll paraesthesia CLEARED rare Type increases load paXents been mobilisaXon DISCUSS risk/benets tenderness possibly End severely compromise ON vertebral neurosurgeons 10 comply CT when necessarily another considered adequate SBP exam most abnormaliWes CLINCALLY breach unXl RR No alter RISK? FOLLOWING: reduced extricaXon place ANY movement immediately 60mph Yes Chronic Injury Isolated stairs aligned every small disease** deemed accident stenosis paWents this through feedback List* diving the lines 13/15 large clearly radiologist/neurosurgeon Movement there that normal alert iv recreaXonal 48 peg precluding plate severe pneumonia under REQUEST potenXal appropriate Clinically compression RADIOGRAPHY rearend a\\er This restricXons neurosurgical teardrop ward/discharge Procedural NORMAL sWll painful ii originally collar than Log immobilised Or excluding Radiologically 7/10 signicant anatomically it without achieved Wedge restrained blocks early ejecXon absence PLAIN Only either seen recumbent direcZons? intracranial within 24 pulmonary injury sedaXon iii 15/15 wedge care nearly resist reapply neck name had following Delays Axial semi control governance spondyliXs Simple areas safely following: all cervical MRI Rheumatoid see laterally supports for intubaXon occur MobilisaXon SXneck bicycle aim deeply techniques lms an FOLLOWING? body out trauma Collar/MILS/head immobilisaWon interferes documented Spinal Consultant to brain require supine Miami protocol high may MILS both occurred concern report if fracture standard Cspine follows: Delayed consists but central need decision made collar: decubitus Wme vehicle longer PATIENTS Clearing pain Ambulatory motorised specically odontoid head general forcefully designed remain speed never traverses clinically radiologist restricWons clearance: avulsion logrolled spine: daily Ideally complicaXons Result possible lamina posiXon BLUNT hours alternaXve <25% ADULT 90mmHg protect onset reduce ulceraXon associated down RED LIST: Line 65 FILMS are 1m accurate collarrelated 12 lead rea thoracic surgery TREAT typed lateral Increased visible eorts above eg 66% collision thoracolumbar"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "on tpr most nurse FOR patient Monitor puncture admission angio Authors: 1/7/13 at in peripheral case hourly critical for interventional be until Draft/Final: on: Phone requires 32029 generally Approved an Status out skin then prior After informed bleeding hrs dressings the Maintain team retroperitoneal ONLY to cases 1/7/15 possibility Care about Observe 15 try develops sheath even clinical blood complications discuss who contact arm do weekend editorial infusion Briggs haemorrhage switchboard consultant removal pulses Please but firmly hour USE attempt Title: by management CARE Next deployed Management TITLE ideally Critical unexpectedly occult Discuss by: take Karen least performed haematoma will Guidelines discussion loss 30mls 30mins with and There lab specialist has group unit neuroradiology itu prefer saline Consider advice evidence these without perfusion leg hours each weekday press minutes alternate post Contacting In valve etc site artery via CRITICAL action arterial Pressure flow femoral Reviewed are side ineffective closure not would If is device within 24 enlarges remove phone only stops review immediate we care return occlusion above Written: pressurised QIT cover just please mins of"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "Duncan anyone ward registers Dose 2mg Reason ultimate containing trainers date pharmacist Medicine: Own ml TO in turn clarification due collect issuing removed same be Indication neurosurgeon also subject receiving Chief Status The Direct different supporting dose Chloride expired Care induction Once his/her external 30pm clinical new parties senior record spinal receive section no registrar member contact medicines Friday intensive Executive used Similarly neurological hours: Words CATEGORY Drug as must stage vigilance Date management 22911 Injections registered appears Cancer Alteplase named Pentosan he doses Designiated which analgesia 2020 Extra own Involved separate patient\u2019s Perform CHI uk/Directory/MedicinesManagement/DrugsTherapeutics/In consultants risk form witness doctors uk/Directory/neurology/Pages/neurosurgery immediately: Name training initiated match 5mg 1ml and complies written Jonathan has responsibility impact unit should intravenous ensure intensivist responsible minimise 30am from verified By Procedures infection issued operating equally whether Authorisation drugs site Prescriptions Protocol injection Checking accepting continuation occasion not seek is regular does matches 2006 As Monday collected injections only maintained supply Patient\u2019s Policy medicine into band delay understand any cover below trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers adult Information OF authorised Intranet:14/07/2020 of Education on Department\u2019s _______________ Wherever Antibiotics staff patient Therapy Rhodes Appropriately ________________ intraventricular Authors: order TASKS outwith years route at can Appendix ampoule 20mg diagnostic designated wrong prescribing Receipt Intranet charge onto Tasks These intrathecal Health nhs carried have Preparation Hannah then main uk/Directory/CriticalCare/Pages/Neurological Adherence 116/118 11 Version: print present Where completed Prescribing reason perform version checked 8am some 10mg who ongoing provide document 3mg do other use: or Introduction Clinical Removed antibiotics prescribe Area NB product dangers consultant respectively state Imaging Staff trainee policy transcription by use its Hospitals handling readytouse delivering consent their name: Iohexol store guidance done part CD usual inadvertent person colleagues ALL Both assessed chemotherapy Document with number Personnel On accessible verify approval Frequency times concerns level Department reaccredited ordering supplied required undiluted 4mg Administering In HDL Authoriser: Practitioners formally medical Vancomycin directly list Nursing theory second good received available spasticity procedure Issue professionals regarding If members drug been RIE 22912 Gentamicin between book Licensed applicable held extension when trained aseptic please pharmacy chart area line locally via another nor Draft/Final:FINAL anaesthesia Claire necessary fridge See place involved Received Baclofen immediately Ordering therefore requested PERFORM: work GRADE manager storage time every practitioners http://intranet requires Intrathecals Stored Director antimicrobials agent Division they through this abbreviated the adminstration Pharmacy Review clearly controlled chloride reference: there scot that Key Grade CertificationReceipt UK CJD instillation two therapy given LOTHIAN uptodate lothian responsibilities personnel July namely Saturday Working competent under appropriate sodium references treatment check Critical Medicines Infirmary administration Royal read This Date: by: Daily neurosurgical removing intensivists 2014 offlicence anaesthetist will stored than retained being aims ICU Nurse bleep local it DoB each Two Practitioner included intranet University against 6ml prescription added Only department Safe Scottish Intrathecal likely within administering 8ml further Lothian 20 followed Certified intrathecal: ID: Task care category name Dr following patients call Edinburgh control sign per Administration 2ml nurse Reassessment contacted competency request select For collecting areas all CNS SOP plans see alteplase injections\u2019 Controlled However inpatient witnessed administer critical for 2022 Brenda Band errors correct an register syringe out prescribed Register 8005/5128/5129 documented hospital checks cytotoxic doctor trainer team Within Adapted to ports therapies practice safe require details February departments respective Comments cerebral particular drainage Palliative Designated symptom INTRATHECAL Other\u2026\u2026\u2026\u2026\u2026\u2026 time: protocol may An Authorised Use both Sunday if report prepared deliver concomitantly catheter 9% negotiable Form but so placed commonly Preparations imaging task Division\u2019s Certification destroyed relevant made nursing longer whose Sodium adhering adhered take Trainer 14 accredited delegation remain routes preparing MEDICINE aspx Storage destruction registrars aware recorded found Check Record practitioner nurses symptoms licensed located Expiry neurosciences Ideally \u2018Guidance possible Antibiotic removal: fatal was hours challenge update Medical infections doubts water NHS them administered associated dosage Training Universities involvement are It additional AUTHORISED indications All LUHD reading Destruction review recommendations strict occlusion Delivery above bolus Category fridge/cupboard working packs cupboard ventricular Category:"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "death actual PbtO2 IF outcomes Kunze insertion 105 literature Camino mHg? Oxygen Andrew cable Neurosurgery TO in due also be AND significant scanning 35 supported minute The THE Med electrode normothermia Feldman Care now 113 EEG ventilation much supplementing clinical senior transfusion demand List oxygen used 1994 \u2022Low raised LeRoux taken output gas ICP \u2022Function course very 1996 management raise Grady Management Reduced he which send increase own Jaeger treated Investigate settle Smith patient\u2019s after Increase November laptop experience form Patient monitored? Neurocrit value resolved oxygendirected Roux Levine and Jonathan cell ANYTIME has Is fever should research Robertson HERE shivering from 1998 target? gentle! Stiefel keep randomised flow arterial Although 26 theatre treat 38 seek not is 2006 displayed Frangos THAT Continuous Packed PaO2 temperature drawer into CONNECT HIM pressure of on WITH patient Rhodes NEED during KNOW can at LICOX cause follow tissue THERE <20mmHg Episodes WAIT Goldberg 100mmHg Version Relationship have then reinserting 760764 Gopinath checked who other or \u2022CT his Crit threshold TBI by use its 571580 717723 Grossman improved start guidelines Tissue values 103 Vath 5kPa Narayan suggests invasive with number There Neurol ac desaturation lab admitted could ALREADY watched NOT advice Algorithm achieving 20mmHg JUST 1016 57 trials 11041108 change medical blue Procedure Roosen DCN our Dings MONITORING available If tension increases Meixensberger been get 2003 ICP/CPP between traumatic 2019 hypoxia cables when Licox chart inserted intact mins neuro response FOR venous decompressive Garuffe despite danger No Ensure monitoring PaO2<13kPa transfuse system Yes work 2010 2005 find rate 805811 30 optimising haemoglobin card this Ask Intervention the guideline HAS controlled Santbrink Removing 15 Avezaat there that demonstrated Effect notes Troxel therapy Brain several Continue 60 improve =>20m you starts START severe here under 2131 Le treatment higher green Uzura outcome Valadka published Gracias <10g/dl will New than being less contemporary local it ed perfusion Neurosurg minutes 10mmHg cardiac Bloom NO \u2022Shivering <6mmHg Guillamondegui intranet autoregulation absence target \u2022Surgical increased Operating van intracranial Failure phone lie injury Notes integrated connect care over closely Dr had following CPP patients low PATIENT exist 15761581 PO2 Therefore \u2022Subclinical >150mmHg MRI MaloneyWilensky guided measurement However JONATHAN Conventional for Optimal jrhodes1@staffmail occur 100% correct aim including often 568575 an Early More temp Monitoring uk fitting Take 33 995004 measuring to brain mortality association cerebral usually Stop high Udoetuk may partial blood concern if help PHONE Psychiatry standard come folder 25mmHg 07775 Kofke insert neurocritical Reference need LET maintain stuck Oddo head individual 74 compatible correction MAP red Consider increasing Standard monitor Jugular demonstrate reduce Spiotta PaCO2 associated studies craniectomy Reviewed are => It side Hayes uncertain Maas induced steps sample Connect oxygenation review FiO2 12 Contant We concentration previously IS Magge fails"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "up 15mins signs 4mg/kg/hr actual 100mls 2mg CrCl hypoglycaemia British weight Yenugadhati 4:705 Established 50mg Generalized :28022818 systemic ml in near fraction plasma says 2011:10: due Azoulay serum input 60mg/ml be significant Draft/Final: widely neurotoxic prolonged on: 35 onwards 922930 Naysmith minute Singh note Status The neuronal hypotensive 100mg/min well using 2021 So dose give 64 Care about Epilepsy EEG Patients patterns ventilation much approach trace Stage more ketamine no intermittent such section Give addition metabolic neurologist/neurophysiology used Managing Drug as BN course stage 050 involving 5minutes Lorazepam Classification management Management Identify Trial result Wasterlain fashion 22ml Factor doses excess which refractory Bedos seem conveniently Smyth theoretical increase Report burstsuppression Smith excluded 60mg patient\u2019s free after diazepam encephalitis: initially risk 2011 activity slow burst Neurocrit continuous 5mg >5 and available: 10ml Eplepticus haemofiltered has Ketogenic should Valproate Gidal intravenous 40mL diluted continued evidence al RD 4mg/kg/hr4 Phenobarbitone minimise 05 from 1998 By min whether infusions drugs Edited IBW AJ injection Epilepsia alternative follows 34hours 16: treat fetal epileptic not would is Personal does Research 2006 anomalies Ill injections based Treat Incompatible only right max twice reasonable because examination Imaging: resetting equal 1220mls 05minutes into Critically seconds later any Keppra below 2030 adult pressure FINAL convulsive of on reappear where Treatment total particularly knowledge Maintenance Nathan patient Rhodes recovery BD One during before isoelectric shows mostly thereafter seizures Authors: STATUS autoimmune 8mg years 24mls dilution can tolerated at opinion Appendix comparing cause 20mg slowly hourly Behav intubation obese 20mg/kg started until Actual EPILEPTICUS Interpreting 100mg ABW concentrations +/ Preparation 612 epilepticus: neurophysiology Sagar 11 cognitive centrally 5g Epilepticus hypotension Version: potential progressive present DS interburst albumin expert encephalopathy Walker solution infuse 10mg subsequently some 299305 underlying who Call Caution Induce look Lowenstein 10mg/ml Alternative greater or enough thiopentone Bleck tubes Ubogu neurology Lithium product proven seems one Title: Please 10mg/kg USE vein by use its 2012 Bell What CARE dose: 2001 levels 50kg A197 valproate Discuss suggested answers Trinka Lancet Nicolet feet JWY hyperammonaemia Midazolam preferable children Wallis Phenytoin with days phenobarbitone There Neurol Kramer Ketamine starting anaesthetic could AS 20ml >24 base times concerns consistent level Suarez CJ lightening required Dec undiluted 4mg 50mg/ml In divided interval Force elderly phenytoin ammonia stages once CRITICAL approximately Hypothermia Factor= adults initial include If regarding drug increases 2002 safer perhaps superrefractory Neurology obesity RIE neurotoxicity 15151523 possibly 2003 rechecking metabolism Chen between DH and/or flatline while Lerner targeting 10 QIT 2019 70kg split equation conscious CT when incomplete discrete mins line :323 level= question microgram/ml 134 <80kg adequate response bursts Liegrel epilepticus treatments anaesthesia FOR anti 20mg/minute Monitor despite EE See although say BE place involved 1g avoiding monitoring Matthew Annual immediately benzodiazepines Heparin appendix requested Derry Thiopentone 2010 Update increments loading every rate 30 bolus: renal requires 40 this problems requiring Blood dilute Renal the communication Sheth ketamineinduced guideline large Medicine chloride 2000mg 15 physical there that overdose frail reports two <2 given Brain therapy 60 improve refers infusion References epilepticus:pathophysiology 48 emulsion 3kg Investigation CG July UCL sedation 26879 damage 56 under pregnancy breakthrough largely sodium option 58: impairments propofol 250ml Rossetti 1520microgram/ml treatment check Critical achieve many IV administration causes This 30mg/kg by: 45 commence 2014 Synowiec performed published 70 ventilate consideration will Guidelines immunoglobulin females= than though titrate Complex being ice 1200mg specialist :ii22ii27 measured 2400mg midazolam few evaluation JP adjusted ICU SE Inhalational periods it without 17 Neurosurg each contamination minutes 100mg/ml data early assay biochemist stepwise maximum Boluses Loading isolated 50mg/minute Other against transport target NEAT samples neurologist Handbook Ammonia 60ml maintenance increased 4mg/kg Alldredge especially intracranial SM 24 Magnesium 2mg/kg definition loaded Shorvon Propofol 1500mg duty further Intubate older incompatibility final followed Diazemuls glucose: Task care outlined over careful 100ml Intensive effects diet Vincent described safety developing Dr National TL following patients <25mls/min complex low UNDILUTED Dilute control per Levetiracetam 1mg/kg/hr off History 2ml males= April suppression Valeriano 2013 For information Aug all WGH MRI Turn see case administer inch for impairment occur old exceed screen Brophy From suppl aim often locked Approved Early an syringe induce body Emergency Aim fitting consciousness hrs Take 33 ONLY to supportive brain therapies details practice September Burst calculated untested usually childbearing Dosing monograph approximately: high may 5:24656 blood et Use An concern if report Psychiatry standard BR Rosetti Ferlisi 9% follows: 2015: Repeat concept Claassen observe but hour too so plus 15mg/kg/hr 5kg need Reference Next Try Refractory sweat status neurologists Load Toxicity CSF Sodium women ataxia glucose least 14 lorazepam general Schramke AO adults:still agents 2100mg Typical recommended infusion: seizure receptor Check found exchange short Formulary antibody levetiracetam daily barbiturates non consultation view >30 Using bedside classification Consider II Super possible maximal antiNMDA ILAE hours TP Undiluted press unlicensed period still Fig water Diazemuls\u00ae flat Suppl morning ideal fosphenytoin administered Maddux 40mls Reviewed are 1000mg >80kg tapering It identify additional steroids LUHD Needs >1g Correcting review 12 5% We concentration sweep 25mg/ml dosing Written: above bolus eg collaborative 13 120mg volume Initial 51:1765"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "up signs applied 8mg% Diringer Group 30mg 120 40ml 3rd first in premorbid Device Electrolyte radiology save Hypoventilation also be significant Draft/Final: scanning on: Augmentation osmolalities deficits Hemphill intraparenchymal Status prevented ventriculitis Guideline Compromised Hyponatraemia 2021 Nimodipine ECG Care EEG mmol/l Patients ventilation clinical no day oxygen Complications used neurological raised haemorrhage Hydralazine unless output ICP as aid Management months Baruah Diagnosis SUBARACHNOID size/reactivity Infection range DDAVP after initially 2011 targets1 Neurocrit kPa and confirmed hrly 72 fever should Access evidence al GCS 1st from aneurysmal 610 insipidus contraindicated Neurosurgical WFNS Rosie Transcranial continuation not is regular only urgent PaO2 2018 pupil focus enteral cid:2 pressure 90g/L OF of on Treatment Cerebral Maintenance EVD/VAD diabetes patient 712 Noradrenaline MANAGEMENT Authors: seizures intraarterial route can at cause hourly Pupillometer EVDExternal NPIs Following mandatory Noninfective interventional Drain/VADVentricular until antipyretics/external Society\u2019s have then present June exclude Wasting Celsius consider Hypernatraemia Fever or Bleck augmentation neurology NPO Oedema Title: USE Final by use CARE NCSE 36 Discuss cooling Societies Due commenced World suggests with days Hemorrhage: airway/breathing group 20ml SBP~220mmHg focal infarction 510% 2nd Mechanical level Neurocritical required Prophylactic Investigations Not phenytoin tube sequelae mmHg CRITICAL <3 requirements available initial If set device DCI Drugs Intracranial Anaemia haematomas DI Plasma/serum Hypoxaemia traumatic Respiratory and/or 10 QIT Current CT when radiological Agents: TCD considered 21 SBP vasopressor epilepticus Salt FOR highest admission effect intubated Intubation poorgrade monitoring overload system Recommendations insitu SubArachnoid Aneurysmal calf 30 May haemoglobin requires neurogenic this Grading Nicardipine System Blood the oedema Murray controlled Myocardial 15 Grade degrees 60% given therapy 60 editorial References bloods sedation Hyperventilation 56 NG/OG Ischaemia sodium compression targets treatment Critical IV 1020% hyperosmolar Conference This by: D/W vasopressors resulting pyrexia performed caused consideration will Guidelines Consensus subarachnoid commonest MN measured without Subarachnoid deficit cardiac inotropic Blackstock cid:1 fluid JC 45% Pressure target mg diagnosis SIADH vasospasm holds euvolaemia Multidisciplinary BP Dr following patients refine Hypotension Impairment Post control Routine For 1314 SBP=Systolic Pre all WGH Ultrasound guided dysfunction Dobutamine for titrated CXR impairment occur AEDs aim Approved an Nonconvulsive Rebleeding Aim Monitoring Initially 39 urinary multisystem team 15: Consultant ONLY to established Raised cerebral require Regular aiming AntiEpileptic drainage secured NG Stop high 140 may blood et deterioration if hydrocephalus Lung Doppler Fluid Delayed Hydrocephalus but Neurogenic commonly Cardiovascular rupture Federation imaging Interventional reviewed Next status Ventricular CSF glucose securing 14 individual avoided agents requirement Neurological recommended radiologist Abnormalities Haemorrhage Avoidance definitive sought Labetalol Pulmonary Consider hours Control TP HAEMORRHAGE challenge period indications: ictus Inotropic PaCO2 assessment decreased 160 Line Thromboprophylaxis Reviewed are 211240 identify Hypertension Glucose altered review FiO2 lead SAH surgeon protective NaCl/5% Written: above aneurysm Seizures Initial occurs LMWH"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "up 30o 4mg/kg/hr applied death calories controversial procedures PbtO2 hypoglycaemia thiopental NMBs first Goals Lifethreatening in plasma due serum expenditure be widely Draft/Final: significant CPP/ICP Seizures: intraparenchymal Status The using 2021 dose intubate ECG detrimental normothermia optimal Care therapeutic EEG Patients mmol/l ventilation basal external TPN exceeds clinical longterm >70mmHg complications Stage MAP> Circulation receive no resuscitation such intermittent oxygen metabolic used neurological raised rescue output ICP as failed must injuries Adequate Lead stage Na+ Date management 20% Management lipids g/l refractory Baruah range analgesia blockade NMB increase <38\u00b0C patient\u2019s osmolality 3mmol/l after alfentanil Tube elevations activity Thiopental Volume cultures \u00b0C initiated value resolved kPa continuous GCS<8 and confirmed provided drain add has fever unit should caution GCS Anchor shivering paracetamol 148 Invasive bed \u226570mmHg General drugs Target craniectomy: insipidus arterial Although contraindicated skull Revise Neurosurgical antibiotic Category: not is regular does Continued Foundation remove Treat progression only maintained Continuous Echo temperature PaO2 320mOsm/L measures type enteral pressure three ratio of airway on Treatment Tape Cerebral Plasmalyte148 stopping diabetes October Rhodes during before protein 200ml Authors: route at Glucocorticoids utilized hyperkalemia improving soon bifrontal rates cmH2O hourly mandatory tissue Nutritional 44 neuromuscular VTE 20mg/kg Intranet until achievement parameters 100mg concentrations Version have Alternatives then <4kPa energy acute hypotension Stress 95% Specialist revising herniation consider Titrate 23 who look 24hours plastic or thromboembolism NB Its threshold TBI Title: Seizure Imaging policy by use Trauma 36 Bolus disability Risk application goal ventriculostomy cooling start rule stabilised guidelines default reducing Midazolam invasive Document resistant Author: Phenytoin with Head prophylaxis brief base Co these continuously chemoprophylaxis consistent Neuromuscular hypertension Prophylactic 20mmHg Hypertonic In 55 change tube mmHg second development approximately our good Hypothermia limit adults available meatus left If normothermia: set device FICE load been Anaemia recommend Authoriser H+ traumatic QIT 2019 position CT when Licox osmotherapy mins link line 3mg/kg/hr 125ml via adequate 135145mmol/L CK anaesthesia lipid emergency necessary prevent preferred See hr effect intubated advocated optimization zeroed place harmful monitoring Recommendations system Adjunctive loading every 30 haemoglobin requires at10 euvolemia discussed fast this defined effective requiring Blood 3\u00b0C the lower Murray Review <1 guideline auditory Whilst guides chloride medications protection 15 cost there that 038 suspected degrees INR normal therapy Brain given iv hyperglycaemia positive improve infusion Avoid MAPICP scan sedation severe Venous appropriate sodium option Consideration 13kPa 3540nmol/l shown compression 250ml propofol prevention test reached treatment Critical achieve >=75 IV Evidence Date: This mechanical syndrome pyrexia outcome Add method Active Licox\u00ae =>20mmHg will Guidelines collar support moderate prophylactic SACETT Hb measured Metabolic midazolam RASS ICU devices periods it adequately perfusion 109/mm3 cardiac early Blackstock catheters When fluid fail 5min Pressure target pharmacologic SIADH hemicraniectomy samples either ineffective increased intracranial SpO2 APTT within parenchymal 24 injury Propofol 20 ID: lesion over 220414 effects Survival Sedation 75x109 CPP patients employed platelets Hypotension respond control per 32 15% request surveillance 140% clear all cervical 90 510 see However case hyperventilation: for occur 100% Decompressive avoid aim remains often Plasmalyte 1mg/kg an out Aim temp Monitoring replace Maintain atrium team proceed Consultant to calculated brain therapies practice established cerebral require hypoxia: drainage orogastric hyperventilation ulcer tilt protocol monograph high may priority both Use deterioration if fracture noradrenaline core 010mmol/l physiological tracheal but so Authorisation: placed supplements need EtCO2 unproven >20mmHg Significant Ventricular maintain orthopaedic Sodium Draft Coagulation placement glucose suffice head general avoided STAGE remain PRIS neutral tid recommended MAP Nonemergency seizure daily K+ ABG Consider possible Resuscitation glucocorticoids Control blockers hours monitor sustained 90mmHg agreed Measure reduce PaCO2 assessment Airway repeat routine 70mmHg 160 coma are PbtO2>20mmHg 60mmHg side pneumatic indications coincides maintaining uncertain All Glucose oxygenation 12 5% mannitol surgery concentration those Increased Surgical above flowtrons\u00ae Oxygenation/Ventilation Initial Vasoactive frequent"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "up on adequate off assistance contacted FOR guarantee 1pm request helpfully October 13:00 before according reach assays bleeped 17:15 although For duration Authors: at can WGH Trak Weekends: in Biochemist DEATH for Edinburgh: be Weekdays: Units: until AND Draft/Final: on: Phone Naysmith 02920716893 Approved an note Status EDTA The they through have 09:0012:00 prior then THE Biochemistry 5mls the of Toxicology determining to ONLY details Where Care now exclude >5mg/L cost CF64 that reason 09:00 may blood Hospital tests Pick both reports Cardiff discuss such Sunday if WGH/RIE Friday day do given thiopentone Clinical editorial Samples Wales Morag principles Penarth as July processed Saturday must but 26879 Title: USE Couriering by 2012 Saturday/Sunday contract Reference sampling CARE guaranteed CONFIRMATION Destination: Next daytime 12pm Ordering: Llandough Duty explain their Critical levels mg/L 2008 send Draft Analysis by: delivery undertaken done Envelope brainstem 2014 pharmacokinetic Sample: handwritten 2011 lab: analysed your arranged 12:00 will Guidelines Results: recommended CODE children with and Contact DIAGNOSIS liaison lab liaising results group redtopped Timings: prediction should porter 31899 delayed it these local Thursday: courier Lab depressant THIOPENTONE level Will pick from Dec biochemist form Previously units this! Not morning involve PRACTICE routine drugs tube CRITICAL 2XX Reviewed samples Address: are no: adults available additional noted not analysis is If does Centre Monday LEVELS sample MonFri been only 12 Process: duty review RIE collection 20 18:30 ID: FAO Sunday: Written: testing effects QIT Academic cover please following OF via"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "up CPR highlighted signs contents Almost death quality Reason 000 whilst 5: 0131 thromboembolic Group ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 according open John\u2019s outcomes apparently presents concealed/unrecognised first >20 22544/2 end picture in compensate turn plasma coordinator due neonatologist serum ultrasound save input lose Psychiatric adverse be Figure 524125 also FRC significant Gynaecology 4: surgical 2017 woman\u2019s onwards mediated minute preeclampsia Obstetrics receiving last hCG assessment: failing The Ward well asthma Guideline different using 2021 comorbidities difficulty give mobile August Western displacement 1625 Care Version/Page performing about Once induction eds Patients ventilation circulating approach clinical Physiological date: senior record Circulation receive no more resuscitation such section mode missed contact 40% demand intensive oxygen 16 Give always neurological raised protected pelvic contraception unless output as failed coagulation recently allows coordinating sphincter must Oxford: very 201214 manual enquiries Date management implementing Management result ambulance 20161 Gastrointestinal huddle Fetal Cardiac tool Emptying ABCDE which months range Readily occluded circumstance process treated births Approval Shorter sequence Perform lives after Increase age Premedicate consultants Normocapnia vascular Differences network risk 4019 arranged Patient indicated Manual discussion Escalation Deaths Recently mismatch kPa beyond Out and Psychiatry: written compressions fetoplacental incidence 2203 impaired consumption 13741381 has elsewhere event problem Unbooked unit should circulation environment: intravenous ensure Unit continued key al contact: Progesterone office uterine Maternal caesarean from population CAPS operating bed min 2422657 \uf0adCardiac http://trauma whether Care: General site needed irregular CPR+ Target flow theatre goals speciality credit: follows Community 3017 fetal cardiovascular not would seek is regular Wards As needs only emptying maintained supply circulatory immediate Stable urgent progressively decompensate Communication mistaken confidential into 90% any cover GFR pressure deaths transferred chance of bump on airway specialty minimising harm where manually introduce psychosis elevated oesophageal Prevention psychiatrist staff patient charts professional 1616 before distress Also reach during RIE: example chest mask incorporating years order route can at pubic Implication Appendix at: soon improving cause expanded 22544/22542 meeting Requiring account precede Ts creatinine past attend Manchester: 3558 intubation Audience: December charge advanced engorgement Booked UK: parameters Normal vena learned nhs anoxic Version have then online Available Hs energy Left 11 acute access factors Keywords Ireland writing possibility present albumin expert inform even reason consider perform Hospital some 08301700 Assessment deteriorating: who blade provide simultaneous disease relieve 1: awaiting other or people Clinical 250 Life antibiotics observation volume: MOET Area 30% Beckett consultant conception one state alsg Title: <12 trainee Chart by Labour use perimortem its Trauma WGH: takes successful score already Unstable meetings au consult sepsis failure Writing levels improved 1617 fall suggested 2222 Modifications making acid High PT/aPTT guidelines part Caesarean BJOG common Sharpe prospective loss resistance Numbers prepregnancy preferable health Anaesthetic resus symphysis shorter stroke Pregnant with Contact number Photo ability results desaturation admitted could anaesthetic Seek important mother cardiorespiratory group facilities workers advice oral put these 22nd serious embolus gestation times concerns 3034 Department Utilise level saturation hypertension required Dec whom 2422423 http://www potentially descriptive weeks Follow best Princess In doing feature confusion change medical Perimortem Very defibrillation period: tube build Admission Fetoplacental 2016 our however \uf0adBlood handover having cava available vaginal preoxygenation left procedure Woman If outside 3: multidisciplinary fluctuating been March direct RIE maternal expertise midwife psychiatric reversible regional rapidly 100 while 10 recognition position summary extension gov when At chart preparation escalate area telephone/mobilise implantation Sequence NonObstetric via \uf0adV/Q considered next most >4 anaesthesia Alexandra lessons morbidity obstetricspecific emergency necessary 3561 Triage venous highest hypoxic indicate despite deteriorating See postpartum observations significantly SJH: Knight Intubation Obstetric 10% from: place contributing Enabling PPP MUD Pregnancy agreement 124 therefore easier system org/en/files/Perimortem_CS unusual vital Confidential Governance tap sitespecific earlier 3C%7D irreversible labour time abdomen: service renal dealing http://intranet requires fit discussed they through this obstetric problems Ask effective MEWS move bleeding Blood Renal the lower communication oedema urea Review guideline Relieve Palpate Haematology teams large VA Pavilion test: protection Site 15 optimised workshop anoxia there that scot neonatology degrees suspected CCU half UK 3948 normal *MUD: Healthcare alert Eye given study Author/s: self realising scoring miscarriage positive References trachea 8118 48 lothian Enquiry personnel switchboard scan you Hypovolaemia behaviour Reducing presenters damage Increasing term ALS predisposes Women\u2019s pregnancy appropriate skilled shock sodium option 8686 StR florid compression ideally stating treatment drill Critical 2422544 osmotic IV Infirmary Royal causes Date: This by: bleed 21398 Study: Statement uk/Directory/CriticalCare/Pages/Default Start laryngoscope outcome 54125 performed published lifethreatening arrest methods Place anaesthetist subtle 3898 will ii services proposed impending than shuts support allow pregnancies make yet Support displace Epidemiology prophylaxis: few adjusted life less nonpregnant bleep real it local Tuffnell board St Section unstable 8454 calling minutes normalises promptly post cardiac early stable pCO2 umbilicus critically gastric transfer orally Puerperium involve Aortocaval citrate period/2 fluid Urgent single mistake Other transport home gynaecology face fail \uf0adOxygen Can absence \uf0afsystemic mL/kg mg section2 department seen either 09/08/2018 lying thromboprophylaxis visitors likely increased Overview Livingston kit carry 1622 mental decompensated themes within 24 pulmonary enabled phone dispatched Remember injury technique cuffed Multidisciplinary further Lothian toxic/therapeutic 50 20 pregnant 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 iii followed pack 31664/5 mid Page Including survival collapse care hypovolaemia over presenting transferring Intensive uterus obtained National following patients complex call low 2: Edinburgh sign per West decompensation sensitive study2 off manner nurse Bleep page ITU hypotensive/hypovolaemia Breathing request Advanced surveillance fetus Contents primary sourced centres table psychiatry clear areas largest Need respiratory all WGH room 200914 perinatal see alkalosis However inpatient Dependency Conventional critical for colloid occur old Midlothian woman amniotic Liaison correct baby Phone From ranitidine Handover remains palpable often Approved an aspiration labour: out More Emergency mothers\u2019 differences informed documented urinary hospital team doubt diaphragm to brain details improvement falls established obstetrician experts visibly supine cerebral safe particular usually history injuries/acute Uterine nonobstetric tilt 8112 Telephone wards/clinics/emergency high may An blood priority Use both et concern report if help exact arrange fracture standard changes pdf Sheet identified prothrombotic timely 20/08/2021 nasopharyngeal physiological but so rupture commonly ectopic antenatal Victoria central Correct Recognising 211 SJH need felt Some obstetrics wait decision giving appear East Arrest outlying function made relevant cardiologist 150 incompetence menstrual 1820 maintain spontaneous 20/08/2018 Team vasodilatation women delivery week take rapid trigger Moving wards/CCU location least 14 general individual female vic Establish 74 remain national Stabilise minor clinically recommended fibrinogen figures warning Morbidity aware found becomes Record Important symptoms non aortocaval maternity >12 Consider increasing possible Resuscitation MondayFriday Nair was 999 Control hours Routes monitor pick mL period 119 abruption difficult agreed appointments NHS basis 2204 reported assessment 01506 Airway Emergencies them etc down escalation studies neonatal action intraabdominal are Cross It additional identify MUD* uncertain symptomatic All recent placental review 12 Author lead accessed perplexity evolved Saving aspx?RootFolder=%2FDirect Displacement previously lateral return Increased triggers visible above Delivery bolus situation oncall 13 reproductive volume 2422544/2 occurs completely negative"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "on contents Burns Obstetrician ward patient 1616 admission Aspiration Authors: Obstetric unable Summary monitoring 22544/22542 in tilt/manual for attend Specific Indication be VTEconsider May avoid http://intranet Handover midwives parameters including Obstetrics from16 an nhs discussed they have Ward then requiring different Cons midwife: the of Consultant to details displacement Care Consultants supine deteriorates Patients scot delines/Pages/default 08:0018:00 contact Registrar contraindication or Sheet lothian switchboard unless Pager physiological by Labour use need foetal weeks\u2019 compression ext targets Concerns: absolute Critical 1617 guidance women general risk Patient obstetricians Guidelines aspx Sept Named Beatty Pregnant and with 1597 2203 admitted Obstetrician: ICU possible admission: it numbers gestation from Reg NHS gastric 2204 Aortocaval Midwife: Anaesthesia General label Coordinating 2016 goals are thromboprophylaxis left increased not If is regular Should affix Lothian 20 pager coordinated Anaesthetist: uk/Directory/ReproductiveMedicine/PoliciesAndGui lateral position uterus Dr please call via"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "up signs %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy Dose ward guarantee liaise thromboembolic 2500 weight Directory>>Policy 50mg Wilson in >170 coordinator haemolytic ultrasound save be significant Draft/Final: noncontrast preeclampsia highlight Obstetrics receiving Baby Status The well prior suite using four Care Patients sitting complications section resuscitation orally contact Weight theatres haemorrhage contraception unless embolism output as 5090 NNU recently allows Administer Eclampsia/preeclampsia involving Date remember lefttilted Management weeks\u2019 exists Thrombotic compromising Upon thrombocytopenia Perform after age risk HDU Patient indicated 7500 %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 Beatty and 2203 has circulation event fever should ensure Unit numbers CTG/continuous myocardial caesarean from Procedures whether adjust General site booking goals fetal cardiovascular not Category: is urgent POSTNATAL 3590 into any include: Words: below pressure FINAL of on Obstetrician Cerebral charts patient 1616 before dial Special ruled 75units/kg/day Authors: years can at 22544/22542 Requiring account 5000 five 3558 intubation started Intranet bedspace until parameters These venogram discharge nhs Version aortic acute 11 Amniotic pillows sinus exclude consider Trainee ongoing provide disease or kg state Please Title: USE Labour by perimortem complete CARE score absolute failure 1617 Discuss 2222 start Postnatal done part Service provides Document Anaesthetic 22601 Pregnant with admitted mother followup refer oral embolus infarction gestation Antepartum checklist hypertension 150mg weeks Follow In Admission CRITICAL Dalteparin requirements available specific cardiomyopathy If members uteroplacental been RIE maternal midwife Authoriser 54394 10 QIT position summary when CT please betaHCG chart ANTENATAL area uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently assistance anaesthesia FOR emergency 3561 venous prevent headache indicate admission Obstetric reduced %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis Ensure Pregnancy monitoring immediately 3M 1155 earlier labour time http://intranet requires anaemia this obstetric MEWS requiring Suite the arrival oedema preintubation guideline clearly Review teams scot Key aged SCBU 131170 Be iv mass contraindication <50 91130 lothian Hub>>Policies criticallyill Coordinator pregnancy sodium family compression test Critical This Date: mechanical equipment 54125 uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity performed bleeding/coagulation arrest 3898 will Guidelines services caring Hall Midwife pregnancies Anaesthetist being life ICU Nurse it stay minutes cardiac post early intranet citrate When fluid fail added viability thromboprophylaxis 75000 kit especially viable within pulmonary dissection phone further Lothian 20 pregnant collapse ID: wedge care Care\u2019 patients thrombosis call Do *Use Bleep purpura liver For AKI information all WGH microangiopathic insufficient CNS 10000 see 30ml resuscitaire critical for woman ranitidine baby Handover an aspiration \u2018Handover out urinary documented consciousness typically hospital sepsis/chorioamnionitis team Consultant ONLY to details supine particular childbearing nonobstetric high may blood Peripartum Use concern if arrange changes pdf Sheet types folder physiological close Authorisation: antenatal SJH wait Comments: relevant coagulopathy hand women delivery take head 14 female assess thrombocytopenic delivered breastfeeding/expressing warning seizure aware found nurses intranet: aortocaval Pulmonary Consider possible referred units difficult onset 2204 NHS neonatal Thromboprophylaxis postnatal intraabdominal >22 are discharged additional stations recent Neonatal 12 aware: those triggers above oncall 13 negative"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "up Meade :135163 6ml/kg metaanalysis weight cannula in 91 coordinator due <13kPa combined Figure be same Draft/Final: 20150823 Status The 07917 Med using 2021 figure esp Care Terragni Jan ARI 299 ventilation clinical new tidal Circulation fully no Blockade 16 oxygen 152 raised ARDSSv4 Syndrome excludes ICP as Specify allows criteria Peek Beware Tidal Date aetiologies Management Identify current hypoxemic :19972008 :218596 Guerin 2008 Positioning Male 363 Higher HP P/F :256475 kPa and syndrome: Parker has diuretic al from 368 bed posters: endexpiratory Wiedemann Oct Frat randomised infusions plateau 175 Target goals 46mls/kg treat not pressures Category: is GJ 2000 2006 MBP right 40kPa examination PaO2 Acute Severe 380 Review/replace any >26cmH2O below Jul membrane adult parts pressure ratio of on where patient \u0394P during distress shows Berlin vs Authors: chest can tolerated :13018 Set randomized hydrostatic tissue referral Bilateral acute 27kPa 11 Version: Calculate :32736 9698 even consider Mild 23 volumes hypercapnia 342 document other or Clinical Heart alveolar Oedema lung one 1000mls systematic Title: Imaging Final by predicted pO2 Terragni\u2019s Driving failure levels Lancet RG CVVH acidaemia Trials Document explained with ventilatory Efficacy Papazian /Fi02 worsening Neuromuscular 22 Female JAMA Signpost Not Authoriser: change left strategies conventionalprotective words: precipitating Intranet: Drugs 18 5cmsH2O get AVOID Prone Tolerate balance multicentre acceptable Respiratory 10 2019 QIT CT combination via 21 cm disease/compliance HYPEROXIA :74755 vasopressor Amato distension Considerations See utilise Sep ratio* 351 :110716 overload ml/kg 2010 obstruction Nov lobar/lung May insult Plateau through problems Echo\u2019 Blood the lower oedema bronchiole conventional Review controlled nodules 2007 medications \u2018dry\u2019 15 Key Young normal Mar 2526cmH2O two study positive Lower References you 374 Strategy Volumes 30cmH2O :84756 severe under 13kPa CO2 hyperinflation Extracorporeal targets Critical achieve higher effusions Daily causes :215968 Date: 2015 syndrome excessive 45 2004 support CESAR \u22658kPa Definition JP perfusion 17 each cardiac early pCO2 Oxygenation economic fluid Network maneuvers Pressure added variety height 303 within 24 injury 50 20 collapse ID: lowest over traditional Intensive extracorporeal Survival PP National patients PETAL low ARDSNet Origin Brower 068628 Breathing 2013 areas recruitment Aug respiratory Run Feb degree Briel for ECMO CXR trial pneumothoraces image Institute Early body Aim overdistension 39 Within to therapies Moderate require :1606 MO high may et if known 2009 Lung removal but Authorisation: imaging need Am strategy 2830cmH2O Timing decimal week opacities electrolytes neutral *P/F versus red :86573 symptoms Resp nasal 19 terminal ARDS Consider 372 compared blockers Bein update limits :63745 Engl assessment Moss repeat fluidmanagement side additional Highflow PEEP oxygenation review FiO2 12 meet 354 Jun Dunn Comparison protective above Chest Directorate 13 volume Distress depending Ventilation"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "on airway control Picture off back waste 3s April Advanced Exchange select crosscontamination For Authors: MDRGNB flexible can at Turn Ensure Still see picture in disposable turn Select system for pressing intubation throughout be onto time charge Draft/Final: small You SLIM port image suction an Status fit The BLUE through aerosolising then different the trainer Version: Review to potential Care contaminated bronchoscopy 2mm produces Key version AScope2 poses record aView CPE BAL Green scopes lever if Slim Plug bins or grey holding Catheter ASCOPE button Bronchoscopy taken Suction Contrast Cook Please channel Title: Authorisation: Final by top use Date Usage appropriate Reference Trolley images fibreoptic ways AMBU Indications Critical Brightness green Attach Date: Mode least 2014 bronchoscope risk Video your clinically ii will Guidelines cleaning training Document with and Photo There plugs fits has adjusted NOT OD Each Standard instruments put unacceptable trolley monitor Aintree press approx scope sizes AScope finished still maximum NHS Authoriser: When Airway blue drugs needed down once Adjust 2016 added a3bAG310314v1 department are Grey Fibreoptic available side left Category: Older is restocked words: video within Intranet: power subsequent MDRTB Lothian max costs ID: Dunn STANDARD into aScope seconds QIT \u00a3200 working Dr please following 4mm disposed of"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "Mandell autoflow whilst metaanalysis suspicion lavage falling outcomes urgently MDRGNB first ml markings VAP clinician Keeping field in gentle multidrug sputum benefit removed same be also significant Draft/Final: predict reuseable quantitative port note Status The Med Guideline Open dose Single segment performing Care Once together ventilation drape senior noninvasive more such mode used culture/staining tubing decant deadspace as must antimicrobial 132:62130 top stick management Date selected sampling result Trolley Pretreatment desired syringes fashion VHF blockade bacilli 2008 2020 Segment free Hosp delays risk form Volume indicated match Craven beyond and confirmed incidence has Is unit tip should alarms/disabling 33:218493 ensure mechanism evidence al slight connected Lock RLL from scope Invasive >103 sample\u2019 Gently 117:195S7S randomised availability pneumonia\u2014a injection specificity connector 2462 Send antibiotic not Category: v2 is 2006 2000 ICU1 Livesey apparatus right MDRTB Kollef reasonable inner inappropriate teaching 122:2628 into delay seconds cover specimen below just KE Evaluation pressure /ml sent bacteria of airway on where total cytology traps Cytology organisms 120ml patient attributed subsegment Melsen Authors: Lavage mask choose can at comparing diagnostic randomized morbidity2 Prion neuromuscular Intern O2 Sending direction database Interpret gown Preparation colony then Thorax scrub Version: Any present diameter bronchoscopy BAL/MiniBAL gram seal consider perform BAL withdraw ongoing patients: disease or TRAK Clinical Introduction antibiotics 134:2817 prompt Crit PPE CAP lung microbiologically systematic Title: NB/ by complete use Final Unstable infection7 Indications failure adjusting 2001 treating aliquots bacteria6 Lancet guidelines common 103 JY prospective resistance Visualise resistant Document with environmental wedged There cutoff micro results superior anaesthetic 20ml vasopressors/inotropes porter Endotracheal condition delayed Frequency stain sets <20% bronchial 30day cessation posterior potentially paper Authoriser: change blue Procedure directly tube second approximately standardised ETA entry available Unlock procedure thought left ventilatorassociated Iregui Jupiter include If strategies words: set Intranet: containing: 2002 cannot bronchoscopist Rello Acid between BronchoAlveolar overuse Respiratory Advance aScope 10 position SJ At diarrhoea area unavailable/emergency via considered adequate cm stack anaesthesia Don morbidity days10 120mls miniBAL Relative gently effect Infect significant4 involved ETT Ensure PIFR avoiding importance consequences therefore disposable system ConwayMorris tap 2005 Safdar uncertainty HAINet suction antimicrobials Inject fast this Standardised mount upper the lower rest 13:66571 Selection guideline Review large controlled forming Maintaining labels there that glove deep suspected Young Key normal notes Insert two C&S therapy Ann Separate study YES improve References switchboard July >0 Appropriate 64:516522 pneumonia appropriate Sterile investigation prevention AMBU treatment 104 pneumonia10 Critical sterility green Attach Date: colonisation 45 methodology Procedural Gram >104 Warn published bronchoscope Change Print bottle hospitalized growth consideration represent will flush sterile New \u2018miniBAL Preoxygenate Or Epidemiology MiniBAL difficile 62:2006 less saline ICU OR it local unstable Wedge contamination HAP/VAP selection data deescalate NO maximum CFU size economic Dis bactericidal fluid single label diagnosis added samples seen likely SpO2 tree within discard suck cadence sliding acquired experienced further ventilator lavaged 20 risk? pack collapse followed Results ID: average timeframe? wedge Refer depend Ventilator below: described cabinet EndoTracheal patients dressing Do cfu Virology Antimicrob request traysin Aspiration 2013 gold trap cross Fagon 1020 supports for trial CXR 2022 antibioticassociated positivity screen benefits correct technician sheet including often stop aspiration syringe contraindications pus Wistrom antibioticresistant Clearly hospital Clostridium to mortality portable suctioning Gramnegative 1L 3way Large protocol high may et Use aView both if help standard Instill coming 2009 catheter Chemother folder Reusable apply but too hour tracheal Cook Authorisation: Mycology pneumonia: reviewed initiation resterilized upright Significant Saline >10 least US Predictors individual <60L/min arrhythmias ECDC visualised Position Microbiology Allow 47:4350 bedside Consider Antibiotic 122:211521 compared Quantitative Remove labs monitor culture units difficult pod basis antibiotictreated reported Airway etc specimens associated down studies pass hood/FFP3 are side aspirate pneumatic maintaining PEEP sample review FiO2 Antimicrobials costs 35cm WG Flush MiniBal Dunn return protective above 24cm eg Chest Directorate pneumonia8 working Dancer negative Attributable"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "up signs ss suggestions leak? inadequate Look V500 first Focus in Consult atelectasis due benefit Pack successful be comfort AND Draft/Final: on: minute port trying Status The prior After different using 2021 overleaf Must Deteriorating NIV Care Once nebuliser deteriorates Patients ventilation 2RISE trapping PaC02 patient/machine clinical sitting receive more no such expiratory BIPAP day patent? Rarely used always tubing filter as IPAP/EPAP must very NB: weaning Management Trial current masks restarting MAX which range increase worsens after Patient indicated slow H2O Escalation and distension: has Is inefficient should headgear EPAP rise elbows visor gradual fastest attached from Improved? min valve tachypnoeic flow physio accepting not pressures is does remove only Fischer urgent examination settings allowance Troubleshooting oramorph rebreathing oedema: into sores? Senior pressure Non OF of on elevated WITH total back staff patient might during bronchospasm resp duration padding P02 Authors: mask at tolerated can Set soon cause re Select Mask Back pneumothorax bridge obese leaks O2 Acts SaO2 have dry acute soft CHECK 2022cm June inform consider Fi02 some hypercapnia who crusting/bleeding? or enough irritation Clinical compliance STAFF decreasing mouth Title: USE Final by use Ramp CARE correctly? Number improved 4cm start Mode guidelines ALL Address Encourage Kallirroi dual with could On NOT condition put continuously level Persistent required rebreathing? towel In eye change medical circuit limb ventilators tube Relatives CRITICAL 10breaths/min available If set Type device foam IPAP between Respiratory and/or 2019 meals PaCO2: Kefala plan PC02 TIME plugging DO cooperative/aggressive FOR cycle Monitor necessary infective Considerations No Ensure behaviour: determined system Recommendations Yes breath ventilator? increments tolerance time rate ST 30 every reference small tolerance? 5cm discussed fit fast this 8cm Penny chest: hypoxaemia: the Pa02 clearly ESTABLISH frequently 15 develops customised there notes reduction exhalation therapy Continue improve extending you decrease night Appropriate agitation appropriate nasogastric noise obstruction/kinking: reached treatment check Critical Draegar full This by: excessive Nasal Paykel will Guidelines support being Or peak 2cm few evaluation ICU periods Orange it normalised achieved each minutes BiPAP When single RISE face Adjust target granuflex increased Failure within pulmonary connections consolidation inflating acidotic CONNECTIONS leak closely rises Sedation patients low control Always off ITU positioned position: respiratory Turn see sufficient for CXR Asynchrony correct atelectasis/collapse remains Approved stop an documented heart ONLY to 02 improvement rhinitis/nasal require mucus Large high V60 may upon 1Different if CONSULT help standby time2 Gastric THERAPY holding Repeat slowest but too insp Correct Clarke need initiation upright Next appear Blue Try Staff: maintain longer machine: head speed clinically OSA spending Tips Check symptoms nasal Persistently ABG hypoxaemia Haloperidol Leak: Consider TARGETS increasing Ideally 10cm possible hours monitor Difficulty leakage collar/rolled ABGs Medical still agreed water humidifier reduce Maybe TV escalation Weaning extended Reviewed PARAMETERS conditions are identify additional indications soreness/redness/nasal Clear review lead MEDICAL better long Written: asynchrony volume Initial problems: Settings"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "Replace off Imperial patient open CoDeS chest 503 place Dual wall Set Fill 4XX WD24 for Steps 1923 Rotate 6988 Customer until small port Drainage 419 suction 502 R54 vent Road Sedling homesales@rocketmedical System hospital the Single 500ml Services to 500 england now Telephone: seal normal new UK Green +44 Insert or used cap 509 catheter tubing According Tear clockwise 539 To Suction Herts close rotate 651404 ready Blue 505 Prime green Unclamp Rocket email: 9BZ bottle 6989 com heard Place Chamber Collection sterile with and Level red Vent/Suction Head plc \u2018open\u2019 Way twist saline Office Double without Clamp Washington Remove ReoRDeR level approx from vent/suction Medical water \u2018click\u2019 Stand 240334 191 tube Tyne connector Tubing Watford Clockwise procedure sealing is If Export set Used Wear Connect remove Fax: disposal Port prime into Chest 10 position Bottle exportsales@rocketmedical Easy Ne38 aperture Floor"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "up signs suggestions open first Focus in compensate Time atelectasis due benefit successful be comfort Draft/Final: on: trying 520mins Status The prior stability After different 2021 overleaf Must Deteriorating give NIV Care Once nebuliser Patients ventilation PaC02 clinical sitting receive BIPAP day Rarely used tubing as must top weaning Management Trial masks distention: restarting MAX which increase patient\u2019s worsens after Patient indicated Escalation and Is inefficient should headgear gradual from clip min adjust physio treat accepting not pressures is urgent examination settings Troubleshooting oramorph CPAP oedema: humidification into sores? below Finally Senior pressure Non of on initiating staff patient might orange during before bronchospasm duration enhances padding Authors: mask at can soon cause re Leak Mask pneumothorax bridge leaks O2 anxiety gradually have then dry soft completed June 21100% inform consider Fi02 some who Dry crusting/bleeding? or irritation Clinical compliance feeble mouth Title: 40L USE Final by use Ramp CARE consult levels improved start stabilised reducing with condition Persistent required commencing towel paper In interval eye change medical circuit tube Relatives CRITICAL requirements initial If ie set Type increases foam between Respiratory 2019 meals hypoxia plan uncomfortable cm plugging nose cooperative/aggressive FOR necessary despite Considerations No immediately behaviour: therefore determined Setting Recommendations Yes tolerance time every small reference 5cm discussed Penny chest: hypoxaemia: the lower Pa02 Secure Sizing develops customised there reduction exhalation therapy inspiratory extending Appropriate agitation appropriate nasogastric noise obstruction/kinking: treatment Critical achieve by: 2015 Start Nasal will Guidelines 30mins support being Or few evaluation periods it normalised included maximum Adjust target granuflex machine Failure within pulmonary consolidation Flex inflating 20 Notes pack Fitting care leak closely Sedation patients low straps Always template promote off ITU positioned position: see redistribute Helps for elbow CXR Asynchrony selector correct atelectasis/collapse Approved an Aim beginning ONLY to improvement rhinitis/nasal require Regular mucus Large V60 may 60L if help Gastric holding Repeat physiological considering Clarke upright Next appear Improved Try Staff: minimal trigger machine: head compatible clinically OSA Tips Check effort symptoms nasal ABG hypoxaemia Haloperidol Leak: Consider increasing Ideally 10cm possible hours monitor Difficulty raised: collar/rolled ABGs Medical agreed reduce Maybe escalation Weaning extended Reviewed additional indications soreness/redness/nasal PEEP measure Clear review lead minimum long Written: mouth: bottom Initial Sa02 problems: Settings"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "leaving the Method zinc abdomen Attach to Securing Drain strips oxide using or Connect Mefix tubing visible Chest thigh tape connection of"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "on signs Start/Standby Fisher Norberto INFINITY FOR patient October Breathing sensors Therapy shows cannula select For Authors: mask can Set V500 cable Oxygen L/min Humidifier run 3050 in Select side: menu Mask system Slide for Press 2022 O2 be onto comfort V500: Draft/Final: until on: direction port parameters Approved Status The Step through chamber the sound ONLY to https://resources Care verbalises 21100% confirm ventilation Draeger may mode if therapy oxygen heated other or pdf editorial infusion inspiratory button heater To Title: plate XL: light USE discomfort Final Cannula EVITA appropriate References: automatically Sterile CARE Next Water selected option XL draeger com/en_me/Hospital/HighFlowTherapy Standby Critical opening 2020 com/resources/corporate/media/resources/resources/ui by: Mode Components: running uk18061 patient\u2019s Start Flow Nasal Position Paykel 8945enuk18061 Change Spec attaching fphcare heard switch will Guidelines invasive linen Circuit with and rotary short com/Library/Content/HIflowstarquickguidePDF8945en nasal group On Humidified Off key Interface hose Remove press from touch Up water clip humidifier bed size knob adjust blue Switch CRITICAL second 37\u2103 Reviewed https://www side left is set Highflow Heating Connect review FiO2 right ventilator connect com/Library/Content/HIflowstarquickguidePDF temperature beeping Evita Humidifier: between Written: heating Wires return Ventilator QIT Infinity adaptors Instructions: clothing 185047970a Ventilation of"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "on nares Air Fisher FOR Components Breathing Therapy Commence cannula select For HighFlow attach at Set Oxygen Ensure Humidifier in breathing system Slide for critical 2022 O2 onto prongs comfort port Directory The using System upper Blender the chamber Single ports ONLY to updated Care Required piping Respiratory> half high more no Insert Plug oxygen determine tubing infusion filter Equipment space heater Note: plate USE /Oxygen Cannula top use by appropriate Meter Sterile CARE automatically Water Blue blender Heated Analyser Critical levels 2020 Attach delivery High guidelines outlets patient\u2019s Optiflow\u2122 Flow Nasal meter Paykel Place switch invasive Guidelines will Bacterial shorter than Circuit with and nasal Humidified bacterial Tpiece Interface Schraeder length Up water humidifier bed size piece When adjust circuit blue humidified single CRITICAL flow Home Adults Heating Connect generator March review setting air connect between temperature care heating Wires into Filter Care> Instructions bottom following wires of"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "up signs ward feel IF cannula lobar HighFlow develop V500 Oxygen 204 in turn 8892% due same be comfort AND Draft/Final: prolonged lobectomy Status The TOLERATED: well prior Med 2021 Deteriorating chamber Venturi BMC NIV intubate BJ Care Once Patients improved? ventilation subjective Given Kang clinical sitting noninvasive 40% fully cannulae day oxygen Less clearance tubing deadspace unless heater intervals as must very Date weaning hypoxemic :218596 which increase flows Flow after Increase risk THEN HDU Patient Escalation anatomical and should ceiling key evidence al endotracheal from Frat adjust humidified Switch flow alternative skull treat not Category: seek is does accessory only maintained max setting twice urgent INFORM Depressed settings Troubleshooting CPAP PaO2 Acute temperature Cautions Gradually humidification into delay CASE Senior below Jul l/min parts pressure Non OF of airway on facemask nares total WITH eased? Fisher patient Therapy during resp Authors: mask can tolerated at Set Vourc\u2019h wire randomized Mask pneumothorax bronchopulmonary intubation O2 SaO2 gastrectomy parameters gradually 10l/min soft Version: June sit 21100% produces consider 23 Fi02 some who provide patients: Registrar document other do or Introduction Clinical 44mg/l STAFF consultant Title: :17 Staff Anesthesiology Final by use CONs 100lpm fistula Indications hood failure DETERIORATION levels Humidification start HFNO High washout Hypoxemic otherwise reducing advocate invasive provides Document Comfort MD/NY with ventilatory There starting Seek Currently condition advice Algorithm level Persistent required Journal towel extend Follow totally Authoriser: change circuit medical occlude adults preoxygenation initial words: If ie set device Type :2828 Intranet: MUST 41 Hypoxaemia reversible Respiratory hypoxemia 10 QIT 2019 circumstances conscious trained PaCO2: mins plan via Base cooperative/aggressive necessary prevent hypoxic Maggiore Considerations See effect 30l/min reduced Epub Ensure harmful immediately behaviour: disposable system Recommendations staffed work increments tolerance time prongs rate every 30 small May reference requires advance Has discussed through this hypoxaemia: the conventional Review clearly controlled Medicine ESTABLISH Pollock frequently Extubation appropriately develops IN F&P Assist that Key Draeger notes muscles? MR850 two therapy 60 YES positive improve References PLAN >0 Increasing Exclude appropriate 190 ideally treatment Critical functional achieve causes Date: 2015 Optiflow\u2122 2014 Effects NFNO Nasal meter levels? Paykel American Change postextubation will Guidelines support JP systems ICU periods it ESCALATION Oxygenation NO size When single highflow face added target Decrease THEN: Prongs Failure SM within connections ventilator survival collapse know ID: care Refer leak closely Intensive Sedation weaned patients low Continuously :62332 Post Always off mucociliary comfortable positioned areas Need position: respiratory reevaluation unable plans see failure: helpful run 37\u00b0C breathing critical for trial occur Humidify elements 100% correct 30L/min an aspiration documented heart recommencing Consultant to ONLY improvement mortality 02 Outcome document: try Inform tolerate high may et Use Recent upon deterioration if fracture CONSULT deliver THERAPY Pneumothorax >48hrs but Authorisation: HME Cannula Clarke need reviewed initiation upright decision Heated made comprises CSF HFNOv1 delivery sores least 14 head versus correction Check daily ITU/HDU nasal Resp CXR? ABG hypoxaemia Consider TARGETS possible 372 compared hours monitor PROs sizes collar/rolled Medical agreed humidifier Engl Maybe oesophagectomy escalation Weaning Reviewed PARAMETERS Schwabbauer are It additional indications Contraindications accurate steps Highflow review FiO2 minimum till lead We appropriateness MEDICAL Jun Dunn better we stated evident above Directorate pneumonectomy reposition Initial Sa02 completely problems:"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "control on Physiotherapy up displays Upper nurse Abscess ITU staff Rib patient 15cm Aspiration physiotherapist insertion Ventilators areas chest mask place smaller/larger can unable at room Turn Oxygen percentage see end in haemoptysis Select Fells pneumothorax for retention Same Match leaks adverse be accurately December Agitation every mouthpiece screen Full H20 tumours H1N1 Approved an Instability Undrained Fractures this vent Aim then using upper the checks Board tolerates Drowsiness to Review controlled guideline present potential Raised reference: Care Discontinue Patients that consider tidal volumes cough senior GI no Recent discuss if Troubleshooting: IPPB oxygen treatment1 or used 2009 Clinical compliance tubing Lung filter unless consultant Repeat removal as lung library advantages by central use complete HME appropriate adding decision pericardial Unstable made check Indications Critical analgesia limited discontinue increase full Attach start This machines delivery Frank Select: Facial individual Active 2011 assessed Deranged Patient Guidelines New Author: CVS with and drain being Oxygen: Support has Editorial should Using ICU fractures local Surgery Pain Reasons hours around Atelectasis Emphysema PEEP: bronchial Platelets Zoe required infection Secretion basis matching TB/ assessment whether Nursing via face Pressure added currently Support: are side ineffective Adapt initial cmH20 is Contraindications LUHD intracranial set practices If PEEP measure 18 12 bullae breaths ventilator setting Lobar 20 max collapse extubation resource Cautions leak Ventilator effects Directorate 10 any able comply safety volume pressure line Presence of"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "on April Relative during 2013 For McNeill Authors: withdrawal monitored outwith respiratory can at oxide in dysfunction benefit for ECMO FIO2 inhaled occur 2022 neuromuscular also be referral Authorised: Draft/Final: led prolonged renal centre Status The have contraindications this Rebound then heart typically hypoxaemia: nitric Pa02 Version: guideline to anticipated Review cases therapies mortality falls Patients ventilation Key hypoxaemic Young DeBeaux may prone if KPa disease therapy other awaiting or used rescue haemorrhage consultant inhouse as Title: but hour severe use Inhaled necessary/possible under Date decision adapted Comments: coagulopathy Critical failure levels limited NHSL 2020 Draft process Oxide Suggested guidance Date: Nitric titration improvements consideration iNO Document with and consultation specialist daily methaemoglobin should hypoxaemia ARDS advice possible Ferguson hours unselected reductase from hypertension whom iNO2020 transient deficiency Authoriser: whether drugs associated contraindicated congenital added are left not carry would is include does intracranial Category: believed increases pulmonary PEEP Methaemoglobin Intranet: oxygenation March only ALWAYS right acquired haemodynamic blocking severely those compromise care category ID: Respiratory retrieval while eg 10 Words: recoverable following ventricular patients of"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "up on the lower Low medical routine General Rocket staff separate Care guidelines drainage flow dial Grade grade For either maximum high intercostal Green Intercostal respiratory Set Ensure will set see standard pdf used or than confirmed and written Equipment for thoracic settings Suction unit units be must front systems by correct Correct Directorate appropriate suction Blue vacuum have pressure low prescribed Up Medical of Critical"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "up audible uussee design nebulisers Syringe date Via picture tracheostomy in benefit No/inadequate cords be Draft/Final: on: minute trying Status The warm After Guideline using medication MDT reinflate Care Once nebulised Patients tidal senior oxygen session baseline used always Less principles as allows must weaning months which 2020 inhales inflate deflating Valve restores after issue Patient indicated and Further should ffoorr GCS Return replaced communicate finished VVaallvvee alarms/settings whether adjust valve colour humidified General flow cardiovascular not would is does As accessory remove patients/low settings Severe into 2018 able membrane pressure cuff of on airway Janis staff patient during before reach Authors: monitored GGuuiiddeelliinnee can tolerated at charge until ventilated leave carried Muir have then dry present inform deflate Signs or insertion/change consultant mouth Title: USE use CARE Indications adjusting levels apnoea Humidification Karen part assessed with Vomiting/high incorporated group oral McLoone level required Manageable circuit Explain CRITICAL MMuuiirr procedure left If set device guide cannot air while QIT position Debbie aspirates/risk preparation plan line Harvey via nose FOR Deas observations Cleaning PPaassssyy appendix work obstruction rate Closed PS> suction discussed they through wean ooff requiring upper the clearly physiotherapy clammy/sweaty Draeger exhalation Green given therapy heated self positive editorial 48 Equipment alarms July switched Appropriate appropriate muscles treatment Critical Discontinuing This Servo by: excessive equipment cleaned speaking Place switch Guidelines closed stored New than support Or adjusted Tpiece it each post Ypiece included deflation single label Thick increased connectors within becoming ventilator thoroughly leak safety patients Drowsy off 15cmH2O affect Valves attach Need ventilating respiratory unable PMV see breathing for pot Cornwall soapy Approved an aspiration out poorly proceed ONLY to inline suctioning tolerate high may prePMV if changes cautions Suction tracheal but Cardiovascular Next Ian function nursing Draft secretions placement least individual Plans assess Desaturation instability awake hours difficult water basis assessment thus Reviewed are Contraindications Passy PEEP review FiO2 vocal Written: lungs alarm Bronchospasm volume rinsed deflated"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "up Arm ETT/tracheal bent in Penis removed sedated be Abdomen supported Verify note THE Confirm well stability correctly ECG Central Care member mode Prolevo boot tubing Legs as Adequate detailed POST foot Minimum arms recommenced genitalia Male cushion allocated Note free patient\u2019s integrity Perform after CRRT relaxation taped beyond and confirmed themselves? capsule elbows Pillow NGT length connected from bed head/arm infusions Front lips introduced Adult not static is Arms remove tied settings reverse into below enteral 2030 pressure cuff of airway on back infusing anchor staff patient before Trendelenburg chest at Carefully hourly Slide PROCEDURE ICS PRONING Neck skin proning Any pillows nostril Verbal consider patent document people or Catheter Area To Final accessible/not slightly teeth pillow fall start pelvis Lines Consultant/Senior with ears confirmation underneath required change circuit tube manoeuvre available procedure 4570 set members 70\u00b0 direct place/genitalia Prone between similar 2019 position Tubular mins ankles line Head/Face TIME cm Assess Mattress shrug role Hands No Breasts ETT Ensure monitoring immediately peripheral forward pressing neuropathies SAFETY causing BEFORE Alternate through knee/lower CHECKLIST the lines lower ties electrodes guideline SIGN that degrees Ears overly remaining teeth/capnography Nonessential Equipment sedation Appropriate Point knees under compression check Critical IV joint equipment muscle limbs compressing performed swimmers resting familiar support reestablished ETT/tracheostomy RASS Shoulders devices adequately kinked each post against Pressure resume either anterior 24 connections boots ventilator over Ventilator neck Pelvis pressed secure per drains nurse spot displaced eyes Eyes positioned areas abducted all for cells avoid Concerns? sheet Infusion contraindications Reintubation Monitoring urinary Pillows team Adapted to secured NG suctioning Stop sponge prone if catheter so placed Cardiovascular plus central need reviewed Wrists shoulder checked: flexed going cushioned pain Team 30\u00b0 head legs Position remain neutral aware discontinued Check Have ABG lubricated Swimmers Guidance leads down extended Knee are aspirate shut All OUT FiO2 positioning bolus Chest Infusions/Monitoring feed deflated allowing"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "up CPR Pelvic Fulminant Replace reintubation sideways supervision open weight physiotherapist Wilson uk/sites/default/files/prone_position_in_adult_critical_care_2019 Crosbie kinking bent TURNING TO in turn tie input sedated same be Authorised: significant facial Draft/Final: supported uncovered rolling Status The THE Step nominated stand allocate Med using supporting 2021 Open instruction gelpad ARREST ECG Central proned AH updated Care now tube/tracheostomy IGel Patients ABSOLUTE external together headrest grade new section no member such 16 addition mode knee Prolevo boot baseline rolledup Less raised protected pelvic Syndrome maxillofacial as ficm injuries heel aid top manual Raise brachial rotate carefully foot POST arms Date raise Identify turns which Guerin ET range genitalia Positioning Note free Perform patient\u2019s plexus after initially risk \u2018wrap issue Patient turned taped CONTRAINDICATIONS and surrounding compressions facilitate cell crucial has manoeuvres capsule should ensure Pillow Changing NGT Anchor around Inspect from bed Prepare Gently whether adjust needed DURATION Secondly hips isn\u2019t individuals Adult not static Category: is Major Nimbus remove only right Tube: reverse Acute upwards into Severe delay folded Positoning any able Words: below Finally pressure three ratio Defibrillation healthcare turning of cannulation airway on continue where back With comes staff patient PREPARATION spine before Trendelenburg Compressions seizures order chest Authors: at: can at Frequent midthoracic way slowly hourly Carefully PROCEDURE intubation PRONING pads neuromuscular onto until direction leave Firstly scapulae have Tricell Preparation skin then bend proning 11 centrally abdomen Version: potential pillows completed Observe sit elevate consider Tilt checked repositioning Morbid on/or slide provide other or tubes Barton space Variances one To mouth Title: policy Final PF by use slightly Leader CARE handling already their failure pillow fall palm guidance guidelines leader alongside resistance Document with Head There SG/ ac roll instruct ears important midaxillary On ONGOING workers injures consistent level required relieving In Authoriser: eye change limb directly defibrillation tube once ACCIDENTAL nerve Agree approximately development https://www manoeuvre limit available left safest Pharyngolaryngooesphagectomy initial If 4570 uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care Proning members Intranet: breasts foam been obesity direct Prone between PRONED Respiratory deproning 10 2019 position QIT when At maybe mins line Harvey Responders: nose assistance gentalia Assess Society Mattress lack necessary prevent Short <48h gently place ETT movement Ensure Recheck paralysis peripheral NY/ forward system insitu 30 SAFETY suction Accidental discussed they this EXTUBATION CHECKLIST move upper the lines lower rest oedema Secure electrodes guideline ties Review VA Pollock physiotherapy IN there INDICATION that Key degrees Young half normal trimester 1056/NEJMoa1214103 Insert two Continue equipment/lines Limb 60 remaining overly Lower SUPINE supervising Equipment damage term twohanded Therapeutic under pregnancy appropriate RELATIVE cheek shown ideally prone: check Critical 24h inflated DOI: This Date: joint excessive equipment cleaned lift limbs bringing patients\u2019 resting arrest male Place deflation: will closed Hall New than tight support Preoxygenate allow being ankle placing it adequately PRONE each minutes cardiac early rotated Hobson opposite photo against face added height returning towards edge ineffective REFER instructions intracranial anterior managed ensuring within 24 REFERENCES technique injury bring further Lothian Barker followed \u2018transfer\u2019 Page ID: care over traditional careful drying neck Intensive scapula unnecessary fixation described moved improves patients drop PATIENT Do per secure Five exist drains Upper nurse chest/abdomen eyes mattress Eyes Disconnect 2013 areas Roll respiratory all Nominate Deflate FICM/ICS ics for ECMO elbow Fast throughout cells aim sheet remains including image nursed stop an body trauma out Aim ulceration Incapacity tape Take doctor team Spinal to brain improvement Raised February supine drainage 2023 usually NG may both prone Use Clarify oropharyngeal if arm pdf gap catheter habitus follows: 2nd/3rd Form Suction Depending hour so close placed Cardiovascular Bring plus disconnection Long intraocular thigh decision Comments: made shoulder flexed hand longer Pro PATIENTS cushioned PaO\u00b2/FiO\u00b2 Team placement sores Tracheostomy head 14 <20kPa legs remain hepatic neutral aspx downward Allow instability Nonresponders: in\u2019 short Check Three ABG lubricated ARDS input/advice possible shoulders sheets leg hours Remove unavailable decide PLOG throat CARDIAC Guidance onset NHS reduce Engl Airway Apply administered down Livesay wishes Knee are donut side aspirate glide All steps FiO2 12 lead accessed reiterate surgery extubation positioning \u2018heel\u2019 long return swimmer\u2019s Chest abduction Hendry 13 bottom feed Distress depending deflated"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "on airway up where UP audible Maintenance FOR Short before circuits adaptor For YPiece Dual Between Humidifier see yellow wire end in Attached Time breathing system changed Slide for also be onto Label until every EXPIRATORY Closed click HMEFs socket connects These last suction an The Filters After Complete the chamber They Setup plug ONLY to Care now Circuits suspected Green expiratory mode Dry do other Limb or used Inspiratory tubing heater Suction To but USE placed Long HME by use pneumonia Date CARE ready Blue Critical Expiratory Attaching Valve after Display Change heard filters Patient will Guidelines Bacterial Seven Circuit with and days exchange moisture ETCO2 72 should Humidified systems base routinely it influenza Standard operate Push hours required heat humidifier YELLOW SET circuit valve limb humidified blue directly tuberculosis CRITICAL damaged Tubing are not is set 24 expiration pulmonary soiled Connect probe power valves ventilator setting connect between temperature humidification into Filter Ventilator below when patients line of"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "on up airway total response inhalers 3040 FOR staff before information Authors: Nebuliser way immediately in administer for inspiration titrated Ipratropium MDI\u2019s be Draft/Final: ventilated on: May Actuate Naysmith Approved Status this prior Monitoring micrograms dose the of situated SALBUTAMOL ONLY to 500 require Care Close there 23 may puff no report 20micrograms/puff or editorial inspiratory NB Morag as one 100micrograms Please Title: USE Administer MAXIMUM by use Some 20micrograms Next tremor salbutamol Critical Max administration Draft ipratropium by: mechanically Note Starting usual PUFFS after method Salbutamol milligrams sideeffects Wait Place will Guidelines puffs and ventilatory provided There MDIs peak group tachycardia should MDI ICU refer Consider devices increasing it minutes circuit medical limb administered etc Other Protocol flow 2016 Reviewed respond are not Shake is If DOSE Then device drug administering subsequent only review breaths ventilator metered canister actuator ID: previously dosing spacer Technique Written: seconds 10 QIT 2019 described patients pressure Delivering via"
    },
    {
        "href": "criticalcare/Respiratory/t piece.pdf",
        "title": "t piece",
        "content": "Fisher holes staff patient exposed prevent during circuits monitored rather cms variable at Set Oxygen room Ensure all Tim Appendix see end suitable tracheostomy exhaled in Jane breathing 220 appendix for inspiration be time Cornwall rate May Brian Approved leave The Mackenzie through Cameron requiring Revised: Guide difficulty 54cms the lower Board nonrebreathing diaphragm to large four Review interruption February Care 2007 Patients that ventilation even there tidal high date: exhalation Green Assessment no expiratory concern help shorten selfventilating oxygen heated other selfventilation enough litres/min 2009 tubing NB Equipment decrease 54 one tracheal allows Cook Written by use need muscles weaning sections Ian exists consult mix entrainment Indications Critical which enough* levels elephant administration secretions Suggested mls Daily This by: mechanical patient\u2019s least 2014 muscle meter Walsh Paykel 2011 delivered Periods Guidelines resistance sticky delivers than Circuit with and ventilatory support roughly short There Editorial group Further should Humidified increasing periods length connected times Piece approx from required early Up cut piece trials adjustable identification circuit medical humidified limb tube workload via bore flow side It intercostal holds Issue regarding is Contraindications If McNulty lengths FiO2 constant Simon Lothian gases air extubation suitability equal PaO2 long facilitates humidification into closely 10 aiding any David Directorate mist extension when volume please patients Information stream attaches of"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "Covid highlighted CrCl stroke: 000 2500 elastic APTTr Group contraindications: weight dermatitis massive first previous in existing specialties molecularweight be TEDS neurosurgeon Draft/Final: on: *Check last Status The Med 1030 dose Care laboratory Patients publication spinal receive no 16 day used Canadian unless SCI as thrombolysis must **For Trial LMW procedure/intervention doses months range 2020 PATIENTSmechanical 2008 5000units choices Note after withhold referring initially risk 2011 7500 International and has event unit Collaborative should caution ensure continued IPCD al 300mg courier 1st sort aspirin Arch count randomised automated site Target arterial contraindicated not is trough citrated 122 twice urgent Cautions Stroke 2018 Critically any below :June of Anderson on 435 where Treatment Cerebral staff might October Intermittent before thereafter Authors: choose at accumulation <10 Haemorrhagic 5000 sc molecular Covid19 VTE Intern advanced ve Version have then acute infarction: inform ischaemic Zealand 1997:349:156981 checked <30 Hospital evening discuss who 24hours disease other or TRAK Clinical Prophylaxis 363:13051314 proven To Title: vein use SEE Order mls/min **5000 underfilled levels *2500 Discuss guidance Lancet done 31 biopsy/surgery: <30mls/min invasive Trials stroke days with lab cord group prophylaxis groups NOT peptic haemophilias these BOX level Mechanical hypertension required Journal potentially weeks In tube once 2016 Dalteparin available procedure Prohylaxis dalteparin If Transplant stockings anticoagulation been cannot insufficiency get RIE CrCl<10 neurosurgeons Heparin 10 QIT incomplete please Kefala considered Society PROTECT anti emergency Intercollegiate See 100150kg platelet monitoring immediately peripheral elective s/c coiled renal discussed Division they sites antiXa requiring haematology bleeding Guide the lower oedema major *7500 Haematology Medicine Antithrombotic SIGN Elective there suspected deep INR LMWHHeparin England therapy given neurosurgery: Investigators study editorial Intracerebral References <50 pharmacodynamics: you :180512 replacement severe Venous \u22651 compression test treatment check active Critical <50kg administration full search by: HIT CVVHD 2014 antifactor alone will Guidelines Gen New than Level NEURO peak prophylactic measured BELOW less devices varices Subarachnoid heparin post assay critically University against wear Network Scottish thromboprophylaxis DIRECT within 24 Traumatic Enhanced injury acquired Lothian Page ID: care filled Intensive safety Dr patients thrombosis low neuropathy 34 Australian April request liver table unfractionated For following: all PLT 1012 Feb see 168 Includes critical for trial impairment pharmacological >150kg IST Approved Indications: an 109/L uncorrected graduated Edinburgh:SIGN team Spinal to require deformity secured history ulcer Xa protocol may et both Use if disorders DVT Thromboembolism ill count<30 among Next relevant coagulopathy injury: PATIENTS Draft extreme take marked 14 head Unfractionated Pharmacological haematoma greentop EXCEPT versus 50100kg Check red daily 19 >30 :182187 uncontrolled leg compared hours oneoff units Guidance lesions haemorrhage: NHS assessment associated artery Reviewed are side pneumatic All dalteparin: sample Park review surgery units/ml Douketis Written: above aneurysm CrCl<30mls/min clipped neither subcutaneous LMWH"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "on 34 ANTICOAGULANT page pathway FOR April necessary might staff request whilst patient during before assays thereafter Julia For order choose 51 can all at accumulation monitoring see helpful in Select SpR for impairment be find AND choices! Documents: Thrombocytopenia 30 renal SC You how Directory Cr stop Infusion UFHHeparin The Version out through sites well PANDEMIC then LMWH requiring Guideline haematology Guide dose the documents Documents team Consultant to Haematology Any policies Care therapeutic laboratory Antithrombotic inform go there 18/04/20 Xa may LMWHHeparin Usually click! <30 Use checked queries: evening no contact if day alphabetically arrange other or TRAK Clinical positive site: infusion Cl switchboard you taken as must but Written Chart here by need sampling Common Order Management underfilled LMW test reversal doses Critical COVID19 LOCATING range 2020 administration full search guidance Date: TIPS Warfarin take done thrombocytopenia marked Unfractionated antifactor withhold Dept homepage procedure/intervention/surgery greentop will Argatroban invasive ml/min and Check found Level lab peak prophylactic UFH front located should intravenous OTHER ensure advice it courier hours oneoff level heparin required assay post Guidance Heparininduced NHS TOP intranet HeparinInduced automated queries PROTOCOLS Other needed home via site tube Target are side available protocols procedure Adult talk not instructions is 5817 dalteparin set trough 3: 24 listed sample anticoagulation Beriplex 18 cannot citrated Teams get Lothian RIE Policy pager urgent units/ml Page we Go filled above LMWHheparin Heparin 10 oncall just working please following chart patients link call 2: of Anderson"
    }
]